Another	O
key	O
factor	O
may	O
be	O
the	O
use	O
of	O
any	O
prenatal	O
,	O
prescription	O
medication	O
[	O
4	O
–	O
6	O
].	O

Maternal	O
25	O
(	O
OH	O
)	O
D	O
throughout	O
pregnancy	O
was	O
calculated	O
using	O
the	O
area	O
under	O
the	O
curve	O
of	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
values	O
from	O
pregnancy	O
visits	O
3	O
–	O
7	O
.	O

As	O
was	O
recently	O
pointed	O
out	O
in	O
a	O
Cochrane	O
review	O
,	O
the	O
topic	O
of	O
maternal	O
vitamin	O
D	O
requirements	O
during	O
pregnancy	O
has	O
been	O
poorly	O
studied	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
25	O
(	O
OH	O
)	O
D	O
,	O
Calcium	O
,	O
Albumin	O
,	O
and	O
PTH	O
status	O
by	O
S	O
-	O
ECC	O
and	O
caries	O
-	O
free	O
groupVariableOverall	O
valueCaries	O
statusP	O
valueS	O
-	O
ECCCaries	O
-	O
FreeN	O
(%)	O
95	O
%	O
CIN	O
(%)	O
95	O
%	O
CI25	O
(	O
OH	O
)	O
D	O
status	O
Mean	O
(	O
nmol	O
/	O
L	O
)†	O
75	O
.	O
4	O
±	O
30	O
.	O
268	O
.	O
9	O
±	O
27	O
.	O
9	O
/	O
82	O
.	O
9	O
±	O
31	O
.	O
1	O
/	O
<	O
0	O
.	O
001Optimal	O
*	O
(≥	O
75	O
nmol	O
/	O
L	O
)	O
Yes12556	O
(	O
44	O
.	O
8	O
)	O
36	O
.	O
1	O
,	O
53	O
.	O
569	O
(	O
55	O
.	O
2	O
)	O
46	O
.	O
0	O
,	O
64	O
.	O
00	O
.	O
006No13684	O
(	O
61	O
.	O
8	O
)	O
53	O
.	O
6	O
,	O
69	O
.	O
952	O
(	O
38	O
.	O
2	O
)	O
30	O
.	O
1	O
,	O
46	O
.	O
4	O
Adequate	O
*	O
(≥	O
50	O
nmol	O
/	O
L	O
)	O
Yes218111	O
(	O
50	O
.	O
9	O
)	O
44	O
.	O
3	O
,	O
57	O
.	O
6107	O
(	O
49	O
.	O
1	O
)	O
42	O
.	O
4	O
,	O
55	O
.	O
70	O
.	O
05No4329	O
(	O
67	O
.	O
4	O
)	O
53	O
.	O
4	O
,	O
81	O
.	O
414	O
(	O
32	O
.	O
6	O
)	O
18	O
.	O
6	O
,	O
46	O
.	O
6	O
Deficient	O
*	O
(<	O
35	O
nmol	O
/	O
L	O
)	O
Yes1612	O
(	O
75	O
.	O
0	O
)	O
53	O
.	O
8	O
,	O
96	O
.	O
24	O
(	O
25	O
.	O
0	O
)	O
3	O
.	O
8	O
,	O
46	O
.	O
20	O
.	O
12aNo245128	O
(	O
52	O
.	O
2	O
)	O
46	O
.	O
0	O
,	O
58	O
.	O
5117	O
(	O
47	O
.	O
8	O
)	O
41	O
.	O
5	O
,	O
54	O
.	O
0	O
Calcium	O
status	O
Mean	O
(	O
mmol	O
/	O
L	O
)†	O
2	O
.	O
3	O
±	O
0	O
.	O
12	O
.	O
2	O
±	O
0	O
.	O
1	O
/	O
2	O
.	O
4	O
±	O
0	O
.	O
1	O
/<	O
0	O
.	O
001Low	O
calcium	O
*	O
Yes1010	O
(	O
100	O
.	O
0	O
)	O
100	O
,	O
1000	O
(	O
0	O
.	O
0	O
)	O
0	O
,	O
00	O
.	O
002aNo248130	O
(	O
52	O
.	O
4	O
)	O
46	O
.	O
2	O
,	O
58	O
.	O
6118	O
(	O
47	O
.	O
6	O
)	O
41	O
.	O
4	O
,	O
53	O
.	O
8	O
Low	O
calcium	O
(	O
Corrected	O
)*	O
Yes66	O
(	O
100	O
)	O
100	O
,	O
1000	O
(	O
0	O
.	O
0	O
)	O
0	O
,	O
0	O
No252134	O
(	O
53	O
.	O
2	O
)	O
47	O
.	O
0	O
,	O
59	O
.	O
3118	O
(	O
46	O
.	O
8	O
)	O
41	O
.	O
0	O
,	O
53	O
.	O
00	O
.	O
03aPTH	O
status	O
Mean	O
(	O
ng	O
/	O
L	O
)†	O
47	O
.	O
3	O
±	O
22	O
.	O
059	O
.	O
1	O
±	O
21	O
.	O
8	O
/	O
32	O
.	O
9	O
±	O
10	O
.	O
8	O
/<	O
0	O
.	O
001Elevated	O
PTH	O
*	O
Yes9285	O
(	O
92	O
.	O
4	O
)	O
87	O
.	O
0	O
,	O
97	O
.	O
87	O
(	O
7	O
.	O
6	O
)	O
2	O
.	O
2	O
,	O
13	O
.	O
0	O
<	O
0	O
.	O
001No16255	O
(	O
34	O
.	O
0	O
)	O
26	O
.	O
7	O
,	O
41	O
.	O
2107	O
(	O
66	O
.	O
0	O
)	O
58	O
.	O
7	O
,	O
73	O
.	O
3	O
Albumin	O
status	O
Mean	O
(	O
g	O
/	O
L	O
)†	O
38	O
.	O
4	O
±	O
3	O
.	O
736	O
.	O
8	O
±	O
3	O
.	O
1	O
/	O
40	O
.	O
3	O
±	O
3	O
.	O
5	O
/<	O
0	O
.	O
001Low	O
albumin	O
*	O
Yes3326	O
(	O
78	O
.	O
8	O
)	O
64	O
.	O
8	O
,	O
92	O
.	O
77	O
(	O
21	O
.	O
2	O
)	O
7	O
.	O
3	O
,	O
35	O
.	O
20	O
.	O
002No225114	O
(	O
50	O
.	O
7	O
)	O
44	O
.	O
1	O
,	O
57	O
.	O
2111	O
(	O
49	O
.	O
3	O
)	O
43	O
.	O
0	O
,	O
56	O
.	O
0	O
S	O
-	O
ECC	O
=	O
Severe	O
Early	O
Childhood	O
Caries	O
.	O

The	O
distinction	O
is	O
important	O
because	O
adjustment	O
for	O
covariates	O
along	O
the	O
causal	O
pathway	O
may	O
spuriously	O
attenuate	O
estimates	O
of	O
association	O
.	O

†	O
t	O
-	O
test	O
,	O
*	O
chi	O
-	O
square	O
,	O
aFisher	O
’	O
s	O
Exact	O
Test	O
.	O

Formula	O
-	O
fed	O
infants	O
typically	O
consume	O
300	O
-	O
500	O
IU	O
/	O
day	O
from	O
their	O
formula	O
and	O
therefore	O
generally	O
meet	O
the	O
current	O
recommendations	O
without	O
an	O
additional	O
oral	O
supplement	O
of	O
vitamin	O
D	O
drops	O
especially	O
after	O
the	O
first	O
6	O
to	O
8	O
weeks	O
of	O
life	O
.	O

Glucose	O
intolerance	O
and	O
gestational	O
diabetes	O
risk	O
in	O
relation	O
to	O
sleep	O
duration	O
and	O
snoring	O
during	O
pregnancy	O
:	O
a	O
pilot	O
study	O
Abstract	O
Background	O
Insufficient	O
sleep	O
and	O
poor	O
sleep	O
quality	O
,	O
considered	O
endemic	O
in	O
modern	O
society	O
,	O
are	O
associated	O
with	O
obesity	O
,	O
impaired	O
glucose	O
tolerance	O
and	O
diabetes	O
.	O

This	O
experiment	O
would	O
provide	O
a	O
better	O
insight	O
into	O
the	O
regulation	O
of	O
GAS5	O
by	O
cortisol	O
.	O

Conversely	O
,	O
vitamin	O
D	O
deficiency	O
results	O
in	O
proximal	O
muscle	O
weakness	O
and	O
decreased	O
lower	O
extremity	O
muscle	O
function	O
perhaps	O
contributing	O
to	O
the	O
risk	O
for	O
cesarean	O
section	O
.	O

RMMCH	O
is	O
a	O
provincial	O
hospital	O
focusing	O
on	O
maternal	O
and	O
paediatric	O
healthcare	O
,	O
delivering	O
more	O
than	O
10	O
,	O
000	O
babies	O
annually	O
.	O

For	O
patients	O
who	O
were	O
already	O
on	O
immunotherapy	O
before	O
the	O
pregnancy	O
,	O
maintenance	O
treatment	O
may	O
be	O
continued	O
safely	O
during	O
pregnancy	O
.	O

These	O
conditions	O
were	O
maintained	O
for	O
six	O
weeks	O
prior	O
to	O
mating	O
and	O
throughout	O
gestation	O
.	O

The	O
authors	O
suggested	O
that	O
feeding	O
concentrate	O
plus	O
roughage	O
or	O
starch	O
after	O
early	O
weaning	O
at	O
a	O
young	O
age	O
could	O
alter	O
adipogenic	O
and	O
lipogenic	O
potential	O
in	O
loin	O
meat	O
.	O

At	O
the	O
verge	O
of	O
the	O
21st	O
century	O
,	O
rickets	O
was	O
sporadically	O
observed	O
in	O
Europe	O
.	O

)	O
52	O
.	O
50	O
±	O
14	O
.	O
25HF	O
(	O
n	O
.	O
u	O
.	O

Few	O
in	O
vivo	O
studies	O
have	O
been	O
performed	O
on	O
the	O
effect	O
of	O
vitamin	O
D	O
on	O
beef	O
marbling	O
.	O

Results	O
We	O
evaluated	O
pregnant	O
women	O
aged	O
20	O
to	O
46	O
yrs	O
.	O

The	O
authors	O
noted	O
that	O
the	O
ART	O
and	O
smoking	O
cessation	O
studies	O
exhibited	O
no	O
evidence	O
of	O
bias	O
and	O
had	O
significant	O
effects	O
on	O
reduced	O
viral	O
load	O
(	O
ART	O
)	O
and	O
biochemically	O
validated	O
smoking	O
cessation	O
[	O
11	O
].	O

The	O
United	O
Nations	O
and	O
other	O
multilateral	O
organistions	O
:	O
Invest	O
•	O
Support	O
countries	O
develop	O
and	O
align	O
their	O
national	O
health	O
plans	O
,	O
including	O
costing	O
and	O
tracking	O
implementation	O
to	O
achieve	O
the	O
health	O
MDGs	O
and	O
preterm	O
birth	O
mortality	O
-	O
reduction	O
targets	O
.	O

Disclaimer	O
The	O
findings	O
and	O
conclusions	O
in	O
this	O
publication	O
are	O
those	O
of	O
the	O
authors	O
and	O
do	O
not	O
necessarily	O
represent	O
the	O
views	O
of	O
the	O
Centers	O
for	O
Disease	O
Control	O
and	O
Prevention	O
and	O
the	O
Pan	O
American	O
Health	O
Organization	O
(	O
PAHO	O
).	O

Our	O
objective	O
,	O
in	O
a	O
randomized	O
controlled	O
trial	O
in	O
rural	O
Bangladesh	O
,	O
was	O
to	O
investigate	O
the	O
impact	O
of	O
this	O
intervention	O
on	O
the	O
handwashing	O
behavior	O
of	O
mothers	O
in	O
the	O
neonatal	O
period	O
.	O

linear	O
mixed	O
effects	O
models	O
),	O
adjusting	O
for	O
potential	O
time	O
-	O
dependent	O
and	O
static	O
covariates	O
.	O

NPR	O
-	O
C	O
acts	O
as	O
a	O
clearance	O
receptor	O
for	O
these	O
peptides	O
through	O
an	O
endocytic	O
mechanism	O
that	O
involves	O
recycling	O
of	O
the	O
receptor	O
at	O
the	O
cellular	O
membrane	O
(	O
Rubattu	O
et	O
al	O
.	O

The	O
active	O
metabolite	O
of	O
vitamin	O
D	O
,	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D	O
[	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
]	O
increases	O
intestinal	O
calcium	O
absorption	O
and	O
decreases	O
renal	O
calcium	O
excretion	O
,	O
thus	O
increasing	O
the	O
pool	O
of	O
calcium	O
available	O
both	O
for	O
mother	O
and	O
foetus	O
.	O

Consent	O
was	O
obtained	O
to	O
request	O
a	O
report	O
from	O
the	O
child	O
'	O
s	O
physician	O
,	O
which	O
included	O
hospital	O
birth	O
records	O
,	O
postnatal	O
assessments	O
and	O
information	O
on	O
congenital	O
malformations	O
and	O
the	O
child	O
'	O
s	O
health	O
.	O

When	O
relative	O
mRNA	O
abundance	O
was	O
calculated	O
,	O
an	O
approximate	O
4	O
-	O
fold	O
change	O
in	O
the	O
GR	O
α	O
/	O
GR	O
-	O
P	O
in	O
the	O
preterm	O
labor	O
group	O
was	O
noted	O
compared	O
with	O
the	O
term	O
group	O
.	O

Among	O
women	O
with	O
BMI	O
<	O
25	O
kg	O
/	O
m2	O
,	O
lack	O
of	O
PNV	O
use	O
was	O
associated	O
with	O
higher	O
odds	O
of	O
25	O
(	O
OH	O
)	O
D	O
levels	O
<	O
50	O
nmol	O
/	O
L	O
during	O
the	O
first	O
trimester	O
(	O
seasonally	O
adjusted	O
OR	O
3	O
.	O
0	O
,	O
95	O
%	O
CI	O
:	O
1	O
.	O
9	O
,	O
4	O
.	O
8	O
),	O
but	O
not	O
at	O
the	O
later	O
time	O
point	O
(	O
OR	O
1	O
.	O
4	O
,	O
95	O
%	O
CI	O
0	O
.	O
9	O
,	O
2	O
.	O
3	O
).	O

SSRIs	O
Selective	O
serotonin	O
reuptake	O
inhibitors	O
(	O
SSRIs	O
)	O
are	O
a	O
class	O
of	O
drugs	O
currently	O
and	O
increasingly	O
prescribed	O
for	O
anxiety	O
disorders	O
and	O
depression	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
3	O
Identification	O
of	O
mutations	O
underlying	O
skeletal	O
morphology	O
mutant	O
1	O
(	O
Skm1	O
)	O
and	O
skeletal	O
morphology	O
mutant	O
2	O
(	O
Skm2	O
).	O

In	O
addition	O
,	O
six	O
mitochondrial	O
proteins	O
were	O
down	O
-	O
regulated	O
in	O
DVD	O
-	O
deficient	O
rats	O
(	O
NDUAA	O
,	O
UQCR1	O
,	O
ODPB	O
,	O
IDH3A	O
,	O
HKK1	O
,	O
VDAC2	O
).	O

These	O
results	O
are	O
in	O
keeping	O
with	O
data	O
showing	O
a	O
physiological	O
role	O
of	O
BAT	O
in	O
whole	O
-	O
body	O
energy	O
expenditure	O
,	O
glucose	O
homeostasis	O
,	O
and	O
insulin	O
sensitivity	O
in	O
humans	O
during	O
prolonged	O
cold	O
exposure	O
(	O
Chondronikola	O
et	O
al	O
.,	O
2014	O
).	O

Results	O
of	O
samples	O
analyzed	O
in	O
this	O
assay	O
are	O
consistently	O
found	O
to	O
agree	O
with	O
the	O
mid	O
-	O
range	O
of	O
outcomes	O
of	O
those	O
using	O
this	O
assay	O
and	O
participating	O
in	O
the	O
international	O
DEQUAS	O
standardization	O
system	O
.	O

Specifically	O
,	O
a	O
test	O
statistic	O
was	O
constructed	O
as	O
the	O
maximum	O
absolute	O
t	O
-	O
statistic	O
for	O
the	O
appropriate	O
coefficient	O
from	O
the	O
regression	O
model	O
,	O
where	O
the	O
maximum	O
was	O
computed	O
over	O
the	O
16	O
or	O
41	O
individual	O
regression	O
models	O
.	O

However	O
,	O
it	O
is	O
likely	O
that	O
by	O
three	O
months	O
of	O
age	O
,	O
vitamin	O
D	O
has	O
a	O
key	O
role	O
in	O
calcium	O
absorption	O
,	O
especially	O
in	O
breast	O
-	O
fed	O
infants	O
with	O
a	O
relatively	O
low	O
calcium	O
intake	O
compared	O
to	O
formula	O
-	O
fed	O
infants	O
.	O

Central	O
administration	O
of	O
BMP8B	O
induced	O
thermogenesis	O
and	O
increased	O
core	O
temperature	O
,	O
leading	O
to	O
weight	O
loss	O
(	O
Contreras	O
et	O
al	O
.,	O
2014	O
).	O

It	O
was	O
found	O
that	O
maternal	O
prenatal	O
weight	O
gain	O
,	O
but	O
not	O
prepregnancy	O
body	O
mass	O
index	O
,	O
is	O
directly	O
related	O
to	O
an	O
increased	O
risk	O
of	O
ASD	O
.	O

Novel	O
approaches	O
to	O
motivating	O
handwashing	O
behavior	O
to	O
protect	O
newborns	O
should	O
be	O
developed	O
and	O
evaluated	O
.	O

These	O
proteins	O
are	O
associated	O
with	O
several	O
biological	O
pathways	O
including	O
oxidative	O
phosphorylation	O
,	O
cytoskeleton	O
maintenance	O
,	O
calcium	O
homeostasis	O
,	O
chaperoning	O
,	O
synaptic	O
plasticity	O
and	O
neurotransmission	O
.	O

3	O
.	O
2	O
.	O

After	O
exclusions	O
,	O
a	O
final	O
sample	O
of	O
3268	O
women	O
was	O
included	O
in	O
the	O
analysis	O
(	O
Fig	O
.	O

Constraints	O
to	O
Successful	O
Preventive	O
Treatments	O
of	O
Iron	O
Deficiency	O
Anaemia	O
in	O
Pregnancy	O
3	O
.	O
4	O
.	O
1	O
.	O

The	O
dose	O
-	O
response	O
effects	O
observed	O
here	O
suggest	O
the	O
need	O
to	O
study	O
methods	O
to	O
evaluate	O
exposure	O
and	O
achieve	O
optimal	O
dosage	O
effects	O
in	O
future	O
research	O
.	O

The	O
average	O
intake	O
of	O
food	O
items	O
from	O
the	O
FFQ	O
were	O
converted	O
into	O
average	O
intake	O
of	O
energy	O
and	O
nutrients	O
by	O
linkage	O
to	O
the	O
database	O
of	O
nutrients	O
created	O
by	O
the	O
Swedish	O
National	O
Food	O
Administration	O
[	O
27	O
].	O

Source	O
Project	O
documentation	O
,	O
University	O
of	O
Melbourne	O
/	O
NIMPE	O
.	O

They	O
speculated	O
that	O
“	O
DDE	O
may	O
be	O
interfering	O
with	O
the	O
mother	O
’	O
s	O
ability	O
to	O
lactate	O
,	O
possibly	O
because	O
of	O
its	O
estrogenic	O
properties	O
.”	O
14	O
Over	O
the	O
next	O
three	O
decades	O
,	O
these	O
and	O
other	O
researchers	O
tried	O
to	O
replicate	O
the	O
findings	O
of	O
the	O
North	O
Carolina	O
study	O
.	O

Zinc	O
concentrations	O
are	O
determined	O
in	O
serum	O
using	O
atomic	O
absorption	O
spectrometry	O
[	O
74	O
].	O

At	O
this	O
time	O
,	O
however	O
,	O
how	O
the	O
protective	O
factor	O
of	O
breast	O
-	O
feeding	O
interacts	O
with	O
transmitting	O
flavor	O
preference	O
for	O
energy	O
-	O
dense	O
foods	O
in	O
overweight	O
mothers	O
is	O
unclear	B
.	O

Although	O
we	O
accept	O
that	O
rodents	O
and	O
humans	O
may	O
differ	O
in	O
their	O
adaptive	O
responses	O
to	O
early	O
life	O
cues	O
,	O
there	O
are	O
many	O
reports	O
outlining	O
associations	O
between	O
a	O
suboptimal	O
early	O
life	O
environment	O
and	O
altered	O
phenotype	O
in	O
both	O
species	O
[	O
60	O
],[	O
61	O
].	O

There	O
are	O
many	O
documented	O
health	O
benefits	O
from	O
fish	O
consumption	O
with	O
regard	O
to	O
foetal	O
health	O
,	O
including	O
improved	O
neurodevelopment	O
,	O
increased	O
birth	O
weight	O
and	O
a	O
reduced	O
risk	O
of	O
spontaneous	O
abortion	O
[	O
11	O
,	O
12	O
].	O

As	O
a	O
consequence	O
the	O
Vietnam	O
National	O
Nutrition	O
Strategy	O
2011	O
–	O
2020	O
has	O
the	O
reduction	O
of	O
iron	O
deficiency	O
anemia	O
in	O
children	O
less	O
than	O
5	O
years	O
of	O
age	O
and	O
reproductive	O
-	O
age	O
women	O
as	O
an	O
objective	O
.	O

However	O
,	O
should	O
the	O
researchers	O
be	O
able	O
to	O
obtain	O
additional	O
funding	O
,	O
additional	O
participants	O
may	O
be	O
included	O
.	O

A	O
separate	O
study	O
from	O
Western	O
Australia	O
concluded	O
that	O
autistic	O
children	O
generally	O
had	O
parents	O
who	O
were	O
older	O
and	O
had	O
greater	O
frequencies	O
of	O
threatened	O
abortions	O
,	O
epidural	O
anesthesia	O
,	O
labor	O
induction	O
,	O
and	O
labor	O
duration	O
of	O
less	O
than	O
1	O
hour	O
.	O

Optimising	O
the	O
pre	O
-	O
and	O
inter	O
-	O
pregnancy	O
micronutritional	O
status	O
of	O
women	O
,	O
particularly	O
in	O
low	O
resource	O
settings	O
could	O
be	O
extremely	O
beneficial	O
(	O
Allen	O
2000	O
,	O
Bartley	O
et	O
al	O
2005	O
,	O
Huffman	O
SL	O
et	O
al	O
1998	O
,	O
Owens	O
and	O
Fall	O
2008	O
)	O
and	O
may	O
lead	O
to	O
improved	O
subsequent	O
maternal	O
and	O
pregnancy	O
outcomes	O
.	O

Similarly	O
,	O
histone	O
acetylases	O
require	O
the	O
co	O
-	O
substrate	O
acetyl	O
-	O
CoA	O
,	O
and	O
altered	O
glycolytic	O
production	O
of	O
acetyl	O
-	O
CoA	O
can	O
lead	O
to	O
changes	O
in	O
histone	O
acetylation	O
(	O
Wellen	O
et	O
al	O
.	O
2009	O
;	O
Moussaieff	O
et	O
al	O
.	O
2015	O
).	O

None	O
of	O
the	O
reports	O
noted	O
a	O
known	O
diagnosis	O
of	O
folic	O
acid	O
allergy	O
.	O

Future	O
studies	O
examining	O
the	O
relationship	O
between	O
maternal	O
diet	O
and	O
components	O
of	O
breast	O
milk	O
including	O
microbial	O
and	O
nutritional	O
profiles	O
,	O
as	O
well	O
as	O
the	O
potential	O
influence	O
of	O
maternal	O
diet	O
on	O
the	O
fetal	O
microbiome	O
,	O
may	O
offer	O
insight	O
into	O
the	O
mechanisms	O
by	O
which	O
maternal	O
diet	O
influences	O
the	O
infant	O
gut	O
microbiome	O
.	O

Black	O
and	O
Hispanic	O
mothers	O
were	O
found	O
to	O
have	O
a	O
statistically	O
significant	O
difference	O
in	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
throughout	O
pregnancy	O
as	O
well	O
(	O
p	O
≤	O
0	O
.	O
0001	O
).	O

Furthermore	O
,	O
there	O
may	O
be	O
possible	O
fetal	O
sex	O
specific	O
differences	O
in	O
vitamin	O
D	O
status	O
worth	O
considering	O
in	O
future	O
studies	O
.	O

3	O
).	O

In	O
humans	O
,	O
the	O
only	O
physiological	O
recovery	O
of	O
insulin	O
sensitivity	O
after	O
a	O
period	O
of	O
insulin	O
resistance	O
,	O
partially	O
due	O
to	O
an	O
increase	O
in	O
food	O
intake	O
and	O
lipogenesis	O
,	O
is	O
observed	O
in	O
women	O
after	O
pregnancy	O
(	O
Barbour	O
et	O
al	O
.,	O
2007	O
).	O

Maternal	O
characteristics	O
which	O
differed	O
across	O
quintiles	O
of	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
included	O
age	O
,	O
parity	O
,	O
pregnancy	O
size	O
,	O
season	O
of	O
birth	O
,	O
breastfeeding	O
duration	O
,	O
educational	O
level	O
,	O
ethnicity	O
,	O
housing	O
tenure	O
,	O
financial	O
difficulties	O
,	O
anxiety	O
level	O
,	O
tobacco	O
exposure	O
and	O
infection	O
during	O
pregnancy	O
.	O

As	O
compared	O
to	O
mothers	O
with	O
suboptimal	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
,	O
mothers	O
with	O
optimal	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
had	O
heavier	O
newborns	O
(	O
P	O
=	O
0	O
.	O
010	O
),	O
but	O
this	O
positive	O
association	O
was	O
not	O
verified	O
in	O
linear	O
regression	O
(	O
B	O
0	O
.	O
00	O
;	O
95	O
%	O
CI	O
-	O
0	O
.	O
00	O
,	O
0	O
.	O
01	O
;	O
P	O
=	O
0	O
.	O
16	O
).	O

Surveys	O
indicate	O
that	O
only	O
52	O
%	O
of	O
rural	O
women	O
reported	O
any	O
use	O
of	O
iron	O
/	O
folic	O
acid	O
in	O
their	O
last	O
pregnancy	O
but	O
this	O
dropped	O
to	O
39	O
%	O
for	O
the	O
poorest	O
households	O
,	O
and	O
to	O
34	O
%	O
for	O
women	O
with	O
no	O
education	O
(	O
3	O
).	O

This	O
sensitivity	O
could	O
be	O
one	O
mechanism	O
linking	O
maternal	O
stress	O
to	O
fetal	O
development	O
.	O

The	O
women	O
in	O
the	O
high	O
level	O
group	O
of	O
psychotic	O
-	O
like	O
symptoms	O
were	O
significantly	O
younger	O
,	O
had	O
a	O
higher	O
prevalence	O
of	O
overweight	O
and	O
obesity	O
and	O
were	O
less	O
educated	O
than	O
women	O
with	O
less	O
or	O
no	O
experience	O
of	O
psychotic	O
-	O
like	O
symptoms	O
.	O

In	O
our	O
study	O
,	O
measures	O
of	O
reliability	O
,	O
including	O
a	O
Cronbach	O
’	O
s	O
alpha	O
and	O
a	O
test	O
-	O
retest	O
correlation	O
were	O
0	O
.	O
86	O
and	O
0	O
.	O
92	O
,	O
respectively	O
.	O

Hence	O
,	O
there	O
is	O
continuing	O
interest	O
in	O
determining	O
how	O
vitamin	O
D	O
influences	O
pregnancy	O
health	O
.	O

Authors	O
’	O
contributions	O
RS	O
:	O
Conception	O
and	O
design	O
,	O
acquisition	O
of	O
data	O
,	O
analysis	O
and	O
interpretation	O
of	O
data	O
,	O
drafting	O
of	O
article	O
,	O
revising	O
article	O
critically	O
for	O
important	O
intellectual	O
content	O
,	O
and	O
final	O
approval	O
of	O
version	O
to	O
be	O
published	O
.	O

The	O
sequences	O
of	O
all	O
the	O
porcine	O
miRNAs	O
were	O
acquired	O
from	O
miRBase	O
(	O
http	O
://	O
www	O
.	O
mirbase	O
.	O
org	O
/).	O

In	O
order	O
to	O
make	O
the	O
MAR	O
assumption	O
more	O
plausible	O
,	O
a	O
range	O
of	O
auxiliary	O
variables	O
,	O
including	O
stratification	O
(	O
centre	O
,	O
parity	O
,	O
BMI	O
category	O
)	O
and	O
adjustment	O
variables	O
(	O
socioeconomic	O
status	O
,	O
smoking	O
,	O
maternal	O
age	O
at	O
consent	O
,	O
infant	O
gender	O
),	O
along	O
with	O
infant	O
birth	O
measures	O
(	O
weight	O
,	O
length	O
,	O
circumferences	O
and	O
skinfold	O
thickness	O
measures	O
),	O
were	O
included	O
in	O
the	O
imputation	O
model	O
.	O

Goodenday	O
,	O
et	O
al	O
.	O

An	O
associated	O
issue	O
is	O
that	O
,	O
after	O
the	O
start	O
of	O
our	O
trial	O
,	O
speculations	O
arose	O
that	O
high	O
fluctuations	O
of	O
natural	O
or	O
supplemented	O
vitamin	O
D	O
intake	O
might	O
be	O
linked	O
to	O
negative	O
outcomes	O
.	O

Pearson	O
'	O
s	O
product	O
moment	O
correlations	O
were	O
conducted	O
to	O
examine	O
unadjusted	O
associations	O
between	O
WFA	O
z	O
-	O
scores	O
and	O
maternal	O
variables	O
.	O

Skm2	O
mice	O
in	O
the	O
supine	O
(	O
E	O
)	O
and	O
lateral	O
(	O
F	O
)	O
positions	O
.	O

[	O
43	O
].	O

In	O
an	O
epidemiological	O
study	O
conducted	O
in	O
India	O
by	O
Mamidala	O
et	O
al	O
.,	O
maternal	O
hormonal	O
intervention	O
was	O
a	O
significant	O
risk	O
factor	O
for	O
ASD	O
,	O
possibly	O
due	O
to	O
maternal	O
hormone	O
disturbances	O
causing	O
obstetric	O
complications	O
,	O
which	O
in	O
turn	O
are	O
a	O
risk	O
for	O
ASD	O
[	O
42	O
].	O

Distribution	O
/	O
storage	O
costs	O
were	O
for	O
receiving	O
the	O
supplements	O
at	O
NIMPE	O
and	O
then	O
periodically	O
transporting	O
them	O
to	O
Yen	O
Bai	O
city	O
.	O

Both	O
bioinformatically	O
informed	O
CpG	O
classes	O
that	O
were	O
significantly	O
associated	O
with	O
AluYb8	O
methylation	O
contained	O
loci	O
that	O
are	O
proximal	O
to	O
TFBSs	O
.	O

After	O
collection	O
the	O
cotton	O
bud	O
end	O
of	O
the	O
swab	O
with	O
the	O
collected	O
sample	O
is	O
immediately	O
preserved	O
in	O
RNAlater	O
(	O
Ambion	O
)	O
and	O
stored	O
at	O
−	O
20	O
°	O
C	O
.	O

Expression	O
of	O
psychotic	O
symptoms	O
in	O
populations	O
is	O
continuous	O
and	O
characterized	O
by	O
differing	O
levels	O
of	O
severity	O
and	O
persistence	O
[	O
7	O
].	O

Other	O
possible	O
pregnancy	O
-	O
related	O
symptoms	O
included	O
are	O
constipation	O
,	O
nausea	O
,	O
vomiting	O
,	O
extreme	O
tiredness	O
and	O
heartburn	O
.	O

Our	O
study	O
was	O
implicitly	O
limited	O
to	O
congenital	O
cryptorchidism	O
because	O
the	O
literature	O
search	O
did	O
not	O
yield	O
any	O
case	O
–	O
control	O
or	O
cohort	O
studies	O
that	O
addressed	O
the	O
question	O
of	O
prenatal	O
exposure	O
to	O
estrogenic	O
compounds	O
and	O
acquired	O
cryptorchidism	O
in	O
humans	O
.	O

A	O
sample	O
of	O
150	O
for	O
each	O
trial	O
arm	O
was	O
required	O
in	O
order	O
to	O
detect	O
a	O
change	O
in	O
haemoglobin	O
of	O
0	O
.	O
5	O
g	O
/	O
dL	O
between	O
study	O
arms	O
with	O
5	O
%	O
significance	O
and	O
80	O
%	O
power	O
.	O

In	O
general	O
,	O
miRNAs	O
repress	O
gene	O
expression	O
by	O
binding	O
to	O
mRNAs	O
in	O
a	O
sequence	O
-	O
specific	O
manner	O
and	O
either	O
inducing	O
their	O
degradation	O
or	O
inhibiting	O
their	O
translation	O
(	O
Ivey	O
&	O
Srivastava2015	O
),	O
whereas	O
piRNAs	O
and	O
esiRNAs	O
bind	O
to	O
complementary	O
transposable	O
elements	O
(	O
TEs	O
)	O
and	O
induce	O
their	O
degradation	O
(	O
Watanabe	O
et	O
al	O
.	O
2006	O
,	O
2008	O
).	O

The	O
effect	O
is	O
characterised	O
by	O
a	O
programming	O
of	O
the	O
genome	O
that	O
leads	O
to	O
different	O
responsiveness	O
and	O
adaptability	O
of	O
the	O
gene	O
expression	O
machinery	O
to	O
chronic	O
and	O
acute	O
environmental	O
stimuli	O
,	O
i	O
.	O
e	O
.	O

)•	O
Create	O
and	O
implement	O
effective	O
community	O
-	O
based	O
approaches	O
(	O
e	O
.	O
g	O
.,	O
community	O
health	O
workers	O
home	O
visit	O
packages	O
,	O
women	O
'	O
s	O
'	O
groups	O
)	O
Typical	O
timeline	O
to	O
impactNear	O
-	O
term	O
to	O
Long	O
-	O
term	O
(	O
2	O
to	O
15	O
years	O
)	O
Long	O
-	O
term	O
(	O
5	O
to	O
15	O
years	O
)	O
Medium	O
-	O
term	O
(	O
5	O
to	O
10	O
years	O
)	O
Near	O
-	O
term	O
(	O
2	O
to	O
5	O
years	O
)	O
Source	O
:	O
Born	O
Too	O
Soon	O
,	O
Chapter	O
6	O
[	O
75	O
].	O

2010	O
;	O
Lin	O
et	O
al	O
.	O

Results	O
Among	O
women	O
with	O
a	O
live	O
,	O
singleton	O
birth	O
and	O
at	O
least	O
one	O
25	O
(	O
OH	O
)	O
D	O
test	O
during	O
pregnancy	O
(	O
N	O
=	O
1	O
,	O
064	O
),	O
the	O
overall	O
PTB	O
rate	O
was	O
13	O
%.	O

The	O
study	O
was	O
approved	O
as	O
minimal	O
risk	O
research	O
by	O
the	O
Madigan	O
Institutional	O
Review	O
Board	O
(	O
IRB	O
)	O
on	O
July	O
26	O
,	O
2011	O
.	O

For	O
those	O
with	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
≥	O
40	O
ng	O
/	O
mL	O
compared	O
to	O
those	O
with	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
<	O
20	O
ng	O
/	O
mL	O
,	O
there	O
was	O
a	O
58	O
%	O
lower	O
risk	O
of	O
spontaneous	O
PTB	O
(	O
OR	O
=	O
0	O
.	O
42	O
,	O
95	O
%	O
CI	O
=	O
0	O
.	O
20	O
–	O
0	O
.	O
89	O
,	O
p	O
=	O
0	O
.	O
02	O
;	O
AAR	O
=	O
4	O
.	O
8	O
%;	O
NNT	O
=	O
21	O
)	O
and	O
a	O
61	O
%	O
lower	O
risk	O
of	O
indicated	O
PTB	O
(	O
OR	O
=	O
0	O
.	O
39	O
,	O
95	O
%	O
CI	O
=	O
0	O
.	O
20	O
–	O
0	O
.	O
76	O
,	O
p	O
=	O
0	O
.	O
006	O
;	O
AAR	O
=	O
6	O
.	O
5	O
%;	O
NNT	O
=	O
15	O
)	O
(	O
Table	O
3	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0180483	O
.	O
t003	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Association	O
between	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
and	O
the	O
risk	O
of	O
preterm	O
birth	O
by	O
preterm	O
birth	O
subtype	O
.	O
Spontaneous	O
Preterm	O
Birth	O
RatesSpontaneous	O
Preterm	O
Birth	O
:	O
ORIndicated	O
Preterm	O
Birth	O
RatesIndicated	O
Preterm	O
Birth	O
:	O
OR	O
(<	O
37	O
Weeks	O
)(	O
95	O
%	O
CI	O
)(<	O
37	O
Weeks	O
)(	O
95	O
%	O
CI	O
)<	O
20	O
ng	O
/	O
mL	O
(	O
N	O
=	O
248	O
)	O
21	O
(	O
8	O
%)	O
1	O
.	O
028	O
(	O
11	O
%)	O
1	O
.	O
0N	O
preterm	O
(%)	O
20	O
to	O
<	O
30	O
ng	O
/	O
mL	O
(	O
N	O
=	O
267	O
)	O
17	O
(	O
6	O
%)	O
0	O
.	O
7416	O
(	O
6	O
%)	O
0	O
.	O
50	O
N	O
preterm	O
(%)(	O
0	O
.	O
38	O
,	O
1	O
.	O
43	O
)	O
(	O
0	O
.	O
26	O
,	O
0	O
.	O
95	O
)	O
30	O
to	O
<	O
40	O
ng	O
/	O
mL	O
(	O
N	O
=	O
255	O
)	O
16	O
(	O
6	O
%)	O
0	O
.	O
7216	O
(	O
6	O
%)	O
0	O
.	O
53	O
N	O
preterm	O
(%)(	O
0	O
.	O
37	O
,	O
1	O
.	O
42	O
)	O
(	O
0	O
.	O
28	O
,	O
0	O
.	O
99	O
)	O
≥	O
40	O
ng	O
/	O
mL	O
(	O
N	O
=	O
294	O
)	O
11	O
(	O
4	O
%)	O
0	O
.	O
42	O
14	O
(	O
5	O
%)	O
0	O
.	O
39	O
N	O
preterm	O
(%)	O
(	O
0	O
.	O
20	O
,	O
0	O
.	O
89	O
)(	O
0	O
.	O
20	O
,	O
0	O
.	O
76	O
)	O
Bold	O
values	O
signify	O
significance	O
at	O
p	O
<	O
0	O
.	O
05	O
.	O

One	O
key	O
reason	O
we	O
conclude	O
that	O
intrauterine	O
or	O
X	O
-	O
mediated	O
influences	O
are	O
important	O
is	O
because	O
the	O
grandmothers	O
of	O
both	O
lineages	O
,	O
who	O
do	O
not	O
share	O
their	O
grandchildren	O
'	O
s	O
direct	O
daily	O
environment	O
,	O
are	O
each	O
exerting	O
an	O
association	O
.	O

P04	O
.	O
49	O
.	O

Participants	O
Members	O
of	O
556	O
families	O
in	O
the	O
Lifeways	O
Cross	O
-	O
Generation	O
Cohort	O
Study	O
2001	O
–	O
2014	O
.	O

A	O
developmental	O
perspective	O
considers	O
family	O
,	O
school	O
,	O
and	O
community	O
context	O
.	O

CT	O
:	O
cholera	O
toxin	O
;	O
ih	O
:	O
intrahippocampal	O
;	O
im	O
:	O
intramuscular	O
;	O
ip	O
:	O
intraperitoneal	O
;	O
sc	O
:	O
subcutaneous	O
.	O

All	O
reports	O
will	O
be	O
auto	O
-	O
generated	O
from	O
the	O
system	O
and	O
will	O
be	O
available	O
anytime	O
for	O
the	O
investigators	O
’	O
assessment	O
.	O

Consent	O
/	O
Assent	O
Process	O
Eligible	O
women	O
were	O
informed	O
of	O
the	O
study	O
and	O
,	O
if	O
interested	O
,	O
consented	O
in	O
their	O
language	O
of	O
preference	O
(	O
Spanish	O
/	O
English	O
).	O

[	O
13	O
]	O
Kruavit	O
et	O
al	O
.	O

Vitamin	O
D3	O
can	O
be	O
synthesized	O
de	O
novo	O
.	O

These	O
women	O
are	O
advised	O
to	O
take	O
10	O
micrograms	O
per	O
day	O
in	O
the	O
form	O
of	O
a	O
multivitamin	O
supplement	O
.	O

Additionally	O
,	O
it	O
was	O
assessed	O
the	O
spontaneous	O
and	O
compulsive	O
feeding	O
behavior	O
,	O
growing	O
parameters	O
,	O
leptin	O
,	O
plasma	O
metabolites	O
,	O
and	O
adiposity	O
after	O
weaning	O
(	O
adolescence	O
and	O
adulthood	O
).	O

However	O
,	O
in	O
Viet	O
Nam	O
fortification	O
of	O
cereals	O
is	O
not	O
easily	O
available	O
for	O
rural	O
areas	O
(	O
rice	O
,	O
the	O
main	O
staple	O
,	O
is	O
more	O
costly	O
to	O
fortify	O
,	O
and	O
less	O
feasible	O
to	O
fortify	O
given	O
the	O
lack	O
of	O
central	O
processing	O
).	O

Knowledge	O
of	O
child	O
feeding	O
has	O
largely	O
evolved	O
from	O
laboratory	O
studies	O
that	O
address	O
cause	O
and	O
effect	O
but	O
provide	O
limited	O
insight	O
on	O
the	O
usual	O
environments	O
and	O
social	O
interactions	O
surrounding	O
children	O
'	O
s	O
behavior	O
.	O

Records	O
included	O
ethnicity	O
,	O
age	O
,	O
body	O
mass	O
index	O
(	O
BMI	O
),	O
socioeconomic	O
index	O
(	O
SEI	O
)	O
and	O
multivitamin	O
use	O
[	O
29	O
].	O

We	O
would	O
like	O
to	O
acknowledge	O
Gefried	O
Pali	O
for	O
the	O
photograph	O
arts	O
.	O

1	O
Posterior	O
95	O
%	O
CIs	O
of	O
BHLM	O
regression	O
coefficients	O
,	O
HOME	O
Study	O
,	O
2003	O
-	O
2006	O
,	O
n	O
=	O
272	O
,	O
Cincinnati	O
,	O
OH	O
Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

The	O
neonates	O
in	O
the	O
exposed	O
and	O
comparison	O
groups	O
did	O
not	O
differ	O
in	O
birth	O
weight	O
or	O
in	O
the	O
proportion	O
of	O
those	O
who	O
were	O
small	O
for	O
gestational	O
age	O
(<	O
10th	O
centile	O
).	O

[	O
18	O
]	O
both	O
found	O
changes	O
in	O
birth	O
weight	O
associated	O
with	O
increased	O
OCP	O
exposure	O
.	O

Between	O
December	O
2003	O
and	O
July	O
2006	O
,	O
1	O
,	O
393	O
(	O
82	O
%)	O
of	O
1	O
,	O
685	O
approached	O
women	O
consented	O
to	O
participate	O
.	O

Appropriate	O
sized	O
cuffs	O
are	O
used	O
for	O
obese	O
participants	O
.	O

A	O
study	O
in	O
human	O
subjects	O
involved	O
the	O
administration	O
of	O
100	O
,	O
000	O
IU	O
vitamin	O
D	O
per	O
day	O
(	O
2	O
.	O
5	O
mg	O
/	O
day	O
)	O
throughout	O
pregnancy	O
to	O
hypoparathyroid	O
women	O
to	O
maintain	O
serum	O
calcium	O
with	O
no	O
fatal	O
outcome	O
.	O

Pubertal	O
onset	O
and	O
adult	O
ovarian	O
function	O
is	O
dependent	O
on	O
maternal	O
nutritional	O
background	O
Pubertal	O
onset	O
in	O
control	O
offspring	O
Pubertal	O
age	O
of	O
offspring	O
born	O
to	O
control	O
dams	O
was	O
similar	O
to	O
that	O
reported	O
previously	O
[	O
38	O
].	O

The	O
fetus	O
seems	O
to	O
be	O
relatively	O
protected	O
from	O
anaphylaxis	O
perhaps	O
because	O
the	O
placenta	O
does	O
not	O
transmit	O
specific	O
IgE	O
antibodies	O
to	O
the	O
fetus	O
[	O
31	O
].	O

Additionally	O
,	O
glucose	O
concentrations	O
were	O
statistically	O
significantly	O
elevated	O
among	O
women	O
who	O
snored	O
during	O
pregnancy	O
;	O
and	O
the	O
relative	O
risk	O
of	O
GDM	O
among	O
overweight	O
women	O
who	O
snored	O
,	O
compared	O
to	O
their	O
non	O
-	O
snoring	O
and	O
lean	O
counterparts	O
was	O
6	O
.	O
91	O
(	O
95	O
%	O
CI	O
2	O
.	O
87	O
-	O
16	O
.	O
6	O
).	O

Statistical	O
analyses	O
were	O
performed	O
using	O
SAS	O
9	O
.	O
3	O
.	O

In	O
group	O
B	O
,	O
second	O
trimester	O
visfatin	O
levels	O
correlated	O
negatively	O
with	O
birth	O
length	O
(	O
p	O
=	O
0	O
.	O
015	O
,	O
r	O
=-	O
0	O
.	O
523	O
)	O
and	O
infant	O
’	O
s	O
head	O
circumference	O
(	O
p2	O
=	O
0	O
.	O
050	O
,	O
r2	O
=-	O
0	O
.	O
392	O
).	O

Therefore	O
,	O
it	O
is	O
justifiable	O
that	O
in	O
our	O
study	O
,	O
vitamin	O
D	O
group	O
had	O
lower	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
compared	O
to	O
those	O
were	O
in	O
the	O
study	O
by	O
Taheri	O
et	O
al	O
.	O

Therefore	O
,	O
it	O
has	O
not	O
been	O
possible	O
to	O
ascertain	O
whether	O
the	O
associations	O
at	O
implantation	O
in	O
early	O
pregnancy	O
differ	O
from	O
those	O
during	O
the	O
fetal	O
growth	O
spurt	O
in	O
late	O
pregnancy	O
.	O

The	O
number	O
of	O
mature	O
glomeruli	O
was	O
20	O
%	O
lower	O
in	O
the	O
F2	O
-	O
VitD	O
-	O
mice	O
than	O
in	O
the	O
F1VitD	O
-	O
mice	O
,	O
and	O
there	O
was	O
no	O
difference	O
in	O
the	O
number	O
of	O
mature	O
glomeruli	O
between	O
the	O
F2	O
-	O
VitD	O
-	O
and	O
F2	O
-	O
SC	O
mice	O
at	O
this	O
age	O
.	O

Serum	O
aliquots	O
were	O
then	O
stored	O
at	O
–	O
80C	O
for	O
further	O
analysis	O
.	O

In	O
the	O
homozygous	O
group	O
for	O
Tth111	O
I	O
polymorphism	O
,	O
mothers	O
with	O
negative	O
attitudes	O
towards	O
the	O
pregnancy	O
gave	O
birth	O
to	O
infants	O
with	O
significantly	O
lower	O
birth	O
weights	O
compared	O
to	O
women	O
with	O
positive	O
/	O
neutral	O
attitudes	O
.	O

Setting	O
Community	O
-	O
based	O
study	O
with	O
linkage	O
to	O
health	O
records	O
in	O
the	O
Republic	O
of	O
Ireland	O
.	O

Values	O
are	O
expressed	O
as	O
means	O
±	O
S	O
.	O
E	O
.	O
M	O
.	O

Clouds	O
and	O
rain	O
retard	O
vitamin	O
D	O
-	O
producing	O
ultraviolet	O
B	O
light	O
from	O
penetrating	O
the	O
atmosphere	O
.	O

Discussion	O
Gestational	O
diabetes	O
insipidus	O
is	O
a	O
rare	O
complication	O
of	O
pregnancy	O
that	O
occurs	O
in	O
4	O
out	O
of	O
100	O
,	O
000	O
pregnancies	O
as	O
discussed	O
by	O
Durr	O
[	O
1	O
].	O

Given	O
the	O
rarity	O
of	O
some	O
infections	O
and	O
brain	O
tumors	O
,	O
the	O
interpretability	O
of	O
seasonal	O
patterns	O
,	O
or	O
the	O
lack	B
thereof	O
,	O
may	O
be	O
confounded	O
by	O
time	O
-	O
and	O
/	O
or	O
space	O
-	O
dependent	O
factors	O
[	O
126	O
].	O

After	O
birth	O
,	O
the	O
adipogenic	O
–	O
fibrogenic	O
progenitor	O
cells	O
re	O
main	O
on	O
some	O
parts	O
of	O
the	O
stromal	O
vascular	O
cells	O
in	O
adipose	O
tissue	O
,	O
later	O
serving	O
as	O
precursors	O
to	O
preadipocytes	O
and	O
adipocytes	O
[	O
16	O
,	O
22	O
].	O

Following	O
widely	O
accepted	O
practice	O
,	O
Cronbach	O
alpha	O
of	O
.	O
6	O
was	O
used	O
to	O
confirm	O
interitem	O
agreement	O
for	O
use	O
of	O
the	O
factor	O
in	O
descriptive	O
and	O
regression	O
analyses	O
[	O
39	O
].	O

Species	O
of	O
the	O
genus	O
Acinetobacter	O
are	O
increasingly	O
involved	O
in	O
nosocomial	O
infections	O
[	O
20	O
],	O
while	O
the	O
species	O
Clostridium	O
neonatale	O
was	O
initially	O
isolated	O
from	O
infants	O
affected	O
by	O
necrotizing	O
enterocolitis	O
[	O
21	O
],	O
and	O
the	O
pathogenic	O
potential	O
of	O
species	O
in	O
the	O
genus	O
Staphylococcus	O
is	O
well	O
-	O
established	O
[	O
22	O
,	O
23	O
].	O

Little	B
is	I
known	I
about	O
the	O
dietary	O
behaviour	O
and	O
nutritional	O
status	O
of	O
pregnant	O
women	O
living	O
in	O
South	O
Africa	O
.	O

SEI	O
was	O
calculated	O
using	O
the	O
New	O
Zealand	O
SEI	O
of	O
occupational	O
status	O
,	O
deriving	O
a	O
number	O
between	O
10	O
and	O
90	O
based	O
on	O
the	O
woman	O
’	O
s	O
occupation	O
;	O
a	O
higher	O
number	O
indicates	O
higher	O
socioeconomic	O
status	O
[	O
30	O
].	O

Of	O
all	O
women	O
included	O
,	O
15	O
%	O
smoked	O
during	O
pregnancy	O
and	O
12	O
%	O
reported	O
having	O
drunk	O
alcohol	O
during	O
pregnancy	O
(	O
Table	O
2	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0043868	O
.	O
t002	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Characteristics	O
of	O
the	O
pregnant	O
women	O
included	O
in	O
the	O
study	O
(	O
n	O
=	O
1311	O
)	O
(	O
Belgian	O
national	O
survey	O
on	O
vitamin	O
D	O
status	O
in	O
pregnant	O
women	O
,	O
2010	O
–	O
2011	O
).	O
CharacteristicNMean	O
age28	O
.	O
5	O
±	O
5	O
.	O
11305Mean	O
BMI	O
*(	O
kg	O
/	O
m2	O
)	O
24	O
.	O
4	O
±	O
5	O
.	O
11290	O
%	O
Underweight5	O
.	O
6673	O
%	O
Healthy	O
weight59	O
.	O
20763	O
%	O
Overweight22	O
.	O
09285	O
%	O
Obese13	O
.	O
10169	O
Ethnicity	O
%	O
White	O
/	O
Caucasian73	O
.	O
61965	O
%	O
Asiatic2	O
.	O
5233	O
%	O
African	O
(	O
Black	O
)	O
4	O
.	O
8864	O
%	O
North	O
African13	O
.	O
42176	O
%	O
Hispanic0	O
.	O
9212	O
%	O
Not	O
known4	O
.	O
6561	O
Education	O
level	O
%	O
Secondary	O
education	O
or	O
lower54	O
.	O
54715	O
%	O
Higher	O
education27	O
.	O
23357	O
%	O
University	O
or	O
higher14	O
.	O
87195	O
%	O
Other	O
education0	O
.	O
233	O
%	O
No	O
diploma0	O
.	O
699	O
%	O
Not	O
known2	O
.	O
4432	O
Smoking	O
%	O
Yes16	O
.	O
78220	O
%	O
Of	O
which	O
during	O
past	O
4	O
wks15	O
.	O
41202	O
%	O
No82	O
.	O
911087	O
%	O
Not	O
known0	O
.	O
314	O
Drinking	O
alcohol	O
%	O
Yes20	O
.	O
37267	O
%	O
Of	O
which	O
during	O
past	O
4	O
wks11	O
.	O
51151	O
%	O
No78	O
.	O
491029	O
%	O
Not	O
known1	O
.	O
1415	O
First	O
trimester	O
BMI	O
used	O
as	O
a	O
proxy	O
for	O
prepregnancy	O
BMI	O
.	O

However	O
,	O
we	O
are	O
not	O
seeking	O
to	O
report	O
or	O
measure	O
adiposity	O
in	O
itself	O
in	O
this	O
analysis	O
;	O
for	O
comparator	O
purposes	O
,	O
we	O
report	O
BMI	O
at	O
the	O
three	O
time	O
points	O
in	O
order	O
to	O
compare	O
like	O
with	O
like	O
both	O
(	O
1	O
)	O
in	O
relation	O
to	O
the	O
child	O
over	O
time	O
and	O
(	O
2	O
)	O
in	O
relation	O
to	O
the	O
adults	O
.	O

Primary	O
prevention	O
addresses	O
symptom	O
-	O
free	O
children	O
at	O
risk	O
(	O
ie	O
,	O
without	O
the	O
established	O
disease	O
).	O

While	O
vitamin	O
D	O
supplementation	O
in	O
pregnancy	O
has	O
previously	O
been	O
associated	O
with	O
reduced	O
risk	O
of	O
wheezing	O
and	O
type	O
1	O
diabetes	O
.	O

As	O
federal	O
and	O
state	O
governments	O
devote	O
attention	O
and	O
resources	O
to	O
the	O
problem	O
,	O
the	O
Report	O
Cards	O
will	O
continue	O
to	O
mobilise	O
stakeholders	O
and	O
mark	O
progress	O
.	O

Examining	O
nutrition	O
and	O
obesity	O
from	O
a	O
developmental	O
perspective	O
combines	O
social	O
context	O
and	O
biological	O
influences	O
with	O
individual	O
behavior	O
(	O
4	O
,	O
5	O
).	O

There	O
were	O
five	O
deaths	O
to	O
6	O
months	O
of	O
age	O
(	O
4	O
neonatal	O
deaths	O
as	O
reported	O
previously	O
[	O
22	O
],	O
and	O
the	O
death	O
of	O
one	O
infant	O
prior	O
to	O
6	O
months	O
of	O
age	O
attributable	O
to	O
sudden	O
infant	O
death	O
syndrome	O
).	O

Do	O
these	O
mechanism	O
(	O
s	O
)	O
function	O
in	O
humans	O
?	O

On	O
the	O
other	O
hand	O
risk	O
of	O
severe	O
vitamin	O
D	O
deficiency	O
decreased	O
for	O
women	O
who	O
reported	O
alcohol	O
consumption	O
during	O
pregnancy	O
.	O

While	O
we	O
did	O
not	O
identify	O
statistically	O
or	O
clinically	O
significant	O
differences	O
in	O
neurodevelopment	O
at	O
6	O
-	O
months	O
of	O
age	O
using	O
a	O
reliable	O
screening	O
tool	O
,	O
ongoing	O
follow	O
-	O
up	O
of	O
participants	O
further	O
into	O
childhood	O
will	O
again	O
be	O
important	O
to	O
determine	O
whether	O
there	O
are	O
any	O
potential	O
benefits	O
of	O
improving	O
maternal	O
diet	O
and	O
physical	O
activity	O
during	O
pregnancy	O
on	O
childhood	O
neurodevelopment	O
.	O

Data	O
collection	O
Figure	O
2summarises	O
the	O
measurements	O
and	O
time	O
points	O
of	O
data	O
collection	O
throughout	O
the	O
project	O
.	O

Statistical	O
Analysis	O
Statistical	O
analyses	O
were	O
conducted	O
using	O
SPSS	O
version	O
21	O
.	O
0	O
for	O
Windows	O
(	O
IBM	O
Corporation	O
,	O
USA	O
).	O

According	O
to	O
recent	O
studies	O
NCAPG	O
is	O
important	O
during	O
mitotic	O
cell	O
division	O
.	O

It	O
is	O
clear	O
,	O
however	O
,	O
that	O
vitamin	O
D	O
requirements	O
are	O
increased	O
in	O
mothers	O
during	O
pregnancy	O
and	O
lactation	O
.	O

Also	O
,	O
intervention	O
exposure	O
,	O
as	O
measured	O
by	O
estimated	O
number	O
of	O
antepartum	O
messages	O
delivered	O
and	O
number	O
of	O
antepartum	O
days	O
enrolled	O
in	O
the	O
messaging	O
campaign	O
,	O
were	O
assessed	O
for	O
all	O
study	O
participants	O
in	O
the	O
intervention	O
group	O
.	O

Oral	O
consent	O
for	O
participation	O
was	O
provided	O
by	O
all	O
women	O
over	O
the	O
phone	O
.	O

Secondary	O
prevention	O
addresses	O
individuals	O
with	O
early	O
indicators	O
of	O
atopic	O
disease	O
.	O

Thus	O
,	O
the	O
amount	O
of	O
UCP1	O
increases	O
during	O
fetal	O
development	O
,	O
peaks	O
at	O
birth	O
,	O
before	O
declining	O
over	O
the	O
first	O
9	O
months	O
(	O
Lean	O
et	O
al	O
.,	O
1986	O
;	O
Tews	O
and	O
Wabitsch	O
,	O
2011	O
).	O

The	O
placenta	O
expresses	O
all	O
the	O
necessary	O
components	O
to	O
convert	O
25	O
(	O
OH	O
)	O
D	O
to	O
the	O
active	O
form	O
and	O
thus	O
utilise	O
active	O
vitamin	O
D	O
either	O
locally	O
or	O
in	O
a	O
paracrine	O
manner	O
[	O
45	O
,	O
47	O
].	O

Attendance	O
at	O
the	O
first	O
antenatal	O
visit	O
in	O
extended	O
winter	O
,	O
compared	O
to	O
summer	O
,	O
was	O
associated	O
with	O
significantly	O
higher	O
HOMA	O
-	O
IR	O
(	O
32	O
.	O
8	O
%)	O
and	O
insulin	O
(	O
32	O
.	O
4	O
%)	O
in	O
early	O
pregnancy	O
,	O
independent	O
of	O
25OHD	O
<	O
30	O
nmol	O
/	O
L	O
.	O

In	O
addition	O
,	O
multiplex	O
PCR	O
was	O
performed	O
for	O
detecting	O
Streptococcus	O
pneumoniae	O
,	O
Haemophilus	O
influenzae	O
,	O
Moraxella	O
catarrhalis	O
,	O
Streptococcus	O
pyogens	O
,	O
and	O
Staphylococcus	O
aureus	O
[	O
20	O
].	O

We	O
then	O
highlight	O
evidence	O
-	O
based	O
interventions	O
for	O
preterm	O
birth	O
in	O
the	O
context	O
of	O
the	O
wider	O
health	O
system	O
drawing	O
on	O
the	O
other	O
papers	O
in	O
this	O
supplement	O
,	O
and	O
here	O
we	O
focus	O
on	O
the	O
implications	O
for	O
integrating	O
and	O
scaling	O
up	O
those	O
available	O
interventions	O
in	O
low	O
-	O
and	O
middle	O
-	O
income	O
countries	O
where	O
the	O
coverage	O
of	O
care	O
is	O
lowest	O
and	O
the	O
potential	O
lives	O
saved	O
as	O
a	O
result	O
.	O

The	O
seasonal	O
variations	O
of	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
level	O
detected	O
in	O
these	O
subjects	O
are	O
consistent	O
with	O
natural	O
environmental	O
changes	O
in	O
the	O
area	O
of	O
residence	O
.	O

Women	O
and	O
children	O
are	O
most	O
vulnerable	O
due	O
to	O
greater	O
iron	O
requirements	O
and	O
those	O
in	O
resource	O
constrained	O
countries	O
are	O
particularly	O
at	O
risk	O
[	O
1	O
].	O

We	O
collected	O
the	O
data	O
from	O
July	O
to	O
October	O
2012	O
,	O
in	O
two	O
villages	O
,	O
one	O
in	O
Mymensingh	O
and	O
one	O
in	O
Netrokona	O
–	O
two	O
of	O
the	O
five	O
districts	O
included	O
in	O
the	O
Shonjibon	O
Trial	O
.	O

The	O
recommended	O
dose	O
of	O
400	O
IU	O
(	O
10	O
micrograms	O
)	O
daily	O
for	O
infants	O
was	O
established	O
based	O
on	O
typical	O
amounts	O
in	O
a	O
teaspoon	O
of	O
cod	O
liver	O
oil	O
[	O
1	O
].	O

Then	O
,	O
preadipocytes	O
can	O
differentiate	O
during	O
the	O
finishing	O
stage	O
when	O
they	O
fill	O
with	O
lipid	O
to	O
grow	O
into	O
visible	O
marbling	O
by	O
hypertrophy	O
.	O

With	O
the	O
MLR	O
models	O
,	O
the	O
adjusted	O
ORs	O
and	O
their	O
respective	O
95	O
%	O
CIs	O
for	O
SGA	O
,	O
PTB	O
,	O
and	O
LWB	O
were	O
1	O
.	O
03	O
(	O
0	O
.	O
82	O
–	O
1	O
.	O
31	O
),	O
0	O
.	O
95	O
(	O
0	O
.	O
75	O
–	O
1	O
.	O
20	O
),	O
and	O
0	O
.	O
89	O
(	O
0	O
.	O
66	O
–	O
1	O
.	O
22	O
).	O

Development	O
of	O
robust	O
,	O
fit	O
-	O
for	O
-	O
purpose	O
equipment	O
,	O
is	O
a	O
critical	O
next	O
frontier	O
for	O
referral	O
care	O
for	O
premature	O
babies	O
in	O
the	O
settings	O
where	O
most	O
die	O
,	O
especially	O
for	O
care	O
in	O
hospitals	O
[	O
6	O
].	O

Mice	O
that	O
lack	O
functional	O
Flnb	O
have	O
been	O
generated	O
that	O
exhibit	O
impaired	O
development	O
of	O
the	O
microvascular	O
and	O
skeletal	O
systems	O
,	O
including	O
lack	O
of	O
invertebral	O
discs	O
and	O
kyphotic	O
and	O
scoliotic	O
spines	O
(	O
Farrington	O
-	O
Rock	O
et	O
al	O
.	O

Schizophrenia	O
in	O
adulthood	O
is	O
often	O
preceded	O
by	O
milder	O
symptoms	O
and	O
delusions	O
during	O
adolescence	O
.	O

An	O
unquantified	O
food	O
frequency	O
questionnaire	O
for	O
the	O
infant	O
is	O
administered	O
at	O
phases	O
6	O
and	O
8	O
for	O
qualitative	O
assessment	O
(	O
types	O
and	O
frequency	O
)	O
of	O
milk	O
and	O
complementary	O
feeding	O
at	O
6	O
and	O
12	O
months	O
postnatally	O
.	O

Obesity	O
is	O
well	O
known	O
to	O
be	O
a	O
risk	O
factor	O
for	O
vitamin	O
D	O
deficiency	O
because	O
of	O
a	O
sequestering	O
of	O
vitamin	O
D	O
in	O
adipose	O
tissue	O
.	O
35Maternal	O
obesity	O
during	O
pregnancy	O
has	O
also	O
been	O
associated	O
with	O
lower	O
vitamin	O
D	O
levels	O
in	O
neonates	O
at	O
delivery	O
.	O
24	O
,	O
36	O
,	O
37	O
,	O
38Our	O
data	O
are	O
consistent	O
and	O
illustrate	O
the	O
inverse	O
relationship	O
between	O
maternal	O
BMI	O
at	O
delivery	O
and	O
vitamin	O
D	O
status	O
after	O
adjusting	O
for	O
confounding	O
variables	O
.	O

We	O
computed	O
the	O
alternative	O
Mediterranean	O
diet	O
(	O
aMED	O
)	O
score	O
based	O
on	O
FFQ	O
-	O
derived	O
measures	O
of	O
daily	O
food	O
intake	O
,	O
following	O
the	O
method	O
of	O
Tobias	O
et	O
al	O
.	O

Normal	O
distribution	O
of	O
variables	O
in	O
each	O
group	O
was	O
assessed	O
using	O
the	O
Kolmogorov	O
-	O
Smirnov	O
test	O
.	O

It	O
is	O
also	O
possible	O
that	O
the	O
associations	O
between	O
fetal	O
growth	O
and	O
maternal	O
vitamin	O
D	O
status	O
are	O
due	O
to	O
residual	O
confounding	O
or	O
reverse	O
causation	O
.	O

Furthermore	O
,	O
many	O
studies	O
found	O
no	O
benefit	O
of	O
a	O
restricted	O
diet	O
avoiding	O
the	O
consumption	O
of	O
allergy	O
-	O
inducing	O
food	O
during	O
pregnancy	O
[	O
82	O
].	O

A	O
brief	O
questionnaire	O
on	O
prenatal	O
vitamins	O
,	O
including	O
name	O
and	O
frequency	O
,	O
and	O
intake	O
of	O
vitamin	O
D	O
rich	O
foods	O
was	O
completed	O
.	O

During	O
hunter	O
-	O
gatherer	O
times	O
,	O
summer	O
was	O
a	O
season	O
of	O
increased	O
daylight	O
and	O
nutritional	O
abundance	O
that	O
prepared	O
our	O
ancestors	O
for	O
harsher	O
winter	O
conditions	O
by	O
depositing	O
fat	O
reserves	O
during	O
autumn	O
[	O
17	O
].	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Body	O
weight	O
(	O
g	O
)	O
and	O
caloric	O
intake	O
(	O
kcal	O
/	O
kg	O
)	O
in	O
dams	O
(	O
A	O
)	O
and	O
their	O
offspring	O
(	O
B	O
–	O
D	O
)	O
in	O
gestation	O
,	O
lactation	O
and	O
/	O
or	O
postweaning	O
periods	O
.	O

In	O
a	O
randomized	O
control	O
trial	O
,	O
a	O
vitamin	O
D	O
supplement	O
can	O
even	O
decrease	O
the	O
risk	O
of	O
seasonal	O
flu	O
in	O
children	O
[	O
50	O
].	O

Previous	O
evidence	O
on	O
the	O
longer	O
-	O
term	O
effects	O
of	O
antenatal	O
dietary	O
and	O
lifestyle	O
interventions	O
is	O
limited	O
.	O

In	O
order	O
to	O
investigate	O
potential	O
unmeasured	O
confounding	O
by	O
genetic	O
or	O
shared	O
environmental	O
or	O
lifestyle	O
factors	O
,	O
we	O
used	O
a	O
parental	O
comparison	O
approach	O
,	O
whereby	O
effect	O
estimates	O
for	O
maternal	O
sugar	O
intake	O
in	O
pregnancy	O
were	O
compared	O
with	O
effect	O
estimates	O
for	O
maternal	O
and	O
paternal	O
sugar	O
intake	O
after	O
pregnancy	O
.	O

The	O
current	O
recommendation	O
of	O
health	O
care	O
professionals	O
is	O
to	O
avoid	O
anticonvulsant	O
drug	O
use	O
such	O
as	O
valproate	O
during	O
pregnancy	O
.	O

The	O
pathogenesis	O
of	O
AAOC	O
remains	B
unclear	I
.	O

Some	O
studies	O
have	O
also	O
noticed	O
that	O
the	O
metabolic	O
profile	O
exhibited	O
by	O
offspring	O
depends	O
on	O
the	O
sex	O
(	O
Desai	O
et	O
al	O
.,	O
2007a	O
;	O
Palou	O
et	O
al	O
.,	O
2010	O
;	O
Suzuki	O
et	O
al	O
.,	O
2010	O
).	O

Implications	O
for	O
regulatory	O
toxicology	O
and	O
intervention	O
All	O
the	O
previous	O
considerations	O
are	O
vital	O
for	O
effective	O
regulatory	O
toxicology	O
and	O
potential	O
intervention	O
.	O

The	O
pellet	O
was	O
air	O
dried	O
for	O
5	O
min	O
and	O
resuspended	O
in	O
Buffer	O
2	O
(	O
7M	O
urea	O
,	O
2M	O
thiourea	O
,	O
1	O
%	O
C7bZO	O
).	O

The	O
interaction	O
of	O
race	O
with	O
the	O
association	O
between	O
PNV	O
use	O
and	O
low	O
25	O
(	O
OH	O
)	O
D	O
levels	O
was	O
not	O
significant	O
later	O
in	O
pregnancy	O
(	O
interaction	O
P	O
value	O
=	O
0	O
.	O
3	O
).	O

Stridor	O
was	O
present	O
while	O
crying	O
and	O
the	O
infant	O
had	O
a	O
barking	O
cough	O
and	O
occasional	O
wheeze	O
.	O

The	O
above	O
studies	O
confirm	O
the	O
present	O
study	O
results	O
.	O

Lactation	O
support	O
includes	O
breastfeeding	O
-	O
related	O
counseling	O
and	O
education	O
from	O
trained	O
specialists	O
both	O
in	O
the	O
hospital	O
shortly	O
after	O
birth	O
and	O
at	O
home	O
for	O
the	O
first	O
months	O
of	O
the	O
baby	O
’	O
s	O
life	O
.	O
9	O
While	O
an	O
absolute	O
inability	O
to	O
lactate	O
is	O
rare	O
,	O
estimated	O
to	O
occur	O
in	O
less	O
than	O
2	O
%	O
of	O
mothers	O
,	O
10	O
“	O
we	O
have	O
no	B
idea	O
about	O
the	O
prevalence	O
of	O
women	O
who	O
are	O
lactating	O
less	O
than	O
optimally	O
,	O
who	O
may	O
be	O
unable	O
to	O
exclusively	O
breastfeed	O
a	O
baby	O
no	O
matter	O
how	O
frequently	O
and	O
thoroughly	O
they	O
breastfeed	O
,”	O
says	O
Nommsen	O
-	O
Rivers	O
.	O

Early	O
weaning	O
(	O
141	O
d	O
of	O
age	O
)	O
followed	O
by	O
a	O
high	O
-	O
starch	O
diet	O
improved	O
MS	O
compared	O
with	O
normal	O
weaning	O
(	O
222	O
d	O
of	O
age	O
)	O
followed	O
by	O
a	O
starch	O
creep	O
-	O
feed	O
diet	O
.	O

Conclusion	O
:	O
It	O
is	O
therefore	O
clear	O
that	O
the	O
diet	O
of	O
pregnant	O
woman	O
according	O
to	O
Ayurveda	O
will	O
prevent	O
many	O
complications	O
of	O
pregnancy	O
,	O
which	O
will	O
lead	O
to	O
healthy	O
pregnancy	O
&	O
healthy	O
fetus	O
&	O
finally	O
good	O
outcome	O
.	O

In	O
the	O
kidneys	O
,	O
25	O
[	O
OH	O
]	O
D	O
is	O
decomposed	O
by	O
1	O
-	O
α	O
-	O
hydroxylase	O
(	O
by	O
CYP27B1	O
)	O
to	O
an	O
active	O
form	O
of	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D	O
[	O
13	O
].	O

To	O
determine	O
if	O
IIH	O
is	O
occurring	O
more	O
commonly	O
,	O
de	O
-	O
identified	O
,	O
first	O
-	O
measured	O
serum	O
calcium	O
from	O
all	O
infants	O
<	O
6	O
months	O
(	O
n	O
=	O
5796	O
)	O
measured	O
in	O
our	O
laboratory	O
,	O
were	O
grouped	O
by	O
years	O
2005	O
-	O
2007	O
(	O
n	O
=	O
1516	O
),	O
2008	O
-	O
2010	O
(	O
n	O
=	O
1945	O
)	O
and	O
2011	O
-	O
2013	O
(	O
n	O
=	O
2335	O
).	O

Image	O
acquisition	O
and	O
analysis	O
Gels	O
were	O
fixed	O
in	O
solution	O
containing	O
25	O
%	O
(	O
v	O
/	O
v	O
)	O
methanol	O
and	O
10	O
%	O
(	O
v	O
/	O
v	O
)	O
acetic	O
acid	O
for	O
1	O
hr	O
and	O
stained	O
using	O
colloidal	O
Coomassie	O
Blue	O
for	O
spot	O
visualization	O
.	O

The	O
seasonal	O
differences	O
outlined	O
in	O
the	O
studies	O
above	O
could	O
be	O
attributed	O
to	O
seasonal	O
25OHD	O
,	O
or	O
evolutionary	O
circannual	O
rhythms	O
to	O
protect	O
mother	O
and	O
fetus	O
.	O

Access	O
to	O
IFA	O
supplements	O
is	O
through	O
antenatal	O
care	O
,	O
however	O
,	O
in	O
rural	O
Bangladesh	O
,	O
the	O
median	O
gestation	O
that	O
women	O
commence	O
antenatal	O
care	O
is	O
5	O
.	O
2	O
months	O
,	O
and	O
44	O
%	O
of	O
women	O
report	O
no	O
use	O
of	O
antenatal	O
care	O
[	O
5	O
].	O

Sunlight	O
expo	O
-	O
sure	O
questionnaires	O
are	O
imprecise	O
and	O
are	O
not	O
currently	O
recommended	O
.	O

Mean	O
haemoglobin	O
concentration	O
change	O
(	O
baseline	O
to	O
follow	O
-	O
up	O
)	O
was	O
compared	O
between	O
treatment	O
groups	O
with	O
analysis	O
of	O
covariance	O
.	O

Protein	O
spots	O
that	O
were	O
significantly	O
altered	O
were	O
excised	O
for	O
identification	O
by	O
mass	O
spectrometry	O
.	O

Briefly	O
,	O
they	O
proposed	O
that	O
mesenchymal	O
stem	O
cells	O
are	O
first	O
committed	O
to	O
the	O
myogenic	O
and	O
adipogenic	O
–	O
fibrogenic	O
cell	O
lineages	O
during	O
fetal	O
muscle	O
development	O
[	O
16	O
].	O

Satiety	O
responsiveness	O
,	O
a	O
separate	O
dimension	O
of	O
child	O
intake	O
regulation	O
,	O
has	O
recently	O
been	O
linked	O
to	O
variations	O
in	O
the	O
FTO	O
gene	O
(	O
69	O
),	O
which	O
confers	O
obesity	O
risk	O
and	O
is	O
highly	O
expressed	O
in	O
the	O
hypothalamus	O
,	O
a	O
center	O
of	O
appetite	O
regulation	O
in	O
the	O
brain	O
.	O

Although	O
,	O
only	O
hypothesis	O
generating	O
,	O
two	O
ecological	O
studies	O
support	O
the	O
hypothesis	O
by	O
reporting	O
the	O
ratio	O
of	O
saturated	O
fat	O
to	O
PUFA	O
in	O
the	O
diet	O
is	O
a	O
strong	O
predictor	O
of	O
schizophrenia	O
outcome	O
,	O
measured	O
as	O
according	O
to	O
either	O
clinical	O
or	O
to	O
social	O
variables	O
[	O
6	O
,	O
14	O
].	O

Body	O
Composition	O
Body	O
composition	O
was	O
evaluated	O
using	O
bioelectrical	O
impedance	O
(	O
BIA	O
)	O
with	O
a	O
single	O
-	O
frequency	O
hand	O
-	O
to	O
-	O
foot	O
(	O
ImpediMed	O
DF50	O
monitor	O
,	O
Impedimed	O
,	O
Australia	O
)	O
[	O
24	O
].	O

Ayurveda	O
has	O
focused	O
on	O
this	O
concept	O
&	O
have	O
explained	O
it	O
very	O
effectively	O
.	O

This	O
group	O
also	O
received	O
routine	O
prenatal	O
care	O
.	O

We	O
also	O
detected	O
interaction	O
between	O
time	O
and	O
diet	O
[	O
F	O
(	O
3	O
,	O
71	O
)=	O
3	O
.	O
64	O
;	O
P	O
<	O
0	O
.	O
05	O
],	O
and	O
time	O
and	O
sex	O
[	O
F	O
(	O
3	O
,	O
71	O
)=	O
2	O
.	O
954	O
,	O
P	O
<	O
0	O
.	O
05	O
].	O

Studies	O
suggest	O
that	O
the	O
effect	O
of	O
influenza	O
vaccination	O
on	O
birth	O
outcomes	O
may	O
be	O
better	O
observed	O
during	O
high	O
influenza	O
circulation	O
period	O
,	O
and	O
there	O
was	O
a	O
substantial	O
influenza	O
circulation	O
in	O
Nicaragua	O
in	O
2014	O
[	O
20	O
],[	O
21	O
],[	O
55	O
].	O

Both	O
diet	O
(	O
P	O
=	O
0	O
.	O
001	O
)	O
and	O
generation	O
(	O
P	O
=	O
0	O
.	O
04	O
)	O
affected	O
the	O
number	O
of	O
glomeruli	O
at	O
6	O
months	O
of	O
age	O
,	O
but	O
there	O
was	O
no	O
interaction	O
between	O
diet	O
and	O
generation	O
(	O
P	O
>	O
0	O
.	O
05	O
;	O
two	O
-	O
way	O
ANOVA	O
).	O

A	O
limitation	O
of	O
this	O
study	O
is	O
that	O
information	O
on	O
pregnancy	O
loss	O
,	O
except	O
IUFD	O
,	O
was	O
self	O
-	O
reported	O
.	O

Far	O
fewer	O
studies	O
have	O
examined	O
the	O
relationship	O
between	O
cord	O
blood	O
vitamin	O
D	O
levels	O
,	O
which	O
may	O
more	O
accurately	O
reflect	O
fetal	O
levels	O
of	O
vitamin	O
D	O
,	O
and	O
neonatal	O
outcomes	O
.	O
14	O
,	O
24Given	O
the	O
racial	O
disparities	O
seen	O
in	O
both	O
vitamin	O
D	O
deficiency	O
and	O
perinatal	O
outcomes	O
,	O
vitamin	O
D	O
has	O
been	O
proposed	O
as	O
part	O
of	O
the	O
explanation	O
for	O
this	O
disparity	O
,	O
particularly	O
with	O
regard	O
to	O
fetal	O
growth	O
and	O
SGA	O
.	O
8	O
Increased	O
awareness	O
of	O
the	O
growing	O
prevalence	O
of	O
maternal	O
vitamin	O
D	O
deficiency	O
has	O
led	O
to	O
an	O
urgent	O
need	O
for	O
consideration	O
of	O
supplementation	O
during	O
pregnancy	O
.	O

We	O
will	O
exclude	O
areas	O
where	O
access	O
is	O
extremely	O
difficult	O
,	O
for	O
example	O
in	O
flood	O
-	O
prone	O
areas	O
.	O

Innovate	O
•	O
Develop	O
affordable	O
new	B
diagnostics	O
,	O
medicines	O
,	O
technologies	O
and	O
other	O
interventions	O
,	O
including	O
social	O
and	O
behavioural	O
change	O
,	O
for	O
preterm	O
birth	O
and	O
make	O
them	O
available	O
to	O
the	O
most	O
vulnerable	O
and	O
marginalised	O
.	O

There	O
were	O
50	O
%	O
more	O
immature	O
glomeruli	O
in	O
the	O
F1	O
-	O
VitD	O
-	O
offspring	O
than	O
in	O
the	O
F1	O
-	O
SC	O
offspring	O
(	O
P	O
<	O
0	O
.	O
0001	O
,	O
t	O
-	O
test	O
)	O
and	O
20	O
%	O
more	O
immature	O
glomeruli	O
in	O
the	O
F2	O
-	O
VitD	O
-	O
offspring	O
than	O
in	O
the	O
F2	O
-	O
SC	O
offspring	O
(	O
P	O
<	O
0	O
.	O
001	O
,	O
t	O
-	O
test	O
).	O

All	O
nutrient	O
values	O
were	O
energy	O
-	O
adjusted	O
using	O
the	O
residuals	O
method	O
.	O

They	O
are	O
also	O
complicated	O
by	O
the	O
fact	O
that	O
the	O
biological	O
material	O
under	O
study	O
,	O
often	O
blood	O
cells	O
,	O
is	O
not	O
from	O
the	O
target	O
organ	O
/	O
tissue	O
.	O

2015	O
.	O

Although	O
thyroid	O
cancer	O
during	O
pregnancy	O
may	O
have	O
a	O
faster	O
growth2728since	O
hormonal	O
factors	O
(	O
mainly	O
HCG	O
)	O
may	O
accelerate	O
tumour	O
progression	O
,	O
the	O
real	O
impact	O
of	O
pregnancy	O
seems	O
to	O
be	O
minimal	O
.	O

Diagnosis	O
of	O
allergy	O
during	O
pregnancy	O
should	O
mainly	O
consist	O
of	O
the	O
patient	O
'	O
s	O
history	O
and	O
in	O
vitro	O
testing	O
.	O

The	O
changes	O
in	O
gene	O
expression	O
were	O
not	O
persistent	O
in	O
terms	O
of	O
consistent	O
differential	O
expression	O
of	O
genes	O
at	O
all	O
stages	O
.	O

The	O
risks	O
were	O
particularly	O
elevated	O
among	O
overweight	O
women	O
with	O
these	O
sleep	O
disorders	O
.	O

Women	O
who	O
have	O
intestinal	O
malabsorption	O
diseases	O
like	O
celiac	O
disease	O
and	O
Crohn	O
'	O
s	O
disease	O
or	O
partial	O
removal	O
or	O
bypass	O
of	O
the	O
stomach	O
or	O
intestines	O
absorb	O
less	O
of	O
both	O
dietary	O
and	O
supplemental	O
vitamin	O
D	O
are	O
at	O
increased	O
risk	O
of	O
deficiency	O
.	O

However	O
,	O
if	O
the	O
mother	O
is	O
already	O
allergic	O
or	O
if	O
there	O
is	O
a	O
family	O
history	O
of	O
atopy	O
or	O
allergy	O
,	O
food	O
comprising	O
potential	O
allergens	O
should	O
be	O
avoided	O
.	O

We	O
hypothesised	O
that	O
gestating	O
through	O
winter	O
in	O
early	O
pregnancy	O
is	O
associated	O
with	O
both	O
reduced	O
serum	O
25OHD	O
and	O
increased	O
markers	O
of	O
glucose	O
metabolism	O
(	O
fasting	O
glucose	O
and	O
insulin	O
resistance	O
);	O
that	O
reduced	O
serum	O
25OHD	O
is	O
associated	O
with	O
increased	O
markers	O
of	O
glucose	O
metabolism	O
;	O
and	O
that	O
seasonal	O
differences	O
in	O
these	O
markers	O
are	O
associated	O
with	O
seasonal	O
variation	O
in	O
serum	O
25OHD	O
.	O

This	O
was	O
then	O
carried	O
out	O
separately	O
for	O
boys	O
and	O
girls	O
.	O

SIRTs	O
have	O
an	O
important	O
role	O
in	O
the	O
process	O
of	O
synapse	O
promotion	O
and	O
modulation	O
of	O
their	O
strength	O
,	O
which	O
is	O
important	O
for	O
memory	O
formation	O
.	O

In	O
a	O
study	O
by	O
Gur	O
et	O
al	O
.	O

Methods	O
This	O
article	O
presents	O
an	O
up	O
-	O
to	O
-	O
date	O
review	O
of	O
publications	O
describing	O
the	O
function	O
of	O
cholecalciferol	O
in	O
reproduction	O
and	O
its	O
place	O
in	O
infertility	O
treatment	O
.	O

The	O
binding	O
of	O
this	O
to	O
vitamin	O
D	O
receptors	O
in	O
turn	O
results	O
in	O
increased	O
intracellular	O
formation	O
of	O
antimicrobial	O
compounds	O
,	O
such	O
as	O
cathelicidins	O
.	O
5The	O
generation	O
of	O
intracellular	O
antimicrobial	O
compounds	O
is	O
impaired	O
in	O
patients	O
who	O
are	O
vitamin	O
D	O
deficient	O
(	O
ie	O
,	O
low	O
serum	O
concentrations	O
of	O
calcifediol	O
).	O

For	O
many	O
years	O
,	O
fast	O
-	O
acting	O
(	O
regular	O
)	O
insulin	O
,	O
and	O
intermediate	O
-	O
acting	O
(	O
isophane	O
)	O
insulin	O
have	O
been	O
the	O
preferred	O
insulins	O
for	O
the	O
treatment	O
of	O
GDM	O
.	O

“	O
The	O
conventional	O
wisdom	O
has	O
been	O
that	O
mothers	O
’	O
worries	O
about	O
milk	O
supply	O
are	O
due	O
either	O
to	O
their	O
misperception	O
of	O
normal	O
lactation	O
and	O
infant	O
breastfeeding	O
behaviors	O
or	O
to	O
mismanagement	O
of	O
breastfeeding	O
technique	O
,	O
and	O
only	O
on	O
very	O
rare	O
occasions	O
due	O
to	O
an	O
intrinsic	O
inability	O
to	O
make	O
enough	O
milk	O
,”	O
says	O
Laurie	O
Nommsen	O
-	O
Rivers	O
,	O
a	O
perinatal	O
nutrition	O
specialist	O
at	O
the	O
University	O
of	O
Cincinnati	O
College	O
of	O
Allied	O
Health	O
Sciences	O
.	O

Skm1	O
homozygous	O
mutant	O
mice	O
were	O
born	O
with	O
expected	O
Mendelian	O
frequency	O
and	O
were	O
easily	O
distinguished	O
from	O
their	O
wild	O
-	O
type	O
littermates	O
at	O
weaning	O
.	O

Adverse	O
health	O
outcomes	O
during	O
pregnancy	O
are	O
preeclampsia	O
;	O
gestational	O
diabetes	O
mellitus	O
and	O
caesarean	O
section	O
.	O

This	O
study	O
investigates	O
the	O
effects	O
of	O
maternal	O
vitamin	O
D	O
deficiency	O
on	O
glomerular	O
development	O
in	O
early	O
postnatal	O
life	O
and	O
its	O
effects	O
on	O
renal	O
structure	O
at	O
maturity	O
.	O

A	O
low	O
protein	O
diet	O
during	O
pregnancy	O
provokes	O
a	O
lasting	O
shift	O
of	O
hepatic	O
expression	O
of	O
genes	O
related	O
to	O
cell	O
cycle	O
throughout	O
ontogenesis	O
in	O
a	O
porcine	O
model	O
Abstract	O
Background	O
In	O
rodent	O
models	O
and	O
in	O
humans	O
the	O
impact	O
of	O
gestational	O
diets	O
on	O
the	O
offspring	O
'	O
s	O
phenotype	O
was	O
shown	O
experimentally	O
and	O
epidemiologically	O
.	O

Methods	O
Study	O
population	O
and	O
setting	O
This	O
preliminary	O
(	O
pilot	O
)	O
study	O
is	O
based	O
on	O
data	O
collected	O
from	O
a	O
cohort	O
of	O
women	O
attending	O
prenatal	O
care	O
clinics	O
affiliated	O
with	O
Swedish	O
Medical	O
Center	O
in	O
Seattle	O
,	O
Washington	O
.	O

However	O
,	O
it	O
is	O
unknown	B
whether	O
changes	O
in	O
nutritional	O
programming	O
by	O
maternal	O
diet	O
restriction	O
during	O
fetal	O
development	O
could	O
modify	O
the	O
expression	O
of	O
ECS	O
components	O
later	O
in	O
life	O
and	O
lead	O
to	O
long	O
-	O
lasting	O
impact	O
on	O
energy	O
metabolism	O
and	O
feeding	O
behavior	O
.	O

The	O
researcher	O
took	O
non	O
-	O
fasting	O
venous	O
blood	O
samples	O
from	O
mothers	O
during	O
6	O
-	O
12	O
and	O
15	O
-	O
20	O
gestational	O
weeks	O
between	O
09	O
:	O
00	O
and	O
11	O
:	O
00	O
am	O
.	O

However	O
,	O
a	O
clinical	O
study	O
that	O
included	O
280	O
pregnant	O
women	O
did	O
not	O
demonstrate	O
correlations	O
between	O
concentrations	O
of	O
VD	O
and	O
PE	O
[	O
59	O
],	O
probably	O
due	O
to	O
its	O
multi	O
-	O
causal	O
etiology	O
.	O

This	O
vitamin	O
is	O
photosynthesized	O
by	O
ultraviolet	O
-	O
B	O
radiation	O
in	O
the	O
epidermis	O
.	O

In	O
the	O
literature	O
,	O
recent	O
studies	O
across	O
a	O
wide	O
range	O
of	O
populations	O
have	O
demonstrated	O
a	O
positive	O
correlation	O
between	O
25	O
(	O
OH	O
)	O
D	O
and	O
cathelicidin	O
[	O
8	O
–	O
11	O
,	O
15	O
,	O
16	O
,	O
18	O
,	O
19	O
].	O

Of	O
the	O
SGA	O
deliveries	O
,	O
37	O
were	O
SGA	O
by	O
weight	O
and	O
56	O
by	O
length	O
.	O

There	O
were	O
nine	O
cases	O
of	O
IUFD	O
at	O
gestational	O
week	O
≥	O
22	O
+	O
0	O
.	O

Taken	O
together	O
,	O
these	O
results	O
suggest	O
that	O
alterations	O
to	O
LINE	O
-	O
1	O
or	O
AluYb8	O
methylation	O
may	O
act	O
as	O
a	O
marker	O
for	O
key	O
changes	O
to	O
the	O
extent	O
of	O
methylation	O
at	O
loci	O
targeted	O
by	O
important	O
transcription	O
factors	O
for	O
normal	O
development	O
and	O
placenta	O
processes	O
necessary	O
for	O
appropriate	O
growth	O
.	O

GWG	O
was	O
adjusted	O
for	O
consecutive	O
gestational	O
week	O
.	O

This	O
questionnaire	O
is	O
comprised	O
of	O
ten	O
multiple	O
choice	O
questions	O
,	O
the	O
minimum	O
score	O
is	O
0	O
and	O
the	O
maximum	O
is	O
30	O
.	O

BMI	O
between	O
18	O
.	O
5	O
and	O
25	O
kg	O
/	O
m2is	O
considered	O
normal	O
,	O
and	O
≥	O
25	O
kg	O
/	O
m2is	O
abnormal	O
.	O

Even	O
after	O
stratifying	O
by	O
season	O
and	O
only	O
analyzing	O
data	O
collected	O
during	O
the	O
winter	O
(	O
October	O
-	O
April	O
)	O
to	O
control	O
for	O
endogenous	O
production	O
,	O
a	O
statistically	O
significant	O
difference	O
remained	O
(	O
63	O
.	O
5	O
±	O
27	O
.	O
7	O
nmol	O
/	O
L	O
vs	O
.	O
79	O
.	O
4	O
±	O
26	O
.	O
7	O
,	O
p	O
<	O
0	O
.	O
001	O
).	O

The	O
frequency	O
of	O
PTB	O
was	O
10	O
%	O
among	O
white	O
women	O
and	O
15	O
%	O
among	O
non	O
-	O
white	O
women	O
.	O

Their	O
offspring	O
were	O
more	O
likely	O
to	O
have	O
weighed	O
less	O
at	O
birth	O
and	O
to	O
have	O
had	O
a	O
lower	O
BMI	O
at	O
age	O
7	O
years	O
(	O
table	O
1	O
).	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
General	O
characteristics	O
of	O
study	O
subjectsGroupsNAge	O
(	O
Year	O
)	O
Gestational	O
weeks	O
(	O
Week	O
)	O
Pre	O
-	O
pregnancy	O
BMI	O
(	O
kg	O
/	O
m2	O
)	O
Control1434	O
.	O
3	O
±	O
4	O
.	O
928	O
.	O
9	O
±	O
4	O
.	O
124	O
.	O
7	O
±	O
4	O
.	O
5Intervention8433	O
.	O
3	O
±	O
3	O
.	O
828	O
.	O
9	O
±	O
3	O
.	O
322	O
.	O
8	O
±	O
3	O
.	O
5	O
Comparison	O
of	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
level	O
in	O
women	O
of	O
the	O
two	O
groups	O
As	O
shown	O
in	O
Table	O
2	O
,	O
the	O
serum	O
levels	O
of	O
total	O
25	O
-	O
OH	O
Vitamin	O
D	O
in	O
the	O
intervention	O
and	O
control	O
group	O
were	O
74	O
.	O

There	O
was	O
a	O
significant	O
positive	O
correlation	O
between	O
age	O
and	O
cathelicidin	O
concentration	O
(	O
ρ	O
=	O
0	O
.	O
236	O
,	O
p	O
=	O
0	O
.	O
005	O
);	O
ρ	O
value	O
represents	O
Spearman	O
correlation	O
.	O

Additionally	O
,	O
multiple	O
other	O
immune	O
symptoms	O
and	O
demographic	O
variables	O
tested	O
were	O
also	O
not	O
predictive	O
of	O
fetal	O
weight	O
.	O

The	O
consumptions	O
of	O
pills	O
were	O
assessed	O
in	O
later	O
prenatal	O
care	O
visits	O
and	O
over	O
the	O
phone	O
.	O

Studies	O
in	O
which	O
participants	O
were	O
chosen	O
at	O
convenience	O
were	O
not	O
considered	O
in	O
this	O
review	O
.	O

On	O
the	O
other	O
hand	O
,	O
it	O
might	O
be	O
associated	O
to	O
the	O
transcriptional	O
excursions	O
within	O
the	O
lipid	O
metabolism	O
in	O
LP	O
offspring	O
.	O

No	O
matter	O
which	O
angle	O
we	O
choose	O
to	O
look	O
at	O
for	O
endometriosis	O
,	O
it	O
is	O
a	O
disease	O
caused	O
by	O
metabolic	O
and	O
biochemical	O
imbalance	O
.	O

In	O
conclusion	O
,	O
developmental	O
vitamin	O
D	O
deficiency	O
is	O
associated	O
with	O
subtle	O
changes	O
in	O
a	O
range	O
of	O
proteins	O
in	O
the	O
nucleus	O
accumbens	O
.	O

Diagnostic	O
Services	O
of	O
Manitoba	O
laboratory	O
reference	O
ranges	O
were	O
adopted	O
for	O
calcium	O
(	O
2	O
.	O
1	O
-	O
2	O
.	O
6	O
mmol	O
/	O
L	O
),	O
albumin	O
(	O
35	O
–	O
47	O
g	O
/	O
L	O
for	O
those	O
<	O
48	O
months	O
and	O
33	O
–	O
39	O
g	O
/	O
L	O
for	O
those	O
≥	O
48	O
months	O
),	O
and	O
PTH	O
(	O
7	O
–	O
50	O
ng	O
/	O
L	O
).	O

Other	O
disadvantages	O
of	O
intravenous	O
iron	O
supplementation	O
include	O
cost	O
and	O
invasiveness	O
of	O
the	O
procedure	O
.	O

Although	O
transplacental	O
transport	O
has	O
not	B
been	I
studied	I
in	O
humans	O
,	O
vitamin	O
D	O
passage	O
from	O
the	O
mother	O
to	O
the	O
fetus	O
would	O
be	O
facilitated	O
by	O
serum	O
concentrations	O
of	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
being	O
higher	O
in	O
the	O
maternal	O
compared	O
to	O
the	O
fetal	O
circulations	O
.	O

2003	O
;	O
Spanò	O
et	O
al	O
.	O

In	O
that	O
final	O
stage	O
,	O
the	O
milk	O
duct	O
system	O
forms	O
in	O
preparation	O
for	O
lactation	O
and	O
breastfeeding	O
.	O

Once	O
transcription	O
within	O
the	O
embryo	O
genome	O
is	O
activated	O
,	O
however	O
,	O
there	O
is	O
rapid	O
cell	O
proliferation	O
and	O
differentiation	O
,	O
processes	O
for	O
which	O
miRNA	O
-	O
mediated	O
regulation	O
is	O
essential	O
(	O
Ivey	O
&	O
Srivastava2015	O
),	O
hence	O
increased	O
expression	O
of	O
miRNAs	O
.	O

Black	O
and	O
Hispanic	O
children	O
also	O
had	O
significantly	O
different	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
at	O
the	O
time	O
of	O
follow	O
-	O
up	O
visit	O
(	O
p	O
=	O
0	O
.	O
023	O
).	O

Behaviourally	O
,	O
adult	O
DVD	O
-	O
deficient	O
rats	O
were	O
more	O
active	O
than	O
controls	O
(	O
i	O
.	O
e	O
.	O

In	O
term	O
labor	O
,	O
GR	O
α	O
'	O
s	O
ΔCt	O
was	O
0	O
.	O
244	O
compared	O
with	O
0	O
.	O
006	O
for	O
GR	O
β	O
,	O
0	O
.	O
006	O
for	O
GR	O
γ	O
,	O
0	O
.	O
023	O
for	O
GR	O
-	O
P	O
,	O
and	O
0	O
.	O
26	O
for	O
GAS5	O
.	O

Disruptions	O
of	O
the	O
process	O
of	O
major	O
neovascularization	O
can	O
lead	O
to	O
serious	O
pregnancy	O
complications	O
,	O
including	O
preeclampsia	O
(	O
PE	O
)	O
in	O
further	O
gestation	O
.	O

In	O
the	O
present	O
study	O
,	O
vitamin	O
D	O
restriction	O
during	O
nephrogenesis	O
reduced	O
podocin	O
expression	O
in	O
the	O
F1	O
generation	O
from	O
weaning	O
until	O
six	O
months	O
of	O
age	O
but	O
not	O
in	O
the	O
F2	O
generation	O
.	O

The	O
GD	O
also	O
decreased	O
approximately	O
5	O
%	O
in	O
the	O
F2	O
-	O
VitD	O
-	O
mice	O
(	O
82	O
.	O
8	O
±	O
0	O
.	O
7	O
µm	O
)	O
in	O
comparison	O
with	O
the	O
F2	O
-	O
SC	O
mice	O
(	O
87	O
.	O
3	O
±	O
1	O
.	O
3	O
µm	O
)	O
(	O
P	O
<	O
0	O
.	O
05	O
,	O
t	O
-	O
test	O
).	O

For	O
now	O
,	O
though	O
,	O
600	O
IU	O
in	O
prenatal	O
vitamins	O
remains	O
the	O
recommended	O
daily	O
intake	O
for	O
pregnant	O
women	O
.	O

However	O
,	O
there	O
is	O
insufficient	O
evidence	O
to	O
implicate	O
any	O
one	O
perinatal	O
or	O
neonatal	O
factor	O
in	O
autism	O
etiology	O
,	O
although	O
there	O
is	O
some	O
evidence	O
to	O
suggest	O
that	O
exposure	O
to	O
a	O
broad	O
class	O
of	O
conditions	O
reflecting	O
general	O
compromises	O
to	O
perinatal	O
and	O
neonatal	O
health	O
may	O
increase	O
the	O
risk	O
.	O

Then	O
,	O
the	O
hypothalamus	O
was	O
dissected	O
out	O
from	O
the	O
base	O
of	O
the	O
brain	O
according	O
the	O
rat	O
brain	O
atlas	O
of	O
Paxinos	O
and	O
Watson	O
(	O
2007	O
).	O

In	O
our	O
study	O
,	O
maternal	O
vitamin	O
D	O
concentrations	O
were	O
similar	O
in	O
non	O
-	O
GDM	O
and	O
GDM	O
mothers	O
,	O
and	O
there	O
was	O
no	O
linear	O
association	O
between	O
vitamin	O
D	O
concentrations	O
and	O
OGTT	O
results	O
.	O

The	O
total	O
number	O
of	O
glomeruli	O
per	O
kidney	O
,	O
adjusted	O
to	O
the	O
entire	O
organ	O
,	O
was	O
estimated	O
from	O
the	O
analyzed	O
fraction	O
of	O
the	O
kidney	O
[	O
17	O
],[	O
18	O
].	O

Specifically	O
,	O
it	O
is	O
the	O
prescriptions	O
taken	O
during	O
pregnancy	O
,	O
the	O
length	O
of	O
labor	O
,	O
viral	O
infection	O
,	O
abnormal	O
presentation	O
at	O
delivery	O
,	O
and	O
finally	O
low	O
birth	O
weight	O
that	O
were	O
associated	O
with	O
autism	O
.	O

Any	O
drug	O
may	O
carry	O
a	O
small	O
risk	O
that	O
must	O
be	O
balanced	O
against	O
the	O
benefits	O
of	O
keeping	O
the	O
mother	O
and	O
baby	O
healthy	O
.	O

Allergic	O
rhinitis	O
is	O
often	O
preexisting	O
but	O
may	O
occur	O
or	O
be	O
recognized	O
for	O
the	O
first	O
time	O
during	O
pregnancy	O
.	O

The	O
average	O
age	O
was	O
29	O
.	O
6	O
±	O
4	O
years	O
,	O
the	O
mean	O
pregnancy	O
days	O
were	O
240	O
±	O
42	O
,	O
and	O
mean	O
fetal	O
weight	O
was	O
2805	O
±	O
95	O
gr	O
.	O

One	O
study	O
reported	O
that	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D3inhibited	O
lipid	O
accumulation	O
by	O
inhibiting	O
key	O
adipogenic	O
factors	O
such	O
as	O
PPARG	O
[	O
143	O
].	O

This	O
study	O
therefore	O
fills	O
a	O
major	O
gap	B
in	O
the	O
cost	O
literature	O
,	O
namely	O
estimating	O
the	O
cost	O
of	O
implementing	O
weekly	O
iron	O
supplementation	O
programs	O
.	O

(	O
2015	O
)*/†	O
Carlin	O
et	O
al	O
.	O

Topical	O
steroids	O
should	O
be	O
selected	O
based	O
on	O
potency	O
considerations	O
,	O
given	O
the	O
potential	O
for	O
systemic	O
absorption	O
and	O
increased	O
skin	O
surface	O
area	O
of	O
pregnancy	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
.	O

Wang	O
et	O
al	O
[	O
144	O
]	O
suggested	O
that	O
the	O
vitamin	O
D	O
receptor	O
(	O
VDR	O
)	O
competes	O
with	O
PPARG	O
for	O
binding	O
to	O
the	O
retinoid	O
X	O
receptor	O
(	O
RXR	O
).	O

Primigravida	O
on	O
the	O
contrary	O
expected	O
vital	O
information	O
from	O
the	O
health	O
talks	O
to	O
help	O
them	O
cope	O
well	O
with	O
their	O
pregnancy	O
and	O
labor	O
[	O
29	O
].	O

A	O
computational	O
analysis	O
of	O
these	O
data	O
revealed	O
that	O
many	O
of	O
the	O
proteins	O
dysregulated	O
in	O
the	O
DVD	O
model	O
have	O
also	O
been	O
shown	O
to	O
be	O
altered	O
in	O
schizophrenia	O
post	O
-	O
mortem	O
brain	O
studies	O
[	O
18	O
].	O

We	O
also	O
aimed	O
to	O
examine	O
the	O
relationship	O
between	O
serum	O
25	O
(	O
OH	O
)	O
D	O
at	O
15	O
±	O
1	O
weeks	O
’	O
gestation	O
and	O
the	O
risk	O
of	O
an	O
adverse	O
pregnancy	O
outcome	O
and	O
included	O
determining	O
the	O
effect	O
modification	O
of	O
fetal	O
sex	O
on	O
the	O
association	O
between	O
maternal	O
vitamin	O
D	O
status	O
and	O
pregnancy	O
outcome	O
.	O

Antenatal	O
corticosteroids	O
and	O
Kangaroo	O
Mother	O
Care	O
(	O
KMC	O
)	O
are	O
evidence	O
-	O
based	O
interventions	O
that	O
are	O
feasible	O
to	O
scale	O
up	O
in	O
low	O
-	O
resource	O
settings	O
and	O
may	O
serve	O
as	O
entry	O
points	O
for	O
strengthening	O
health	O
systems	O
[	O
20	O
,	O
21	O
].	O

When	O
compared	O
with	O
the	O
neonates	O
exposed	O
to	O
monotherapy	O
,	O
a	O
larger	O
proportion	O
of	O
neonates	O
in	O
the	O
polytherapy	O
group	O
were	O
admitted	O
to	O
the	O
NICU	O
(	O
28	O
.	O
8	O
%	O
vs	O
16	O
%)	O
and	O
presented	O
with	O
PNA	O
signs	O
(	O
21	O
.	O
2	O
%	O
vs	O
4	O
%).	O

Finally	O
,	O
for	O
thyroid	O
cancer	O
patients	O
,	O
hypothyroidism	O
can	O
rise	O
the	O
maternal	O
risk	O
of	O
recurrence	O
.	O

Majority	O
(	O
95	O
%)	O
of	O
the	O
mothers	O
took	O
vitamin	O
D	O
supplements	O
during	O
pregnancy	O
,	O
most	O
of	O
them	O
were	O
highly	O
educated	O
(	O
75	O
%	O
had	O
at	O
least	O
a	O
bachelor	O
level	O
education	O
),	O
and	O
73	O
%	O
had	O
normal	O
weight	O
before	O
pregnancy	O
.	O

The	O
search	O
generated	O
27	O
related	O
articles	O
in	O
the	O
following	O
categories	O
:	O
prevalence	O
—	O
2	O
,	O
treatments	O
—	O
8	O
,	O
reviews	O
—	O
6	O
,	O
interventions	O
/	O
trials	O
—	O
6	O
,	O
dosage	O
—	O
1	O
,	O
and	O
technical	O
reports	O
—	O
4	O
.	O

Exposure	O
to	O
winter	O
in	O
early	O
pregnancy	O
was	O
not	O
associated	O
with	O
glucose	O
challenge	O
test	O
results	O
,	O
however	O
it	O
was	O
associated	O
with	O
increased	O
fasting	O
glucose	O
and	O
insulin	O
resistance	O
at	O
28	O
weeks	O
.	O

Averaging	O
parameters	O
were	O
set	O
at	O
70	O
%,	O
therefore	O
for	O
a	O
protein	O
spot	O
to	O
appear	O
in	O
the	O
averaged	O
gel	O
it	O
must	O
be	O
present	O
in	O
70	O
%	O
of	O
all	O
gels	O
within	O
a	O
group	O
.	O

Infant	O
psychomotor	O
and	O
socio	O
-	O
emotional	O
development	O
Psychomotor	O
and	O
socio	O
-	O
emotional	O
development	O
of	O
the	O
offspring	O
is	O
being	O
assessed	O
using	O
the	O
Protocol	O
for	O
Child	O
Monitoring	O
–	O
Infant	O
version	O
(	O
PCM	O
-	O
I	O
),	O
which	O
combines	O
both	O
parental	O
report	O
and	O
direct	O
observation	O
by	O
trained	O
assessors	O
to	O
provide	O
a	O
comprehensive	O
evaluation	O
of	O
a	O
child	O
’	O
s	O
motor	O
skills	O
,	O
cognition	O
,	O
language	O
,	O
personal	O
and	O
socio	O
-	O
emotional	O
development	O
[	O
62	O
].	O

Of	O
those	O
who	O
reported	O
receiving	O
advice	O
on	O
GWG	O
,	O
59	O
%	O
(	O
17	O
/	O
29	O
)	O
reported	O
receiving	O
advice	O
that	O
fell	O
within	O
and	O
31	O
%	O
(	O
9	O
/	O
29	O
)	O
that	O
was	O
above	O
the	O
IOM	O
recommendations	O
,	O
and	O
10	O
%	O
(	O
3	O
/	O
29	O
)	O
could	O
not	O
remember	O
the	O
advice	O
.	O

(	O
2015	O
)*	O
Kundakovic	O
et	O
al	O
.	O

The	O
children	O
’	O
s	O
mean	O
current	O
25	O
(	O
OH	O
)	O
D	O
at	O
the	O
time	O
of	O
the	O
follow	O
-	O
up	O
visit	O
was	O
27	O
.	O
2	O
ng	O
/	O
mL	O
(	O
range	O
8	O
.	O
30	O
–	O
61	O
.	O
5	O
ng	O
/	O
mL	O
;	O
68	O
.	O
3	O
nmol	O
/	O
L	O
).	O

Solid	O
gray	O
circles	O
and	O
solid	O
black	O
line	O
represent	O
MUSC	O
cohort	O
(	O
N	O
=	O
1064	O
)	O
and	O
open	O
circles	O
and	O
dashed	O
line	O
represent	O
Hollis	O
and	O
Wagner	O
et	O
al	O
.	O

Studies	O
on	O
children	O
are	O
likely	O
to	O
be	O
over	O
-	O
representative	O
of	O
individuals	O
from	O
more	O
recent	O
birth	O
years	O
,	O
but	O
the	O
separation	O
of	O
birth	O
cohort	O
and	O
age	O
effects	O
on	O
BMI	O
correlation	O
was	O
possible	O
in	O
this	O
study	O
by	O
including	O
age	O
-	O
fixed	O
and	O
generation	O
-	O
fixed	O
effects	O
in	O
the	O
model	O
.	O

Prolonged	O
labor	O
may	O
also	O
lead	O
to	O
neurological	O
deficits	O
and	O
thus	O
autism	O
.	O

Methods	O
The	O
current	O
prospective	O
observational	O
study	O
is	O
based	O
on	O
the	O
data	O
collected	O
from	O
812	O
pregnant	O
women	O
.	O

Some	O
of	O
the	O
most	O
robust	O
and	O
consistent	O
findings	O
in	O
the	O
DVD	O
model	O
have	O
emerged	O
in	O
behavioural	O
pharmacological	O
studies	O
.	O

These	O
findings	O
suggest	O
that	O
cellular	O
energics	O
may	O
be	O
altered	O
in	O
this	O
brain	O
region	O
in	O
the	O
DVD	O
-	O
deficient	O
rat	O
.	O

Furthermore	O
,	O
two	O
Vietnamese	O
studies	O
showed	O
similar	O
improvements	O
in	O
iron	O
stores	O
following	O
ingestion	O
of	O
ironfortified	O
fish	O
sauce	O
for	O
six	O
to	O
12	O
months	O
[	O
42	O
,	O
43	O
].	O

For	O
that	O
matter	O
,	O
the	O
requirement	O
for	O
the	O
general	O
population	O
is	O
not	B
known	I
either	O
.	O

The	O
mean	O
birth	O
weight	O
of	O
our	O
study	O
cohort	O
was	O
3119	O
g	O
and	O
12	O
.	O
8	O
%	O
of	O
our	O
study	O
population	O
was	O
SGA	O
.	O

Results	O
from	O
the	O
Northern	O
Finland	O
1966	O
Birth	O
Cohort	O
showed	O
that	O
vitamin	O
D	O
supplementation	O
during	O
the	O
first	O
year	O
of	O
life	O
was	O
associated	O
with	O
a	O
reduced	O
risk	O
of	O
schizophrenia	O
in	O
males	O
,	O
but	B
not	I
in	O
women	O
[	O
32	O
].	O

In	O
this	O
issue	O
of	O
Journal	O
of	O
Clinical	O
and	O
Translational	O
Endocrinology	O
,	O
Alissa	O
et	O
al	O
.	O

Potential	O
confounders	O
for	O
vitamin	O
D	O
status	O
were	O
assessed	O
using	O
linear	O
modelling	O
.	O

This	O
simple	O
,	O
inexpensive	O
and	O
safe	O
treatment	O
may	O
prevent	O
the	O
need	O
to	O
use	O
more	O
invasive	O
therapy	O
.	O

Anaemia	O
prevalence	O
was	O
almost	O
halved	O
in	O
supplemented	O
women	O
and	O
anaemic	O
women	O
showed	O
the	O
greatest	O
increase	O
in	O
haemoglobin	O
concentration	O
following	O
supplementation	O
(+	O
1	O
.	O
2g	O
/	O
dL	O
).	O

As	O
stated	O
by	O
the	O
authors	O
,	O
the	O
results	O
of	O
their	O
study	O
prove	O
an	O
increased	O
production	O
of	O
active	O
form	O
of	O
vitamin	O
D	O
in	O
the	O
first	O
trimester	O
decidua	O
,	O
which	O
modulates	O
reactions	O
in	O
a	O
paracrine	O
manner	O
between	O
the	O
mother	O
’	O
s	O
and	O
the	O
embryo	O
’	O
s	O
immune	O
system	O
during	O
the	O
implantation	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Adjusted	O
and	O
unadjusted	O
GEE	O
models	O
comparing	O
treatment	O
(	O
text4baby	O
group	O
)	O
and	O
control	O
(	O
no	O
text4baby	O
enrollment	O
).	O
Questionnaire	O
itemsTreatment	O
vs	O
controlUnadjustedAdjustedaOR	O
(	O
95	O
%	O
CI	O
)	O
P	O
OR	O
(	O
95	O
%	O
CI	O
)	O
PKAB	O
items	O
Eating	O
5	O
or	O
more	O
fruits	O
and	O
vegetables	O
per	O
day	O
is	O
important	O
to	O
the	O
health	O
of	O
my	O
developing	O
baby1	O
.	O
781	O
(	O
0	O
.	O
409	O
,	O
7	O
.	O
760	O
).	O
442	O
.	O
261	O
(	O
0	O
.	O
400	O
,	O
12	O
.	O
787	O
).	O
36Taking	O
a	O
prenatal	O
vitamin	O
is	O
important	O
to	O
the	O
health	O
of	O
my	O
developing	O
baby2	O
.	O
931	O
(	O
0	O
.	O
463	O
,	O
18	O
.	O
551	O
).	O
251	O
.	O
512	O
(	O
0	O
.	O
162	O
,	O
14	O
.	O
092	O
).	O
72I	O
am	O
prepared	O
to	O
be	O
a	O
new	O
mother0	O
.	O
923	O
(	O
0	O
.	O
563	O
,	O
1	O
.	O
514	O
).	O
750	O
.	O
976	O
(	O
0	O
.	O
495	O
,	O
1	O
.	O
924	O
).	O
94If	O
I	O
visit	O
my	O
health	O
care	O
provider	O
on	O
a	O
regular	O
basis	O
,	O
I	O
will	O
be	O
a	O
healthy	O
new	O
mother1	O
.	O
016	O
(	O
0	O
.	O
666	O
,	O
1	O
.	O
549	O
).	O
940	O
.	O
759	O
(	O
0	O
.	O
461	O
,	O
1	O
.	O
251	O
).	O
28If	O
I	O
visit	O
my	O
health	O
care	O
provider	O
on	O
a	O
regular	O
basis	O
,	O
my	O
baby	O
will	O
be	O
healthy1	O
.	O
188	O
(	O
0	O
.	O
771	O
,	O
1	O
.	O
829	O
).	O
430	O
.	O
949	O
(	O
0	O
.	O
595	O
,	O
1	O
.	O
513	O
).	O
83Smoking	O
will	O
harm	O
the	O
health	O
of	O
my	O
developing	O
baby0	O
.	O
880	O
(	O
0	O
.	O
583	O
,	O
1	O
.	O
328	O
).	O
540	O
.	O
753	O
(	O
0	O
.	O
473	O
,	O
1	O
.	O
198	O
).	O
23Secondhand	O
smoke	O
will	O
not	O
harm	O
the	O
health	O
of	O
my	O
developing	O
baby	O
(	O
reverse	O
coded	O
)	O
1	O
.	O
189	O
(	O
0	O
.	O
944	O
,	O
1	O
.	O
497	O
).	O
140	O
.	O
978	O
(	O
0	O
.	O
715	O
,	O
1	O
.	O
336	O
).	O
89Drinking	O
alcohol	O
will	O
harm	O
the	O
health	O
of	O
my	O
developing	O
baby1	O
.	O
018	O
(	O
0	O
.	O
619	O
,	O
1	O
.	O
675	O
).	O
941	O
.	O
253	O
(	O
0	O
.	O
717	O
,	O
2	O
.	O
188	O
).	O
43Taking	O
prenatal	O
vitamins	O
will	O
improve	O
the	O
health	O
of	O
my	O
developing	O
baby0	O
.	O
943	O
(	O
0	O
.	O
722	O
,	O
1	O
.	O
233	O
).	O
670	O
.	O
709	O
(	O
0	O
.	O
488	O
,	O
1	O
.	O
030	O
).	O
07	O
Behaviors	O
Since	O
you	O
found	O
out	O
about	O
your	O
pregnancy	O
,	O
have	O
you	O
consumed	O
alcoholic	O
beverages	O
?	O
0	O
.	O
699	O
(	O
0	O
.	O
293	O
,	O
1	O
.	O
665	O
).	O
432	O
.	O
310	O
(	O
0	O
.	O
491	O
,	O
10	O
.	O
874	O
).	O
29In	O
the	O
last	O
30	O
days	O
,	O
did	O
you	O
smoke	O
?	O
0	O
.	O
927	O
(	O
0	O
.	O
533	O
,	O
1	O
.	O
615	O
).	O
790	O
.	O
938	O
(	O
0	O
.	O
318	O
,	O
2	O
.	O
770	O
).	O
91Ate	O
3	O
or	O
more	O
servings	O
of	O
fruit	O
a	O
day1	O
.	O
160	O
(	O
0	O
.	O
924	O
,	O
1	O
.	O
456	O
).	O
201	O
.	O
107	O
(	O
0	O
.	O
835	O
,	O
1	O
.	O
468	O
).	O
48Ate	O
3	O
or	O
more	O
servings	O
of	O
vegetables	O
a	O
day1	O
.	O
065	O
(	O
0	O
.	O
846	O
,	O
1	O
.	O
339	O
).	O
591	O
.	O
042	O
(	O
0	O
.	O
755	O
,	O
1	O
.	O
438	O
).	O
80Have	O
you	O
ever	O
gone	O
online	O
to	O
search	O
for	O
prenatal	O
care	O
information	O
?	O
0	O
.	O
853	O
(	O
0	O
.	O
584	O
,	O
1	O
.	O
246	O
).	O
410	O
.	O
822	O
(	O
0	O
.	O
476	O
,	O
1	O
.	O
420	O
).	O
48	O
aAdjusted	O
for	O
age	O
,	O
parity	O
,	O
imputed	O
marital	O
status	O
,	O
and	O
race	O
.	O

Increased	O
age	O
and	O
male	O
gender	O
were	O
correlated	O
with	O
increased	O
cathelicidin	O
when	O
controlling	O
for	O
race	O
/	O
ethnicity	O
,	O
percent	O
fat	O
,	O
and	O
child	O
’	O
s	O
current	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
(	O
p	O
=	O
0	O
.	O
028	O
&	O
p	O
=	O
0	O
.	O
047	O
,	O
respectively	O
).	O

Important	O
research	O
priorities	O
have	O
been	O
highlighted	O
[	O
4	O
-	O
6	O
].	O

It	O
has	O
a	O
critical	O
role	O
in	O
enamel	O
,	O
dentin	O
,	O
and	O
oral	O
bone	O
formation	O
as	O
ameloblasts	O
and	O
odontoblasts	O
are	O
target	O
cells	O
for	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D	O
,	O
the	O
active	O
form	O
of	O
vitamin	O
D	O
[	O
17	O
].	O

Data	O
were	O
assessed	O
for	O
normality	O
using	O
the	O
Kolmogorov	O
-	O
Smirnov	O
test	O
and	O
visual	O
inspection	O
of	O
histograms	O
.	O

Table3details	O
actions	O
for	O
the	O
seven	O
constituencies	O
and	O
Figures9	O
,	O
10	O
,	O
11	O
,	O
12	O
,	O
13	O
,	O
14provide	O
examples	O
of	O
action	O
.	O

Gene	O
rs12800438	O
is	O
correlated	O
with	O
higher	O
serum	O
25	O
[	O
OH	O
]	O
D	O
levels	O
,	O
and	O
gene	O
rs6058017	O
-	O
with	O
lighter	O
skin	O
pigmentation	O
[	O
35	O
].	O

This	O
tissue	O
also	O
responds	O
to	O
insulin	O
with	O
a	O
5	O
-	O
fold	O
increase	O
in	O
glucose	O
uptake	O
,	O
without	O
any	O
change	O
in	O
blood	O
flow	O
(	O
Orava	O
et	O
al	O
.,	O
2011	O
),	O
while	O
under	O
cold	O
exposure	O
,	O
glucose	O
uptake	O
increases	O
by	O
12	O
-	O
folds	O
,	O
dissipating	O
energy	O
as	O
a	O
function	O
of	O
increased	O
blood	O
flow	O
(	O
Orava	O
et	O
al	O
.,	O
2011	O
).	O

(	O
2012	O
)*/†	O
MethylmercuryMouseOral	O
(	O
water	O
)	O
(	O
0	O
.	O
5	O
mg	O
/	O
kg	O
)	O
In	O
utero	O
+	O
neonatalAdulthoodBehavioral	O
abnormalitiesHistone	O
modification	O
DNA	O
methylationOnishchenko	O
et	O
al	O
.	O

One	O
study	O
observed	O
that	O
maternal	O
high	O
-	O
fat	O
diet	O
during	O
pregnancy	O
was	O
associated	O
with	O
meconium	O
microbial	O
composition	O
but	O
had	O
limited	O
maternal	O
diet	O
data	O
[	O
6	O
].	O

Furthermore	O
,	O
some	O
studies	O
have	O
found	O
a	O
beneficial	O
effect	O
of	O
influenza	O
vaccination	O
on	O
birth	O
outcomes	O
,	O
specifically	O
a	O
decreased	O
likelihood	O
of	O
delivering	O
a	O
baby	O
preterm	O
or	O
small	O
for	O
gestational	O
age	O
[	O
16	O
],[	O
17	O
],[	O
18	O
],[	O
19	O
],[	O
20	O
],[	O
21	O
],[	O
22	O
].	O

Regardless	O
,	O
serum	O
calcium	O
in	O
the	O
cord	O
blood	O
and	O
in	O
the	O
first	O
days	O
of	O
life	O
is	O
likely	O
controlled	O
by	O
a	O
variety	O
of	O
factors	O
,	O
of	O
which	O
vitamin	O
D	O
is	O
only	O
one	O
factor	O
.	O

2008	O
).	O

Potential	O
for	O
lives	O
saved	O
To	O
understand	O
the	O
impact	O
of	O
evidence	O
-	O
based	O
interventions	O
on	O
deaths	O
due	O
to	O
complications	O
of	O
preterm	O
birth	O
,	O
we	O
considered	O
analyses	O
including	O
historical	O
data	O
from	O
high	O
income	O
countries	O
(	O
Figure4	O
),	O
recent	O
change	O
in	O
middle	O
income	O
countries	O
(	O
Figures5and6	O
)	O
and	O
a	O
new	B
analysis	O
using	O
lives	O
saved	O
modelling	O
.	O

The	O
animal	O
experiment	O
was	O
performed	O
as	O
described	O
[	O
15	O
].	O

There	O
was	O
insufficient	O
case	O
information	O
available	O
to	O
assess	O
any	O
causal	O
association	O
between	O
the	O
allergic	O
reaction	O
and	O
the	O
fetal	O
loss	O
.	O

Such	O
low	O
consumption	O
rate	O
and	O
amount	O
cannot	O
be	O
the	O
leading	O
cause	O
of	O
high	O
Vitamin	O
D	O
detection	O
rate	O
in	O
these	O
participants	O
.	O

The	O
concentrate	O
constitutes	O
36	O
.	O
8	O
%	O
to	O
86	O
.	O
4	O
%	O
of	O
feed	O
from	O
11	O
to	O
18	O
months	O
of	O
age	O
.	O

Multiple	O
studies	O
in	O
high	O
-	O
income	O
contexts	O
have	O
attempted	O
to	O
prevent	O
preterm	O
birth	O
,	O
but	O
have	O
not	B
yet	O-
identified	I
high	O
-	O
impact	O
interventions	O
in	O
the	O
preconception	O
and	O
antenatal	O
periods	O
.	O

Calcium	O
is	O
transported	O
from	O
the	O
mother	O
to	O
the	O
fetus	O
through	O
the	O
placenta	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Clinical	O
recommendations	O
for	O
cumulative	O
gestational	O
weight	O
gain	O
by	O
pre	O
-	O
pregnancy	O
BMI	O
for	O
mothers	O
of	O
singletons	O
and	O
twins	O
at	O
gestational	O
ages	O
37	O
–	O
42	O
weeks	O
(	O
IOM	O
,	O
2009	O
)	O
Prepregnancy	O
BMIRecommended	O
range	O
ofCumulative	O
weight	O
gain	O
(	O
lbs	O
)	O
SingletonTwinsUnderweight	O
(<	O
18	O
.	O
5	O
kg	O
/	O
m2	O
)	O
28	O
–	O
40	O
–	O
Normal	O
(	O
18	O
.	O
5	O
–	O
24	O
.	O
9	O
kg	O
/	O
m2	O
)	O
25	O
–	O
3537	O
–	O
54Overweight	O
(	O
25	O
.	O
0	O
–	O
29	O
.	O
9	O
kg	O
/	O
m2	O
)	O
15	O
–	O
2531	O
–	O
50Obese	O
(≥	O
30	O
.	O
0	O
kg	O
/	O
m2	O
)	O
11	O
–	O
2024	O
–	O
42	O
Actual	O
weight	O
gain	O
during	O
pregnancy	O
is	O
strongly	O
influenced	O
by	O
provider	O
recommendation	O
[	O
6	O
,	O
7	O
].	O

Our	O
results	O
may	O
have	O
differed	O
for	O
several	O
reasons	O
.	O

In	O
particular	O
,	O
the	O
low	O
protein	O
diet	O
provides	O
a	O
model	O
for	O
prenatal	O
dietary	O
undersupply	O
and	O
exposure	O
to	O
famine	O
that	O
regrettably	O
still	O
burdens	O
a	O
considerable	O
proportion	O
of	O
the	O
human	O
population	O
.	O

(	O
2003	O
)	O
demonstrated	O
a	O
decrease	O
in	O
the	O
hypothalamic	O
levels	O
of	O
AEA	O
(	O
confirmed	O
by	O
Ramírez	O
-	O
López	O
et	O
al	O
.,	O
2016	O
)	O
and	O
an	O
absence	O
of	O
significant	O
changes	O
in	O
the	O
gene	O
expression	O
of	O
Cnr1	O
and	O
Faah	O
in	O
the	O
hypothalamus	O
of	O
weaned	O
pups	O
after	O
a	O
maternal	O
undernutrition	O
throughout	O
the	O
last	O
part	O
of	O
pregnancy	O
and	O
/	O
or	O
lactation	O
.	O

In	O
this	O
study	O
,	O
we	O
observed	O
marginal	O
sex	O
-	O
specific	O
differences	O
between	O
early	O
pregnancy	O
vitamin	O
D	O
status	O
and	O
pregnancy	O
outcome	O
where	O
by	O
high	O
vitamin	O
D	O
status	O
and	O
carrying	O
a	O
male	O
fetus	O
was	O
moderately	O
associated	O
with	O
decreasing	O
the	O
risk	O
of	O
having	O
any	O
pregnancy	O
complication	O
.	O

An	O
increased	O
calcidiol	O
level	O
increases	O
the	O
risk	O
of	O
endometriosis	O
occurrence	O
,	O
but	O
in	O
already	O
existing	O
cysts	O
,	O
it	O
is	O
a	O
powerful	O
inhibitor	O
of	O
neovascularization	O
.	O

Moreover	O
,	O
control	O
women	O
who	O
reported	O
a	O
history	O
of	O
psychiatric	O
disorders	O
or	O
who	O
were	O
exposed	O
in	O
their	O
current	O
pregnancy	O
to	O
a	O
known	O
teratogen	O
were	O
excluded	O
.	O

Height	O
is	O
also	O
examined	O
for	O
comparative	O
purposes	O
.	O

However	O
,	O
allergen	O
avoidance	O
may	O
not	O
be	O
preventive	O
or	O
practical	O
in	O
all	O
cohorts	O
[	O
113	O
].	O

These	O
factors	O
can	O
contribute	O
to	O
poor	O
judgment	O
when	O
it	O
comes	O
to	O
food	O
selection	O
and	O
other	O
health	O
-	O
related	O
behaviors	O
.	O

LBW	O
was	O
defined	O
as	O
weight	O
at	O
birth	O
<	O
2500	O
g	O
.	O
Preterm	O
delivery	O
was	O
defined	O
as	O
delivery	O
before	O
gestational	O
week	O
+	O
days	O
37	O
+	O
0	O
,	O
including	O
both	O
induced	O
and	O
spontaneous	O
preterm	O
delivery	O
.	O

On	O
the	O
basis	O
of	O
these	O
criteria	O
,	O
we	O
controlled	O
for	O
maternal	O
age	O
and	O
race	O
/	O
ethnicity	O
.	O

study	O
which	O
showed	O
that	O
“	O
health	O
conscious	O
”	O
dietary	O
patterns	O
were	O
negatively	O
associated	O
with	O
decreasing	O
educational	O
level	O
,	O
age	O
,	O
and	O
socioeconomic	O
status	O
[	O
21	O
].	O

The	O
location	O
of	O
the	O
mutation	O
is	O
indicated	O
by	O
the	O
arrowhead	O
.	O

GAS5	O
was	O
significantly	O
lower	O
in	O
expression	O
in	O
JEG	O
-	O
3	O
cells	O
when	O
compared	O
to	O
BeWo	O
under	O
basal	O
conditions	O
(	O
Figure	O
3	O
(	O
a	O
)).	O

Anthropometric	O
Measures	O
Height	O
(	O
cm	O
)	O
was	O
measured	O
with	O
a	O
Harpenden	O
stadiometer	O
(	O
Holtain	O
,	O
Limited	O
,	O
Crosswell	O
,	O
UK	O
)	O
and	O
weight	O
(	O
kg	O
)	O
was	O
measured	O
using	O
the	O
Healthometer	O
ProPlus	O
scale	O
,	O
(	O
Welch	O
Allyn	O
,	O
Inc	O
.,	O
Skaneateles	O
Falls	O
,	O
NY	O
).	O

The	O
curvilinear	O
relationship	O
remained	O
evident	O
after	O
participants	O
were	O
stratified	O
on	O
the	O
basis	O
of	O
lean	O
(<	O
25	O
kg	O
/	O
m2	O
)	O
and	O
overweight	O
(≥	O
25	O
kg	O
/	O
m2	O
)	O
pre	O
-	O
pregnancy	O
status	O
(	O
Figure2a	O
).	O

In	O
order	O
to	O
explore	O
the	O
biological	O
plausibility	O
of	O
this	O
candidate	O
,	O
we	O
have	O
a	O
rat	O
model	O
that	O
we	O
call	O
the	O
Developmental	O
Vitamin	O
D	O
(	O
DVD	O
)	O
model	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Relationship	O
between	O
changes	O
in	O
25	O
(	O
OH	O
)	O
D	O
level	O
during	O
3	O
months	O
of	O
supplementation	O
and	O
change	O
in	O
total	O
body	O
bone	O
mineral	O
content	O
,	O
r	O
=	O
0	O
.	O
17	O
,	O
p	O
=	O
0	O
.	O
30	O
,	O
effect	O
size	O
=	O
0	O
.	O
18	O
.	O

2	O
.	O
2	O
.	O
3	O
.	O

However	O
,	O
some	O
researchers	O
think	O
mammary	O
gland	O
development	O
and	O
maternal	O
metabolism	O
may	O
provide	O
some	O
clues	O
.	O

Its	O
chemical	O
structure	O
resembles	O
steroid	O
hormones	O
and	O
it	O
acts	O
likewise	O
via	O
nuclear	O
receptor	O
(	O
VDR	O
,	O
vitamin	O
D	O
receptor	O
).	O

There	O
is	O
a	O
growing	O
concern	O
about	O
the	O
health	O
consequences	O
of	O
the	O
high	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
worldwide	O
among	O
the	O
general	O
population	O
,	O
including	O
pregnant	O
women	O
.	O

Based	O
on	O
the	O
PAR	O
hypothesis	O
,	O
the	O
high	O
multivitamin	O
gestational	O
diet	O
would	O
lead	O
to	O
developmental	O
adaptation	O
in	O
the	O
offspring	O
consistent	O
with	O
a	O
high	O
vitamin	O
post	O
-	O
weaning	O
environment	O
.	O

Offspring	O
biometry	O
Body	O
mass	O
(	O
Figures	O
1and2	O
)	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0041740	O
.	O
g001	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Body	O
mass	O
evolution	O
in	O
both	O
the	O
F1	O
and	O
F2	O
generations	O
at	O
earlier	O
stages	O
of	O
development	O
.	O

Our	O
study	O
did	O
not	O
have	O
a	O
sample	O
group	O
large	O
or	O
accessible	O
enough	O
to	O
allow	O
an	O
assessment	O
of	O
long	O
-	O
term	O
pregnancy	O
outcomes	O
.	O

In	O
addition	O
,	O
individuals	O
with	O
the	O
risk	O
factors	O
that	O
we	O
have	O
identified	O
may	O
benefit	O
even	O
more	O
from	O
supplementation	O
or	O
higher	O
dose	O
supplementation	O
.	O

Low	O
adherence	O
with	O
advice	O
about	O
supplements	O
was	O
associated	O
with	O
unwanted	O
pregnancy	O
,	O
low	O
maternal	O
age	O
and	O
low	O
economic	O
status	O
in	O
the	O
United	O
Kingdom	O
[	O
36	O
],	O
unplanned	O
pregnancy	O
and	O
lack	O
of	O
education	O
regarding	O
the	O
role	O
of	O
folic	O
acid	O
in	O
South	O
Korea	O
[	O
37	O
].	O

However	O
,	O
subungual	O
exostosis	O
has	O
a	O
fibrous	O
cap	O
and	O
lacks	O
capillary	O
proliferation	O
.	O

The	O
other	O
seasonal	O
behaviours	O
were	O
not	O
significantly	O
associated	O
with	O
metabolic	O
markers	O
.	O

The	O
infant	O
is	O
weighed	O
on	O
a	O
calibrated	O
scale	O
with	O
minimum	O
of	O
clothing	O
,	O
namely	O
only	O
a	O
vest	O
,	O
and	O
without	O
a	O
nappy	O
;	O
and	O
recorded	O
to	O
the	O
nearest	O
5	O
g	O
.	O
Recumbent	O
length	O
of	O
the	O
infants	O
is	O
taken	O
by	O
means	O
of	O
an	O
infantometer	O
to	O
the	O
nearest	O
0	O
.	O
1	O
cm	O
.	O

We	O
only	O
found	O
a	O
difference	O
between	O
RC	O
and	O
CC	O
female	O
offspring	O
at	O
PND	O
20	O
.	O

(	O
2015	O
)	O
described	O
a	O
protective	O
effect	O
of	O
early	O
(	O
in	O
utero	O
through	O
lactation	O
)	O
exposure	O
to	O
dietary	O
omega	O
-	O
3	O
fatty	O
acids	O
on	O
neuroplasticity	O
in	O
rats	O
that	O
involved	O
specific	O
changes	O
in	O
DNA	O
methylation	O
.	O

Both	O
diet	O
(	O
P	O
<	O
0	O
.	O
0001	O
)	O
and	O
generation	O
(	O
P	O
=	O
0	O
.	O
003	O
)	O
affected	O
the	O
GD	O
,	O
but	O
there	O
was	O
no	O
interaction	O
between	O
diet	O
and	O
generation	O
(	O
P	O
>	O
0	O
.	O
05	O
;	O
two	O
-	O
way	O
ANOVA	O
).	O

Several	O
factors	O
,	O
including	O
MS	O
or	O
QG	O
,	O
feed	O
costs	O
,	O
and	O
carcass	O
prices	O
need	O
to	O
be	O
considered	O
to	O
determine	O
the	O
optimum	O
slaughter	O
weight	O
for	O
the	O
maximum	O
profit	O
.	O

The	O
duration	O
of	O
natural	O
sunlight	O
in	O
our	O
environment	O
varies	O
depending	O
on	O
season	O
,	O
and	O
although	O
it	O
is	O
known	O
that	O
many	O
animals	O
adapt	O
physiologically	O
and	O
behaviourally	O
in	O
order	O
to	O
survive	O
the	O
changing	O
seasons	O
,	O
there	O
is	O
also	O
evidence	O
of	O
circannual	O
biological	O
clocks	O
among	O
humans	O
[	O
15	O
,	O
17	O
].	O

However	O
,	O
by	O
weeks	O
28	O
to	O
36	O
,	O
women	O
taking	O
the	O
daily	O
supplement	O
had	O
a	O
significantly	O
higher	O
prevalence	O
of	O
hemoconcentration	O
,	O
a	O
condition	O
defined	O
as	O
hemoglobin	O
levels	O
above	O
145	O
g	O
/	O
L	O
.	O

Only	O
a	O
very	O
limited	O
number	O
of	O
human	O
studies	O
on	O
the	O
maternofetal	O
transfer	O
of	O
cytokines	O
and	O
chemokines	O
are	O
available	O
.	O

As	O
a	O
sensitivity	O
analysis	O
,	O
we	O
repeated	O
the	O
analyses	O
including	O
all	O
women	O
who	O
self	O
-	O
reported	O
vaccination	O
,	O
regardless	O
of	O
proof	O
of	O
evidence	O
.	O

However	O
,	O
the	O
age	O
of	O
the	O
mother	O
needs	O
to	O
be	O
taken	O
into	O
consideration	O
,	O
as	O
artificial	O
insemination	O
among	O
older	O
mothers	O
has	O
been	O
studied	O
to	O
lead	O
to	O
more	O
complications	O
.	O

The	O
BRAC	O
PO	O
will	O
provide	O
technical	O
support	O
to	O
the	O
SK	O
and	O
SS	O
,	O
and	O
will	O
help	O
them	O
resolve	O
any	O
problems	O
through	O
regular	O
meetings	O
in	O
the	O
field	O
.	O

Mice	O
reared	O
under	O
conditions	O
favoring	O
the	O
right	O
limb	O
develop	O
a	O
right	O
-	O
limb	O
preference	O
,	O
and	O
vice	O
versa	O
[	O
201	O
],	O
further	O
suggesting	O
that	O
environmental	O
factors	O
influence	O
handedness	O
.	O

At	O
PND	O
22	O
–	O
23	O
,	O
offspring	O
were	O
weaned	O
,	O
housed	O
in	O
groups	O
(	O
2	O
–	O
3	O
rats	O
/	O
cage	O
)	O
according	O
to	O
the	O
litter	O
and	O
fed	O
ad	O
libitum	O
with	O
the	O
same	O
standard	O
chow	O
.	O

Excessive	O
GWG	O
was	O
related	O
to	O
offspring	O
weight	O
but	O
more	O
strongly	O
at	O
birth	O
than	O
at	O
6	O
months	O
and	O
was	O
not	O
significantly	O
related	O
to	O
changes	O
in	O
WFA	O
z	O
-	O
scores	O
.	O

Conflict	O
of	O
interest	O
statement	O
The	O
authors	O
declare	O
that	O
the	O
research	O
was	O
conducted	O
in	O
the	O
absence	O
of	O
any	O
commercial	O
or	O
financial	O
relationships	O
that	O
could	O
be	O
construed	O
as	O
a	O
potential	O
conflict	O
of	O
interest	O
.	O

Bonferrroni	O
post	O
-	O
hoc	O
test	O
:*/**	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
vs	O
.	O
respective	O
vehicle	O
males	O
;#/##	O
P	O
<	O
0	O
.	O
05	O
for	O
CC	O
vs	O
.	O
RC	O
(	O
vehicle	O
)	O
females	O
;&/&&/&&&	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
/	O
0	O
.	O
001	O
for	O
CC	O
males	O
vs	O
.	O
females	O
;$/$$/$$$	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
/	O
0	O
.	O
001	O
for	O
RC	O
males	O
vs	O
.	O
females	O
;§	O
P	O
<	O
0	O
.	O
05	O
vs	O
.	O
AM251	O
-	O
treated	O
CC	O
females	O
.	O

Although	O
not	O
prespecified	O
,	O
we	O
also	O
generated	O
rate	O
ratios	O
to	O
compare	O
the	O
proportion	O
of	O
intervention	O
-	O
recommended	O
times	O
at	O
which	O
hands	O
were	O
washed	O
in	O
the	O
two	O
study	O
arms	O
;	O
we	O
used	O
log	O
binomial	O
regression	O
,	O
accounting	O
for	O
repeated	O
measures	O
at	O
the	O
caregiver	O
level	O
to	O
adjust	O
standard	O
errors	O
.	O

Likewise	O
,	O
non	O
-	O
vaccination	O
status	O
was	O
corroborated	O
if	O
no	O
information	O
on	O
vaccination	O
including	O
specific	O
date	O
for	O
vaccination	O
was	O
identified	O
from	O
these	O
sources	O
.	O

Anderson	O
Cancer	O
Center	O
are	O
currently	O
conducting	O
clinical	O
trials	O
in	O
Shanghai	O
on	O
a	O
cancer	O
therapy	O
that	O
uses	O
the	O
venom	O
of	O
the	O
Asiatic	O
toad	O
(	O
Bufo	O
gargarizans	O
).	O

The	O
speculative	O
negative	O
role	O
of	O
fluctuations	O
is	O
vitamin	O
D	O
needs	O
to	O
be	O
considered	O
with	O
caution	O
until	O
further	O
evidence	O
is	O
available	O
.	O

Furthermore	O
,	O
it	O
is	O
perhaps	O
unsurprising	O
that	O
women	O
with	O
higher	O
educational	O
achievement	O
and	O
also	O
those	O
with	O
greater	O
engagement	O
with	O
prenatal	O
care	O
had	O
better	O
nutritional	O
knowledge	O
and	O
used	O
supplements	O
more	O
.	O

Questions	O
on	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
(	O
Community	O
Assessment	O
of	O
Psychic	O
Experiences	O
,	O
CAPE	O
-	O
42	O
,	O
Stefanis	O
et	O
al	O
.,	O
2002	O
[	O
1	O
]),	O
answered	O
by	O
33	O
623	O
women	O
in	O
the	O
follow	O
-	O
up	O
study	O
of	O
Women	O
'	O
s	O
Lifestyle	O
and	O
Health	O
Cohort	O
Caption	O
(	O
MEDIA	O
)	O
Click	O
here	O
for	O
file	O
PubMed	O
Central	O
:	O

As	O
shown	O
in	O
Table	O
1	O
,	O
the	O
age	O
was	O
33	O
.	O
4	O
±	O
4	O
.	O
1	O
years	O
old	O
(	O
ranges	O
from	O
24	O
to	O
46	O
years	O
old	O
),	O
the	O
gestational	O
weeks	O
were	O
29	O
.	O
0	O
±	O
3	O
.	O
3	O
weeks	O
(	O
ranges	O
from	O
14	O
to	O
39	O
weeks	O
),	O
pre	O
-	O
pregnancy	O
BMI	O
was	O
23	O
.	O
0	O
±	O
3	O
.	O
7	O
(	O
ranges	O
from	O
15	O
.	O
6	O
to	O
37	O
.	O
2	O
)	O
kg	O
/	O
m2	O
.	O

Specifically	O
they	O
were	O
asked	O
"	O
Since	O
becoming	O
pregnant	O
,	O
when	O
you	O
are	O
asleep	O
,	O
to	O
the	O
best	O
of	O
your	O
knowledge	O
,	O
have	O
you	O
snored	O
?"	O

But	O
she	O
will	O
need	O
to	O
consume	O
much	O
more	O
to	O
obtain	O
this	O
daily	O
requirement	O
(	O
i	O
.	O
e	O
.,	O
between	O
20	O
and	O
48	O
mg	O
of	O
dietary	O
iron	O
)	O
[	O
18	O
].	O

found	O
that	O
early	O
pregnancy	O
25OHD	O
concentrations	O
<	O
75	O
nmol	O
/	O
L	O
were	O
associated	O
with	O
higher	O
risk	O
of	O
both	O
medically	O
indicated	O
and	O
spontaneous	O
preterm	O
delivery	O
[	O
11	O
].	O

Questionnaire	O
The	O
questionnaire	O
included	O
demographic	O
information	O
(	O
age	O
,	O
race	O
,	O
living	O
environment	O
,	O
education	O
level	O
,	O
type	O
of	O
fuel	O
used	O
for	O
cooking	O
,	O
number	O
of	O
persons	O
in	O
the	O
household	O
,	O
delivery	O
hospital	O
),	O
antenatal	O
care	O
(	O
number	O
of	O
antenatal	O
visits	O
,	O
vaccinations	O
received	O
during	O
pregnancy	O
,	O
consumption	O
of	O
antenatal	O
supplements	O
),	O
presence	O
of	O
medical	O
conditions	O
prior	O
to	O
pregnancy	O
(	O
obesity	O
,	O
diabetes	O
,	O
asthma	O
,	O
renal	O
disease	O
,	O
liver	O
disease	O
,	O
blood	O
disease	O
,	O
neurologic	O
disease	O
),	O
any	O
complications	O
during	O
pregnancy	O
(	O
hospitalization	O
for	O
any	O
specific	O
complication	O
such	O
as	O
preeclampsia	O
,	O
eclampsia	O
,	O
hemorrhage	O
,	O
sepsis	O
,	O
urinary	O
infection	O
,	O
diabetes	O
,	O
severe	O
acute	O
respiratory	O
infection	O
,	O
or	O
influenza	O
-	O
like	O
illness	O
),	O
other	O
risk	O
factors	O
for	O
adverse	O
pregnancy	O
outcomes	O
(	O
alcohol	O
consumption	O
and	O
smoking	O
before	O
and	O
during	O
pregnancy	O
),	O
obstetric	O
characteristics	O
of	O
the	O
mother	O
(	O
number	O
of	O
parturitions	O
,	O
number	O
of	O
abortions	O
,	O
number	O
of	O
livebirths	O
and	O
stillbirths	O
,	O
type	O
of	O
delivery	O
),	O
and	O
characteristics	O
of	O
the	O
offspring	O
(	O
sex	O
,	O
weight	O
,	O
gestational	O
age	O
at	O
delivery	O
).	O

The	O
incidence	O
of	O
GDM	O
is	O
increasing	O
,	O
in	O
parallel	O
to	O
the	O
increase	O
in	O
type	O
2	O
diabetes	O
.	O

Personal	O
and	O
family	O
medical	O
histories	O
were	O
obtained	O
using	O
a	O
questionnaire	O
completed	O
during	O
an	O
interview	O
with	O
the	O
parents	O
.	O

They	O
also	O
demonstrated	O
that	O
intake	O
of	O
prenatal	O
vitamins	O
at	O
the	O
vitamin	O
D	O
dose	O
of	O
400	O
IU	O
/	O
day	O
was	O
sufficient	O
to	O
prevent	O
vitamin	O
D	O
deficiency	O
but	O
was	O
not	O
high	O
enough	O
to	O
prevent	O
vitamin	O
D	O
insufficiency	O
.	O

Concerning	O
hyperphagia	O
,	O
several	O
studies	O
have	O
reported	O
this	O
feeding	O
alteration	O
after	O
the	O
exposure	O
to	O
undernutrition	O
in	O
critical	O
windows	O
of	O
development	O
(	O
Vickers	O
et	O
al	O
.,	O
2000	O
;	O
Desai	O
et	O
al	O
.,	O
2005	O
;	O
Breton	O
et	O
al	O
.,	O
2009	O
;	O
Palou	O
et	O
al	O
.,	O
2010	O
;	O
Lukaszewski	O
et	O
al	O
.,	O
2011	O
;	O
Manuel	O
-	O
Apolinar	O
et	O
al	O
.,	O
2014	O
),	O
so	O
it	O
has	O
been	O
proposed	O
as	O
an	O
important	O
contributor	O
of	O
the	O
excessive	O
body	O
weight	O
.	O

For	O
this	O
reason	O
,	O
a	O
large	O
amount	O
of	O
concentrate	O
is	O
fed	O
during	O
the	O
fattening	O
period	O
in	O
Japanese	O
Wagyu	O
and	O
Korean	O
beef	O
cattle	O
[	O
95	O
,	O
96	O
].	O

Discovery	O
research	O
Discovery	O
research	O
focuses	O
on	O
better	O
understanding	O
the	O
causes	O
and	O
mechanisms	O
of	O
preterm	O
birth	O
and	O
elucidating	O
factors	O
that	O
regulate	O
uterine	O
quiescence	O
,	O
initiation	O
of	O
labour	O
,	O
and	O
the	O
multiple	O
host	O
,	O
agent	O
,	O
and	O
environmental	O
factors	O
that	O
cause	O
aberrations	O
in	O
these	O
normal	O
processes	O
of	O
pregnancy	O
.	O

The	O
RNA	O
-	O
Seq	O
transcriptome	O
and	O
KEGG	O
pathway	O
analyses	O
of	O
differentially	O
expressed	O
genes	O
showed	O
that	O
pathways	O
for	O
PPAR	O
signaling	O
,	O
regulation	O
of	O
the	O
actin	O
cytoskeleton	O
,	O
biosynthesis	O
of	O
unsaturated	O
fatty	O
acids	O
(	O
FA	O
),	O
and	O
Wnt	O
signaling	O
changed	O
in	O
the	O
milk	O
replacement	O
+	O
concentrate	O
+	O
roughage	O
group	O
compared	O
with	O
those	O
in	O
the	O
control	O
group	O
,	O
whereas	O
the	O
milk	O
replacement	O
+	O
concentrate	O
+	O
30	O
%	O
starch	O
diet	O
group	O
showed	O
changes	O
in	O
insulin	O
signaling	O
and	O
mTOR	O
signaling	O
pathways	O
.	O

It	O
has	O
been	O
suggested	O
that	O
these	O
results	O
may	O
reflect	O
a	O
regression	O
to	O
the	O
mean	O
phenomenon	O
or	O
may	O
be	O
related	O
in	O
part	O
to	O
measurement	O
variability	O
(	O
8	O
).	O

The	O
study	O
lacked	O
a	O
valid	O
measurement	O
of	O
infant	O
height	O
.	O

This	O
is	O
carried	O
out	O
at	O
each	O
age	O
point	O
of	O
the	O
index	O
child	O
—	O
at	O
birth	O
and	O
at	O
ages	O
5	O
and	O
9	O
.	O

One	O
male	O
mouse	O
per	O
litter	O
was	O
randomly	O
selected	O
to	O
form	O
the	O
groups	O
(	O
the	O
animals	O
from	O
the	O
same	O
litter	O
were	O
never	O
allocated	O
to	O
the	O
same	O
group	O
).	O

Steam	O
flaking	O
further	O
increases	O
marbling	O
in	O
cases	O
of	O
maize	O
and	O
sorghum	O
,	O
and	O
is	O
more	O
effective	O
for	O
sorghum	O
.	O

The	O
US	O
military	O
has	O
made	O
major	O
investments	O
in	O
mHealth	O
programs	O
to	O
promote	O
health	O
and	O
improve	O
treatment	O
among	O
enlisted	O
personnel	O
and	O
their	O
families	O
[	O
32	O
].	O

Our	O
results	O
suggested	O
that	O
impaired	O
cardiac	O
autonomic	O
modulation	O
characterized	O
by	O
a	O
reduction	O
in	O
the	O
parasympathetic	O
activity	O
occurs	O
in	O
children	O
with	O
low	O
birth	O
weight	O
.	O

4	O
.	O

Maternal	O
and	O
newborn	O
data	O
Maternal	O
data	O
were	O
obtained	O
from	O
a	O
self	O
-	O
administered	O
baseline	O
questionnaire	O
,	O
filled	O
in	O
after	O
delivery	O
,	O
and	O
from	O
medical	O
records	O
.	O

Surgery	O
is	O
the	O
only	O
treatment	O
which	O
is	O
considered	O
potentially	O
curative	O
for	O
metastatic	O
or	O
recurrent	O
medullary	O
carcinoma	O
.	O

In	O
addition	O
,	O
follow	O
-	O
up	O
studies	O
have	O
shown	O
no	O
significant	O
increase	O
in	O
risk	O
.	O

The	O
frequency	O
-	O
domain	O
components	O
were	O
also	O
evaluated	O
by	O
a	O
2	O
power	O
spectrum	O
.	O

The	O
lower	O
serum	O
VD	O
level	O
was	O
also	O
related	O
to	O
worse	O
sperm	O
parameters	O
[	O
52	O
].	O

However	O
,	O
studies	O
in	O
women	O
from	O
Australia	O
and	O
New	O
Zealand	O
are	O
less	O
consistent	O
.	O

Studies	O
of	O
protein	O
intake	O
in	O
pregnancy	O
have	O
indicated	O
that	O
higher	O
maternal	O
protein	O
intake	O
was	O
positively	O
associated	O
with	O
birth	O
weight	O
[	O
8	O
,	O
9	O
],	O
but	O
there	O
are	O
notable	O
exceptions	O
[	O
34	O
,	O
35	O
]	O
and	O
most	O
studies	O
assessed	O
diet	O
later	O
in	O
gestation	O
.	O

So	O
in	O
this	O
survey	O
,	O
we	O
investigated	O
the	O
serum	O
level	O
of	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
in	O
MS	O
patients	O
and	O
compared	O
it	O
with	O
controls	O
in	O
central	O
region	O
of	O
Iran	O
,	O
an	O
area	O
with	O
medium	O
to	O
high	O
risk	O
for	O
MS	O
disease	O
,	O
in	O
spite	O
of	O
high	O
sun	O
exposure	O
.	O

However	O
,	O
diets	O
are	O
often	O
stable	O
,	O
and	O
a	O
mid	O
-	O
pregnancy	O
food	O
frequency	O
questionnaire	O
(	O
FFQ	O
)-	O
assessment	O
is	O
likely	O
to	O
be	O
sufficiently	O
representative	O
of	O
late	O
pregnancy	O
and	O
lactation	O
diet	O
in	O
a	O
high	O
proportion	O
of	O
individuals	O
[	O
25	O
,	O
26	O
].	O

Thus	O
,	O
there	O
is	O
a	O
lack	O
of	O
published	O
information	O
regarding	O
the	O
efficacy	O
of	O
perinatal	O
handwashing	O
promotion	O
interventions	O
on	O
maternal	O
handwashing	O
behavior	O
in	O
the	O
neonatal	O
period	O
and	O
on	O
neonatal	O
mortality	O
.	O

PubMed	O
Central	O
:	O

Loss	O
to	O
follow	O
-	O
up	O
is	O
described	O
inFigure	O
2	O
.	O

Assessment	O
of	O
25	O
(	O
OH	O
)	O
D	O
On	O
the	O
day	O
that	O
the	O
study	O
medication	O
was	O
dispensed	O
and	O
at	O
34	O
weeks	O
of	O
gestation	O
,	O
a	O
nonfasted	O
venous	O
blood	O
sample	O
was	O
obtained	O
and	O
serum	O
stored	O
at	O
−	O
80	O
°	O
C	O
.	O

Multianalyte	O
profiling	O
was	O
performed	O
on	O
the	O
Luminex	O
Magpix	O
system	O
(	O
Luminex	O
Corporation	O
Austin	O
,	O
USA	O
).	O

However	O
,	O
an	O
Australian	O
study	O
showed	O
that	O
both	O
women	O
and	O
providers	O
thought	O
the	O
time	O
for	O
antenatal	O
classes	O
was	O
too	O
small	O
to	O
incorporate	O
all	O
they	O
had	O
to	O
learn	O
with	O
some	O
women	O
complaining	O
of	O
having	O
received	O
too	O
much	O
information	O
[	O
29	O
].	O

The	O
field	O
supervision	O
team	O
will	O
comprise	O
of	O
five	O
Field	O
Research	O
Officers	O
and	O
five	O
District	O
Managers	O
.	O

p	O
value	O
is	O
in	O
bold	O
when	O
statistically	O
significant	O
aAdjusted	O
for	O
maternal	O
height	O
and	O
other	O
listed	O
maternal	O
factors	O
as	O
changing	O
covariates	O
bTwo	O
values	O
are	O
missing	O
from	O
analyses	O
cAdjusted	O
for	O
gestational	O
age	O
Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

Delivery	O
research	O
Delivery	O
or	O
implementation	O
research	O
addresses	O
how	O
interventions	O
can	O
be	O
best	O
implemented	O
,	O
especially	O
in	O
resource	O
-	O
constrained	O
settings	O
where	O
coverage	O
inequalities	O
are	O
more	O
pronounced	O
so	O
that	O
all	O
families	O
are	O
reached	O
with	O
effective	O
care	O
.	O

We	O
also	O
undertook	O
sensitivity	O
analysis	O
in	O
which	O
women	O
who	O
reported	O
having	O
taken	O
any	O
additional	O
vitamin	O
D	O
–	O
containing	O
supplements	O
within	O
90	O
days	O
of	O
the	O
late	O
-	O
pregnancy	O
blood	O
sampling	O
were	O
excluded	O
.	O

Among	O
the	O
proteins	O
,	O
beef	O
and	O
beans	O
—	O
both	O
sources	O
of	O
the	O
antioxidant	O
glutathione	O
—	O
showed	O
the	O
highest	O
inverse	O
effect	O
.	O

A	O
study	O
was	O
performed	O
to	O
understand	O
the	O
mechanism	O
re	O
sponsible	O
for	O
improved	O
MS	O
after	O
early	O
weaning	O
and	O
high	O
-	O
concentrate	O
feeding	O
in	O
Angus	O
and	O
Angus	O
×	O
Simmental	O
steers	O
[	O
55	O
].	O

Methods	O
The	O
data	O
form	O
part	O
of	O
the	O
Lifeways	O
Cross	O
-	O
Generation	O
Cohort	O
Study	O
,	O
established	O
in	O
2001	O
and	O
followed	O
up	O
through	O
to	O
2013	O
.	O

According	O
to	O
Ayurvedic	O
diets	O
,	O
the	O
junk	O
&	O
fast	O
food	O
which	O
is	O
prevalent	O
now	O
is	O
not	O
benificial	O
for	O
mother	O
&	O
fetus	O
is	O
also	O
described	O
.	O

These	O
disparities	O
may	O
have	O
been	O
due	O
to	O
the	O
use	O
of	O
different	O
routes	O
of	O
administration	O
and	O
variations	O
in	O
rat	O
strains	O
/	O
stocks	O
.	O

In	O
the	O
study	O
,	O
steers	O
from	O
dams	O
fed	O
a	O
corn	O
-	O
based	O
diet	O
during	O
late	O
gestation	O
had	O
a	O
lower	O
MS	O
compared	O
with	O
progeny	O
from	O
dams	O
fed	O
diets	O
low	O
in	O
starch	O
(	O
grass	O
hay	O
or	O
dried	O
corn	O
distillers	O
grains	O
with	O
solubles	O
).	O

In	O
this	O
study	O
,	O
215	O
women	O
with	O
GDM	O
were	O
seen	O
at	O
sites	O
randomized	O
to	O
deliver	O
either	O
MNT	O
or	O
standard	O
care	O
.	O
27Fewer	O
subjects	O
in	O
the	O
MNT	O
group	O
required	O
insulin	O
(	O
24	O
.	O
6	O
%	O
vs	O
31	O
.	O
7	O
%,	O
p	O
=	O
0	O
.	O
05	O
)	O
and	O
there	O
was	O
a	O
trend	O
to	O
fewer	O
women	O
having	O
a	O
glycated	O
hemoglobin	O
(	O
HbA1c	O
)	O
>	O
6	O
%	O
(	O
8	O
.	O
1	O
%	O
vs	O
13	O
.	O
6	O
%,	O
p	O
=	O
0	O
.	O
25	O
).	O

Promotion	O
of	O
handwashing	O
with	O
soap	O
before	O
umbilical	O
cord	O
care	O
should	O
be	O
emphasized	O
in	O
antenatal	O
and	O
neonatal	O
care	O
messaging	O
,	O
given	O
existing	O
evidence	O
supporting	O
prevention	O
of	O
umbilical	O
cord	O
infections	O
by	O
caregiver	O
handwashing	O
.	O

At	O
birth	O
10	O
piglets	O
in	O
each	O
litter	O
were	O
distributed	O
over	O
three	O
time	O
points	O
(	O
1	O
,	O
28	O
,	O
188	O
dpn	O
).	O

Predictors	O
with	O
p	O
level	O
≤	O
0	O
.	O
1	O
were	O
further	O
includes	O
in	O
multivariate	O
logistic	O
or	O
linear	O
regression	O
analysis	O
.	O

There	O
is	O
also	O
evidence	O
that	O
decreased	O
parasympathetic	O
activity	O
is	O
correlated	O
with	O
high	O
blood	O
pressure	O
and	O
obesity	O
in	O
childhood	O
[	O
41	O
].	O

In	O
agreement	O
with	O
our	O
findings	O
,	O
others	O
have	O
discovered	O
that	O
mothers	O
with	O
higher	O
vitamin	O
D	O
concentration	O
have	O
infants	O
with	O
smaller	O
head	O
circumference	O
at	O
birth	O
[	O
36	O
,	O
37	O
].	O

It	O
would	O
have	O
been	O
worthwhile	O
to	O
include	O
some	O
more	O
topics	O
such	O
as	O
management	O
of	O
severely	O
acute	O
malnutrition	O
,	O
examples	O
of	O
high	O
,	O
low	O
and	O
moderate	O
glycaemic	O
index	O
foods	O
,	O
how	O
to	O
read	O
food	O
labels	O
(	O
with	O
examples	O
),	O
etc	O
and	O
also	O
additional	O
references	O
for	O
further	O
reading	O
would	O
have	O
been	O
beneficial	O
as	O
the	O
chapters	O
are	O
a	O
quick	O
guide	O
to	O
appraise	O
the	O
topic	O
.	O

We	O
identified	O
households	O
with	O
young	O
children	O
with	O
detailed	O
maps	O
and	O
advice	O
from	O
staff	O
of	O
the	O
Agha	O
Khan	O
Trust	O
for	O
Culture	O
,	O
a	O
non	O
-	O
governmental	O
organisation	O
working	O
in	O
the	O
region	O
.	O

Therefore	O
these	O
costs	O
need	O
to	O
be	O
incorporated	O
into	O
the	O
overall	O
cost	O
of	O
an	O
intervention	O
program	O
.	O

Conversely	O
,	O
the	O
two	O
studies	O
by	O
Oken	O
et	O
al	O
.	O

Animals	O
were	O
assigned	O
to	O
one	O
of	O
6	O
nutritional	O
groups	O
:	O
1	O
)	O
dams	O
fed	O
a	O
standard	O
diet	O
(	O
protein	O
18	O
%,	O
fat	O
5	O
%,	O
digestible	O
energy	O
3	O
.	O
4	O
kcal	O
/	O
gm	O
,	O
Teklad	O
Global	O
18	O
%	O
Protein	O
Diet	O
,	O
Diet	O
2018	O
)	O
ad	O
libitum	O
throughout	O
pregnancy	O
and	O
lactation	O
(	O
Cont	O
group	O
),	O
2	O
)	O
undernourished	O
dams	O
fed	O
50	O
%	O
of	O
a	O
standard	O
diet	O
throughout	O
pregnancy	O
and	O
lactation	O
(	O
UNPL	O
group	O
),	O
3	O
)	O
undernourished	O
dams	O
fed	O
50	O
%	O
of	O
a	O
standard	O
diet	O
throughout	O
pregnancy	O
only	O
(	O
UNP	O
group	O
),	O
4	O
)	O
undernourished	O
dams	O
fed	O
50	O
%	O
of	O
a	O
standard	O
diet	O
throughout	O
lactation	O
only	O
(	O
UNL	O
group	O
),	O
5	O
)	O
dams	O
fed	O
a	O
high	O
-	O
fat	O
diet	O
throughout	O
pregnancy	O
and	O
lactation	O
(	O
PLHF	O
group	O
;	O
45	O
%	O
kcal	O
as	O
fat	O
,	O
20	O
%	O
protein	O
;	O
4	O
.	O
73	O
kcal	O
/	O
gm	O
,	O
Research	O
Diets	O
Inc	O
.	O
D12451	O
)	O
and	O
6	O
)	O
dams	O
fed	O
a	O
pre	O
-	O
conceptional	O
high	O
-	O
fat	O
diet	O
,	O
from	O
the	O
time	O
of	O
their	O
weaning	O
(	O
22	O
days	O
of	O
age	O
)	O
through	O
to	O
conception	O
and	O
throughout	O
pregnancy	O
and	O
lactation	O
(	O
MHF	O
group	O
;	O
45	O
%	O
kcal	O
as	O
fat	O
,	O
20	O
%	O
protein	O
;	O
Research	O
Diets	O
Inc	O
.	O
D12451	O
).	O

Studies	O
in	O
migrants	O
implicate	O
postnatal	O
environmental	O
exposures	O
,	O
but	O
do	O
not	O
exclude	O
prenatal	O
effects	O
.	O
1529Blood	O
concentrations	O
of	O
25	O
-	O
hydroxyvitamin	O
D	O
fluctuate	O
with	O
season	O
,	O
but	O
the	O
etiological	O
relevance	O
of	O
these	O
fluctuations	O
to	O
MS	O
risk	O
is	O
unknown	B
.	O

Their	O
liver	O
showed	O
a	O
decreased	O
gene	O
expression	O
of	O
Cnr1	O
,	O
Ppar	O
α	O
,	O
Ppar	O
γ	O
,	O
the	O
eCBs	O
-	O
degrading	O
enzymes	O
Faah	O
and	O
Mgll	O
,	O
the	O
de	O
novo	O
lipogenic	O
enzymes	O
Acaca	O
and	O
Fasn	O
,	O
and	O
the	O
liver	O
-	O
specific	O
cholesterol	O
biosynthesis	O
regulators	O
Insig1	O
and	O
Hmgcr	O
.	O

Supplementary	O
material10	O
.	O
1183	O
/	O
13993003	O
.	O
00073	O
-	O
2017	O
.	O
Supp1	O
Please	O
note	O
:	O
supplementary	O
material	O
is	O
not	O
edited	O
by	O
the	O
Editorial	O
Office	O
,	O
and	O
is	O
uploaded	O
as	O
it	O
has	O
been	O
supplied	O
by	O
the	O
author	O
.	O

The	O
risk	O
of	O
autism	O
spectrum	O
disorders	O
was	O
shown	O
to	O
be	O
doubled	O
with	O
maternal	O
use	O
of	O
SSRIs	O
in	O
a	O
recent	O
case	O
controlled	O
study	O
of	O
298	O
children	O
,	O
with	O
prenatal	O
exposure	O
reported	O
for	O
20	O
of	O
those	O
children	O
[	O
36	O
].	O

To	O
date	O
,	O
four	O
splice	O
variants	O
of	O
the	O
GR	O
gene	O
have	O
been	O
reported	O
,	O
formed	O
by	O
alternative	O
splicing	O
,	O
termed	O
GR	O
α	O
,	O
GR	O
β	O
,	O
GR	O
γ	O
,	O
and	O
GR	O
-	O
P	O
[	O
2	O
].	O

Also	O
in	O
our	O
study	O
,	O
selection	O
of	O
participants	O
at	O
the	O
beginning	O
was	O
through	O
convenience	O
method	O
.	O

This	O
may	O
be	O
attributed	O
to	O
regular	O
milk	O
intake	O
,	O
which	O
was	O
common	O
in	O
both	O
groups	O
.	O

We	O
therefore	O
undertook	O
this	O
study	O
to	O
determine	O
whether	O
SNPs	O
within	O
the	O
vitamin	O
D	O
metabolism	O
pathway	O
known	O
to	O
modify	O
vitamin	O
D	O
status	O
are	O
also	O
associated	O
with	O
the	O
response	O
to	O
antenatal	O
vitamin	O
D	O
supplementation	O
.	O

PFHXS	O
exhibited	O
the	O
largest	O
association	O
in	O
the	O
BHLM	O
with	O
a	O
10	O
-	O
fold	O
exposure	O
increase	O
associated	O
with	O
a	O
17	O
g	O
birth	O
weight	O
decrease	O
,	O
whereas	O
PFNA	O
was	O
the	O
weakest	O
predictor	O
of	O
birth	O
weight	O
.	O

It	O
should	O
be	O
noted	O
,	O
however	O
,	O
that	O
,	O
from	O
a	O
stand	O
-	O
alone	O
perspective	O
,	O
each	O
of	O
the	O
factors	O
(	O
as	O
listed	O
above	O
)	O
that	O
link	O
autism	O
with	O
pre	O
-,	O
peri	O
-,	O
and	O
neonatal	O
care	O
does	O
not	O
correlate	O
consistently	O
as	O
the	O
incidence	O
of	O
autism	O
is	O
reviewed	O
in	O
terms	O
of	O
its	O
cross	O
-	O
reference	O
amongst	O
various	O
research	O
studies	O
.	O

Weight	O
,	O
blood	O
pressure	O
,	O
and	O
heart	O
rate	O
of	O
the	O
fetus	O
were	O
measured	O
by	O
the	O
same	O
person	O
using	O
a	O
digital	O
scale	O
,	O
digital	O
barometer	O
,	O
and	O
fetal	O
heart	O
detector	O
(	O
sonicaid	O
).	O

However	O
,	O
getting	O
25	O
(	O
OH	O
)	O
D	O
levels	O
consistently	O
above	O
75	O
nmol	O
/	O
L	O
(	O
30	O
ng	O
/	O
mL	O
)	O
may	O
require	O
at	O
least	O
1500	O
-	O
2000	O
IU	O
/	O
day	O
of	O
vitamin	O
D	O
.	O
If	O
a	O
mother	O
is	O
vitamin	O
D	O
deficient	O
,	O
breast	O
milk	O
is	O
not	O
a	O
good	O
source	O
of	O
vitamin	O
D	O
,	O
so	O
infants	O
need	O
to	O
be	O
given	O
vitamin	O
D	O
supplementation	O
until	O
they	O
are	O
weaned	O
.	O

Furthermore	O
,	O
mean	O
LINE	O
-	O
1	O
methylation	O
levels	O
were	O
significantly	O
different	O
by	O
maternal	O
alcohol	O
use	O
during	O
pregnancy	O
;	O
however	O
,	O
limited	O
numbers	O
may	O
affect	O
our	O
precision	O
,	O
so	O
this	O
result	O
should	O
be	O
confirmed	O
in	O
further	O
analyses	O
.	O

The	O
expression	O
of	O
adipogenic	O
factors	O
(	O
CCAAT	O
/	O
enhancer	O
binding	O
protein	O
beta	O
,	O
CCAAT	O
/	O
enhancer	O
binding	O
protein	O
alpha	O
,	O
and	O
PPARG	O
)	O
in	O
the	O
subcutaneous	O
fat	O
and	O
IMF	O
was	O
higher	O
in	O
the	O
high	O
-	O
concentrate	O
group	O
than	O
that	O
in	O
the	O
low	O
-	O
concentrate	O
group	O
,	O
indicating	O
that	O
the	O
dietary	O
roughage	O
/	O
concentrate	O
ratio	O
affects	O
adipogenic	O
gene	O
expression	O
in	O
fat	O
tissues	O
.	O

The	O
genome	O
scan	O
was	O
conducted	O
using	O
an	O
Illumina	O
Mouse	O
Medium	O
density	O
SNP	O
panel	O
(	O
Genetic	O
Analysis	O
Facility	O
,	O
Centre	O
for	O
Applied	O
Genomics	O
,	O
Hospital	O
for	O
Sick	O
Children	O
,	O
Toronto	O
,	O
ON	O
).	O

More	O
research	O
in	O
this	O
area	O
is	O
required	O
to	O
draw	O
sound	O
conclusions	O
.	O

In	O
the	O
late	O
1990s	O
/	O
early	O
2000s	O
,	O
these	O
studies	O
began	O
to	O
associate	O
adverse	O
phenotypes	O
resulting	O
from	O
environmental	O
exposures	O
with	O
epigenetic	O
mechanisms	O
(	O
Issa	O
et	O
al	O
.	O
1996	O
;	O
Tao	O
et	O
al	O
.	O
1998	O
,	O
1999	O
;	O
Choi	O
et	O
al	O
.	O
1999	O
;	O
Bielawski	O
et	O
al	O
.	O
2002	O
;	O
Govindarajan	O
et	O
al	O
.	O
2002	O
;	O
Chen	O
et	O
al	O
.	O
2004	O
;	O
Marwick	O
et	O
al	O
.	O
2004	O
;	O
Pulling	O
et	O
al	O
.	O
2004	O
;	O
Vuillemenot	O
et	O
al	O
.	O
2004	O
;	O
Wu	O
et	O
al	O
.	O
2004	O
).	O

##:	O
adjusted	O
OR	O
for	O
total	O
number	O
of	O
prenatal	O
checks	O
,	O
age	O
,	O
schooling	O
,	O
residence	O
area	O
.	O

After	O
adjustments	O
(	O
infant	O
sex	O
,	O
recruitment	O
clinic	O
,	O
weeks	O
of	O
gestation	O
at	O
delivery	O
,	O
and	O
breastfeeding	O
),	O
no	O
significant	O
interactions	O
were	O
observed	O
in	O
normal	O
weight	O
or	O
overweight	O
/	O
obese	O
mothers	O
(	O
data	O
not	O
shown	O
).	O

Predictors	O
included	O
both	O
baseline	O
and	O
pregnancy	O
changes	O
over	O
time	O
(	O
between	O
entry	O
and	O
30	O
-	O
weeks	O
gestation	O
).	O

DNA	O
methylation	O
also	O
alters	O
the	O
interaction	O
between	O
DNA	O
and	O
DNA	O
binding	O
proteins	O
to	O
regulate	O
gene	O
expression	O
.	O

However	O
,	O
the	O
prevalence	O
of	O
iron	O
deficiency	O
was	O
lower	O
.	O

None	O
of	O
the	O
other	O
variables	O
listed	O
in	O
Table1were	O
found	O
to	O
be	O
confounders	O
.	O

Effective	O
interventions	O
directed	O
specifically	O
at	O
preventing	O
neonatal	O
deaths	O
are	O
required	O
to	O
improve	O
overall	O
child	O
survival	O
.	O

In	O
our	O
study	O
,	O
no	O
hypocalcaemia	O
was	O
observed	O
indicating	O
the	O
safety	O
and	O
efficiency	O
of	O
this	O
supplementation	O
method	O
.	O

Additionally	O
,	O
more	O
women	O
using	O
metformin	O
indicated	O
that	O
their	O
treatment	O
was	O
acceptable	O
compared	O
to	O
those	O
on	O
insulin	O
.	O

We	O
recorded	O
GWG	O
at	O
first	O
measurement	O
,	O
at	O
approximately	O
the	O
12th	O
,	O
20th	O
and	O
30th	O
gestational	O
weeks	O
,	O
and	O
at	O
last	O
measurement	O
.	O

of	O
regulated	O
genesGenes	O
involved	O
in	O
pathway94	O
dpcWnt	O
signalingup1	O
.	O
20	O
*	O
E	O
-	O
29ACVR1	O
,	O
CSNK1G3	O
,	O
FZD4	O
,	O
FZD6	O
,	O
MAP3K7	O
,	O
MMP7	O
,	O
TCF4	O
,	O
TCF7L2	O
,	O
WNT5AMitotic	O
roles	O
of	O
Polo	O
-	O
like	O
kinasedown5	O
.	O
15	O
*	O
E	O
-	O
811CCNB1	O
,	O
CCNB2	O
,	O
CDC23	O
,	O
CDC25B	O
,	O
CDK1	O
,	O
FZR1	O
,	O
SP90AA1	O
,	O
KIF11	O
,	O
PLK1	O
,	O
PPP2R1B	O
,	O
PTTG1G1	O
/	O
S	O
checkpoint	O
regulationdown2	O
.	O
76	O
*	O
E	O
-	O
58CCND2	O
,	O
CCND3	O
,	O
CCNE1	O
,	O
CDK4	O
,	O
E2F1	O
,	O
E2F4	O
,	O
RB1	O
,	O
TFDP1G2	O
/	O
M	O
DNA	O
damage	O
checkpoint	O
regulationdown1	O
.	O
53	O
*	O
E	O
-	O
35CCNB1	O
,	O
CCNB2	O
,	O
CDC25B	O
,	O
CDK1	O
,	O
PLK11	O
dpn	O
-----	O
28	O
dpnComplement	O
systemup2	O
.	O
07	O
*	O
E	O
-	O
55C4B	O
,	O
C5	O
,	O
C6	O
,	O
C9	O
,	O
CD55G1	O
/	O
S	O
checkpoint	O
regulationdown2	O
.	O
49	O
*	O
E	O
-	O
23CDKN1B	O
,	O
HDAC11	O
,	O
TGFB3188	O
dpnVEGF	O
signalingup2	O
.	O
80	O
*	O
E	O
-	O
412ACTA2	O
,	O
AKT3	O
,	O
BCL2	O
,	O
EIF2B1	O
,	O
KDR	O
,	O
MAPK1	O
,	O
MRAS	O
,	O
PIK3R3	O
,	O
PRKCB	O
,	O
RRAS2	O
,	O
VCL	O
,	O
VEGFCmTOR	O
signalingup6	O
.	O
29	O
*	O
E	O
-	O
313AKT3	O
,	O
EIF3B	O
,	O
EIF4B	O
,	O
MAPK1	O
,	O
MRAS	O
,	O
PIK3R3	O
,	O
PPP2CB	O
,	O
PRKAB2	O
,	O
PRKCB	O
,	O
RHOJ	O
,	O
RRAS2	O
,	O
TSC1	O
,	O
VEGFCSynthesis	O
and	O
degradation	O
of	O
ketone	O
bodiesup1	O
.	O
18	O
*	O
E	O
-	O
34ACAA1	O
,	O
BDH1	O
,	O
HADHA	O
,	O
HADHBBile	O
acid	O
synthesisup3	O
.	O
33	O
*	O
E	O
-	O
37ACAA1	O
,	O
ADH5	O
,	O
ADHFE1	O
,	O
ALDH7A1	O
,	O
HADHA	O
,	O
HADHB	O
,	O
LIPAFatty	O
acid	O
elongation	O
in	O
mitochondriaup4	O
.	O
81	O
*	O
E	O
-	O
34ACAA1	O
,	O
AUH	O
,	O
HADHA	O
,	O
HADHBGlucocorticoid	O
receptor	O
signalingup3	O
.	O
99	O
*	O
E	O
-	O
217AKT3	O
,	O
BCL2	O
,	O
CCL2	O
,	O
GTF2A2	O
,	O
GTF2B	O
,	O
GTF2E2	O
,	O
HSP90AB1	O
,	O
HSPA1B	O
,	O
IL1RN	O
,	O
MAPK1	O
,	O
MRAS	O
,	O
NCOR1	O
,	O
PBX1	O
,	O
PIK3R3	O
,	O
RRAS2	O
,	O
TAF4	O
,	O
VCAM1Val	O
,	O
Leu	O
,	O
Ile	O
degradationup8	O
.	O
32	O
*	O
E	O
-	O
38ACAA1	O
,	O
ACAD10	O
,	O
ALDH7A1	O
,	O
AUH	O
,	O
BCKDHB	O
,	O
HADHA	O
,	O
HADHB	O
,	O
HIBADHBiosynthesis	O
of	O
steroidsdown7	O
.	O
65	O
*	O
E	O
-	O
35CYP24A1	O
,	O
CYP7B1	O
,	O
DHCR7	O
,	O
FDFT1	O
,	O
MVD	O
The	O
comparison	O
between	O
the	O
dietary	O
gestational	O
protein	O
diets	O
(	O
LP	O
vs	O
.	O
AP	O
)	O
is	O
shown	O
in	O
dependence	O
of	O
the	O
regulatory	O
direction	O
(	O
up	O
or	O
down	O
).	O

Ethnicity	O
was	O
also	O
a	O
major	O
determinant	O
of	O
vitamin	O
D	O
status	O
in	O
the	O
present	O
study	O
,	O
as	O
previously	O
reported	O
in	O
the	O
adult	O
population	O
[	O
32	O
]	O
and	O
in	O
pregnant	O
women	O
[	O
29	O
],[	O
48	O
],[	O
49	O
].	O

Deaths	O
in	O
the	O
neonatal	O
period	O
have	O
reduced	O
more	O
slowly	O
than	O
those	O
in	O
the	O
postneonatal	O
period	O
since	O
2000	O
.	O

One	O
approach	O
is	O
to	O
consider	O
serum	O
testing	O
in	O
patients	O
at	O
high	O
risk	O
for	O
vitamin	O
D	O
deficiency	O
but	O
treating	O
without	O
testing	O
those	O
at	O
lower	O
risk	O
.	O

However	O
,	O
substitution	O
of	O
equivalent	O
amount	O
of	O
energy	O
from	O
grazed	O
pasture	O
with	O
high	O
-	O
energy	O
grain	O
-	O
based	O
feed	O
has	O
not	O
increased	O
IMF	O
contents	O
.	O

All	O
that	O
changed	O
on	O
16	O
July	O
1979	O
.	O

The	O
women	O
were	O
asked	O
to	O
fill	O
in	O
a	O
paper	O
questionnaire	O
,	O
including	O
a	O
food	O
frequency	O
questionnaire	O
(	O
FFQ	O
),	O
and	O
levels	O
of	O
fish	O
,	O
PUFAs	O
and	O
vitamin	O
D	O
intake	O
were	O
evaluated	O
.	O

At	O
stage	O
94	O
dpc	O
1	O
,	O
001	O
probe	O
-	O
sets	O
differed	O
significantly	O
between	O
LP	O
and	O
AP	O
fetuses	O
(	O
541	O
LP	O
≻	O
AP	O
).	O

In	O
Romania	O
,	O
almost	O
all	O
women	O
are	O
hospitalised	O
for	O
at	O
least	O
3	O
days	O
post	O
-	O
partum	O
during	O
which	O
time	O
the	O
newborn	O
is	O
immunised	O
against	O
tuberculosis	O
and	O
hepatitis	O
B	O
;	O
it	O
is	O
very	O
uncommon	O
to	O
leave	O
the	O
hospital	O
earlier	O
.	O

Examining	O
GWG	O
as	O
a	O
potential	O
mediator	O
,	O
the	O
effects	O
of	O
maternal	O
prenatal	O
behaviors	O
on	O
offspring	O
weight	O
outcomes	O
were	O
generally	O
attenuated	O
(	O
Table	O
4	O
).	O

Among	O
the	O
SGA	O
cases	O
defined	O
by	O
length	O
only	O
,	O
most	O
were	O
close	O
to	O
also	O
meeting	O
the	O
SGA	O
definition	O
for	O
birth	O
weight	O
.	O

In	O
their	O
cross	O
sectional	O
study	O
of	O
740	O
Canadians	O
(	O
323	O
men	O
and	O
417	O
women	O
),	O
Chaput	O
et	O
al	O
noted	O
that	O
short	O
sleep	O
duration	O
(<	O
7	O
hours	O
)	O
was	O
associated	O
with	O
prevalent	O
type	O
2	O
diabetes	O
(	O
OR	O
=	O
1	O
.	O
58	O
;	O
95	O
%	O
CI	O
1	O
.	O
13	O
-	O
2	O
.	O
31	O
)	O
[	O
33	O
].	O

Briefly	O
,	O
data	O
are	O
collected	O
early	O
pregnancy	O
,	O
mid	O
-	O
pregnancy	O
,	O
late	O
pregnancy	O
and	O
at	O
birth	O
.	O

Particularly	O
,	O
we	O
evaluated	O
the	O
gene	O
expression	O
of	O
relevant	O
components	O
of	O
the	O
endocannabinoid	O
system	O
,	O
and	O
key	O
enzymes	O
and	O
regulators	O
of	O
the	O
lipid	O
and	O
cholesterol	O
metabolism	O
in	O
metabolically	O
relevant	O
tissues	O
,	O
such	O
as	O
the	O
hypothalamus	O
,	O
the	O
liver	O
,	O
and	O
the	O
perirenal	O
adipose	O
tissue	O
(	O
PAT	O
),	O
of	O
male	O
and	O
female	O
adult	O
offspring	O
.	O

Compared	O
with	O
women	O
who	O
did	O
not	O
snore	O
during	O
pregnancy	O
,	O
the	O
adjusted	O
mean	O
1	O
-	O
hour	O
glucose	O
concentrations	O
were	O
noted	O
to	O
be	O
6	O
.	O
4	O
mg	O
/	O
dl	O
higher	O
among	O
those	O
women	O
who	O
snored	O
during	O
pregnancy	O
(	O
β	O
=	O
6	O
.	O
4	O
mg	O
/	O
dl	O
,	O
95	O
%	O
CI	O
0	O
.	O
32	O
-	O
12	O
.	O
5	O
,	O
p	O
=	O
0	O
.	O
04	O
).	O

a	O
Principal	O
coordinate	O
plot	O
of	O
generalized	O
UniFrac	O
distances	O
(	O
PERMANOVA	O
p	O
=	O
0	O
.	O
034	O
for	O
maternal	O
dairy	O
as	O
a	O
continuous	O
variable	O
),	O
colored	O
by	O
maternal	O
dairy	O
intake	O
tertiles	O
.	O

In	O
this	O
sample	O
there	O
was	O
a	O
high	O
prevalence	O
of	O
:	O
unfavorable	O
pre	O
-	O
pregnancy	O
nutritional	O
status	O
(	O
overweight	O
or	O
obesity	O
),	O
gestational	O
weight	O
gain	O
above	O
recommendations	O
(	O
PPBMI	O
<	O
25	O
kg	O
/	O
m2is	O
associated	O
with	O
greater	O
weight	O
gain	O
compared	O
to	O
obese	O
),	O
family	O
history	O
of	O
diabetes	O
,	O
advanced	O
age	O
(	O
38	O
.	O
2	O
%)	O
and	O
low	O
levels	O
of	O
physical	O
activity	O
(	O
data	O
shown	O
in	O
Figure1	O
).	O

What	O
is	O
the	O
role	O
of	O
cholecalciferol	O
in	O
human	O
reproduction	O
?	O

Maternal	O
use	O
of	O
supplements	O
,	O
specific	O
brand	O
names	O
,	O
dosing	O
,	O
and	O
date	O
of	O
commencement	O
were	O
recorded	O
.	O

Pre	O
-	O
pregnancy	O
weight	O
and	O
height	O
were	O
also	O
based	O
on	O
self	O
-	O
reports	O
made	O
during	O
the	O
interview	O
.	O

(	O
2015	O
)*	O
Zhou	O
et	O
al	O
.	O

Using	O
both	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
as	O
covariates	O
in	O
the	O
GWG	O
analysis	O
induced	O
a	O
multicollinearity	O
problem	O
based	O
on	O
Cook	O
’	O
s	O
Distance	O
and	O
Levene	O
’	O
s	O
test	O
,	O
but	O
excluding	O
these	O
covariates	O
from	O
the	O
model	O
did	O
not	O
change	O
the	O
results	O
.	O

The	O
general	O
principles	O
of	O
treatment	O
of	O
pregnant	O
women	O
with	O
asthma	O
[	O
21	O
,	O
22	O
,	O
28	O
]	O
and	O
AR	O
[	O
29	O
]	O
do	O
not	O
differ	O
from	O
the	O
stepwise	O
approach	O
recommended	O
for	O
treatment	O
of	O
nonpregnant	O
women	O
.	O

In	O
the	O
high	O
level	O
symptoms	O
group	O
compared	O
with	O
the	O
low	O
level	O
symptoms	O
group	O
,	O
the	O
intake	O
of	O
shellfish	O
1	O
-	O
3	O
times	O
per	O
month	O
was	O
associated	O
with	O
a	O
reduced	O
risk	O
,	O
whereas	O
the	O
intake	O
of	O
shellfish	O
more	O
than	O
three	O
times	O
per	O
week	O
was	O
associated	O
with	O
an	O
increased	O
risk	O
.	O

Prevalence	O
of	O
vitamin	O
D	O
deficiency	O
in	O
non	O
-	O
GDM	O
and	O
GDM	O
mothers	O
were	O
tested	O
with	O
Fisher	O
’	O
s	O
Exact	O
test	O
.	O

Pubertal	O
data	O
are	O
represented	O
as	O
group	O
means	O
and	O
as	O
percentage	O
of	O
offspring	O
entering	O
puberty	O
as	O
a	O
proportion	O
of	O
total	O
.	O

The	O
delivery	O
mode	O
was	O
drawn	O
from	O
maternal	O
delivery	O
records	O
,	O
and	O
maternal	O
pre	O
-	O
pregnancy	O
height	O
,	O
weight	O
,	O
and	O
parity	O
were	O
determined	O
via	O
a	O
self	O
-	O
administered	O
questionnaire	O
upon	O
study	O
entry	O
and	O
used	O
to	O
compute	O
pre	O
-	O
pregnancy	O
BMI	O
.	O

Discussion	O
In	O
this	O
study	O
we	O
examined	O
the	O
relationship	O
between	O
gestational	O
exposure	O
to	O
53	O
different	O
EDCs	O
and	O
birth	O
weight	O
in	O
a	O
prospective	O
birth	O
cohort	O
of	O
mother	O
-	O
infant	O
pairs	O
.	O

More	O
information	O
on	O
Voxiva	O
and	O
text4baby	O
has	O
been	O
published	O
elsewhere	O
[	O
24	O
].	O

General	O
health	O
,	O
health	O
service	O
utilisation	O
,	O
and	O
quality	O
of	O
life	O
:	O
as	O
assessed	O
by	O
questionnaire	O
[	O
34	O
]	O
completed	O
by	O
the	O
infant	O
’	O
s	O
primary	O
caregiver	O
.	O

Cord	O
25	O
(	O
OH	O
)	O
D	O
averaged	O
16	O
.	O
3	O
ng	O
/	O
mL	O
and	O
BMC	O
at	O
one	O
week	O
of	O
life	O
averaged	O
72	O
.	O
6	O
g	O
for	O
the	O
8	O
Hispanic	O
infants	O
who	O
did	O
not	O
return	O
at	O
3	O
months	O
.	O

Stage	O
of	O
development	O
Environmental	O
exposureExposureEffectAdverse	O
phenotype	O
(	O
s	O
)	O
Epigenetic	O
change	O
(	O
s	O
)	O
Reference	O
(	O
s	O
)	O
Air	O
pollution	O
ECATChildhoodChildhoodAsthmaEpigenetic	O
machinerySomineni	O
et	O
al	O
.	O

Compared	O
with	O
lean	O
women	O
who	O
did	O
not	O
snore	O
,	O
those	O
who	O
were	O
overweight	O
and	O
snored	O
had	O
a	O
6	O
.	O
9	O
-	O
fold	O
increased	O
risk	O
of	O
GDM	O
(	O
95	O
%	O
CI	O
2	O
.	O
87	O
-	O
16	O
.	O
6	O
).	O

Exposure	O
to	O
an	O
adverse	O
intrauterine	O
environment	O
during	O
sensitive	O
periods	O
of	O
fetal	O
development	O
produces	O
long	O
-	O
term	O
alterations	O
in	O
the	O
autonomic	O
nervous	O
system	O
(	O
ANS	O
)	O
[	O
15	O
,	O
16	O
,	O
17	O
].	O

Interestingly	O
,	O
GAS5	O
and	O
GR	O
α	O
were	O
the	O
predominant	O
transcripts	O
in	O
both	O
term	O
and	O
preterm	O
placentas	O
.	O

We	O
will	O
use	O
physician	O
-	O
certified	O
verbal	O
autopsy	O
method	O
to	O
identify	O
cases	O
of	O
death	O
related	O
to	O
preterm	O
delivery	O
and	O
birth	O
asphyxia	O
using	O
the	O
hierarchical	O
assignment	O
of	O
causes	O
of	O
death	O
.	O

Wrote	O
the	O
paper	O
:	O
MO	O
KW	O
.	O

Larger	O
observational	O
studies	O
are	O
required	O
to	O
establish	O
a	O
true	O
link	O
between	O
the	O
use	O
of	O
SSRIs	O
and	O
autism	O
.	O

Accelerating	O
evidence	O
-	O
based	O
action	O
for	O
prevention	O
and	O
care	O
Addressing	O
the	O
burden	O
of	O
preterm	O
birth	O
has	O
a	O
dual	O
track	O
--	O
prevention	O
and	O
care	O
(	O
Figure1	O
).	O

The	O
sequences	O
of	O
all	O
the	O
porcine	O
miRNAs	O
were	O
acquired	O
from	O
miRBase	O
(	O
http	O
://	O
www	O
.	O
mirbase	O
.	O
org	O
/).	O

Emulsifier	O
supplementation	O
increased	O
digestion	O
and	O
absorption	O
of	O
a	O
high	O
energy	O
/	O
fat	O
diet	O
in	O
ruminants	O
[	O
106	O
,	O
107	O
].	O

Adequate	O
Vitamin	O
D	O
status	O
(>	O
30	O
nmol	O
/	O
L	O
)	O
significantly	O
promotes	O
calcium	O
absorption	O
and	O
reduces	O
rickets	O
risks	O
,	O
which	O
was	O
deemed	O
as	O
good	O
Vitamin	O
D	O
nutritional	O
status	O
.	O

[	O
50	O
]	O
found	O
that	O
the	O
beneficial	O
effects	O
of	O
prenatal	O
zinc	O
supplementation	O
on	O
the	O
ANS	O
balance	O
persisted	O
until	O
early	O
infancy	O
,	O
suggesting	O
that	O
the	O
nutritional	O
status	O
of	O
the	O
mother	O
is	O
important	O
to	O
fetal	O
ANS	O
development	O
.	O

Some	O
ncRNAs	O
can	O
also	O
promote	O
changes	O
in	O
DNA	O
methylation	O
,	O
histone	O
modifications	O
,	O
and	O
/	O
or	O
the	O
expression	O
of	O
other	O
ncRNAs	O
.	O

Furthermore	O
,	O
metformin	O
can	O
promote	O
the	O
development	O
of	O
lactic	O
acidosis	O
,	O
which	O
surely	O
must	O
be	O
a	O
concern	O
in	O
situations	O
of	O
fetal	O
distress	O
.	O

Even	O
in	O
the	O
last	O
published	O
guidelines	O
the	O
treatment	O
of	O
vitamin	O
D	O
deficient	O
women	O
is	O
not	O
specifically	O
discussed	O
[	O
24	O
].	O

Thus	O
,	O
these	O
neuropeptides	O
are	O
of	O
interest	O
as	O
potential	O
targets	O
for	O
novel	B
antipsychotic	O
agents	O
[	O
39	O
],[	O
40	O
].	O

Vitamin	O
D	O
,	O
which	O
has	O
a	O
unique	O
role	O
in	O
brain	O
homeostasis	O
,	O
embryogenesis	O
and	O
neurodevelopment	O
,	O
neural	O
differentiation	O
,	O
and	O
gene	O
regulation	O
,	O
has	O
recently	O
been	O
proposed	O
as	O
a	O
possible	O
environmental	O
risk	O
factor	O
for	O
autism	O
during	O
early	O
childhood	O
.	O

We	O
have	O
previously	O
suggested	O
the	O
U	O
-	O
shaped	O
association	O
between	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
and	O
inflammatory	O
biomarkers	O
in	O
cord	O
blood	O
[	O
5	O
].	O

We	O
find	O
no	O
support	O
for	O
this	O
in	O
our	O
results	O
,	O
since	O
,	O
the	O
effect	O
of	O
omega	O
-	O
3	O
:	O
omega	O
-	O
6	O
fatty	O
acids	O
on	O
psychotic	O
-	O
like	O
symptoms	O
were	O
almost	O
similar	O
to	O
those	O
of	O
omega	O
-	O
3	O
fatty	O
acids	O
.	O

We	O
therefore	O
sought	O
to	O
review	O
the	O
existing	O
literature	O
(	O
up	O
to	O
7	O
March	O
2016	O
)	O
to	O
evaluate	O
the	O
current	O
evidence	O
for	O
such	O
toxicity	O
.	O

Are	O
multiple	O
exposures	O
additive	O
and	O
/	O
or	O
cumulative	O
?	O

analyzed	O
the	O
large	O
Vaccine	O
Safety	O
Datalink	O
dataset	O
(	O
n	O
=	O
57	O
,	O
554	O
pregnant	O
women	O
in	O
the	O
United	O
States	O
)	O
to	O
assess	O
these	O
associations	O
and	O
after	O
using	O
propensity	O
score	O
to	O
minimize	O
bias	O
introduced	O
by	O
the	O
probability	O
of	O
being	O
vaccinated	O
found	O
no	O
association	O
between	O
influenza	O
vaccination	O
during	O
pregnancy	O
and	O
risk	O
of	O
SGA	O
or	O
PTB	O
[	O
26	O
].	O

Statistical	O
significance	O
was	O
declared	O
at	O
α	O
=	O
0	O
.	O
05	O
.	O

In	O
this	O
study	O
,	O
they	O
selected	O
mothers	O
who	O
needed	O
antidepressant	O
drugs	O
after	O
childbirth	O
as	O
the	O
case	O
group	O
.	O

There	O
were	O
420	O
fathers	O
with	O
height	O
and	O
weight	O
recorded	O
when	O
the	O
child	O
was	O
aged	O
5	O
,	O
but	O
most	O
of	O
these	O
were	O
based	O
on	O
partners	O
’	O
self	O
-	O
report	O
and	O
only	O
77	O
were	O
measured	O
.	O

The	O
contaminated	O
water	O
looked	O
and	O
tasted	O
perfectly	O
clean	O
.	O

Adjusted	O
mean	O
±	O
SEM	O
values	O
of	O
birth	O
weight	O
,	O
length	O
,	O
head	O
circumference	O
SD	O
-	O
scores	O
and	O
ponderal	O
index	O
z	O
-	O
score	O
between	O
(	O
a	O
)	O
maternal	O
prepregnancy	O
BMI	O
groups	O
of	O
underweight	O
,	O
normal	O
weight	O
,	O
overweight	O
and	O
obese	O
;	O
(	O
b	O
)	O
mothers	O
’	O
inadequate	O
GWG	O
,	O
adequate	O
GWG	O
and	O
excessive	O
GWG	O
;	O
(	O
c	O
)	O
GDM	O
and	O
non	O
-	O
GDM	O
mothers	O
;	O
(	O
d	O
)	O
suboptimal	O
and	O
optimal	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
;	O
and	O
(	O
e	O
)	O
suboptimal	O
and	O
optimal	O
UCB	O
25	O
(	O
OH	O
)	O
D	O
.	O
Statistical	O
significance	O
is	O
denoted	O
by	O
*	O
P	O
<	O
0	O
.	O
05	O
,	O
**	O
P	O
<	O
0	O
.	O
01	O
and	O
***	O
P	O
<	O
0	O
.	O
001	O
.	O

This	O
has	O
been	O
elegantly	O
demonstrated	O
by	O
the	O
long	O
-	O
term	O
follow	O
-	O
up	O
of	O
the	O
offspring	O
of	O
Pima	O
Indian	O
mothers	O
.	O
16	O
,	O
17Offspring	O
who	O
were	O
born	O
to	O
mothers	O
who	O
were	O
already	O
diabetic	O
when	O
pregnant	O
had	O
a	O
45	O
%	O
likelihood	O
of	O
type	O
2	O
diabetes	O
by	O
the	O
age	O
of	O
20	O
–	O
24	O
,	O
whereas	O
it	O
was	O
8	O
.	O
6	O
%	O
amongst	O
those	O
with	O
mothers	O
who	O
only	O
developed	O
diabetes	O
after	O
pregnancy	O
(	O
ie	O
,	O
were	O
prediabetic	O
).	O

Grace	O
and	O
colleagues	O
have	O
suggested	O
that	O
dopamine	O
may	O
modulate	O
a	O
range	O
of	O
limbic	O
and	O
cortical	O
functions	O
relevant	O
to	O
the	O
pathophysiology	O
of	O
schizophrenia	O
via	O
the	O
nucleus	O
accumbens	O
[	O
17	O
].	O

There	O
were	O
no	O
significant	O
associations	O
between	O
the	O
SNPs	O
at	O
rs12785878	O
(	O
DHCR7	O
)	O
and	O
rs6013897	O
(	O
CYP24A1	O
)	O
and	O
25	O
(	O
OH	O
)	O
D	O
at	O
34	O
weeks	O
of	O
gestation	O
(	O
Table	O
3	O
).	O

The	O
limited	O
number	O
and	O
effectiveness	O
of	O
available	O
interventions	O
for	O
preterm	O
prevention	O
further	O
underscores	O
this	O
critical	O
major	O
knowledge	B
gap	I
,	O
and	O
makes	O
the	O
case	O
for	O
a	O
strategic	O
and	O
coordinated	O
research	O
effort	O
to	O
advance	O
understanding	O
of	O
causes	O
and	O
mechanisms	O
of	O
preterm	O
birth	O
and	O
identification	O
of	O
innovative	O
solutions	O
.	O

Since	O
Cesarean	O
delivery	O
results	O
in	O
differential	O
microbial	O
community	O
structure	O
of	O
the	O
infant	O
gut	O
[	O
24	O
],	O
and	O
the	O
gut	O
microbiome	O
is	O
a	O
complex	O
system	O
,	O
such	O
differences	O
are	O
plausible	O
;	O
experimental	O
studies	O
will	O
be	O
required	O
to	O
confirm	O
this	O
observation	O
.	O

McBride	O
et	O
al	O
.	O

The	O
ability	O
to	O
find	O
associations	O
between	O
specific	O
seasonal	O
risk	O
factors	O
occurring	O
around	O
the	O
time	O
of	O
birth	O
and	O
adult	O
glioma	O
incidence	O
is	O
limited	O
by	O
the	O
rarity	O
of	O
this	O
cancer	O
in	O
the	O
population	O
and	O
the	O
vast	O
time	O
period	O
from	O
exposure	O
to	O
disease	O
.	O

PubMed	O
Central	O
:	O

In	O
subjects	O
with	O
type	O
2	O
diabetes	O
,	O
the	O
ADOPT	O
Study	O
has	O
demonstrated	O
that	O
metformin	O
is	O
superior	O
to	O
glyburide	O
in	O
this	O
regard	O
.	O
76As	O
there	O
is	O
transplacental	O
passage	O
of	O
metformin	O
,	O
77	O
,	O
78its	O
effect	O
on	O
fetal	O
insulin	O
resistance	O
might	O
even	O
provide	O
further	O
benefit	O
in	O
light	O
of	O
data	O
of	O
insulin	O
resistance	O
and	O
insulin	O
secretory	O
defects	O
in	O
offspring	O
of	O
diabetic	O
pregnancies	O
.	O
19However	O
,	O
any	O
pharmacological	O
agent	O
which	O
crosses	O
the	O
placenta	O
must	O
be	O
viewed	O
with	O
caution	O
as	O
there	O
always	O
remains	O
the	O
possibility	O
of	O
unexpected	O
long	O
-	O
term	O
effects	O
.	O

Nephrin	O
does	O
not	O
affect	O
podocyte	O
apoptosis	O
and	O
gene	O
expression	O
patterns	O
[	O
36	O
].	O

This	O
finding	O
is	O
consistent	O
with	O
the	O
high	O
renin	O
and	O
AT1r	O
expressions	O
observed	O
in	O
the	O
present	O
study	O
.	O

Both	O
intervention	O
and	O
control	O
participants	O
received	O
maternal	O
and	O
neonatal	O
health	O
counseling	O
,	O
patterned	O
on	O
information	O
delivered	O
in	O
Projahnmo	O
[	O
17	O
]	O
(	O
see	O
visit	O
schedule	O
inFigure	O
1	O
).	O

End	O
Note	O
Research	O
for	O
this	O
article	O
was	O
supported	O
by	O
Hertha	O
Firnberg	O
stipend	O
T283	O
-	O
B13	O
and	O
SFB	O
F1808	O
-	O
B13	O
from	O
the	O
Austrian	O
Science	O
Fund	O
(	O
FWF	O
).	O

It	O
would	O
be	O
of	O
interest	O
to	O
repeat	O
these	O
experiments	O
in	O
primary	O
cell	O
lines	O
of	O
syncytialised	O
trophoblasts	O
.	O

Excessive	O
weight	O
gain	O
during	O
pregnancy	O
is	O
associated	O
with	O
complications	O
in	O
delivery	O
[	O
3	O
],	O
increased	O
postpartum	O
weight	O
retention	O
[	O
4	O
],	O
persistent	O
obesity	O
[	O
4	O
],	O
increased	O
BMI	O
in	O
offspring	O
in	O
childhood	O
,	O
adolescence	O
and	O
adulthood	O
[	O
5	O
],	O
and	O
longer	O
maternal	O
hospital	O
stay	O
after	O
labor	O
and	O
delivery	O
[	O
5	O
].	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
.	O

The	O
correlation	O
between	O
testosterone	O
and	O
VD	O
has	O
not	B
been	O-
observed	I
yet	O
in	O
another	O
study	O
conducted	O
in	O
Denmark	O
on	O
307	O
fertile	O
men	O
.	O

Also	O
,	O
emphasis	O
is	O
placed	O
on	O
dished	O
food	O
not	O
eaten	O
and	O
the	O
amount	O
left	O
in	O
the	O
bowl	O
to	O
ensure	O
actual	O
intake	O
is	O
reported	O
.	O

Whereas	O
the	O
number	O
of	O
years	O
of	O
education	O
for	O
the	O
participant	O
herself	O
was	O
similar	O
in	O
the	O
two	O
arms	O
,	O
participants	O
in	O
the	O
control	O
arm	O
reported	O
a	O
mean	O
of	O
7	O
.	O
2	O
years	O
(	O
SD	O
3	O
.	O
3	O
)	O
of	O
education	O
for	O
the	O
husband	O
,	O
compared	O
to	O
those	O
in	O
the	O
intervention	O
arm	O
who	O
reported	O
a	O
mean	O
of	O
8	O
.	O
8	O
years	O
(	O
SD	O
12	O
.	O
0	O
).	O

If	O
nodal	O
involvement	O
is	O
confirmed	O
,	O
total	O
thyroidectomy	O
and	O
modified	O
radical	O
neck	O
dissection	O
are	O
indicated	O
.	O

There	O
is	O
a	O
similar	O
gap	B
in	O
the	O
knowledge	O
base	O
for	O
optimal	O
dosing	O
,	O
as	O
there	O
is	O
little	O
empirical	O
robust	O
evidence	O
to	O
support	O
600	O
IU	O
/	O
day	O
.	O

In	O
a	O
cohort	O
study	O
by	O
Evans	O
et	O
al	O
.	O

Similar	O
inconsistent	O
associations	O
exist	O
for	O
phthalates	O
and	O
BPA	O
[	O
22	O
–	O
24	O
],	O
OCPs	O
[	O
18	O
,	O
25	O
]	O
and	O
PBDEs	O
[	O
26	O
,	O
27	O
].	O

After	O
12	O
months	O
of	O
the	O
project	O
mean	O
hemoglobin	O
increased	O
from	O
122	O
g	O
/	O
L	O
to	O
130g	O
/	O
L	O
,	O
the	O
prevalence	O
of	O
anaemia	O
decreased	O
from	O
38	O
%	O
to	O
20	O
%	O
and	O
the	O
prevalence	O
of	O
hookworm	O
infection	O
decreased	O
from	O
76	O
%	O
to	O
22	O
%[	O
13	O
].	O

The	O
prevalence	O
of	O
postnatal	O
depression	O
in	O
some	O
Asian	O
countries	O
has	O
been	O
reported	O
between	O
22	O
and	O
46	O
.	O
9	O
%	O
[	O
7	O
,	O
8	O
].	O

PTB	O
rates	O
by	O
serum	O
25	O
(	O
OH	O
)	O
D	O
group	O
and	O
PTB	O
subtype	O
are	O
shown	O
inTable	O
3	O
.	O

We	O
aimed	O
to	O
examine	O
associations	O
for	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
across	O
three	O
generations	O
of	O
the	O
same	O
families	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
the	O
relationship	O
between	O
nutritional	O
knowledge	O
and	O
the	O
use	O
of	O
folic	O
acid	O
,	O
iron	O
and	O
multivitamin	O
supplements	O
during	O
pregnancy	O
and	O
to	O
assess	O
the	O
influence	O
of	O
socio	O
-	O
demographic	O
factors	O
and	O
prenatal	O
care	O
.	O

Reported	O
sleep	O
duration	O
before	O
pregnancy	O
was	O
highly	O
correlated	O
with	O
sleep	O
duration	O
during	O
pregnancy	O
(	O
ρ	O
=	O
0	O
.	O
92	O
,	O
p	O
<	O
0	O
.	O
002	O
).	O

The	O
p	O
value	O
of	O
each	O
correlation	O
(	O
or	O
equivalently	O
the	O
SE	O
of	O
the	O
correlation	O
)	O
is	O
adjusted	O
for	O
the	O
estimation	O
of	O
the	O
other	O
correlation	O
coefficients	O
and	O
the	O
fixed	O
effects	O
.	O

The	O
odds	O
ratios	O
of	O
MS	O
among	O
individuals	O
who	O
reported	O
spending	O
at	O
least	O
2	O
hours	O
per	O
day	O
in	O
the	O
sun	O
during	O
holidays	O
and	O
at	O
weekends	O
at	O
ages	O
6	O
-	O
10	O
years	O
were	O
0	O
.	O
47	O
(	O
95	O
%	O
CI	O
0	O
.	O
26	O
-	O
0	O
.	O
84	O
)	O
for	O
winter	O
and	O
0	O
.	O
50	O
(	O
0	O
.	O
24	O
-	O
1	O
.	O
02	O
)	O
for	O
exposure	O
;	O
inverse	O
but	O
weaker	O
associations	O
were	O
observed	O
with	O
sun	O
exposure	O
at	O
older	O
ages	O
.	O

For	O
descriptive	O
purposes	O
,	O
the	O
race	O
variable	O
was	O
defined	O
as	O
non	O
-	O
Hispanic	O
Caucasian	O
,	O
Latina	O
/	O
Hispanic	O
,	O
African	O
-	O
American	O
,	O
and	O
“	O
other	O
.”	O
In	O
other	O
analyses	O
,	O
race	O
was	O
categorized	O
as	O
non	O
-	O
Hispanic	O
Caucasian	O
versus	O
all	O
other	O
groups	O
combined	O
.	O

The	O
results	O
indicated	O
that	O
CC	O
male	O
rats	O
showed	O
an	O
increase	O
in	O
body	O
weight	O
and	O
abdominal	O
fat	O
mass	O
that	O
contrasted	O
with	O
a	O
decrease	O
in	O
caloric	O
intake	O
and	O
compulsive	O
feeding	O
during	O
the	O
adolescence	O
and	O
adulthood	O
compared	O
to	O
CC	O
female	O
rats	O
.	O

A	O
study	O
of	O
Bangladeshi	O
adolescents	O
receiving	O
a	O
micronutrient	O
fortified	O
beverage	O
6d	O
/	O
week	O
reported	O
haematological	O
effects	O
which	O
were	O
of	O
a	O
similar	O
magnitude	O
to	O
those	O
in	O
the	O
current	O
study	O
(	O
Hyder	O
et	O
al	O
2007	O
).	O

On	O
the	O
other	O
hand	O
,	O
the	O
involvement	O
of	O
maternal	O
vitamin	O
D	O
during	O
pregnancy	O
in	O
autism	O
requires	O
proper	O
investigation	O
.	O

As	O
S	O
-	O
ECC	O
is	O
influenced	O
by	O
the	O
social	O
determinants	O
of	O
health	O
,	O
there	O
were	O
differences	O
in	O
parental	O
education	O
levels	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
household	O
income	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
between	O
groups	O
,	O
with	O
lower	O
levels	O
of	O
both	O
education	O
and	O
household	O
income	O
in	O
the	O
S	O
-	O
ECC	O
group	O
.	O

In	O
early	O
pregnancy	O
,	O
those	O
who	O
attended	O
their	O
first	O
antenatal	O
visit	O
in	O
extended	O
winter	O
were	O
significantly	O
more	O
likely	O
to	O
be	O
at	O
risk	O
of	O
25OHD	O
deficiency	O
(<	O
30	O
nmol	O
/	O
L	O
)	O
and	O
25OHD	O
inadequacy	O
(<	O
50	O
nmol	O
/	O
L	O
),	O
than	O
those	O
who	O
attended	O
their	O
first	O
antenatal	O
visit	O
in	O
extended	O
summer	O
(	O
Table2	O
).	O

If	O
the	O
PTB	O
was	O
indicated	O
,	O
the	O
reason	O
was	O
also	O
collected	O
.	O

Little	B
is	I
known	I
about	O
the	O
actual	O
mechanisms	O
by	O
which	O
maternal	O
diet	O
affects	O
children	O
’	O
s	O
health	O
;	O
we	O
hypothesize	O
that	O
maternal	O
diet	O
impacts	O
the	O
development	O
of	O
the	O
gut	O
microbiome	O
in	O
infancy	O
and	O
subsequently	O
influences	O
child	O
health	O
outcomes	O
.	O

PTB	O
rates	O
were	O
calculated	O
for	O
the	O
overall	O
population	O
as	O
well	O
as	O
among	O
women	O
with	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
of	O
<	O
20	O
ng	O
/	O
mL	O
,	O
20	O
to	O
<	O
30	O
ng	O
/	O
mL	O
,	O
30	O
to	O
<	O
40	O
ng	O
/	O
mL	O
and	O
≥	O
40	O
ng	O
/	O
mL	O
closest	O
to	O
delivery	O
.	O

Another	O
paper	O
published	O
after	O
my	O
original	O
paper	O
found	O
that	O
autistic	O
boys	O
have	O
unexplained	O
reductions	O
in	O
metacarpal	O
bone	O
thickness	O
(	O
15	O
).	O

Animals	O
may	O
require	O
more	O
energy	O
to	O
meet	O
the	O
increased	O
maintenance	O
energy	O
requirements	O
.	O

We	O
were	O
unable	O
to	O
assess	O
associations	O
with	O
maternal	O
sugar	O
intake	O
in	O
early	O
pregnancy	O
;	O
however	O
,	O
intakes	O
in	O
early	O
and	O
late	O
pregnancy	O
are	O
likely	O
to	O
be	O
highly	O
correlated	O
.	O

Briefly	O
,	O
100	O
µL	O
of	O
IS	O
(	O
20	O
ng	O
/	O
mL	O
in	O
water	O
)	O
was	O
added	O
to	O
200	O
µL	O
plasma	O
or	O
standard	O
mixture	O
in	O
a	O
glass	O
tube	O
.	O

Meaning	O
that	O
over	O
time	O
,	O
depression	O
scores	O
decreased	O
much	O
more	O
in	O
the	O
vitamin	O
D	O
group	O
in	O
comparison	O
to	O
control	O
group	O
and	O
this	O
shows	O
the	O
possible	O
effects	O
of	O
the	O
vitamin	O
D3supplementation	O
.	O

Because	O
of	O
changes	O
in	O
the	O
diagnostic	O
criteria	O
for	O
GDM	O
over	O
the	O
years	O
,	O
Beischer	O
(	O
1996	O
)	O
was	O
able	O
to	O
examine	O
perinatal	O
mortality	O
amongst	O
women	O
who	O
would	O
have	O
been	O
diagnosed	O
as	O
having	O
GDM	O
by	O
contemporary	O
criteria	O
,	O
but	O
were	O
not	O
considered	O
to	O
have	O
GDM	O
at	O
the	O
time	O
,	O
and	O
were	O
therefore	O
untreated	O
.	O

For	O
example	O
,	O
based	O
on	O
the	O
polymorphic	O
profile	O
and	O
our	O
brief	O
assessment	O
of	O
mothers	O
'	O
attitude	O
towards	O
the	O
pregnancy	O
,	O
we	O
could	O
screen	O
noninvasively	O
and	O
identify	O
mothers	O
during	O
pregnancy	O
that	O
may	O
benefit	O
from	O
stress	O
-	O
management	O
strategies	O
,	O
and	O
this	O
could	O
possibly	O
dramatically	O
improve	O
health	O
outcomes	O
for	O
the	O
mother	O
as	O
well	O
as	O
the	O
fetus	O
.	O

Last	O
,	O
the	O
sample	O
size	O
was	O
rather	O
small	O
,	O
and	O
the	O
vitamin	O
D	O
levels	O
of	O
the	O
participants	O
were	O
generally	O
suboptimal	O
in	O
our	O
study	O
.	O

Results	O
The	O
prevalence	O
of	O
the	O
use	O
of	O
supplements	O
during	O
pregnancy	O
was	O
48	O
%	O
for	O
folic	O
acid	O
,	O
45	O
.	O
3	O
%	O
for	O
iron	O
and	O
68	O
%	O
for	O
multivitamins	O
.	O

We	O
also	O
had	O
no	B
information	I
on	O
frequency	O
of	O
use	O
which	O
could	O
have	O
varied	O
from	O
daily	O
to	O
sparse	O
use	O
.	O

Five	O
QG	O
levels	O
are	O
used	O
in	O
the	O
Korean	O
beef	O
QG	O
system	O
[	O
QG1	O
++	O
(	O
highest	O
),	O
QG1	O
+,	O
QG1	O
,	O
QG2	O
,	O
and	O
QG3	O
(	O
lowest	O
)]	O
[	O
59	O
].	O

Sustained	O
effort	O
by	O
healthcare	O
leaders	O
and	O
advocates	O
at	O
all	O
levels	O
,	O
inside	O
and	O
outside	O
of	O
government	O
,	O
has	O
elevated	O
the	O
issue	O
of	O
preterm	O
birth	O
on	O
the	O
nation	O
'	O
s	O
health	O
agenda	O
,	O
contributing	O
to	O
an	O
announcement	O
of	O
new	O
federal	O
resources	O
to	O
test	O
promising	O
practices	O
in	O
February	O
2012	O
.	O

Acute	O
lymphoblastic	O
leukemia	O
(	O
ALL	O
)	O
is	O
the	O
most	O
common	O
childhood	O
cancer	O
(	O
with	O
2	O
,	O
400	O
cases	O
diagnosed	O
each	O
year	O
in	O
those	O
under	O
age	O
20	O
)	O
and	O
the	O
second	O
most	O
common	O
cause	O
of	O
mortality	O
in	O
children	O
aged	O
1	O
–	O
14	O
.	O

Multiple	O
gestations	O
and	O
terminated	O
pregnancies	O
were	O
excluded	O
from	O
the	O
analyses	O
.	O

Although	O
there	O
are	O
contradicting	O
epidemiological	O
and	O
experimental	O
results	O
regarding	O
the	O
direct	O
influence	O
of	O
smoking	O
on	O
total	O
and	O
specific	O
IgE	O
production	O
,[	O
97	O
,	O
98	O
]	O
smoking	O
should	O
nevertheless	O
be	O
avoided	O
for	O
obvious	O
reasons	O
,	O
such	O
as	O
carcinogenic	O
smoke	O
constituents	O
and	O
the	O
vasoconstrictive	O
effect	O
of	O
nicotine	O
.	O

There	O
are	O
a	O
wealth	O
of	O
data	O
showing	O
that	O
in	O
the	O
rat	O
,	O
compromising	O
early	O
life	O
signals	O
such	O
as	O
maternal	O
undernutrition	O
or	O
glucocorticoid	O
exposure	O
lead	O
to	O
offspring	O
that	O
develop	O
a	O
deleterious	O
metabolic	O
phenotype	O
;	O
including	O
obesity	O
,	O
with	O
both	O
peripheral	O
components	O
such	O
as	O
sarcopenia	O
and	O
insulin	O
resistance	O
,	O
and	O
central	O
components	O
including	O
hyperphagia	O
,	O
a	O
preference	O
for	O
fatty	O
foods	O
and	O
altered	O
willingness	O
to	O
exercise	O
[	O
27	O
]–[	O
29	O
].	O

When	O
corporate	O
and	O
government	O
officials	O
appeared	O
in	O
the	O
spill	O
’	O
s	O
aftermath	O
and	O
began	O
inquiring	O
into	O
exposure	O
to	O
the	O
slurry	O
and	O
potential	O
health	O
problems	O
,	O
the	O
Navajo	O
people	O
finally	O
learned	O
the	O
truth	O
—	O
far	O
from	O
being	O
harmless	O
,	O
these	O
uranium	O
mines	O
were	O
poisoning	O
people	O
,	O
and	O
researchers	O
say	O
they	O
will	O
continue	O
to	O
do	O
so	O
for	O
decades	O
to	O
come	O
.	O

Only	O
expression	O
of	O
GAS5	O
was	O
significantly	O
upregulated	O
by	O
cortisol	O
in	O
all	O
treatments	O
compared	O
with	O
basal	O
levels	O
,	O
but	O
none	O
of	O
the	O
GRs	O
changed	O
expression	O
significantly	O
.	O

Pre	O
-	O
publication	O
history	O
The	O
pre	O
-	O
publication	O
history	O
for	O
this	O
paper	O
can	O
be	O
accessed	O
here	O
:	O
http	O
://	O
www	O
.	O
biomedcentral	O
.	O
com	O
/	O
1471	O
-	O
2431	O
/	O
13	O
/	O
174	O
/	O
prepub	O
PubMed	O
Central	O
:	O

For	O
a	O
second	O
filtering	O
step	O
standard	O
deviations	O
were	O
calculated	O
for	O
each	O
probe	O
-	O
set	O
over	O
all	O
subsets	O
of	O
arrays	O
of	O
the	O
particular	O
comparisons	O
.	O

Likewise	O
,	O
in	O
patients	O
with	O
vitamin	O
D	O
deficiency	O
,	O
a	O
higher	O
occurrence	O
of	O
uterine	O
myomas	O
is	O
observed	O
—	O
another	O
established	O
reason	O
for	O
infertility	O
.	O

Briefly	O
,	O
vitamin	O
D	O
concentrations	O
were	O
standardized	O
by	O
taking	O
the	O
difference	O
of	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
to	O
the	O
average	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
of	O
the	O
corresponding	O
month	O
.	O

Methods	O
A	O
search	O
of	O
the	O
Canada	O
Vigilance	O
Database	O
from	O
April	O
1	O
,	O
2008	O
to	O
August	O
31	O
,	O
2013	O
identified	O
15	O
cases	O
of	O
anaphylaxis	O
and	O
16	O
reports	O
of	O
serious	O
non	O
-	O
anaphylactic	O
allergic	O
reactions	O
.	O

PubMed	O
Central	O
:	O

The	O
questionnaire	O
asked	O
about	O
their	O
current	O
weekly	O
frequency	O
of	O
consumption	O
of	O
43	O
food	O
groups	O
and	O
food	O
items	O
.	O

We	O
are	O
beginning	O
to	O
learn	O
that	O
it	O
plays	O
a	O
much	O
wider	O
role	O
in	O
health	O
and	O
disease	O
prevention	O
.	O

The	O
dietary	O
intake	O
of	O
vitamin	O
D	O
in	O
this	O
cohort	O
is	O
comparable	O
to	O
several	O
other	O
European	O
populations	O
[	O
58	O
].	O

Half	O
took	O
60	O
mg	O
of	O
iron	O
as	O
ferrous	O
sulfate	O
with	O
200	O
μg	O
of	O
folic	O
acid	O
and	O
1	O
μg	O
of	O
vitamin	O
B12once	O
a	O
day	O
;	O
the	O
others	O
took	O
double	O
this	O
dose	O
once	O
a	O
week	O
.	O

The	O
study	O
nurses	O
obtain	O
maternal	O
weight	O
before	O
birth	O
with	O
a	O
calibrated	O
digital	O
scale	O
.	O

It	O
is	O
well	O
known	O
that	O
lower	O
HRV	O
parameters	O
are	O
associated	O
with	O
increased	O
mortality	O
due	O
to	O
heart	O
failure	O
,	O
coronary	O
heart	O
disease	O
and	O
ischemic	O
cardiomyopathy	O
during	O
adulthood	O
[	O
40	O
].	O

Patrick	O
and	O
colleagues	O
[	O
14	O
]	O
found	O
that	O
,	O
compared	O
to	O
control	O
,	O
short	O
message	O
service	O
(	O
SMS	O
)	O
text	O
messaging	O
and	O
multimedia	O
message	O
service	O
(	O
MMS	O
)	O
participants	O
achieved	O
1	O
.	O
97	O
kg	O
greater	O
weight	O
loss	O
.	O

(%)	O
northern	O
countries18	O
060	O
(	O
98	O
)	O
13	O
942	O
(	O
97	O
)	O
744	O
(	O
91	O
)	O
other	O
countries318	O
(	O
2	O
)	O
427	O
(	O
3	O
)	O
68	O
(	O
8	O
)	O
missing33	O
(	O
0	O
.	O
2	O
)	O
26	O
(	O
0	O
.	O
2	O
)	O
5	O
(	O
0	O
.	O
6	O
)	O
Smokers	O
,	O
No	O
.	O

This	O
is	O
where	O
dose	O
/	O
level	O
of	O
exposure	O
and	O
relevance	O
to	O
humans	O
is	O
crucial	O
,	O
but	O
considerations	O
of	O
alternative	O
replacements	O
are	O
also	O
important	O
.	O

Treatment	O
to	O
post	O
-	O
prandial	O
targets	O
results	O
in	O
superior	O
pregnancy	O
outcomes	O
compared	O
to	O
pre	O
-	O
prandial	O
targets	O
.	O
25The	O
recommended	O
treatment	O
targets	O
vary	O
from	O
country	O
to	O
country	O
(	O
Table	O
2	O
).	O

Ninety	O
-	O
nine	O
percent	O
(	O
99	O
%)	O
of	O
the	O
respondents	O
affirmed	O
that	O
ANC	O
was	O
important	O
not	O
only	O
for	O
the	O
mother	O
but	O
for	O
the	O
foetus	O
as	O
well	O
.	O

Current	O
OECD	O
human	O
health	O
related	O
TGs	O
that	O
have	O
the	O
potential	O
for	O
adaptation	O
to	O
include	O
epigenetic	O
endpoints	O
.	O
Type	O
of	O
studyTGsDescriptionGeneral	O
exposure	O
studiesTG	O
451Carcinogenicity	O
studies	O
TG	O
452Chronic	O
toxicity	O
studies	O
TG	O
453Combined	O
chronic	O
toxicity	O
/	O
carcinogenicity	O
studiesPost	O
-	O
mitotic	O
cell	O
studiesTG	O
424Neurotoxicity	O
study	O
in	O
rodentsPrenatal	O
effectsTG	O
414Prenatal	O
development	O
toxicity	O
study	O
TG	O
426Developmental	O
neurotoxicity	O
studyReproductive	O
effectsTGs	O
415	O
,	O
416One	O
-	O
and	O
two	O
-	O
generation	O
reproduction	O
toxicity	O
TG	O
421	O
(	O
Revised	O
)	O
Reproduction	O
/	O
developmental	O
toxicity	O
screening	O
test	O
TG	O
422	O
(	O
Revised	O
)	O
Combined	O
repeated	O
dose	O
toxicity	O
study	O
with	O
the	O
reproduction	O
/	O
developmental	O
toxicity	O
screening	O
test	O
TG	O
443Extended	O
one	O
-	O
generation	O
reproductive	O
toxicity	O
studyGenotoxicity	O
testsTG	O
483	O
(	O
Revised	O
2015	O
)	O
Mammalian	O
spermatogonial	O
chromosome	O
aberration	O
testAlternative	O
models	O
integrating	O
multiple	O
mechanisms	O
of	O
toxicityTG	O
236	O
-	O
Zebrafish	O
embryo	O
epigenetic	O
toxicity	O
assay	O
Xenopus	O
Embryo	O
Thyroid	O
Assay	O
(	O
XETA	O
Assay	O
)	O
(	O
in	O
validation	O
)	O
Updated	O
from	O
Greally	O
and	O
Jacobs	O
(	O
2013	O
).	O

The	O
positive	O
predictive	O
value	O
(	O
PPV	O
)	O
and	O
negative	O
predictive	O
value	O
(	O
NPV	O
)	O
of	O
self	O
-	O
reporting	O
vaccination	O
and	O
non	O
-	O
vaccination	O
status	O
were	O
then	O
calculated	O
.	O

The	O
role	O
of	O
1	O
,	O
25	O
-(	O
OH	O
)	O
2D	O
during	O
pregnancy	O
to	O
increase	O
intestinal	O
calcium	O
absorption	O
is	O
since	O
long	O
acknowledged	O
[	O
24	O
].	O

Fieldworkers	O
allocated	O
children	O
to	O
randomisation	O
groups	O
during	O
recruitment	O
and	O
gave	O
vitamin	O
D	O
or	O
placebo	O
.	O

Moreover	O
,	O
the	O
outcomes	O
of	O
the	O
present	O
study	O
enhance	O
the	O
importance	O
of	O
the	O
periconceptional	O
period	O
as	O
well	O
as	O
the	O
role	O
of	O
maternal	O
diet	O
in	O
the	O
early	O
life	O
programming	O
,	O
due	O
to	O
the	O
fact	O
that	O
the	O
maternal	O
undernutrition	O
was	O
implemented	O
before	O
mating	O
and	O
offspring	O
were	O
raised	O
in	O
an	O
ad	O
libitum	O
standard	O
feeding	O
.	O

The	O
use	O
of	O
forward	O
primers	O
containing	O
one	O
of	O
eight	O
five	O
-	O
nucleotide	O
barcodes	O
between	O
the	O
Illumina	O
-	O
specific	O
bridge	O
and	O
sequencing	O
primer	O
regions	O
and	O
the	O
16S	O
-	O
specific	O
region	O
and	O
a	O
single	O
reverse	O
primer	O
containing	O
1	O
of	O
12	O
Illumina	O
indices	O
enables	O
96	O
samples	O
per	O
lane	O
multiplexing	O
.	O

Thus	O
,	O
a	O
similar	O
sncRNA	O
switch	O
,	O
this	O
time	O
back	O
to	O
increased	O
genome	O
protection	O
makes	O
functional	O
sense	O
.	O

Although	O
a	O
weak	O
correlation	O
was	O
found	O
between	O
poor	O
intrauterine	O
environments	O
and	O
ASD	O
with	O
intellectual	O
disabilities	O
,	O
there	O
was	O
no	O
relationship	O
found	O
between	O
ASD	O
without	O
intellectual	O
disabilities	O
and	O
perinatal	O
factors	O
[	O
12	O
].	O

did	O
not	O
find	O
an	O
association	O
between	O
season	O
and	O
gestational	O
diabetes	O
incidence	O
among	O
4942	O
British	O
women	O
between	O
1996	O
and	O
1997	O
[	O
28	O
].	O

Besides	O
,	O
depression	O
scores	O
were	O
evaluated	O
four	O
times	O
:	O
at	O
26	O
–	O
28	O
and	O
38	O
–	O
40	O
weeks	O
of	O
gestation	O
,	O
and	O
finally	O
at	O
4	O
and	O
8	O
weeks	O
after	O
birth	O
.	O

Several	O
recent	O
studies	O
have	O
reported	O
an	O
association	O
between	O
season	O
of	O
birth	O
and	O
glioma	O
risk	O
.	O

Despite	O
few	O
cases	O
of	O
IUFD	O
in	O
the	O
GraviD	O
cohort	O
,	O
our	O
results	O
suggest	O
that	O
vitamin	O
D	O
deficiency	O
in	O
early	O
pregnancy	O
may	O
be	O
linked	O
to	O
IUFD	O
.	O

Concerns	O
about	O
vitamin	O
D	O
have	O
resurfaced	O
in	O
medical	O
and	O
scientific	O
literature	O
owing	O
to	O
its	O
multiple	O
effects	O
on	O
human	O
health	O
.	O

Depression	O
scores	O
were	O
determined	O
four	O
times	O
:	O
at	O
26	O
–	O
28	O
weeks	O
of	O
gestation	O
(	O
baseline	O
),	O
at	O
38	O
–	O
40	O
weeks	O
of	O
gestation	O
,	O
and	O
finally	O
at	O
4	O
and	O
8	O
weeks	O
after	O
birth	O
.	O

Data	O
relating	O
to	O
pre	O
-	O
pregnancy	O
lifestyle	O
behaviours	O
were	O
not	O
collected	O
.	O

Consenting	O
subjects	O
who	O
were	O
present	O
in	O
the	O
village	O
on	O
an	O
allotted	O
day	O
were	O
recruited	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Flow	O
diagram	O
for	O
inclusion	O
of	O
journal	O
articles	O
[	O
17	O
].	O

Results	O
Demographic	O
and	O
underlying	O
variables	O
from	O
the	O
two	O
groups	O
are	O
presented	O
inTable	O
1	O
.	O

Ethics	O
approval	O
was	O
obtained	O
from	O
the	O
ALSPAC	O
Ethics	O
and	O
Law	O
Committee	O
(	O
IRB	O
00003312	O
)	O
and	O
the	O
Local	O
National	O
Health	O
Service	O
Research	O
Ethics	O
Committees	O
.	O

Follow	O
-	O
up	O
assessments	O
of	O
mothers	O
include	O
anthropometric	O
measures	O
,	O
diet	O
history	O
,	O
nutrient	O
status	O
,	O
blood	O
pressure	O
,	O
breast	O
milk	O
composition	O
,	O
and	O
measures	O
of	O
postnatal	O
depression	O
and	O
fatigue	O
.	O

Of	O
the	O
3268	O
women	O
included	O
in	O
the	O
analysis	O
,	O
55	O
%	O
(	O
1789	O
)	O
had	O
documented	O
influenza	O
vaccination	O
in	O
2014	O
.	O

Preventive	O
Measures	O
for	O
Mother	O
and	O
Child	O
Strategies	O
for	O
prevention	O
of	O
atopic	O
diseases	O
may	O
be	O
categorized	O
as	O
primary	O
,	O
secondary	O
,	O
and	O
tertiary	O
.	O

The	O
Remaining	O
169	O
participants	O
were	O
assigned	O
to	O
the	O
control	O
or	O
vitamin	O
D	O
groups	O
with	O
a	O
block	O
randomization	O
design	O
,	O
and	O
they	O
were	O
referred	O
to	O
the	O
laboratory	O
to	O
provide	O
blood	O
sample	O
.	O

In	O
view	O
of	O
the	O
foregoing	O
,	O
a	O
review	O
of	O
effectiveness	O
of	O
preventive	O
treatments	O
of	O
iron	O
deficiency	O
anaemia	O
in	O
pregnancy	O
was	O
conducted	O
;	O
furthermore	O
,	O
constraints	O
were	O
highlighted	O
and	O
suggestions	O
for	O
improvement	O
were	O
provided	O
.	O

We	O
will	O
estimate	O
incremental	O
cost	O
-	O
effectiveness	O
ratios	O
as	O
incremental	O
cost	O
per	O
neonate	O
death	O
avoided	O
;	O
per	O
low	O
birth	O
weight	O
infant	O
avoided	O
and	O
per	O
life	O
-	O
year	O
saved	O
.	O

Pre	O
-	O
publication	O
history	O
The	O
pre	O
-	O
publication	O
history	O
for	O
this	O
paper	O
can	O
be	O
accessed	O
here	O
:	O
http	O
://	O
www	O
.	O
biomedcentral	O
.	O
com	O
/	O
1471	O
-	O
2431	O
/	O
12	O
/	O
6	O
/	O
prepub	O
PubMed	O
Central	O
:	O

The	O
heritability	O
marbling	O
phenotype	O
in	O
Japanese	O
Wagyu	O
is	O
0	O
.	O
40	O
to	O
0	O
.	O
55	O
[	O
44	O
–	O
46	O
],	O
and	O
MS	O
heritabilities	O
in	O
Angus	O
and	O
Brahman	O
are	O
0	O
.	O
48	O
[	O
47	O
]	O
and	O
0	O
.	O
37	O
to	O
0	O
.	O
44	O
[	O
48	O
,	O
49	O
],	O
respectively	O
.	O

All	O
the	O
malformations	O
reported	O
were	O
observed	O
in	O
the	O
neonates	O
exposed	O
to	O
polytherapy	O
.	O

We	O
will	O
financially	O
incentivise	O
the	O
SS	O
for	O
early	O
identification	O
of	O
pregnant	O
women	O
.	O

Accordingly	O
,	O
we	O
adjusted	O
for	O
feeding	O
method	O
(	O
exclusively	O
breastfed	O
,	O
combination	O
fed	O
,	O
exclusively	O
formula	O
fed	O
),	O
maternal	O
BMI	O
(	O
continuous	O
),	O
parity	O
(	O
continuous	O
),	O
and	O
batch	O
and	O
performed	O
a	O
sensitivity	O
analysis	O
in	O
exclusively	O
breastfed	O
infants	O
.	O

We	O
identified	O
76	O
human	O
cohort	O
studies	O
within	O
PubMed	O
that	O
associated	O
adverse	O
phenotype	O
(	O
s	O
)	O
(	O
such	O
as	O
birth	O
outcomes	O
,	O
organ	O
-	O
specific	O
abnormalities	O
/	O
disorders	O
,	O
cancer	O
or	O
mortality	O
)	O
with	O
epigenetic	O
change	O
(	O
s	O
)	O
(	O
mainly	O
DNA	O
methylation	O
to	O
-	O
date	O
,	O
but	O
also	O
histone	O
modification	O
,	O
epigenetic	O
machinery	O
and	O
miRNAs	O
)	O
and	O
exposure	O
to	O
environmental	O
factor	O
(	O
s	O
)	O
(	O
including	O
air	O
pollution	O
,	O
chemicals	O
,	O
fibers	O
,	O
radiation	O
or	O
lifestyle	O
factors	O
(	O
alcohol	O
,	O
nutrition	O
or	O
smoking	O
))	O
at	O
various	O
stages	O
of	O
development	O
(	O
pre	O
-	O
conception	O
,	O
in	O
utero	O
,	O
neonatal	O
,	O
childhood	O
,	O
adolescence	O
,	O
adulthood	O
and	O
lifetime	O
).	O

Interestingly	O
,	O
risk	O
of	O
severe	O
vitamin	O
D	O
deficiency	O
decreased	O
with	O
more	O
frequent	O
use	O
of	O
sunscreen	O
lotion	O
and	O
increased	O
for	O
women	O
who	O
reported	O
preference	O
for	O
shadow	O
(	O
Table	O
5	O
).	O

Methods	O
A	O
cohort	O
of	O
1	O
,	O
290	O
women	O
was	O
interviewed	O
during	O
early	O
pregnancy	O
.	O

Iranian	O
usual	O
diet	O
also	O
contains	O
high	O
amounts	O
of	O
salt	O
,	O
which	O
means	O
that	O
salt	O
intake	O
among	O
them	O
is	O
almost	O
twofold	O
the	O
recommended	O
levels	O
.	O

Conclusions	O
These	O
preliminary	O
findings	O
suggest	O
associations	O
of	O
short	O
sleep	O
duration	O
and	O
snoring	O
with	O
glucose	O
intolerance	O
and	O
GDM	O
.	O

Sampling	O
The	O
target	O
population	O
of	O
the	O
survey	O
comprised	O
all	O
pregnant	O
women	O
in	O
Belgium	O
during	O
the	O
first	O
and	O
the	O
third	O
trimester	O
of	O
pregnancy	O
in	O
the	O
period	O
from	O
September	O
2010	O
to	O
June	O
2011	O
.	O

It	O
is	O
also	O
associated	O
with	O
the	O
formation	O
of	O
new	O
thyroid	O
nodules	O
with	O
the	O
histological	O
features	O
of	O
nodular	O
hyperplasia	O
.	O

The	O
group	O
noted	O
that	O
low	O
birth	O
weight	O
increased	O
chances	O
of	O
developing	O
ASD	O
,	O
as	O
well	O
as	O
rapid	O
head	O
growth	O
.	O

In	O
the	O
nucleus	O
accumbens	O
,	O
dopamine	O
influences	O
the	O
integration	O
of	O
inputs	O
from	O
the	O
ventral	O
hippocampus	O
,	O
the	O
amygdala	O
,	O
and	O
the	O
prefrontal	O
cortex	O
.	O

The	O
adult	O
male	O
offspring	O
from	O
calorie	O
-	O
restricted	O
dams	O
specifically	O
exhibited	O
an	O
increased	O
gene	O
expression	O
of	O
the	O
cannabinoid	O
receptors	O
Cnr1	O
and	O
Cnr2	O
in	O
the	O
hypothalamus	O
,	O
and	O
showed	O
a	O
decreased	O
gene	O
expression	O
of	O
the	O
eCBs	O
-	O
metabolizing	O
enzymes	O
Napepld	O
in	O
liver	O
,	O
and	O
Faah	O
,	O
Dagl	O
α	O
,	O
Dagl	O
β	O
,	O
and	O
Mgll	O
in	O
PAT	O
.	O

To	O
validate	O
the	O
nutritional	O
knowledge	O
questionnaire	O
,	O
item	O
analysis	O
was	O
performed	O
to	O
determine	O
item	O
difficulty	O
and	O
item	O
discrimination	O
indices	O
to	O
increase	O
reliability	O
.	O

IFA	O
supplements	O
have	O
also	O
been	O
found	O
to	O
reduce	O
the	O
preterm	O
delivery	O
rate	O
and	O
neonatal	O
mortality	O
attributable	O
to	O
prematurity	O
and	O
birth	O
asphyxia	O
.	O

Participants	O
Women	O
who	O
participated	O
in	O
the	O
LIMIT	O
randomised	O
trial	O
,	O
gave	O
birth	O
to	O
a	O
live	O
infant	O
,	O
and	O
who	O
provided	O
consent	O
to	O
the	O
ongoing	O
follow	O
-	O
up	O
of	O
their	O
child	O
,	O
were	O
eligible	O
for	O
inclusion	O
.	O

Additionally	O
,	O
the	O
initial	O
test	O
was	O
not	O
automated	O
until	O
May	O
2016	O
so	O
many	O
women	O
who	O
delivered	O
during	O
the	O
early	O
study	O
time	O
period	O
did	O
not	O
have	O
a	O
25	O
(	O
OH	O
)	O
D	O
measurement	O
and	O
therefore	O
could	O
not	O
be	O
included	O
in	O
this	O
analysis	O
.	O

Moreover	O
,	O
a	O
more	O
detailed	O
investigation	O
into	O
maternal	O
mental	O
health	O
,	O
which	O
includes	O
measures	O
of	O
the	O
frequency	O
and	O
severity	O
of	O
specific	O
psychiatric	O
symptoms	O
during	O
pregnancy	O
,	O
would	O
allow	O
for	O
a	O
more	O
thorough	O
investigation	O
into	O
these	O
critical	O
confounding	O
variables	O
.	O

Tissue	O
Collection	O
Whole	O
rat	O
brains	O
were	O
removed	O
rapidly	O
after	O
decapitation	O
at	O
29	O
weeks	O
post	O
-	O
weaning	O
and	O
immediately	O
frozen	O
on	O
dry	O
ice	O
,	O
and	O
then	O
stored	O
at	O
−	O
80	O
°	O
C	O
.	O

Follow	O
-	O
up	O
of	O
a	O
smaller	O
proportion	O
of	O
child	O
participants	O
at	O
2	O
to	O
3	O
years	O
of	O
age	O
[	O
42	O
,	O
43	O
]	O
demonstrated	O
no	O
significant	O
differences	O
in	O
the	O
metabolic	O
profile	O
of	O
children	O
[	O
42	O
],	O
or	O
on	O
measures	O
of	O
growth	O
and	O
adiposity	O
[	O
43	O
].	O

This	O
questionnaire	O
has	O
been	O
well	O
validated	O
[	O
23	O
]	O
and	O
validated	O
in	O
pregnancy	O
[	O
24	O
].	O

Body	O
weight	O
and	O
cumulative	O
caloric	O
intake	O
relative	O
to	O
body	O
weight	O
in	O
offspring	O
were	O
evaluated	O
during	O
the	O
lactation	O
and	O
/	O
or	O
post	O
-	O
weaning	O
periods	O
(	O
Figures2B	O
,	O
C	O
).	O

Medullary	O
Thyroid	O
Cancer	O
(	O
MTC	O
)	O
–	O
cancer	O
arising	O
from	O
parafollicular	O
thyroid	O
cells	O
Medullary	O
carcinoma	O
of	O
the	O
thyroid	O
(	O
MTC	O
)	O
constitutes	O
approximately	O
5	O
-	O
10	O
%	O
of	O
thyroid	O
cancers	O
,	O
although	O
there	B
are	I
no	I
precise	O
figures	O
for	O
incidence	O
and	O
survival	O
rates	O
because	O
of	O
the	O
large	O
geographic	O
variations	O
,	O
mainly	O
due	O
to	O
its	O
familial	O
pattern	O
.	O

The	O
porcine	O
expression	O
patterns	O
in	O
this	O
study	O
showed	O
a	O
decreased	O
mRNA	O
expression	O
of	O
genes	O
associated	O
with	O
the	O
control	O
of	O
mitosis	O
and	O
cell	O
cycle	O
checkpoint	O
regulation	O
at	O
stage	O
94	O
dpc	O
in	O
LP	O
fetuses	O
.	O

Our	O
age	O
limits	O
were	O
15	O
to	O
55	O
years	O
and	O
those	O
patients	O
with	O
estimated	O
expanded	O
disability	O
status	O
scale	O
less	O
than	O
5	O
were	O
introduced	O
to	O
the	O
study	O
.	O

The	O
associations	O
for	O
fatty	O
fish	O
or	O
shellfish	O
were	O
J	O
-	O
shaped	O
,	O
with	O
the	O
strongest	O
inverse	O
association	O
for	O
an	O
intermediate	O
dietary	O
intake	O
,	O
whereas	O
a	O
high	O
intake	O
was	O
associated	O
with	O
a	O
higher	O
rate	O
of	O
high	O
level	O
psychotic	O
-	O
like	O
symptoms	O
.	O

Height	O
The	O
estimated	O
height	O
correlations	O
at	O
each	O
age	O
and	O
across	O
generations	O
are	O
displayed	O
in	O
(	O
table	O
5	O
).	O

All	O
participants	O
provided	O
written	O
or	O
verbal	O
informed	O
consent	O
.	O

[	O
44	O
]	O
Although	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
is	O
the	O
active	O
circulating	O
form	O
of	O
vitamin	O
D	O
,	O
measuring	O
this	O
level	O
is	O
not	O
helpful	O
because	O
it	O
is	O
quickly	O
and	O
tightly	O
regulated	O
by	O
the	O
kidney	O
.	O

For	O
boys	O
,	O
there	O
was	O
a	O
positive	O
change	O
associated	O
with	O
the	O
BMI	O
of	O
the	O
mother	O
,	O
p	O
=	O
0	O
.	O
002	O
,	O
but	O
no	O
association	O
with	O
other	O
family	O
members	O
.	O

All	O
procedures	O
were	O
performed	O
with	O
approval	O
from	O
the	O
Queensland	O
University	O
Animal	O
Ethics	O
Committee	O
,	O
under	O
the	O
guidelines	O
of	O
the	O
National	O
Health	O
and	O
Medical	O
Research	O
Council	O
of	O
Australia	O
.	O

The	O
majority	O
of	O
women	O
(	O
80	O
.	O
8	O
%)	O
were	O
married	O
.	O

Additionally	O
,	O
since	O
women	O
with	O
a	O
history	O
of	O
PTB	O
have	O
a	O
known	O
2	O
to	O
3	O
-	O
fold	O
increased	O
risk	O
of	O
a	O
recurrent	O
premature	O
delivery	O
compared	O
to	O
women	O
without	O
a	O
history	O
of	O
PTB	O
[	O
18	O
],	O
logistic	O
regression	O
was	O
conducted	O
for	O
this	O
subgroup	O
as	O
well	O
.	O

In	O
Indonesia	O
,	O
the	O
haemoglobin	O
concentration	O
of	O
adolescent	O
girls	O
improved	O
on	O
supplementation	O
with	O
combinations	O
of	O
iron	O
,	O
folic	O
acid	O
,	O
retinol	O
and	O
vitamin	O
C	O
,	O
over	O
placebo	O
but	O
did	O
not	O
respond	O
better	O
to	O
daily	O
rather	O
that	O
weekly	O
supplementation	O
,	O
although	O
serum	O
ferritin	O
increased	O
more	O
in	O
the	O
daily	O
supplemented	O
group	O
(	O
Angeles	O
-	O
Agdeppa	O
et	O
al	O
1997	O
).	O

Whether	O
the	O
greater	O
bioavailability	O
of	O
calcium	O
from	O
human	O
milk	O
compared	O
to	O
formula	O
affects	O
the	O
needed	O
level	O
of	O
25	O
(	O
OH	O
)	O
D	O
by	O
infants	O
is	O
unknown	B
.	O

However	O
,	O
it	O
is	O
possible	O
that	O
alternate	O
SNPs	O
/	O
genes	O
that	O
are	O
not	O
clinically	O
important	O
to	O
25	O
(	O
OH	O
)	O
D	O
level	O
in	O
nonpregnant	O
adults	O
would	O
be	O
significant	O
in	O
pregnant	O
women	O
and	O
could	O
be	O
identified	O
by	O
GWAS	O
.	O

A	O
curvilinear	O
relation	O
was	O
seen	O
across	O
levels	O
of	O
maternal	O
habitual	O
nightly	O
sleep	O
duration	O
in	O
early	O
pregnancy	O
for	O
maternal	O
mean	O
-	O
1	O
hour	O
plasma	O
glucose	O
concentration	O
after	O
a	O
50	O
-	O
gram	O
oral	O
glucose	O
challenge	O
during	O
weeks	O
24	O
-	O
28	O
gestation	O
(	O
Figure1	O
).	O

Progesterone	O
Measures	O
Circulating	O
progesterone	O
concentrations	O
were	O
measured	O
in	O
adult	O
female	O
offspring	O
in	O
the	O
proestrous	O
stage	O
.	O

The	O
Born	O
Too	O
Soon	O
report	O
was	O
funded	O
by	O
March	O
of	O
Dimes	O
,	O
the	O
Partnership	O
for	O
Maternal	O
,	O
Newborn	O
and	O
Child	O
Health	O
and	O
Save	O
the	O
Children	O
.	O

The	O
contribution	O
of	O
dietary	O
intakes	O
of	O
PUFAs	O
to	O
total	O
dietary	O
fat	O
is	O
comparable	O
to	O
other	O
Western	O
cohorts	O
[	O
55	O
].	O

This	O
is	O
the	O
first	O
time	O
that	O
a	O
gene	O
-	O
environment	O
interaction	O
between	O
a	O
GR	O
polymorphism	O
and	O
maternal	O
attitudes	O
towards	O
pregnancy	O
was	O
found	O
,	O
in	O
relation	O
to	O
fetal	O
weight	O
.	O

These	O
concerns	O
had	O
been	O
attributed	O
to	O
inadequate	O
infrastructure	O
and	O
poor	O
compliance	O
with	O
preventive	O
treatment	O
,	O
among	O
others	O
[	O
34	O
].	O

;	O
P	O
=	O
.	O
002	O
).	O

After	O
PSM	O
,	O
we	O
evaluated	O
these	O
variables	O
for	O
significant	O
differences	O
between	O
the	O
vaccination	O
status	O
groups	O
in	O
order	O
to	O
know	O
how	O
well	O
matching	O
occurred	O
.	O

Vitamin	O
D	O
is	O
definitely	O
not	O
a	O
Trojan	O
Horse	O
in	O
reproductive	O
health	O
,	O
since	O
there	O
were	O
no	O
adverse	O
effects	O
reported	O
for	O
vitamin	O
D	O
intake	O
of	O
up	O
to	O
10	O
,	O
000	O
IU	O
/	O
day	O
,	O
but	O
to	O
proclaim	O
it	O
the	O
Golden	O
Fleece	O
,	O
more	O
evidence	O
is	O
needed	O
.	O

Physical	O
activity	O
and	O
emotional	O
well	O
-	O
being	O
scores	O
were	O
similar	O
between	O
extended	O
winter	O
and	O
extended	O
summer	O
groups	O
.	O

Given	O
the	O
high	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
in	O
pregnant	O
women	O
in	O
Belgium	O
and	O
probably	O
in	O
many	O
European	O
countries	O
,	O
a	O
vitamin	O
D	O
nutrition	O
policy	O
is	O
needed	O
at	O
the	O
country	O
and	O
European	O
level	O
.	O

Regular	O
milk	O
drinkers	O
had	O
better	O
vitamin	O
D	O
concentrations	O
,	O
a	O
finding	O
supported	O
by	O
a	O
large	O
-	O
scale	O
clinical	O
study	O
observing	O
an	O
association	O
between	O
frequent	O
milk	O
consumption	O
and	O
increased	O
25	O
(	O
OH	O
)	O
D	O
[	O
33	O
].	O

However	O
,	O
we	O
could	O
not	O
do	O
it	O
,	O
which	O
is	O
a	O
limitation	O
of	O
our	O
study	O
.	O

These	O
genes	O
display	O
diet	O
-	O
dependent	O
longitudinal	O
transcriptomic	O
regulation	O
(	O
Figure1	O
).	O

Finally	O
,	O
thyroid	O
cancer	O
patients	O
often	O
undergo	O
total	O
thyroidectomy	O
and	O
thus	O
need	O
adequate	O
supplementation	O
of	O
both	O
calcium	O
and	O
thyroxine	O
.	O

Iron	O
deficiency	O
is	O
an	O
important	O
risk	O
factor	O
for	O
increased	O
maternal	O
mortality	O
,	O
low	O
birth	O
weight	O
and	O
preterm	O
delivery	O
(	O
Brabin	O
et	O
al	O
2001	O
)	O
and	O
the	O
availability	O
of	O
calcium	O
,	O
iodine	O
,	O
folate	O
and	O
vitamins	O
A	O
and	O
D	O
may	O
modulate	O
fetal	O
development	O
(	O
Bartley	O
et	O
al	O
2005	O
).	O

If	O
so	O
,	O
then	O
in	O
terms	O
of	O
policy	O
and	O
guidelines	O
,	O
it	O
is	O
hard	O
to	O
know	O
what	O
regimen	O
to	O
recommend	O
for	O
future	O
trials	O
,	O
given	O
that	O
clinical	O
practice	O
and	O
evidence	O
suggests	O
that	O
daily	O
or	O
weekly	O
supplementations	O
though	O
ideal	O
are	O
not	O
complied	O
with13	O
,	O
14and	O
are	O
impractical	O
for	O
families	O
,	O
especially	O
in	O
developing	O
countries	O
,	O
and	O
food	O
fortification	O
at	O
the	O
population	O
level	O
will	O
not	O
be	O
an	O
option	O
during	O
exclusive	O
breastfeeding	O
periods	O
(	O
aged	O
<	O
6	O
months	O
),	O
nor	O
is	O
it	O
likely	O
to	O
be	O
adequate	O
in	O
highly	O
deficient	O
populations	O
.	O

4	O
.	O

*:	O
p	O
<	O
0	O
.	O
05	O
compared	O
between	O
the	O
two	O
groups	O
Vitamin	O
D	O
supplement	O
intake	O
situation	O
There	O
were	O
fourteen	O
out	O
of	O
total	O
ninety	O
-	O
eight	O
participants	O
(	O
19	O
.	O
5	O
%)	O
who	O
did	O
not	O
take	O
Vitamin	O
D	O
supplement	O
.	O

Questionnaires	O
were	O
recorded	O
at	O
birth	O
and	O
6	O
months	O
of	O
age	O
.	O

χ2test	O
or	O
Fisher	O
’	O
s	O
Exact	O
test	O
after	O
adjusting	O
for	O
cluster	O
effect	O
will	O
be	O
used	O
when	O
appropriate	O
.	O

In	O
cases	O
where	O
the	O
serum	O
albumin	O
levels	O
were	O
below	O
the	O
appropriate	O
thresholds	O
for	O
a	O
child	O
’	O
s	O
age	O
,	O
the	O
corrected	O
calcium	O
level	O
was	O
used	O
in	O
place	O
of	O
the	O
standard	O
calcium	O
values	O
.	O

This	O
may	O
account	O
for	O
improper	O
protein	O
synthesis	O
[	O
35	O
]	O
in	O
LP	O
offspring	O
.	O

The	O
association	O
of	O
later	O
life	O
health	O
with	O
pre	O
-	O
conception	O
,	O
in	O
utero	O
or	O
childhood	O
environmental	O
factors	O
has	O
led	O
to	O
the	O
“	O
Developmental	O
Origins	O
of	O
Health	O
and	O
Disease	O
”	O
(	O
DOHaD	O
)	O
hypothesis	O
(	O
Wadhwa	O
et	O
al	O
.	O
2009	O
).	O

Vasopressinase	O
is	O
a	O
cysteine	O
aminopeptidase	O
of	O
molecular	O
weight	O
330	O
kDa	O
,	O
and	O
is	O
produced	O
by	O
the	O
placental	O
trophoblasts	O
during	O
pregnancy	O
as	O
discussed	O
by	O
Gordge	O
et	O
al	O
.	O

Where	O
possible	O
,	O
estimation	O
of	O
serum	O
ferritin	O
level	O
is	O
desirable	O
to	O
adjust	O
the	O
dose	O
of	O
iron	O
supplements	O
[	O
62	O
].	O

Introduction	O
There	O
were	O
15	O
million	O
preterm	O
births	O
(	O
PTB	O
)	O
(<	O
37	O
weeks	O
)	O
worldwide	O
and	O
more	O
than	O
1	O
million	O
infant	O
deaths	O
from	O
PTB	O
complications	O
in	O
2010	O
[	O
1	O
].	O

Among	O
these	O
subjects	O
,	O
their	O
initial	O
mean	O
total	O
circulating	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
was	O
34	O
.	O
8	O
ng	O
/	O
mL	O
(	O
SD	O
13	O
.	O
0	O
ng	O
/	O
mL	O
)	O
and	O
approximately	O
12	O
months	O
later	O
the	O
mean	O
concentration	O
was	O
28	O
.	O
9	O
ng	O
/	O
mL	O
(	O
SD	O
9	O
.	O
2	O
ng	O
/	O
mL	O
),	O
which	O
was	O
not	O
a	O
clinically	O
significant	O
or	O
statistically	O
significant	O
difference	O
.	O

Maternal	O
vitamin	O
D	O
deficiency	O
may	O
also	O
have	O
contributed	O
to	O
an	O
increased	O
number	O
of	O
glomeruli	O
,	O
thus	O
producing	O
smaller	O
glomeruli	O
than	O
in	O
animals	O
fed	O
SC	O
.	O

Whilst	O
18	O
-	O
month	O
follow	O
-	O
up	O
data	O
on	O
126	O
offspring	O
of	O
women	O
with	O
polycystic	O
ovary	O
syndrome	O
treated	O
with	O
metformin	O
during	O
pregnancy	O
have	O
not	O
revealed	O
any	O
deficiencies	O
in	O
growth	O
or	O
motor	O
-	O
social	O
development	O
,	O
this	O
may	O
be	O
too	O
short	O
a	O
time	O
frame	O
for	O
potential	O
programming	O
effects	O
of	O
metformin	O
to	O
become	O
evident	O
.	O
80	O
In	O
view	O
of	O
the	O
above	O
concerns	O
regarding	O
the	O
potential	O
of	O
glyburide	O
and	O
metformin	O
to	O
have	O
long	O
-	O
term	O
effects	O
on	O
the	O
mother	O
and	O
child	O
,	O
I	O
would	O
recommend	O
caution	O
with	O
their	O
use	O
in	O
the	O
treatment	O
of	O
GDM	O
.	O

We	O
found	O
that	O
among	O
the	O
subgroup	O
of	O
high	O
-	O
exposure	O
participants	O
,	O
text4baby	O
had	O
a	O
positive	O
effect	O
on	O
reducing	O
alcohol	O
use	O
behavior	O
of	O
pregnant	O
and	O
postpartum	O
women	O
.	O

In	O
the	O
studies	O
conducted	O
to	O
date	O
,	O
risk	O
estimates	O
and	O
p	O
-	O
values	O
for	O
the	O
association	O
between	O
season	O
of	O
birth	O
and	O
glioma	O
risk	O
have	O
been	O
nominal	O
to	O
borderline	O
in	O
strength	O
.	O

4	O
.	O

The	O
Edinburgh	O
Postnatal	O
Depression	O
scale	O
was	O
used	O
to	O
evaluate	O
depression	O
scores	O
.	O

Breastfeeding	O
,	O
child	O
fish	O
consumption	O
,	O
maternal	O
dental	O
&	O
lifestyle	O
questionnaires	O
.	O
Neurodevelopmental	O
testing	O
of	O
child	O
completed	O
by	O
mother	O
using	O
ALSPAC	O
adaption	O
of	O
the	O
MacArthur	O
Communicative	O
Development	O
Inventory	O
(	O
MCDI	O
)	O
at	O
15	O
months	O
and	O
Denver	O
Developmental	O
Screening	O
Test	O
(	O
DDST	O
)	O
at	O
18	O
months	O
of	O
age	O
.	O
Fish	O
and	O
seafood	O
intake	O
measured	O
via	O
a	O
validated	O
FFQ	O
(	O
calibrated	O
for	O
LC	O
n	O
-	O
3PUFAs	O
in	O
blood	O
)	O
at	O
28	O
weeks	O
gestation	O
.	O
Infant	O
cognition	O
measured	O
usingVisual	O
Recognition	O
Memory	O
(	O
VRM	O
)	O
paradigm	O
at	O
6	O
months	O
of	O
age	O
.	O
Seafood	O
consumption	O
assessed	O
at	O
32	O
weeks	O
gestation	O
via	O
FFQ	O
.	O
Postal	O
questionnaires	O
on	O
diet	O
,	O
education	O
,	O
social	O
,	O
behavioural	O
and	O
developmental	O
outcomes	O
at	O
child	O
age	O
:	O
6	O
,	O
18	O
,	O
30	O
,	O
42	O
,	O
and	O
81	O
months	O
.	O
Wechsler	O
Intelligence	O
Scale	O
for	O
Children	O
III	O
used	O
to	O
assess	O
Intelligence	O
Quotient	O
(	O
IQ	O
)	O
at	O
8	O
years	O
and	O
Strengths	O
and	O
Difficulties	O
Questionnaire	O
(	O
SDQ	O
)	O
conducted	O
.	O

Genes	O
also	O
can	O
affect	O
vitamin	O
D	O
metabolism	O
,	O
skin	O
color	O
,	O
and	O
behavior	O
,	O
all	O
of	O
which	O
can	O
influence	O
circulating	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
.	O

This	O
mutation	O
occurs	O
within	O
the	O
membrane	O
proximal	O
region	O
of	O
the	O
extracellular	O
domain	O
of	O
the	O
receptor	O
,	O
which	O
is	O
important	O
for	O
ligand	O
binding	O
(	O
Figure	O
3C	O
,	O
upper	O
panel	O
).	O

Cranial	O
ultrasound	O
was	O
done	O
following	O
the	O
seizures	O
and	O
was	O
reported	O
as	O
normal	O
.	O

It	O
would	O
not	O
be	O
possible	O
however	O
to	O
relate	O
such	O
levels	O
to	O
prenatal	O
exposure	O
.	O

These	O
findings	O
were	O
subsequently	O
corroborated	O
and	O
extended	O
by	O
others	O
,	O
including	O
,	O
Al	O
-	O
Delaimy	O
et	O
al	O
[	O
32	O
]	O
who	O
reported	O
that	O
self	O
-	O
reported	O
regular	O
snoring	O
was	O
independently	O
associated	O
with	O
a	O
2	O
-	O
fold	O
increased	O
risk	O
(	O
RR	O
=	O
2	O
.	O
03	O
;	O
95	O
%	O
CI	O
1	O
.	O
71	O
-	O
2	O
.	O
40	O
)	O
of	O
developing	O
type	O
2	O
diabetes	O
over	O
a	O
10	O
-	O
year	O
follow	O
-	O
up	O
period	O
.	O

Despite	O
these	O
limitations	O
,	O
the	O
strengths	O
of	O
our	O
study	O
include	O
having	O
access	O
to	O
birth	O
outcomes	O
from	O
medical	O
records	O
as	O
well	O
as	O
having	O
available	O
influenza	O
surveillance	O
data	O
.	O

Results	O
We	O
identified	O
637	O
spots	O
in	O
DVD	O
deplete	O
samples	O
and	O
655	O
spots	O
in	O
Control	O
samples	O
(	O
seeFigure	O
1for	O
a	O
representative	O
gel	O
).	O

Short	O
-	O
term	O
diets	O
comprised	O
solely	O
of	O
either	O
plant	O
or	O
animal	O
foods	O
have	O
been	O
shown	O
to	O
alter	O
the	O
human	O
gut	O
microbiome	O
[	O
3	O
].	O

Source	O
:	O
Born	O
Too	O
Soon	O
,	O
Chapter	O
6	O
[	O
75	O
].	O

Results	O
Descriptive	O
analysis	O
From	O
July	O
21st	O
through	O
December	O
4th	O
2014	O
,	O
we	O
interviewed	O
and	O
collected	O
surveys	O
on	O
4808	O
post	O
-	O
partum	O
women	O
.	O

We	O
were	O
able	O
to	O
adjust	O
for	O
smoking	O
,	O
BMI	O
,	O
migration	O
,	O
education	O
and	O
alcohol	O
that	O
could	O
confound	O
our	O
associations	O
between	O
diet	O
and	O
psychotic	O
-	O
like	O
symptoms	O
.	O

At	O
child	O
birth	O
,	O
blood	O
sample	O
was	O
collected	O
for	O
130	O
mothers	O
.	O

This	O
review	O
critically	O
evaluates	O
literature	O
on	O
fish	O
intake	O
in	O
pregnant	O
women	O
,	O
with	O
a	O
focus	O
on	O
the	O
association	O
between	O
neurodevelopmental	O
outcomes	O
in	O
the	O
offspring	O
and	O
maternal	O
fish	O
intake	O
during	O
pregnancy	O
.	O

Almost	O
half	O
of	O
the	O
intervention	O
group	O
achieved	O
concentrations	O
of	O
30	O
ng	O
/	O
mL	O
[	O
59	O
].	O

Food	O
intake	O
was	O
recorded	O
daily	O
until	O
the	O
end	O
of	O
pregnancy	O
.	O

On	O
the	O
other	O
hand	O
,	O
increased	O
serum	O
calcium	O
causes	O
the	O
intracellular	O
calcium	O
to	O
attach	O
to	O
calcium	O
receptors	O
on	O
the	O
surface	O
of	O
parathyroid	O
cells	O
causing	O
a	O
change	O
in	O
a	O
special	O
form	O
of	O
the	O
receptors	O
.	O

Moreover	O
,	O
there	O
was	O
no	O
significant	O
difference	O
between	O
the	O
two	O
groups	O
in	O
terms	O
of	O
plasma	O
HA1C	O
,	O
literacy	O
level	O
,	O
type	O
of	O
treatment	O
for	O
GDM	O
,	O
or	O
type	O
of	O
delivery	O
.	O

These	O
studies	O
were	O
largely	O
retrospective	O
,	O
unrandomized	O
,	O
or	O
lacked	O
power	O
to	O
detect	O
differences	O
in	O
serious	O
adverse	O
perinatal	O
outcomes	O
and	O
will	O
not	O
be	O
listed	O
here	O
.	O

The	O
order	O
of	O
introduction	O
seems	O
to	O
have	O
little	O
effect	O
on	O
AM	O
.	O

The	O
emulsifier	O
PROSOL	O
(	O
sodium	O
stearoyl	O
-	O
2	O
-	O
lactylate	O
)	O
increases	O
IMF	O
deposition	O
and	O
QG	O
in	O
Korean	O
cattle	O
[	O
108	O
].	O

In	O
addition	O
,	O
IMF	O
has	O
higher	O
ATP	O
-	O
citrate	O
lyase	O
activity	O
compared	O
to	O
subcutaneous	O
fat	O
[	O
90	O
].	O

Although	O
a	O
few	O
other	O
studies	O
have	O
correlated	O
array	O
-	O
based	O
methylation	O
levels	O
with	O
repetitive	O
element	O
methylation	O
markers	O
(	O
Fryer	O
et	O
al	O
.	O

Methods	O
Employing	O
a	O
novel	O
mixed	O
-	O
method	O
approach	O
which	O
adjusts	O
for	O
age	O
and	O
familial	O
group	O
,	O
BMI	O
correlations	O
were	O
estimated	O
at	O
three	O
ages	O
of	O
the	O
index	O
child	O
,	O
that	O
is	O
,	O
at	O
birth	O
and	O
at	O
ages	O
5	O
and	O
9	O
.	O

Usually	O
,	O
patients	O
are	O
recommended	O
to	O
postpone	O
pregnancy	O
to	O
6	O
-	O
12	O
months	O
after	O
radioiodine	O
(	O
I	O
-	O
131	O
)	O
treatment	O
to	O
avoid	O
a	O
potentially	O
higher	O
risk	O
of	O
miscarriage	O
in	O
the	O
first	O
few	O
months	O
after	O
radioiodine	O
therapy	O
and	O
to	O
allow	O
time	O
enough	O
to	O
exclude	O
residual	O
disease	O
requiring	O
further	O
treatment41438	O
.	O

We	O
did	B
not	I
have	I
data	I
on	O
whether	O
women	O
were	O
taking	O
separate	O
calcium	O
or	O
vitamin	O
D	O
supplements	O
beyond	O
what	O
is	O
contained	O
in	O
PNVs	O
.	O

Finally	O
,	O
any	O
possible	O
reduction	O
in	O
the	O
incidence	O
of	O
pneumonia	O
in	O
our	O
trial	O
might	O
be	O
restricted	O
to	O
only	O
certain	O
genotypes	O
as	O
recorded	O
in	O
a	O
single	O
tt	O
genotype	O
after	O
the	O
start	O
of	O
our	O
trial	O
in	O
a	O
study	O
of	O
tuberculosis	O
.	O
20Both	O
the	O
pneumonia	O
treatment	O
and	O
the	O
population	O
supplementation	O
trials	O
need	O
to	O
be	O
repeated	O
in	O
other	O
settings	O
for	O
confirmation	O
,	O
and	O
frequent	O
determination	O
of	O
serum	O
calcifediol	O
concentrations	O
might	O
guide	O
the	O
interpretation	O
of	O
the	O
findings	O
.	O

We	O
found	O
a	O
significant	O
correlation	O
(	O
at	O
the	O
0	O
.	O
01	O
level	O
,	O
two	O
-	O
tailed	O
)	O
between	O
maternal	O
pre	O
-	O
pregnancy	O
weight	O
and	O
neonatal	O
birth	O
weight	O
.	O

Rodent	O
models	O
of	O
leptin	O
deficiency	O
exhibit	O
marked	O
decreases	O
in	O
BAT	O
thermogenic	O
capacity	O
,	O
as	O
well	O
as	O
activity	O
(	O
Ueno	O
et	O
al	O
.,	O
1998	O
).	O

Insulin	O
resistance	O
is	O
present	O
even	O
in	O
simple	O
obesity	O
,	O
without	O
hyperglycemia	O
,	O
indicating	O
a	O
fundamental	O
abnormality	O
of	O
insulin	O
signaling	O
in	O
states	O
of	O
excess	O
adipose	O
tissue	O
mass	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Associations	O
between	O
use	O
of	O
folic	O
acid	O
,	O
iron	O
and	O
multivitamin	O
supplements	O
and	O
number	O
of	O
prenatal	O
visits	O
,	O
among	O
categories	O
of	O
formal	O
educationFormal	O
education	O
(	O
years	O
)	O
Number	O
of	O
prenatal	O
visitsp	O
<	O
44	O
-	O
10	O
>	O
10	O
Folic	O
acid	O
use	O
(%)≤	O
8	O
2	O
.	O
114	O
.	O
630	O
.	O
8	O
.	O
007	O
9	O
-	O
12	O
4	O
.	O
344	O
.	O
372	O
.	O
5	O
<.	O
001	O
>	O
12	O
069	O
.	O
474	O
.	O
7	O
.	O
21	O
Iron	O
use	O
(%)≤	O
8	O
16	O
.	O
756	O
.	O
176	O
.	O
9	O
<.	O
001	O
9	O
-	O
12	O
21	O
.	O
751	O
.	O
466	O
.	O
7	O
<.	O
001	O
>	O
12	O
10077	O
.	O
862	O
.	O
6	O
.	O
19	O
Multivitamins	O
use	O
(%)≤	O
8	O
22	O
.	O
953	O
.	O
776	O
.	O
9	O
<.	O
001	O
9	O
-	O
12	O
26	O
.	O
17079	O
.	O
7	O
<.	O
001	O
>	O
12	O
10088	O
.	O
987	O
.	O
5	O
.	O
88	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
4	O
Associations	O
between	O
use	O
of	O
folic	O
acid	O
,	O
iron	O
and	O
multivitamin	O
supplements	O
and	O
the	O
interaction	O
between	O
the	O
number	O
of	O
prenatal	O
visits	O
and	O
formal	O
education	O
level	O
Folic	O
acidIronVitamins	O
OR	O
(	O
95	O
%	O
CI	O
)	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
OR	O
(	O
95	O
%	O
CI	O
)	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
OR	O
(	O
95	O
%	O
CI	O
)	O
OR	O
#(	O
95	O
%	O
CI	O
)	O
Education	O
*	O
Prenatal	O
care	O
interaction	O
PC1	O
*	O
E1110	O
.	O
63	O
(	O
14	O
.	O
94	O
-	O
818	O
.	O
97	O
)	O
63	O
.	O
86	O
(	O
8	O
.	O
47	O
-	O
481	O
.	O
41	O
)	O
10	O
.	O
35	O
(	O
4	O
.	O
60	O
-	O
23	O
.	O
27	O
)	O
7	O
.	O
95	O
(	O
3	O
.	O
36	O
-	O
18	O
.	O
83	O
)	O
18	O
.	O
20	O
(	O
8	O
.	O
46	O
-	O
39	O
.	O
16	O
)	O
11	O
.	O
25	O
(	O
4	O
.	O
96	O
-	O
25	O
.	O
49	O
)	O
PC1	O
*	O
E251	O
.	O
78	O
(	O
6	O
.	O
83	O
-	O
392	O
.	O
29	O
)	O
32	O
.	O
281	O
(	O
4	O
.	O
97	O
-	O
294	O
.	O
63	O
)	O
7	O
.	O
45	O
(	O
2	O
.	O
66	O
-	O
20	O
.	O
88	O
)	O
6	O
.	O
20	O
(	O
2	O
.	O
17	O
-	O
17	O
.	O
73	O
)	O
15	O
.	O
33	O
(	O
5	O
.	O
64	O
-	O
41	O
.	O
68	O
)	O
11	O
.	O
71	O
(	O
4	O
.	O
17	O
-	O
32	O
.	O
87	O
)	O
PC2	O
*	O
E113	O
.	O
73	O
(	O
5	O
.	O
50	O
-	O
34	O
.	O
22	O
)	O
10	O
.	O
941	O
(	O
4	O
.	O
30	O
-	O
27	O
.	O
78	O
)	O
1	O
.	O
62	O
(	O
0	O
.	O
82	O
-	O
3	O
.	O
19	O
)	O
1	O
.	O
38	O
(	O
0	O
.	O
68	O
-	O
2	O
.	O
79	O
)	O
4	O
.	O
67	O
(	O
2	O
.	O
28	O
-	O
9	O
.	O
55	O
)	O
3	O
.	O
65	O
(	O
1	O
.	O
72	O
-	O
7	O
.	O
71	O
)	O
PC2	O
*	O
E22	O
.	O
96	O
(	O
1	O
.	O
70	O
-	O
5	O
.	O
15	O
)	O
2	O
.	O
51	O
(	O
1	O
.	O
41	O
-	O
4	O
.	O
49	O
)	O
1	O
.	O
95	O
(	O
1	O
.	O
13	O
-	O
3	O
.	O
38	O
)	O
1	O
.	O
73	O
(	O
1	O
.	O
10	O
-	O
3	O
.	O
03	O
)	O
2	O
.	O
31	O
(	O
1	O
.	O
23	O
-	O
4	O
.	O
34	O
)	O
2	O
.	O
03	O
(	O
1	O
.	O
05	O
-	O
3	O
.	O
91	O
)	O
Nutritional	O
knowledge	O
score	O
Low111111	O
Medium6	O
.	O
67	O
(	O
2	O
.	O
62	O
-	O
17	O
.	O
01	O
)	O
1	O
.	O
47	O
(	O
0	O
.	O
74	O
-	O
2	O
.	O
89	O
)	O
1	O
.	O
80	O
(	O
0	O
.	O
99	O
-	O
3	O
.	O
27	O
)	O
1	O
.	O
65	O
(	O
0	O
.	O
86	O
-	O
3	O
.	O
15	O
)	O
3	O
.	O
58	O
(	O
1	O
.	O
88	O
-	O
6	O
.	O
80	O
)	O
1	O
.	O
14	O
(	O
0	O
.	O
52	O
-	O
2	O
.	O
50	O
)	O
High8	O
.	O
30	O
(	O
2	O
.	O
99	O
-	O
23	O
.	O
4	O
)	O
7	O
.	O
13	O
(	O
2	O
.	O
33	O
-	O
21	O
.	O
80	O
)	O
2	O
.	O
41	O
(	O
1	O
.	O
14	O
-	O
5	O
.	O
14	O
)	O
2	O
.	O
37	O
(	O
1	O
.	O
50	O
-	O
5	O
.	O
65	O
)	O
3	O
.	O
48	O
(	O
1	O
.	O
50	O
-	O
8	O
.	O
10	O
)	O
3	O
.	O
62	O
(	O
1	O
.	O
38	O
-	O
9	O
.	O
51	O
)	O
PC1	O
–	O
prenatal	O
care	O
:≥	O
10	O
visits	O
;	O
PC2	O
-	O
prenatal	O
care	O
:	O
4	O
–	O
9	O
visits	O
;	O
reference	O
category	O
-	O
<	O
4	O
visits	O
.	O

Regarding	O
the	O
fate	O
of	O
glucose	O
in	O
brown	O
adipocytes	O
under	O
anabolic	O
conditions	O
characterized	O
by	O
high	O
insulin	O
levels	O
,	O
it	O
is	O
essentially	O
metabolized	O
to	O
provide	O
glycerol	O
-	O
3	O
-	O
phosphate	O
for	O
triglyceride	O
synthesis	O
or	O
acetyl	O
-	O
CoA	O
for	O
de	O
novo	O
fatty	O
acid	O
synthesis	O
(	O
Cannon	O
and	O
Nedergaard	O
,	O
2004	O
).	O

Therefore	O
,	O
these	O
three	O
subjects	O
were	O
included	O
in	O
the	O
analysis	O
.	O

Management	O
consists	O
of	O
correcting	O
hypocalcemia	O
and	O
determining	O
the	O
cause	O
of	O
hypocalcemia	O
and	O
treating	O
it	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
6	O
Well	O
-	O
preforming	O
countries	O
for	O
preterm	O
-	O
specific	O
neonatal	O
mortality	O
reduction	O
by	O
region	O
.	O

A	O
barrier	O
to	O
maternal	O
handwashing	O
in	O
rural	O
Bangladesh	O
was	O
the	O
lack	O
of	O
self	O
-	O
efficacy	O
on	O
the	O
part	O
of	O
the	O
mother	O
to	O
prioritize	O
and	O
carry	O
out	O
the	O
behavior	O
because	O
of	O
conflicting	O
opinions	O
from	O
her	O
in	O
-	O
laws	O
,	O
who	O
may	O
drive	O
decision	O
-	O
making	O
regarding	O
childcare	O
and	O
household	O
expenditures	O
.	O

Data	O
and	O
sample	O
collection	O
Individual	O
informed	O
consent	O
was	O
obtained	O
in	O
the	O
local	O
language	O
by	O
Gambian	O
MRC	O
fieldworkers	O
.	O

2011	O
).	O

(	O
2010	O
)	O
*	O
Ostrow	O
et	O
al	O
.	O

According	O
to	O
the	O
World	O
Health	O
Organization	O
,	O
347	O
millions	O
of	O
people	O
are	O
diabetic	O
in	O
the	O
world	O
,	O
and	O
it	O
is	O
predicted	O
that	O
in	O
2030	O
,	O
diabetes	O
will	O
be	O
the	O
7th	O
cause	O
of	O
death	O
considering	O
the	O
worldwide	O
population	O
(	O
WHO	O
,	O
2014	O
).	O

Results	O
Study	O
population	O
Characteristics	O
of	O
the	O
study	O
population	O
are	O
summarized	O
in	O
Table	O
1	O
(	O
n	O
=	O
145	O
).	O

The	O
total	O
intake	O
of	O
all	O
fish	O
and	O
seafood	O
was	O
grouped	O
into	O
six	O
categories	O
(	O
none	O
,	O
1	O
-	O
3	O
times	O
per	O
month	O
,	O
once	O
per	O
week	O
,	O
twice	O
per	O
week	O
,	O
3	O
-	O
4	O
times	O
per	O
week	O
and	O
5	O
times	O
per	O
week	O
or	O
more	O
).	O

Furthermore	O
,	O
the	O
common	O
practice	O
of	O
swaddling	O
infants	O
might	O
reduce	O
exposure	O
to	O
sunlight	O
.	O
2Thus	O
young	O
children	O
are	O
at	O
a	O
high	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
.	O

The	O
dietary	O
source	O
of	O
Vitamin	O
D2	O
can	O
be	O
plants	O
and	O
/	O
or	O
fortified	O
food	O
products	O
.	O

Haematological	O
effects	O
of	O
multimicronutrient	O
supplementation	O
in	O
non	O
-	O
pregnant	O
Gambian	O
women	O
Abstract	O
Background	O
/	O
Objectives	O
:	O
The	O
use	O
of	O
multimicronutrient	O
(	O
MMN	O
)	O
supplementation	O
to	O
reduce	O
the	O
burden	O
of	O
anaemia	O
in	O
non	O
-	O
pregnant	O
women	O
of	O
reproductive	O
age	O
has	O
been	O
little	O
studied	O
,	O
particularly	O
in	O
Africa	O
.	O

This	O
may	O
reflect	O
the	O
lower	O
power	O
of	O
this	O
study	O
,	O
although	O
our	O
findings	O
are	O
similar	O
to	O
other	O
small	O
studies	O
(	O
10	O
,	O
11	O
).	O

We	O
calculated	O
person	O
-	O
time	O
at	O
risk	O
for	O
each	O
child	O
up	O
to	O
the	O
date	O
a	O
child	O
reached	O
our	O
primary	O
endpoint	O
,	O
was	O
last	O
seen	O
at	O
the	O
end	O
of	O
our	O
study	O
,	O
or	O
when	O
censored	O
because	O
they	O
were	O
lost	O
to	O
follow	O
-	O
up	O
.	O

However	O
,	O
little	B
is	I
known	I
about	O
how	O
well	O
the	O
recommendations	O
were	O
implemented	O
.	O

Furthermore	O
,	O
women	O
were	O
asked	O
a	O
validated	O
,	O
single	O
-	O
item	O
question	O
on	O
food	O
insufficiency	O
–“	O
How	O
many	O
days	O
in	O
the	O
past	O
week	O
have	O
you	O
gone	O
hungry	O
?	O

Detecting	O
a	O
thyroid	O
cancer	O
during	O
pregnancy	O
should	O
not	O
be	O
a	O
reason	O
for	O
termination	O
of	O
pregnancy	O
,	O
and	O
in	O
the	O
large	O
majority	O
of	O
cases	O
it	O
does	O
not	O
require	O
urgent	O
surgery4	O
.	O

EAH	O
is	O
seen	O
more	O
often	O
in	O
children	O
who	O
are	O
overweight	O
(	O
39	O
,	O
47	O
,	O
49	O
,	O
52	O
)	O
and	O
in	O
children	O
with	O
higher	O
1	O
-	O
year	O
weight	O
gains	O
(	O
53	O
).	O

For	O
example	O
,	O
antenatal	O
corticosteroids	O
administered	O
to	O
a	O
pregnant	O
woman	O
in	O
preterm	O
labour	O
can	O
prevent	O
respiratory	O
distress	O
syndrome	O
in	O
premature	O
babies	O
reducing	O
newborn	O
mortality	O
and	O
morbidity	O
[	O
5	O
].	O

Vitamin	O
A	O
-	O
unsupplemented	O
TT	O
steers	O
(	O
approximately	O
6	O
.	O
15	O
%)	O
had	O
24	O
.	O
4	O
%	O
greater	O
IMF	O
content	O
compared	O
with	O
supplemented	O
TT	O
steers	O
(	O
approximately	O
4	O
.	O
9	O
%).	O

Academic	O
and	O
research	O
institutions	O
:	O
Invest	O
•	O
Agree	O
upon	O
and	O
promote	O
an	O
innovative	O
research	O
agenda	O
for	O
prevention	O
of	O
preterm	O
birth	O
and	O
improved	O
pregnancy	O
outcomes	O
and	O
implementation	O
research	O
to	O
reduce	O
deaths	O
from	O
preterm	O
birth	O
.	O

For	O
the	O
Yen	O
Bai	O
iron	O
-	O
folic	O
acid	O
supplementation	O
program	O
,	O
promotion	O
accounted	O
for	O
1	O
%	O
of	O
the	O
non	O
-	O
supplement	O
costs	O
,	O
training	O
6	O
%,	O
monitoring	O
36	O
%,	O
village	O
health	O
worker	O
time	O
39	O
%,	O
and	O
permanent	O
,	O
salaried	O
staff	O
18	O
%.	O

We	O
combined	O
EPA	O
,	O
DHA	O
and	O
DPA	O
to	O
estimate	O
the	O
total	O
intake	O
of	O
marine	O
fatty	O
acids	O
.	O

Staying	O
on	O
vitamin	O
D	O
consumption	O
until	O
childbirth	O
resulted	O
in	O
higher	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
that	O
induced	O
the	O
effect	O
on	O
postnatal	O
depression	O
exceeding	O
than	O
prenatal	O
depression	O
.	O

What	O
Might	O
Delay	O
Lactogenesis	O
?	O

In	O
addition	O
,	O
vitamin	O
C	O
may	O
help	O
to	O
regulate	O
adipogenesis	O
.	O

Vitamin	O
D	O
status	O
could	O
also	O
facilitate	O
fetal	O
development	O
by	O
regulating	O
placental	O
inflammation	O
[	O
23	O
].	O

Due	O
to	O
the	O
risks	O
associated	O
with	O
consuming	O
fish	O
and	O
seafood	O
during	O
pregnancy	O
related	O
to	O
food	O
safety	O
and	O
heavy	O
metal	O
contamination	O
,	O
pregnant	O
women	O
may	O
question	O
the	O
necessity	O
of	O
including	O
these	O
foods	O
in	O
their	O
diets	O
,	O
when	O
nutrition	O
supplements	O
are	O
readily	O
accessible	O
in	O
Western	O
countries	O
[	O
32	O
].	O

The	O
Guidelines	O
for	O
maternity	O
care	O
in	O
South	O
Africa	O
[	O
26	O
]	O
therefore	O
recommend	O
routine	O
nutritional	O
assessment	O
–	O
such	O
as	O
measuring	O
mid	O
-	O
upper	O
arm	O
circumference	O
and	O
haemoglobin	O
levels	O
–	O
and	O
daily	O
supplementation	O
of	O
200	O
mg	O
ferrous	O
sulphate	O
,	O
1000	O
mg	O
calcium	O
and	O
5	O
mg	O
folic	O
acid	O
.	O

Forty	O
participants	O
in	O
this	O
study	O
had	O
plasma	O
samples	O
collected	O
at	O
two	O
subsequent	O
yearly	O
visits	O
,	O
spaced	O
roughly	O
twelve	O
months	O
apart	O
.	O

Methods	O
:	O
This	O
is	O
a	O
randomized	O
clinical	O
trial	O
with	O
the	O
follow	O
-	O
up	O
period	O
of	O
3	O
months	O
.	O

All	O
12	O
%	O
of	O
the	O
instrumental	O
deliveries	O
were	O
observed	O
in	O
the	O
polytherapy	O
subgroup	O
.	O

Thus	O
,	O
it	O
is	O
clear	O
that	O
a	O
southern	O
US	O
location	O
is	O
not	O
protective	O
against	O
seasonal	O
deficiency	O
of	O
vitamin	O
D	O
or	O
low	O
cord	O
25	O
(	O
OH	O
)	O
D	O
levels	O
.	O

We	O
identified	O
additive	O
and	O
modifiable	O
maternal	O
risk	O
factors	O
that	O
would	O
benefit	O
most	O
from	O
risk	O
reduction	O
and	O
targeted	O
vitamin	O
D	O
supplementation	O
.	O

There	O
has	O
been	O
increasing	O
concerns	O
by	O
consumers	O
about	O
the	O
negative	O
impact	O
of	O
extremely	O
highly	O
marbled	O
beef	O
on	O
human	O
health	O
,	O
such	O
as	O
cardiovascular	O
diseases	O
and	O
arteriosclerosis	O
.	O

Subjects	O
were	O
enrolled	O
whose	O
mother	O
was	O
healthy	O
(	O
non	O
insulin	O
-	O
dependent	O
diabetic	O
,	O
no	O
other	O
major	O
pregnancy	O
complications	O
),	O
who	O
were	O
expected	O
to	O
have	O
a	O
singleton	O
,	O
non	O
-	O
small	O
for	O
dates	O
infant	O
,	O
and	O
had	O
been	O
admitted	O
to	O
the	O
labor	O
and	O
delivery	O
unit	O
due	O
to	O
the	O
onset	O
of	O
labor	O
or	O
were	O
admitted	O
for	O
a	O
planned	O
induction	O
or	O
c	O
-	O
section	O
delivery	O
at	O
37	O
to	O
41	O
weeks	O
gestation	O
.	O

We	O
analyzed	O
maternal	O
plasma	O
glucose	O
concentrations	O
1	O
hour	O
after	O
a	O
50	O
-	O
gram	O
oral	O
glucose	O
challenge	O
as	O
part	O
of	O
routine	O
mid	O
-	O
pregnancy	O
screening	O
for	O
GDM	O
.	O

Expression	O
of	O
hepatic	O
miRNAs	O
targeting	O
porcine	O
glucocorticoid	O
receptor	O
(	O
GR	O
)	O
3	O
′	O
UTR	O
in	O
the	O
neonatal	O
piglets	O
under	O
a	O
maternal	O
gestational	O
betaine	O
supplementation	O
Abstract	O
Glucocorticoid	O
receptor	O
(	O
GR	O
)	O
has	O
been	O
previously	O
demonstrated	O
an	O
important	O
transcriptional	O
factor	O
of	O
hepatic	O
metabolic	O
genes	O
in	O
the	O
neonates	O
under	O
a	O
maternal	O
gestational	O
betaine	O
supplementation	O
(“	O
Gestational	O
dietary	O
betaine	O
supplementation	O
suppresses	O
hepatic	O
expression	O
of	O
lipogenic	O
genes	O
in	O
neonatal	O
piglets	O
through	O
epigenetic	O
and	O
glucocorticoid	O
receptor	O
-	O
dependent	O
mechanisms	O
”	O
Cai	O
et	O
al	O
.,	O
2015	O
[	O
1	O
]).	O

Cold	O
stress	O
stimulates	O
lipolysis	O
by	O
increasing	O
the	O
secretion	O
of	O
stress	O
hormones	O
including	O
epinephrine	O
and	O
norepinephrine	O
in	O
humans	O
[	O
101	O
].	O

Hence	O
,	O
it	O
would	O
be	O
expected	O
,	O
with	O
the	O
inclusion	O
of	O
these	O
and	O
other	O
innovations	O
,	O
that	O
mortality	O
reduction	O
could	O
be	O
more	O
rapid	O
than	O
for	O
the	O
historical	O
examples	O
.	O

In	O
a	O
group	O
of	O
1245	O
adult	O
patients	O
with	O
documented	O
asthma	O
,	O
24	O
%	O
had	O
seasonal	O
AR	O
only	O
,	O
6	O
%	O
had	O
perennial	O
AR	O
only	O
,	O
and	O
22	O
%	O
were	O
considered	O
to	O
have	O
both	O
[	O
26	O
].	O

The	O
authors	O
suggested	O
that	O
future	O
studies	O
with	O
larger	O
sample	O
sizes	O
would	O
be	O
helpful	O
to	O
endorse	O
or	O
challenge	O
their	O
findings	O
.	O

Scenario	O
3	O
:	O
Countries	O
achieve	O
universal	O
coverage	O
of	O
basic	O
interventions	O
Should	O
governments	O
adopt	O
universal	O
coverage	O
of	O
interventions	O
(	O
95	O
%)	O
ensuring	O
that	O
every	O
woman	O
and	O
child	O
who	O
needs	O
an	O
intervention	O
receives	O
it	O
,	O
then	O
,	O
according	O
to	O
the	O
LiST	O
analysis	O
(	O
Table2	O
)	O
and	O
the	O
historical	O
data	O
(	O
Figure4	O
),	O
countries	O
could	O
achieve	O
an	O
84	O
%	O
reduction	O
of	O
1	O
.	O
1	O
million	O
deaths	O
due	O
to	O
preterm	O
birth	O
complications	O
.	O

Also	O
,	O
future	O
adequately	O
powered	O
randomized	O
clinical	O
trials	O
are	O
needed	O
to	O
determine	O
whether	O
modifying	O
maternal	O
prenatal	O
behaviors	O
and	O
GWG	O
can	O
prevent	O
offspring	O
obesity	O
.	O

Prepregnancy	O
smoking	O
status	O
was	O
assessed	O
as	O
number	O
of	O
cigarettes	O
per	O
day	O
.	O

Application	O
of	O
fetal	O
nutritional	O
programming	O
to	O
increase	O
IMF	O
deposition	O
of	O
progeny	O
in	O
later	O
life	O
is	O
reviewed	O
.	O

After	O
determination	O
of	O
estrous	O
stage	O
,	O
samples	O
were	O
air	O
dried	O
and	O
stained	O
using	O
an	O
adaptation	O
of	O
the	O
Papanicolaou	O
(	O
PAP	O
)	O
stain	O
used	O
for	O
humans	O
[	O
63	O
].	O

Vitamin	O
D	O
uptake	O
in	O
the	O
common	O
diet	O
is	O
of	O
minor	O
significance	O
,	O
although	O
cholecalciferol	O
can	O
be	O
found	O
in	O
sea	O
fish	O
fat	O
and	O
liver	O
oil	O
,	O
while	O
ergocalciferol	O
in	O
green	O
plants	O
and	O
mushrooms	O
.	O

Vitamin	O
D	O
induces	O
insulin	O
receptor	O
expression	O
through	O
Vitamin	O
D	O
receptor	O
(	O
VDR	O
),	O
enhancing	O
insulin	O
-	O
dependent	O
glucose	O
transport	O
.	O

In	O
both	O
models	O
,	O
we	O
observed	O
a	O
trend	O
whereby	O
the	O
later	O
in	O
pregnancy	O
a	O
women	O
received	O
vaccination	O
the	O
lower	O
her	O
adjusted	O
odds	O
of	O
PTB	O
.	O

Finally	O
,	O
while	O
the	O
use	O
of	O
rodent	O
models	O
for	O
reproductive	O
investigation	O
is	O
generally	O
well	O
accepted	O
,	O
a	O
number	O
of	O
differences	O
must	O
be	O
recognized	O
.	O

Adverse	O
environmental	O
conditions	O
during	O
fetal	O
development	O
provoke	O
an	O
intrauterine	O
adaptive	O
response	O
termed	O
'	O
fetal	O
programming	O
',	O
which	O
may	O
lead	O
to	O
both	O
persistently	O
biased	O
responsiveness	O
to	O
extrinsic	O
factors	O
and	O
permanent	O
consequences	O
for	O
the	O
organismal	O
phenotype	O
.	O

Lower	O
vitamin	O
D	O
levels	O
have	O
been	O
found	O
in	O
many	O
autoimmune	O
diseases	O
,	O
such	O
as	O
rheumatoid	O
arthritis	O
,	O
systemic	O
lupus	O
erythematosus	O
,	O
systemic	O
sclerosis	O
,	O
type	O
1	O
diabetes	O
mellitus	O
,	O
multiple	O
sclerosis	O
,	O
inflammatory	O
bowel	O
diseases	O
,	O
autoimmune	O
thyroid	O
diseases	O
[	O
6	O
,	O
7	O
].	O

The	O
spicules	O
of	O
bone	O
contained	O
osteocytes	O
and	O
were	O
lined	O
by	O
benign	O
-	O
appearing	O
osteoblasts	O
(	O
Fig	O
3	O
).	O

RC	O
male	O
offspring	O
showed	O
a	O
decrease	O
in	O
the	O
gene	O
expression	O
of	O
Cpt1b	O
,	O
Acox1	O
,	O
and	O
Cox4i1	O
in	O
PAT	O
(	O
Figures5C	O
,	O
D	O
).	O

In	O
early	O
childhood	O
,	O
feeding	O
practices	O
,	O
taste	O
acquisition	O
,	O
and	O
eating	O
in	O
the	O
absence	O
of	O
hunger	O
must	O
be	O
considered	O
.	O

Prenatal	O
diet	O
influences	O
the	O
risk	O
of	O
infant	O
and	O
child	O
allergy	O
.	O

Indeed	O
,	O
vaccine	O
uptake	O
remained	O
somewhat	O
higher	O
among	O
pregnant	O
women	O
with	O
pre	O
-	O
existing	O
chronic	O
medical	O
conditions	O
in	O
our	O
study	O
year	O
suggesting	O
that	O
the	O
recommendation	O
may	O
have	O
been	O
slow	O
to	O
take	O
effect	O
.	O

P	O
-	O
values	O
refer	O
to	O
differences	O
between	O
the	O
groupsMaternal	O
characteristics	O
n	O
Non	O
-	O
GDM	O
n	O
GDM	O
p	O
valueAge	O
at	O
delivery	O
(	O
y	O
)	O
64231	O
.	O
4	O
±	O
4	O
.	O
38132	O
.	O
7	O
±	O
4	O
.	O
50	O
.	O
018Level	O
of	O
educationa6325	O
.	O
0	O
±	O
1	O
.	O
3794	O
.	O
7	O
±	O
1	O
.	O
40	O
.	O
051Parity6401	O
.	O
5	O
±	O
0	O
.	O
7811	O
.	O
5	O
±	O
0	O
.	O
70	O
.	O
275Prepregnancy	O
smoking	O
,	O
number	O
of	O
cigarettes	O
daily6251	O
.	O
2	O
±	O
3	O
.	O
7762	O
.	O
0	O
±	O
4	O
.	O
60	O
.	O
064Alcohol	O
consumption	O
before	O
pregnancy	O
,	O
portion	O
/	O
wk	O
.	O
6251	O
.	O
9	O
±	O
2	O
.	O
0782	O
.	O
3	O
±	O
3	O
.	O
50	O
.	O
755Prepregnancy	O
height	O
(	O
cm	O
)	O
642166	O
.	O
3	O
±	O
6	O
.	O
081165	O
.	O
9	O
±	O
5	O
.	O
40	O
.	O
398Prepregnancy	O
weight	O
(	O
kg	O
)	O
63163	O
.	O
5	O
±	O
10	O
.	O
28172	O
.	O
1	O
±	O
13	O
.	O
5	O
<	O
0	O
.	O
001Prepregnancy	O
BMI	O
(	O
kg	O
/	O
m2	O
)	O
63923	O
.	O
0	O
±	O
3	O
.	O
58126	O
.	O
2	O
±	O
4	O
.	O
8	O
<	O
0	O
.	O
001Duration	O
of	O
gestation	O
at	O
OGTT	O
(	O
wk	O
)	O
32326	O
.	O
3	O
±	O
4	O
.	O
38025	O
.	O
9	O
±	O
5	O
.	O
90	O
.	O
774Duration	O
of	O
gestation	O
at	O
pregnancy	O
blood	O
sampling	O
(	O
wk	O
)	O
64211	O
.	O
3	O
±	O
1	O
.	O
98111	O
.	O
2	O
±	O
2	O
.	O
20	O
.	O
089Duration	O
of	O
gestation	O
at	O
delivery	O
(	O
wk	O
)	O
64240	O
.	O
2	O
±	O
1	O
.	O
18140	O
.	O
1	O
±	O
1	O
.	O
10	O
.	O
410Pregnancy	O
25	O
(	O
OH	O
)	O
D	O
(	O
nmol	O
/	O
L	O
)	O
64281	O
.	O
9	O
±	O
19	O
.	O
58180	O
.	O
0	O
±	O
21	O
.	O
20	O
.	O
417UCB	O
25	O
(	O
OH	O
)	O
D	O
(	O
nmol	O
/	O
L	O
)	O
64280	O
.	O
1	O
±	O
20	O
.	O
08178	O
.	O
4	O
±	O
18	O
.	O
80	O
.	O
448Supplemental	O
vitamin	O
D	O
intake	O
during	O
pregnancy	O
(	O
μ	O
g	O
/	O
d	O
)	O
62115	O
.	O
5	O
±	O
16	O
.	O
67613	O
.	O
5	O
±	O
10	O
.	O
80	O
.	O
162Cumulative	O
gestational	O
weight	O
gain	O
atb	O
(	O
kg	O
)	O
0	O
.	O
093	O
first	O
measurement5801	O
.	O
7	O
±	O
0	O
.	O
5741	O
.	O
6	O
±	O
0	O
.	O
5	O
12th	O
gestational	O
week5803	O
.	O
8	O
±	O
1	O
.	O
0743	O
.	O
6	O
±	O
1	O
.	O
1	O
20th	O
gestational	O
week5806	O
.	O
3	O
±	O
0	O
.	O
8746	O
.	O
2	O
±	O
0	O
.	O
8	O
30th	O
gestational	O
week5809	O
.	O
7	O
±	O
0	O
.	O
5749	O
.	O
7	O
±	O
0	O
.	O
4	O
last	O
measurement58013	O
.	O
8	O
±	O
0	O
.	O
47413	O
.	O
7	O
±	O
0	O
.	O
3	O
GDM	O
gestational	O
diabetes	O
mellitus	O
,	O
25	O
(	O
OH	O
)	O
D	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
,	O
UCB	O
umbilical	O
cord	O
blood	O
Values	O
are	O
means	O
±	O
SD	O
aScale	O
from	O
1	O
=	O
lower	O
secondary	O
education	O
to	O
6	O
=	O
first	O
or	O
second	O
stage	O
of	O
tertiary	O
education	O
bValues	O
are	O
adjusted	O
for	O
duration	O
of	O
gestation	O
Independent	O
sample	O
t	O
-	O
tests	O
,	O
Mann	O
-	O
Whitney	O
U	O
-	O
tests	O
,	O
repeated	O
measures	O
ANOVA	O
or	O
the	O
Pearson	O
Chi	O
-	O
Square	O
test	O
,	O
when	O
appropriate	O
,	O
were	O
applied	O
to	O
compare	O
maternal	O
characteristics	O
between	O
GDM	O
and	O
non	O
-	O
GDM	O
mothers	O
.	O

The	O
VD	O
levels	O
in	O
patients	O
with	O
clinical	O
pregnancy	O
(	O
30	O
.	O
95	O
%)	O
were	O
significantly	O
higher	O
(	O
p	O
=	O
0	O
.	O
01	O
)	O
compared	O
to	O
those	O
with	O
early	O
spontaneous	O
abortion	O
.	O

Researchers	O
at	O
the	O
University	O
of	O
Texas	O
M	O
.	O
D	O
.	O

Social	O
and	O
racial	O
disparities	O
in	O
preterm	O
birth	O
rates	O
are	O
a	O
major	O
issue	O
,	O
yet	O
remain	O
poorly	B
understood	I
.	O

We	O
used	O
targeted	O
sequencing	O
of	O
the	O
16S	O
rRNA	O
V4	O
-	O
V5	O
hypervariable	O
region	O
to	O
characterize	O
infant	O
gut	O
microbiota	O
.	O

We	O
speculate	O
that	O
whereas	O
pubertal	O
onset	O
was	O
accelerated	O
in	O
the	O
UNP	O
group	O
to	O
maintain	O
some	O
potential	O
for	O
reproduction	O
in	O
an	O
environment	O
predicted	O
to	O
have	O
a	O
higher	O
mortality	O
risk	O
,	O
in	O
the	O
HF	O
offspring	O
maturation	O
was	O
accelerated	O
to	O
opportunistically	O
enhance	O
fitness	O
.	O

Continuous	O
variables	O
Serum	O
total	O
IgE	O
(	O
kU	O
·	O
L	O
−	O
1	O
)	O
was	O
measured	O
by	O
fluoroimmunoassay	O
using	O
the	O
Pharmacia	O
UNICAP	O
system	O
(	O
Pharmacia	O
and	O
Upjohn	O
Diagnostics	O
,	O
Uppsala	O
,	O
Sweden	O
).	O

All	O
of	O
these	O
complications	O
could	O
lead	O
to	O
permanent	O
damages	O
in	O
the	O
neonates	O
'	O
developing	O
brain	O
[	O
52	O
].	O

There	O
were	O
1754	O
infants	O
who	O
were	O
assessed	O
at	O
6	O
months	O
of	O
age	O
(	O
Lifestyle	O
Advice	O
n	O
=	O
869	O
;	O
Standard	O
Care	O
n	O
=	O
885	O
),	O
representing	O
82	O
.	O
1	O
%	O
of	O
the	O
eligible	O
sample	O
.	O

BMI	O
change	O
in	O
boys	O
was	O
associated	O
(	O
with	O
borderline	O
significance	O
)	O
with	O
the	O
PGF	O
,	O
p	O
=	O
0	O
.	O
061	O
.	O

A	O
multi	O
-	O
centered	O
study	O
of	O
four	O
Midwest	O
states	O
examining	O
rural	O
and	O
farm	O
exposures	O
observed	O
a	O
statistically	O
significant	O
increased	O
risk	O
of	O
adult	O
gliomas	O
for	O
springtime	O
births	O
,	O
but	O
only	O
among	O
those	O
born	O
“	O
off	O
”	O
a	O
farm	O
[	O
21	O
].	O

We	O
used	O
a	O
zero	O
replacement	O
procedure	O
and	O
log	O
-	O
ratio	O
transformation	O
to	O
account	O
for	O
the	O
zero	O
-	O
inflated	O
and	O
compositional	O
nature	O
of	O
the	O
data	O
[	O
48	O
]	O
before	O
running	O
linear	O
models	O
.	O

Although	O
not	O
statistically	O
significant	O
,	O
the	O
MLR	O
approach	O
also	O
trended	O
in	O
the	O
same	O
direction	O
.	O

In	O
overweight	O
/	O
obese	O
(	O
OW	O
/	O
OB	O
;	O
n	O
=	O
132	O
)	O
mothers	O
,	O
greater	O
%	O
kcal	O
from	O
sweets	O
early	O
in	O
pregnancy	O
was	O
the	O
strongest	O
,	O
independent	O
predictor	O
of	O
higher	O
weight	O
for	O
age	O
(	O
WFA	O
)	O
(	O
beta	O
=	O
0	O
.	O
19	O
;	O
P	O
=	O
0	O
.	O
004	O
),	O
higher	O
odds	O
of	O
macrosomia	O
(	O
OR	O
=	O
1	O
.	O
1	O
(	O
1	O
.	O
0	O
–	O
1	O
.	O
2	O
);	O
P	O
=	O
0	O
.	O
004	O
)	O
andWFA	O
>	O
90th	O
percentile	O
at	O
birth	O
(	O
OR	O
=	O
1	O
.	O
2	O
(	O
1	O
.	O
1	O
–	O
1	O
.	O
3	O
);	O
P	O
=	O
0	O
.	O
002	O
)	O
and	O
higher	O
WFA	O
at	O
6	O
months	O
(	O
beta	O
=	O
0	O
.	O
30	O
;	O
P	O
=	O
0	O
.	O
002	O
).	O

Thus	O
,	O
migrating	O
women	O
or	O
those	O
unable	O
to	O
speak	O
local	O
languages	O
could	O
not	O
be	O
included	O
in	O
the	O
study	O
.	O

Participants	O
completed	O
the	O
questionnaire	O
in	O
reference	O
to	O
intake	O
over	O
the	O
past	O
month	O
.	O

For	O
example	O
,	O
chemicals	O
can	O
have	O
far	O
-	O
reaching	O
benefits	O
to	O
society	O
,	O
from	O
agriculture	O
to	O
medicine	O
and	O
food	O
/	O
product	O
safety	O
to	O
the	O
development	O
of	O
new	B
technologies	O
.	O

Moreover	O
,	O
vitamin	O
D	O
is	O
associated	O
with	O
premature	O
births	O
,	O
obesity	O
and	O
renal	O
dysfunction	O
in	O
adulthood	O
,	O
making	O
it	O
more	O
than	O
an	O
essential	O
fat	O
-	O
soluble	O
vitamin	O
responsible	O
for	O
calcium	O
metabolism	O
[	O
9	O
],[	O
10	O
].	O

BAT	O
activation	O
by	O
cold	O
exposure	O
,	O
β3	O
-	O
agonist	O
or	O
thyroid	O
hormone	O
treatment	O
was	O
shown	O
to	O
improve	O
glucose	O
tolerance	O
and	O
insulin	O
sensitivity	O
(	O
Cawthorne	O
et	O
al	O
.,	O
1984	O
;	O
Forest	O
et	O
al	O
.,	O
1987	O
;	O
Peirce	O
and	O
Vidal	O
-	O
Puig	O
,	O
2013	O
).	O

For	O
example	O
,	O
after	O
multivariate	O
adjustment	O
,	O
the	O
risk	O
of	O
middle	O
respective	O
high	O
level	O
psychotic	O
-	O
like	O
symptoms	O
for	O
intake	O
of	O
vitamin	O
D	O
were	O
respectively	O
18	O
%	O
and	O
37	O
%	O
lower	O
in	O
the	O
highest	O
quartile	O
compared	O
to	O
the	O
lowest	O
quartile	O
of	O
intake	O
.	O

However	O
,	O
it	O
could	O
be	O
argued	O
that	O
,	O
for	O
our	O
results	O
to	O
be	O
totally	O
spurious	O
in	O
those	O
included	O
in	O
our	O
analysis	O
(	O
and	O
for	O
the	O
associations	O
to	O
be	O
truly	O
null	O
in	O
the	O
population	O
as	O
a	O
whole	O
),	O
associations	O
in	O
the	O
excluded	O
mother	O
–	O
child	O
pairs	O
would	O
have	O
to	O
be	O
in	O
the	O
opposite	O
direction	O
and	O
much	O
stronger	O
,	O
compared	O
with	O
the	O
positive	O
associations	O
we	O
reported	O
in	O
the	O
included	O
mother	O
–	O
child	O
pairs	O
,	O
which	O
seems	O
extremely	O
unlikely	O
.	O

Both	O
overweight	O
/	O
obesity	O
as	O
well	O
as	O
darker	O
skin	O
pigmentation	O
are	O
both	O
well	O
-	O
established	O
risk	O
factors	O
for	O
vitamin	O
D	O
deficiency	O
.	O

MTRL	O
,	O
JS	O
,	O
and	O
FR	O
wrote	O
the	O
first	O
draft	O
of	O
the	O
manuscript	O
that	O
was	O
revised	O
by	O
all	O
authors	O
.	O

This	O
review	O
concludes	O
with	O
a	O
discussion	O
highlighting	O
some	O
of	O
the	O
methodological	O
issues	O
in	O
researching	O
associations	O
between	O
diet	O
and	O
infant	O
neurodevelopment	O
.	O

Second	O
,	O
the	O
high	O
follow	O
-	O
up	O
rate	O
(>	O
95	O
%)	O
minimized	O
possible	O
selection	O
bias	O
.	O

For	O
all	O
analyses	O
a	O
p	O
value	O
<	O
0	O
.	O
05	O
was	O
considered	O
significant	O
;	O
all	O
were	O
undertaken	O
using	O
the	O
Statistical	O
Package	O
for	O
Social	O
Science	O
(	O
SPSS	O
)	O
program	O
for	O
Windows	O
Version	O
13	O
.	O
0	O
(	O
SPSS	O
13	O
.	O
0	O
,	O
Chicago	O
,	O
IL	O
,	O
USA	O
).	O

There	O
has	O
been	O
considerable	O
research	O
interest	O
in	O
the	O
provision	O
of	O
antenatal	O
dietary	O
interventions	O
during	O
pregnancy	O
to	O
limit	O
weight	O
gain	O
and	O
improve	O
pregnancy	O
and	O
birth	O
outcomes	O
for	O
women	O
and	O
their	O
infants	O
.	O

It	O
was	O
remarkably	O
observed	O
that	O
preparation	O
for	O
hibernation	O
was	O
characterized	O
by	O
striking	O
increases	O
in	O
body	O
weight	O
and	O
in	O
fat	O
mass	O
.	O

Experts	O
have	O
decried	O
the	O
lack	O
of	O
trustworthy	O
statistics	O
on	O
the	O
sources	O
and	O
extent	O
of	O
pollution	O
and	O
the	O
number	O
of	O
remediation	O
facilities	O
.	O

Future	O
mHealth	O
interventions	O
may	O
build	O
on	O
these	O
lessons	O
to	O
engage	O
audiences	O
in	O
health	O
programs	O
through	O
multiple	O
digital	O
channels	O
[	O
31	O
,	O
32	O
].	O

Collaboration	O
between	O
scientists	O
from	O
academia	O
,	O
industry	O
,	O
and	O
governmental	O
and	O
regulatory	O
bodies	O
will	O
promote	O
further	O
research	O
within	O
a	O
regulatory	O
context	O
,	O
and	O
drive	O
the	O
development	O
and	O
implementation	O
of	O
epigenetically	O
relevant	O
integrated	O
testing	O
strategies	O
or	O
policies	O
for	O
the	O
continued	O
protection	O
of	O
public	O
health	O
.	O

We	O
decided	O
to	O
incorporate	O
GAS5	O
in	O
the	O
current	O
study	O
as	O
it	O
can	O
act	O
as	O
a	O
GR	O
DNA	O
binding	O
decoy	O
and	O
as	O
a	O
result	O
compromise	O
its	O
activity	O
[	O
8	O
].	O

†	O
Mann	O
-	O
Whitney	O
U	O
test	O
.	O

Imprinted	O
genes	O
are	O
generally	O
widely	O
and	O
highly	O
expressed	O
during	O
prenatal	O
development	O
and	O
predominantly	O
down	O
-	O
regulated	O
after	O
birth	O
.	O

Because	O
they	O
are	O
widely	O
distributed	O
in	O
the	O
environment	O
,	O
the	O
majority	O
of	O
pregnant	O
women	O
in	O
the	O
United	O
States	O
have	O
detectable	O
levels	O
of	O
multiple	O
EDCs	O
in	O
their	O
blood	O
or	O
urine	O
[	O
6	O
,	O
7	O
].	O

There	O
may	O
be	O
a	O
postnatal	O
override	O
such	O
that	O
if	O
energetics	O
remain	O
poor	O
during	O
postnatal	O
life	O
,	O
reproductive	O
maturation	O
may	O
be	O
delayed	O
until	O
the	O
nutritional	O
environment	O
is	O
improved	O
sufficiently	O
to	O
support	O
a	O
first	O
pregnancy	O
.	O

Trial	O
registration	O
The	O
project	O
protocol	O
is	O
registered	O
in	O
ClinicalTrials	O
.	O
gov	O
in	O
November	O
8	O
,	O
2012	O
(	O
NCT01723852	O
).	O

(	O
2015	O
)	O
*	O
Metals	O
:	O
Arsenic	O
(	O
As	O
)	O
LifetimeAdulthoodSkin	O
abnormalitiesDNA	O
methylationPaul	O
et	O
al	O
.	O

Although	O
age	O
and	O
economic	O
deficit	O
were	O
predictors	O
of	O
anaemia	O
at	O
baseline	O
,	O
in	O
a	O
sub	O
analysis	O
these	O
groups	O
did	O
not	O
respond	O
differently	O
to	O
supplementation	O
.	O
Table	O
3includes	O
the	O
haematological	O
findings	O
at	O
follow	O
up	O
.	O

In	O
order	O
to	O
contribute	O
to	O
a	O
comprehensive	O
inventory	O
of	O
genes	O
and	O
functional	O
networks	O
that	O
are	O
targets	O
of	O
nutritional	O
programming	O
initiated	O
during	O
fetal	O
life	O
,	O
we	O
applied	O
whole	O
-	O
genome	O
microarrays	O
for	O
expression	O
profiling	O
in	O
a	O
longitudinal	O
experimental	O
design	O
covering	O
prenatal	O
,	O
perinatal	O
,	O
juvenile	O
,	O
and	O
adult	O
ontogenetic	O
stages	O
in	O
a	O
porcine	O
model	O
.	O

These	O
suboptimal	O
levels	O
were	O
also	O
seen	O
in	O
recent	O
reports	O
by	O
Liao	O
et	O
al	O
[	O
31	O
].	O

Conversely	O
,	O
if	O
a	O
woman	O
was	O
carrying	O
a	O
female	O
fetus	O
,	O
there	O
was	O
generally	O
no	O
effect	O
of	O
having	O
low	O
,	O
low	O
-	O
moderate	O
or	O
high	O
standardised	O
serum	O
25	O
(	O
OH	O
)	O
D	O
on	O
developing	O
any	O
pregnancy	O
complication	O
compared	O
to	O
moderate	O
-	O
high	O
levels	O
(	O
Table3	O
).	O

The	O
HFol	O
pup	O
diet	O
reduced	O
SeroR2A	O
expression	O
in	O
mature	O
offspring	O
of	O
the	O
dams	O
fed	O
the	O
HV	O
diet	O
,	O
but	O
not	O
by	O
the	O
HV	O
pup	O
diet	O
(	O
Figure	O
5b	O
).	O

The	O
PFAS	O
exhibited	O
a	O
minimum	O
GM	O
of	O
1	O
μg	O
/	O
L	O
(	O
PFNA	O
)	O
and	O
maximum	O
GM	O
of	O
13	O
.	O
6	O
μg	O
/	O
L	O
(	O
PFOS	O
).	O

Due	O
to	O
the	O
seasonal	O
nature	O
of	O
25OHD	O
concentrations	O
in	O
many	O
parts	O
of	O
the	O
world	O
[	O
32	O
],	O
and	O
the	O
observed	O
associations	O
between	O
vitamin	O
D	O
and	O
insulin	O
resistance	O
,	O
it	O
would	O
seem	O
prudent	O
to	O
hypothesise	O
that	O
seasonal	O
variation	O
of	O
glucose	O
homeostasis	O
may	O
be	O
mediated	O
through	O
25OHD	O
.	O

A	O
study	O
of	O
Angus	O
-	O
crossbred	O
steers	O
showed	O
that	O
animals	O
not	O
supplemented	O
with	O
vitamin	O
A	O
had	O
higher	O
MS	O
and	O
QG	O
compared	O
to	O
vitamin	O
A	O
-	O
supplemented	O
animals	O
[	O
132	O
].	O

The	O
nutritional	O
and	O
physiological	O
condition	O
of	O
the	O
fetus	O
and	O
the	O
early	O
postnatal	O
stage	O
affects	O
the	O
number	O
of	O
adipocytes	O
in	O
adipose	O
tissues	O
of	O
animals	O
[	O
16	O
].	O

The	O
participants	O
who	O
had	O
depression	O
scores	O
of	O
>	O
13	O
were	O
exited	O
from	O
this	O
clinical	O
trial	O
and	O
referred	O
to	O
psychiatrist	O
for	O
further	O
assessment	O
and	O
treatment	O
,	O
because	O
,	O
the	O
nature	O
of	O
our	O
study	O
was	O
preventative	O
than	O
management	O
.	O

Therefore	O
,	O
it	O
seems	O
reasonable	O
to	O
recommend	O
that	O
when	O
there	O
is	O
no	O
medical	O
or	O
obstetric	O
contraindication	O
,	O
women	O
with	O
GDM	O
should	O
maintain	O
a	O
sensible	O
level	O
of	O
light	O
and	O
moderate	O
intensity	O
physical	O
activity	O
until	O
the	O
latter	O
stages	O
of	O
the	O
pregnancy	O
.	O

This	O
document	O
also	O
includes	O
a	O
summary	O
of	O
evidence	O
-	O
based	O
guidelines	O
and	O
strength	O
of	O
recommendations	O
.	O

Methods	O
This	O
case	O
–	O
control	O
study	O
was	O
conducted	O
from	O
2009	O
to	O
2011	O
in	O
the	O
city	O
of	O
Winnipeg	O
,	O
Manitoba	O
,	O
Canada	O
.	O

AluYb8	O
levels	O
were	O
found	O
to	O
marginally	O
differ	O
by	O
infant	O
sex	O
,	O
which	O
is	O
consistent	O
with	O
the	O
previous	O
literature	O
in	O
that	O
repetitive	O
element	O
methylation	O
markers	O
in	O
blood	O
may	O
vary	O
by	O
sex	O
(	O
Cash	O
et	O
al	O
.	O

Adequate	O
vitamin	O
D	O
intake	O
is	O
associated	O
with	O
a	O
lower	O
risk	O
of	O
cancer	O
[	O
7	O
],[	O
8	O
],[	O
9	O
],[	O
10	O
],[	O
11	O
],	O
cardiovascular	O
diseases	O
[	O
12	O
],	O
autoimmune	O
diseases	O
[	O
13	O
],	O
neurological	O
disorders	O
[	O
14	O
]	O
and	O
diabetes	O
[	O
15	O
].	O

Stratified	O
random	O
sampling	O
was	O
performed	O
in	O
this	O
study	O
.	O

Interventions	O
in	O
the	O
LiST	O
analysis	O
included	O
KMC	O
,	O
antenatal	O
corticosteroids	O
,	O
antibiotics	O
for	O
pPRoM	O
,	O
skilled	O
birth	O
attendance	O
,	O
and	O
others	O
.	O

Diet	O
There	O
should	O
be	O
no	O
special	O
diet	O
for	O
the	O
mother	O
during	O
pregnancy	O
and	O
lactation	O
,	O
unless	O
the	O
mother	O
or	O
child	O
has	O
a	O
diagnosed	O
food	O
sensitization	O
.	O

First	O
Lamarck	O
,	O
and	O
then	O
Waddington	O
,	O
suggested	O
that	O
alternative	O
mechanisms	O
,	O
now	O
termed	O
epigenetics	O
,	O
must	O
also	O
contribute	O
to	O
phenotypic	O
outcomes	O
(	O
Noble2006	O
).	O

Same	O
result	O
was	O
obtained	O
about	O
healthy	O
dietary	O
pattern	O
[	O
OR	O
3	O
.	O
70	O
,	O
95	O
%	O
(	O
CI	O
)	O
(	O
0	O
.	O
72	O
-	O
17	O
.	O
86	O
),	O
P	O
=	O
0	O
.	O
52	O
].	O

Randomisation	O
was	O
by	O
use	O
of	O
a	O
computer	O
-	O
generated	O
list	O
.	O

[	O
9	O
]	O
The	O
actions	O
of	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
are	O
mediated	O
through	O
specific	O
,	O
high	O
affinity	O
binding	O
to	O
the	O
vitamin	O
D	O
receptor	O
(	O
VDR	O
),	O
which	O
is	O
present	O
in	O
multiple	O
tissues	O
.	O

The	O
primary	O
purpose	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
effect	O
of	O
perinatal	O
vitamin	O
D	O
levels	O
on	O
the	O
performance	O
of	O
respiratory	O
function	O
in	O
infancy	O
.	O

However	O
,	O
a	O
recent	O
multi	O
-	O
centered	O
international	O
case	O
-	O
control	O
study	O
of	O
adult	O
diet	O
and	O
brain	O
tumor	O
risk	O
found	O
no	O
evidence	O
of	O
confounding	O
or	O
effect	O
modification	O
by	O
vitamin	O
supplementation	O
,	O
especially	O
in	O
the	O
association	O
between	O
consumption	O
of	O
cured	O
meats	O
(	O
containing	O
high	O
levels	O
of	O
nitrates	O
)	O
and	O
gliomas	O
[	O
167	O
].	O

The	O
transfer	O
of	O
maternal	O
cytokines	O
was	O
confirmed	O
in	O
a	O
study	O
of	O
suckling	O
piglets	O
[	O
65	O
].	O

Therefore	O
,	O
the	O
down	O
-	O
regulation	O
of	O
the	O
endocannabinoid	O
machinery	O
in	O
the	O
adipose	O
tissue	O
of	O
male	O
offspring	O
at	O
adulthood	O
may	O
result	O
in	O
a	O
putative	O
compensatory	O
effect	O
in	O
order	O
to	O
respond	O
to	O
an	O
unbalanced	O
endocannabinoid	O
tone	O
originated	O
at	O
birth	O
after	O
maternal	O
undernutrition	O
.	O

The	O
PRISMA	O
statement	O
process	O
was	O
followed	O
[	O
17	O
]	O
as	O
shown	O
inFigure	O
1	O
.	O

It	O
is	O
important	O
to	O
recognize	O
that	O
many	O
individuals	O
who	O
use	O
text	O
messages	O
receive	O
large	O
numbers	O
of	O
texts	O
per	O
day	O
.	O

Furthermore	O
,	O
in	O
this	O
study	O
,	O
we	O
performed	O
analysis	O
only	O
of	O
candidate	O
SNPs	O
previously	O
identified	O
to	O
be	O
associated	O
with	O
differences	O
in	O
25	O
(	O
OH	O
)	O
D	O
status	O
.	O

Importantly	O
,	O
our	O
study	O
illustrates	O
the	O
additive	O
effect	O
of	O
maternal	O
risk	O
factors	O
and	O
their	O
predictive	O
probabilities	O
for	O
vitamin	O
D	O
deficiency	O
and	O
SGA	O
.	O

Characteristics	O
of	O
the	O
women	O
in	O
the	O
two	O
treatment	O
arms	O
were	O
compared	O
using	O
the	O
t	O
test	O
,	O
Mann	O
-	O
Whitney	O
U	O
test	O
,	O
and	O
χ2test	O
for	O
normally	O
distributed	O
,	O
nonnormally	O
distributed	O
,	O
and	O
categorical	O
variables	O
,	O
respectively	O
.	O

We	O
used	O
multivariable	O
logistic	O
regression	O
to	O
analyze	O
associations	O
of	O
PNV	O
use	O
and	O
odds	O
of	O
vitamin	O
D	O
deficiency	O
defined	O
as	O
25	O
(	O
OH	O
)	O
D	O
levels	O
<	O
50	O
nmol	O
/	O
L	O
.	O

Concerning	O
the	O
analysis	O
of	O
total	O
GWG	O
,	O
absolute	O
values	O
were	O
used	O
,	O
and	O
women	O
who	O
had	O
their	O
final	O
weight	O
recorded	O
more	O
than	O
three	O
weeks	O
before	O
the	O
delivery	O
were	O
omitted	O
(	O
n	O
=	O
7	O
).	O

We	O
think	O
that	O
confounding	O
of	O
the	O
main	O
findings	O
by	O
lifestyle	O
or	O
other	O
aspects	O
of	O
maternal	O
diet	O
in	O
pregnancy	O
is	O
unlikely	O
,	O
as	O
we	O
controlled	O
for	O
numerous	O
potential	O
confounders	O
in	O
the	O
analyses	O
,	O
including	O
nutrients	O
and	O
foods	O
that	O
have	O
been	O
previously	O
linked	O
to	O
childhood	O
asthma	O
and	O
atopy	O
.	O

Due	O
to	O
ethical	O
restrictions	O
,	O
we	O
were	O
only	O
able	O
to	O
assess	O
the	O
expression	O
of	O
GR	O
α	O
/	O
β	O
in	O
4	O
term	O
and	O
3	O
preterm	O
placentas	O
.	O

Serum	O
visfatin	O
levels	O
fluctuate	O
as	O
pregnancy	O
advances	O
(	O
10	O
).	O

Researchers	O
were	O
blinded	O
to	O
subject	O
allocation	O
scheme	O
and	O
subjects	O
and	O
field	O
staff	O
knew	O
only	O
the	O
colour	O
-	O
coded	O
allocation	O
groups	O
.	O

Anthropometry	O
and	O
blood	O
samples	O
were	O
collected	O
from	O
participants	O
during	O
village	O
visits	O
Sample	O
size	O
Mean	O
recruitment	O
haemoglobin	O
for	O
the	O
PMMST	O
study	O
was	O
11	O
.	O
7	O
g	O
/	O
dL	O
,	O
(	O
SD	O
1	O
.	O
5	O
g	O
/	O
dL	O
)	O
for	O
a	O
population	O
of	O
1156	O
.	O

JF	O
:	O
Analysis	O
and	O
interpretation	O
of	O
data	O
,	O
revising	O
article	O
critically	O
for	O
important	O
intellectual	O
content	O
,	O
and	O
final	O
approval	O
of	O
version	O
to	O
be	O
published	O
.	O

To	O
assess	O
the	O
relationship	O
between	O
maternal	O
dietary	O
factors	O
and	O
infant	O
gut	O
cluster	O
membership	O
,	O
we	O
used	O
multinomial	O
logistic	O
regression	O
with	O
cluster	O
1	O
as	O
the	O
reference	O
group	O
.	O

“	O
There	O
are	O
inherent	O
difficulties	O
with	O
studying	O
breastfeeding	O
prospectively	O
in	O
a	O
rigorous	O
manner	O
,”	O
explains	O
Tonse	O
Raju	O
,	O
chief	O
of	O
the	O
Pregnancy	O
and	O
Perinatology	O
Branch	O
at	O
the	O
Eunice	O
Kennedy	O
Shriver	O
National	O
Institute	O
of	O
Child	O
Health	O
and	O
Human	O
Development	O
.	O

Text	O
messaging	O
interventions	O
can	O
do	O
much	O
more	O
than	O
simply	O
deliver	O
text	O
reminders	O
—	O
they	O
can	O
deliver	O
right	O
into	O
the	O
hands	O
of	O
highly	O
targeted	O
population	O
the	O
public	O
service	O
announcements	O
that	O
in	O
years	O
past	O
would	O
have	O
appeared	O
in	O
mass	O
media	O
[	O
45	O
].	O

The	O
first	O
section	O
comprises	O
10	O
chapters	O
on	O
various	O
aspects	O
of	O
nutrition	O
such	O
as	O
nutrition	O
adequacy	O
to	O
dietary	O
supplements	O
.	O

Drug	O
Allergy	O
There	O
is	O
a	O
lack	B
of	I
data	I
on	O
the	O
prevalence	O
of	O
adverse	O
drug	O
reactions	O
during	O
pregnancy	O
.	O

The	O
obvious	O
explanations	O
to	O
the	O
higher	O
body	O
weight	O
found	O
in	O
RC	O
males	O
after	O
weaning	O
could	O
be	O
as	O
a	O
consequence	O
of	O
an	O
increased	O
food	O
intake	O
,	O
decreased	O
energy	O
expenditure	O
or	O
higher	O
metabolic	O
efficiency	O
.	O

In	O
addition	O
to	O
the	O
most	O
common	O
factors	O
the	O
sedentary	O
lifestyle	O
may	O
also	O
be	O
a	O
risk	O
factor	O
for	O
GDM	O
.	O

The	O
costs	O
of	O
the	O
intervention	O
will	O
include	O
cost	O
and	O
distribution	O
of	O
the	O
supplements	O
,	O
training	O
of	O
SS	O
workers	O
,	O
organisational	O
costs	O
associated	O
with	O
the	O
administration	O
of	O
the	O
programme	O
and	O
the	O
cost	O
of	O
incentives	O
.	O

We	O
computed	O
generalized	O
UniFrac	O
distances	O
between	O
pairs	O
of	O
samples	O
using	O
OTU	O
tables	O
and	O
the	O
midpoint	O
rooted	O
phylogenetic	O
tree	O
.	O

Moreover	O
,	O
there	O
was	O
no	O
difference	O
between	O
the	O
serum	O
concentration	O
of	O
Ca	O
of	O
the	O
IG	O
and	O
CG	O
prior	O
or	O
after	O
the	O
intervention	O
.	O

Moreover	O
,	O
by	O
examining	O
the	O
relationship	O
between	O
repetitive	O
element	O
DNA	O
methylation	O
and	O
genomewide	O
(	O
array	O
)	O
gene	O
-	O
associated	O
methylation	O
,	O
this	O
work	O
suggests	O
potential	O
epigenetic	O
mechanisms	O
underlying	O
changes	O
to	O
placental	O
function	O
that	O
may	O
lead	O
to	O
altered	O
fetal	O
development	O
and	O
programming	O
.	O

The	O
following	O
were	O
found	O
not	O
to	O
be	O
associated	O
with	O
oesophageal	O
cancer	O
:	O
consumption	O
of	O
sheep	O
'	O
s	O
milk	O
and	O
yoghurt	O
,	O
sesame	O
oil	O
,	O
chewing	O
of	O
nass	O
,	O
making	O
of	O
carpets	O
,	O
use	O
of	O
pregnancy	O
diets	O
,	O
salting	O
and	O
sun	O
-	O
drying	O
of	O
meat	O
and	O
use	O
of	O
wild	O
spinach	O
.	O

More	O
information	O
is	O
urgently	O
needed	O
from	O
both	O
providers	O
and	O
patients	O
on	O
the	O
reasons	O
for	O
these	O
shifts	O
in	O
clinical	O
practice	O
and	O
how	O
to	O
promote	O
more	O
conservative	O
obstetric	O
management	O
.	O

Subgroup	O
analyses	O
revealed	O
some	O
potentially	O
key	O
findings	O
.	O

2011	O
).	O

This	O
study	O
surprisingly	O
found	O
that	O
the	O
effect	O
of	O
intermediate	O
doses	O
of	O
EPA	O
increased	O
the	O
levels	O
of	O
AA	O
(	O
an	O
omega	O
-	O
6	O
PUFA	O
)	O
in	O
the	O
membrane	O
of	O
red	O
cells	O
,	O
whereas	O
higher	O
doses	O
of	O
EPA	O
did	O
not	O
,	O
and	O
the	O
EPA	O
-	O
induced	O
rise	O
in	O
AA	O
was	O
associated	O
with	O
a	O
clinical	O
improvement	O
.	O

(	O
2014	O
)*/†	O
Nutrition	O
:	O
High	O
fat	O
dietMouse	O
RatOral	O
(	O
diet	O
)	O
(	O
60	O
%	O
fat	O
)	O
Pre	O
-	O
conception	O
(	O
maternal	O
)	O
to	O
lactation	O
Early	O
adulthoodAdulthood	O
F0	O
-	O
F1generationsWeight	O
-,	O
glucose	O
-	O
and	O
lipid	O
-	O
related	O
metabolic	O
and	O
food	O
preference	O
abnormalitiesDNA	O
methylation	O
miRNAsBaselga	O
-	O
Escudero	O
et	O
al	O
.	O

Food	O
restriction	O
in	O
dams	O
produced	O
a	O
decrease	O
in	O
caloric	O
intake	O
of	O
female	O
offspring	O
treated	O
with	O
AM251	O
(	O
Figure3H	O
).	O

Due	O
to	O
this	O
heterogeneity	O
a	O
qualitative	O
rather	O
than	O
quantitative	O
approach	O
was	O
deemed	O
appropriate	O
for	O
comparison	O
and	O
presentation	O
of	O
findings	O
.	O

Generalized	O
estimating	O
equation	O
models	O
were	O
used	O
to	O
evaluate	O
outcomes	O
.	O

Concerning	O
the	O
number	O
of	O
ANC	O
visits	O
,	O
the	O
health	O
centres	O
follow	O
the	O
Western	O
model	O
of	O
clinic	O
visits	O
with	O
an	O
average	O
of	O
10	O
to	O
12	O
visits	O
.	O

A	O
recent	O
international	O
expert	O
consultation	O
organized	O
by	O
WHO	O
went	O
further	O
and	O
recommended	O
weekly	O
supplementation	O
with	O
iron	O
and	O
folic	O
acid	O
for	O
all	O
non	O
-	O
pregnant	O
women	O
of	O
reproductive	O
age	O
in	O
areas	O
where	O
anaemia	O
prevalence	O
is	O
greater	O
than	O
20	O
%[	O
8	O
].	O

Perceptions	O
of	O
pregnant	O
women	O
The	O
respondent	O
'	O
s	O
knowledge	O
about	O
ANC	O
was	O
evaluated	O
using	O
three	O
questions	O
.	O

Snoring	O
that	O
is	O
infrequent	O
or	O
non	O
-	O
habitual	O
has	O
not	O
been	O
shown	O
to	O
be	O
a	O
useful	O
screen	O
for	O
sleep	O
disordered	O
breathing	O
in	O
large	O
epidemiologic	O
studies	O
[	O
41	O
,	O
42	O
].	O

Caption	O
(	O
BOXED	O
-	O
TEXT	O
)	O
Box	O
1	O
.	O

Here	O
,	O
we	O
review	O
results	O
of	O
research	O
on	O
genetic	O
factors	O
(	O
breed	O
and	O
sex	O
differences	O
and	O
heritability	O
)	O
that	O
affect	O
IMF	O
deposition	O
.	O

The	O
position	O
of	O
chocolate	O
mixture	O
was	O
switched	O
every	O
day	O
.	O

Both	O
cutaneous	O
production	O
and	O
dietary	O
consumption	O
of	O
vitamin	O
D	O
must	O
undergo	O
two	O
hydroxylations	O
in	O
the	O
body	O
for	O
activation	O
.	O

Given	O
this	O
scenario	O
and	O
taking	O
into	O
account	O
changing	O
numbers	O
of	O
births	O
,	O
the	O
global	O
total	O
of	O
preterm	O
deaths	O
will	O
not	O
reduce	O
significantly	O
by	O
2025	O
,	O
with	O
around	O
900	O
,	O
000	O
premature	O
babies	O
continuing	O
to	O
die	O
every	O
year	O
.	O

The	O
physiological	O
response	O
to	O
sunlight	O
exposure	O
,	O
beyond	O
that	O
of	O
vitamin	O
D	O
production	O
,	O
includes	O
regulation	O
of	O
biological	O
circadian	O
and	O
circannual	O
rhythms	O
,	O
control	O
of	O
circulating	O
melatonin	O
,	O
as	O
well	O
as	O
production	O
of	O
nitric	O
oxide	O
,	O
a	O
vasodilator	O
,	O
and	O
beta	O
-	O
endorphins	O
which	O
promote	O
a	O
feeling	O
of	O
well	O
-	O
being	O
[	O
11	O
–	O
13	O
].	O

Formative	O
research	O
Before	O
the	O
intervention	O
started	O
,	O
we	O
conducted	O
a	O
formative	O
study	O
using	O
qualitative	O
methods	O
.	O

The	O
ECS	O
keeps	O
a	O
homeostatic	O
role	O
in	O
regulating	O
energy	O
balance	O
and	O
food	O
intake	O
(	O
Cristino	O
et	O
al	O
.,	O
2014	O
),	O
and	O
its	O
overactivation	O
,	O
mainly	O
via	O
CB1	O
receptors	O
,	O
favors	O
the	O
energy	O
accumulation	O
,	O
increases	O
the	O
appetite	O
for	O
highly	O
palatable	O
foods	O
,	O
decreases	O
the	O
satiety	O
and	O
reduces	O
the	O
energy	O
expenditure	O
.	O

Expression	O
of	O
Placental	O
GAS5	O
and	O
GRs	O
Quantitative	O
RT	O
-	O
PCR	O
revealed	O
that	O
GAS5	O
and	O
all	O
GRs	O
were	O
expressed	O
in	O
human	O
placentas	O
(	O
n	O
=	O
23	O
);	O
13	O
were	O
preterm	O
labor	O
(<	O
37	O
gestational	O
weeks	O
)	O
and	O
10	O
were	O
term	O
(>	O
37	O
gestational	O
weeks	O
)	O
labor	O
,	O
with	O
GAS5	O
and	O
GR	O
α	O
being	O
the	O
predominant	O
transcripts	O
.	O

All	O
potential	O
participants	O
were	O
identified	O
from	O
a	O
database	O
of	O
women	O
who	O
directly	O
contacted	O
the	O
Motherisk	O
Program	O
at	O
the	O
Hospital	O
for	O
Sick	O
Children	O
in	O
Toronto	O
,	O
Canada	O
,	O
between	O
2005	O
and	O
2009	O
.	O

MAW	O
conceived	O
,	O
designed	O
and	O
obtained	O
funding	O
for	O
the	O
study	O
.	O

From	O
652	O
children	O
during	O
five	O
separate	O
periods	O
of	O
testing	O
serum	O
calcifediol	O
,	O
only	O
one	O
child	O
in	O
each	O
of	O
two	O
testing	O
periods	O
had	O
results	O
greater	O
than	O
375	O
nmol	O
/	O
L	O
in	O
the	O
intervention	O
group	O
—	O
a	O
toxic	O
level	O
.	O

Robinson	O
et	O
al	O
.	O

Conclusions	O
Women	O
who	O
attended	O
their	O
first	O
antenatal	O
visit	O
during	O
the	O
months	O
of	O
extended	O
winter	O
were	O
more	O
likely	O
to	O
have	O
raised	O
insulin	O
resistance	O
in	O
early	O
pregnancy	O
,	O
which	O
had	O
a	O
lasting	O
association	O
to	O
28	O
weeks	O
,	O
and	O
was	O
independent	O
of	O
25OHD	O
.	O

To	O
this	O
end	O
,	O
a	O
variety	O
of	O
food	O
items	O
such	O
as	O
cereal	O
flour	O
(	O
maize	O
or	O
wheat	O
),	O
salt	O
,	O
beverage	O
,	O
milk	O
,	O
sugar	O
,	O
noodles	O
,	O
rice	O
,	O
and	O
fish	O
sauce	O
had	O
been	O
fortified	O
with	O
iron	O
and	O
used	O
successfully	O
as	O
dietary	O
supplements	O
to	O
boost	O
iron	O
stores	O
,	O
and	O
hence	O
improve	O
haemoglobin	O
levels	O
in	O
the	O
population	O
[	O
28	O
–	O
31	O
].	O

Both	O
excessive	O
[	O
4	O
]	O
and	O
inadequate	O
[	O
5	O
]	O
weight	O
gain	O
in	O
the	O
mother	O
during	O
gestation	O
have	O
been	O
shown	O
to	O
lead	O
to	O
overly	O
rapid	O
fetal	O
and	O
infant	O
growth	O
rates	O
and	O
the	O
programming	O
of	O
future	O
risk	O
of	O
childhood	O
overweight	O
and	O
metabolic	O
disease	O
.	O

Vitamin	O
D	O
group	O
received	O
2000	O
IU	O
vitamin	O
D3daily	O
from	O
26	O
to	O
28	O
weeks	O
of	O
gestation	O
until	O
childbirth	O
.	O

To	O
compare	O
pregnancy	O
outcomes	O
following	O
maternal	O
use	O
of	O
SGA	O
monotherapy	O
and	O
polytherapy	O
involving	O
other	O
psychotropic	O
medications	O
.	O

The	O
average	O
values	O
were	O
measured	O
and	O
equal	O
protein	O
loading	O
was	O
confirmed	O
by	O
probing	O
blots	O
with	O
beta	O
-	O
actin	O
antibody	O
and	O
is	O
expressed	O
as	O
a	O
percentage	O
of	O
the	O
SC	O
counterpart	O
.	O

Hence	O
,	O
pre	O
-	O
pregnancy	O
BMI	O
appears	O
to	O
be	O
a	O
determining	O
factor	O
in	O
creating	O
the	O
difference	O
and	O
the	O
amount	O
of	O
maternal	O
plasma	O
visfatin	O
during	O
pregnancy	O
,	O
which	O
can	O
predict	O
maternal	O
serum	O
visfatin	O
and	O
neonatal	O
and	O
maternal	O
outcomes	O
.	O

However	O
,	O
these	O
children	O
represent	O
a	O
small	O
proportion	O
of	O
the	O
individuals	O
with	O
a	O
suboptimal	O
vitamin	O
D	O
status	O
in	O
the	O
population	O
.	O

3	O
.	O
3	O
.	O

Birth	O
weight	O
and	O
gestational	O
age	O
were	O
recorded	O
for	O
each	O
infant	O
.	O

De	O
novo	O
methylation	O
is	O
established	O
by	O
the	O
de	O
novo	O
DNMTs	O
3A	O
and	O
3B	O
,	O
which	O
preferentially	O
methylate	O
unmethylated	O
DNA	O
.	O

These	O
pregnancies	O
resulted	O
in	O
13	O
972	O
singleton	O
or	O
twin	O
children	O
who	O
were	O
alive	O
at	O
1	O
year	O
of	O
age	O
.	O

Recommendations	O
The	O
World	O
Health	O
Organization	O
has	O
recommended	O
that	O
weekly	O
iron	O
and	O
folic	O
acid	O
supplementation	O
should	O
be	O
considered	O
as	O
a	O
strategy	O
for	O
prevention	O
of	O
iron	O
deficiency	O
in	O
population	O
groups	O
.	O

The	O
lab	O
technicians	O
were	O
blind	O
to	O
group	O
allocations	O
.	O

According	O
to	O
our	O
knowledge	O
,	O
this	O
study	O
was	O
the	O
first	O
trial	O
held	O
on	O
vitamin	O
D	O
and	O
perinatal	O
depression	O
.	O

Immature	O
glomeruli	O
begin	O
to	O
disappear	O
at	O
10	O
days	O
,	O
but	O
at	O
this	O
age	O
,	O
F1	O
-	O
VitD	O
-	O
mice	O
had	O
more	O
immature	O
and	O
mature	O
glomeruli	O
than	O
F1	O
-	O
SC	O
mice	O
.	O

Negative	O
maternal	O
energy	O
status	O
at	O
mid	O
-	O
gestation	O
(	O
80	O
%	O
of	O
the	O
energy	O
requirements	O
for	O
maintenance	O
of	O
body	O
weight	O
)	O
did	O
not	O
affect	O
MS	O
,	O
intramuscular	O
fat	O
percentage	O
,	O
and	O
HCW	O
,	O
but	O
increased	O
the	O
ratio	O
of	O
MS	O
to	O
12th	O
rib	O
fat	O
thickness	O
and	O
the	O
ratio	O
of	O
percent	O
intramuscular	O
fat	O
to	O
12th	O
rib	O
fat	O
thickness	O
in	O
offspring	O
compared	O
with	O
positive	O
energy	O
status	O
[	O
154	O
].	O

Similarly	O
,	O
the	O
first	O
animal	O
study	O
to	O
demonstrate	O
that	O
an	O
in	O
utero	O
exposure	O
could	O
induce	O
adverse	O
phenotypes	O
in	O
subsequent	O
generations	O
administered	O
the	O
environmental	O
chemical	O
vinclozolin	O
via	O
the	O
intraperitoneal	O
route	O
(	O
Anway	O
et	O
al	O
.	O
2005	O
).	O

Exposing	O
fetal	O
rats	O
to	O
high	O
levels	O
of	O
glucocorticoids	O
reduces	O
birth	O
weight	O
and	O
results	O
in	O
adults	O
with	O
high	O
blood	O
levels	O
of	O
insulin	O
and	O
glucose	O
.	O

Evidence	O
of	O
an	O
association	O
between	O
adult	O
-	O
onset	O
glioma	O
and	O
date	O
of	O
birth	O
suggests	O
an	O
etiologic	O
role	O
for	O
a	O
seasonally	O
variable	O
environmental	O
exposure	O
occurring	O
prenatally	O
around	O
the	O
time	O
of	O
birth	O
.	O

Both	O
the	O
maternal	O
and	O
paternal	O
grandparental	O
couples	O
had	O
significant	O
BMI	O
associations	O
(	O
p	O
=	O
0	O
.	O
033	O
and	O
p	O
=	O
0	O
.	O
013	O
,	O
respectively	O
).	O

In	O
conclusion	O
,	O
despite	O
that	O
more	O
than	O
60	O
%	O
of	O
the	O
pregnant	O
women	O
reported	O
taking	O
multivitamins	O
containing	O
vitamin	O
D	O
,	O
vitamin	O
D	O
deficiency	O
is	O
highly	O
prevalent	O
among	O
pregnant	O
women	O
in	O
Belgium	O
and	O
up	O
to	O
12	O
%	O
of	O
pregnant	O
women	O
are	O
severely	O
vitamin	O
D	O
deficient	O
.	O

Despite	O
this	O
fact	O
,	O
the	O
overall	O
direction	O
of	O
results	O
was	O
consistent	O
with	O
previous	O
text4baby	O
studies	O
and	O
additionally	O
we	O
found	O
a	O
behavioral	O
effect	O
.	O

3	O
.	O
4	O
.	O

When	O
women	O
were	O
categorised	O
based	O
on	O
clinical	O
definitions	O
of	O
vitamin	O
D	O
deficiency	O
and	O
serum	O
25	O
(	O
OH	O
)	O
D	O
between	O
50	O
and	O
75	O
nmol	O
/	O
L	O
used	O
as	O
the	O
reference	O
,	O
no	O
significant	O
relationship	O
between	O
vitamin	O
D	O
status	O
and	O
adverse	O
pregnancy	O
outcome	O
was	O
found	O
(	O
Table2	O
).	O

Other	O
familial	O
associations	O
for	O
BMI	O
The	O
mother	O
'	O
s	O
BMI	O
was	O
highly	O
significantly	O
correlated	O
with	O
that	O
of	O
her	O
own	O
mother	O
p	O
<	O
0	O
.	O
001	O
).	O

The	O
assertion	O
that	O
autism	O
patients	O
engage	O
in	O
repetitive	O
,	O
behavioral	O
patterns	O
has	O
arguably	O
become	O
stereotyped	O
.	O

Economic	O
situation	O
was	O
assessed	O
by	O
ownership	O
of	O
radio	O
and	O
/	O
or	O
bicycle	O
and	O
information	O
on	O
perceived	O
economic	O
status	O
.	O

Children	O
with	O
autism	O
had	O
significantly	O
lower	O
serum	O
levels	O
of	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
than	O
healthy	O
children	O
.	O

In	O
this	O
study	O
,	O
data	O
collection	O
lasted	O
from	O
November	O
2014	O
until	O
early	O
October	O
2015	O
.	O

However	O
,	O
we	O
plan	O
to	O
re	O
-	O
examine	O
this	O
hypothesis	O
in	O
another	O
birth	O
cohort	O
to	O
see	O
if	O
we	O
can	O
replicate	O
the	O
main	O
findings	O
.	O

For	O
this	O
model	O
,	O
gender	O
,	O
birth	O
weight	O
,	O
season	O
of	O
measurement	O
and	O
ethnicity	O
were	O
covariates	O
.	O

This	O
outcome	O
represented	O
a	O
simple	O
,	O
clinically	O
relevant	O
measure	O
of	O
composite	O
micronutrient	O
status	O
,	O
achievable	O
within	O
the	O
time	O
and	O
resource	O
constraints	O
under	O
which	O
the	O
nested	O
study	O
was	O
carried	O
out	O
.	O

(	O
A	O
)	O
female	O
offspring	O
in	O
all	O
groups	O
fed	O
a	O
chow	O
diet	O
;	O
(	O
B	O
,	O
C	O
,	O
D	O
)	O
female	O
offspring	O
fed	O
a	O
postnatal	O
high	O
-	O
fat	O
diet	O
.	O

Statistics	O
Both	O
R	O
(	O
version	O
2	O
.	O
11	O
.	O
1	O
)	O
and	O
SPSS	O
(	O
PASW	O
version	O
18	O
.	O
0	O
.	O
1	O
)	O
statistical	O
packages	O
were	O
used	O
.	O

that	O
late	O
but	O
not	O
early	O
pregnancy	O
25OHD	O
was	O
related	O
to	O
gestational	O
length	O
and	O
neonatal	O
birth	O
size	O
[	O
8	O
].	O

Meconium	O
Aspiration	O
Syndrome	O
Meconium	O
aspiration	O
syndrome	O
,	O
which	O
occurs	O
when	O
a	O
fetus	O
who	O
is	O
under	O
stress	O
and	O
not	O
getting	O
enough	O
oxygen	O
inhales	O
waste	O
products	O
inside	O
the	O
womb	O
,	O
was	O
linked	O
to	O
a	O
sevenfold	O
increase	O
in	O
the	O
likelihood	O
that	O
a	O
child	O
would	O
later	O
develop	O
autism	O
.	O

Based	O
on	O
1000	O
simulations	O
when	O
requirement	O
one	O
-	O
to	O
-	O
two	O
vaccinated	O
-	O
to	O
-	O
unvaccinated	O
proportion	O
for	O
good	O
propensity	O
score	O
matching	O
was	O
not	O
met	O
;	O
point	O
estimate	O
and	O
lower	O
and	O
upper	O
confidence	O
interval	O
represent	O
50th	O
,	O
25th	O
and	O
97	O
.	O
5th	O
percentiles	O
of	O
point	O
estimates	O
(	O
n	O
=	O
1000	O
),	O
respectively	O
.	O

PubMed	O
Central	O
:	O

After	O
expert	O
review	O
,	O
the	O
final	O
questionnaire	O
used	O
had	O
29	O
items	O
(	O
see	O
Additional	O
file1	O
).	O

These	O
authors	O
estimate	O
that	O
the	O
productivity	O
gains	O
for	O
an	O
individual	O
removed	O
from	O
anaemia	O
are	O
5	O
%	O
in	O
manual	O
occupations	O
(	O
70	O
%	O
of	O
employment	O
in	O
a	O
country	O
such	O
as	O
Viet	O
Nam	O
),	O
and	O
17	O
%	O
in	O
heavy	O
manual	O
occupations	O
(	O
which	O
form	O
12	O
.	O
7	O
%	O
of	O
employment	O
in	O
manual	O
occupations	O
in	O
Viet	O
Nam	O
:	O
the	O
share	O
of	O
agriculture	O
in	O
GDP	O
is	O
22	O
.	O
1	O
%)[	O
16	O
].	O

The	O
FFQ	O
was	O
used	O
to	O
estimate	O
total	O
energy	O
intake	O
and	O
daily	O
nutrient	O
intake	O
,	O
by	O
multiplying	O
the	O
daily	O
frequency	O
of	O
consumption	O
of	O
a	O
food	O
by	O
the	O
nutrient	O
content	O
[	O
14	O
]	O
of	O
a	O
standard	O
portion	O
[	O
15	O
]	O
of	O
that	O
food	O
,	O
and	O
summing	O
this	O
for	O
all	O
the	O
foods	O
consumed	O
.	O

Background	O
With	O
an	O
increasing	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
and	O
insufficiency	O
reported	O
both	O
in	O
Australia	O
and	O
New	O
Zealand	O
,	O
as	O
well	O
as	O
worldwide	O
[	O
1	O
],	O
there	O
is	O
continuing	O
interest	O
in	O
determining	O
how	O
vitamin	O
D	O
deficiency	O
may	O
influence	O
health	O
in	O
pregnancy	O
.	O

[	O
45	O
]	O
The	O
NICE	O
guidelines	O
for	O
antenatal	O
care	O
were	O
therefore	O
updated	O
in	O
2008	O
.	O

study	O
[	O
4	O
]	O
assessed	O
the	O
non	O
-	O
linear	O
relationship	O
between	O
25	O
(	O
OH	O
)	O
D	O
and	O
PTB	O
,	O
both	O
identifying	O
a	O
decreasing	O
risk	O
of	O
PTB	O
as	O
25	O
(	O
OH	O
)	O
D	O
increased	O
to	O
approximately	O
40	O
ng	O
/	O
mL	O
.	O
Fig	O
1shows	O
that	O
the	O
increase	O
in	O
gestational	O
age	O
at	O
birth	O
with	O
rising	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
is	O
similar	O
between	O
the	O
general	O
obstetrical	O
population	O
at	O
MUSC	O
and	O
the	O
Hollis	O
and	O
Wagner	O
et	O
al	O
.	O

PCBs	O
,	O
PBDEs	O
,	O
OCPs	O
and	O
OPPs	O
were	O
lipid	O
-	O
normalized	O
in	O
units	O
of	O
ng	O
/	O
g	O
serum	O
lipid	O
.	O

In	O
the	O
clinical	O
setting	O
,	O
pregnant	O
women	O
should	O
receive	O
advice	O
about	O
vitamin	O
D	O
,	O
especially	O
during	O
winter	O
.	O

The	O
plasma	O
of	O
CC	O
and	O
RC	O
females	O
presented	O
a	O
higher	O
AST	O
/	O
ALT	O
ratio	O
than	O
the	O
plasma	O
of	O
CC	O
and	O
RC	O
males	O
,	O
respectively	O
(	O
Table1	O
).	O

Samples	O
were	O
precipitated	O
using	O
5	O
volumes	O
of	O
room	O
temperature	O
acetone	O
for	O
10	O
min	O
and	O
centrifuged	O
at	O
3	O
,	O
500	O
×	O
g	O
for	O
15	O
min	O
at	O
15	O
°	O
C	O
.	O

Briefly	O
,	O
women	O
attending	O
one	O
of	O
three	O
UK	O
hospitals	O
[	O
University	O
Hospital	O
Southampton	O
National	O
Health	O
Service	O
(	O
NHS	O
)	O
Foundation	O
Trust	O
,	O
Southampton	O
,	O
UK	O
(	O
latitude	O
50	O
.	O
9	O
°	O
North	O
);	O
Oxford	O
University	O
Hospitals	O
NHS	O
Foundation	O
Trust	O
,	O
Oxford	O
,	O
UK	O
(	O
latitude	O
51	O
.	O
8	O
°	O
North	O
);	O
Sheffield	O
Hospitals	O
NHS	O
Trust	O
(	O
University	O
of	O
Sheffield	O
),	O
Sheffield	O
,	O
UK	O
(	O
latitude	O
53	O
.	O
4	O
°	O
North	O
)]	O
for	O
early	O
pregnancy	O
ultrasound	O
screening	O
(	O
11	O
to	O
14	O
weeks	O
of	O
gestation	O
)	O
between	O
6	O
October	O
2008	O
and	O
11	O
February	O
2014	O
were	O
invited	O
to	O
participate	O
in	O
the	O
study	O
.	O

Hip	O
circumference	O
(	O
HP	O
)	O
was	O
measured	O
at	O
the	O
maximum	O
circumference	O
of	O
the	O
buttocks	O
.	O

An	O
OGTT	O
was	O
performed	O
at	O
gestational	O
weeks	O
10	O
to	O
40	O
between	O
October	O
2012	O
and	O
March	O
2014	O
,	O
and	O
the	O
results	O
were	O
collected	O
from	O
prenatal	O
maternity	O
cards	O
or	O
the	O
hospital	O
laboratory	O
database	O
.	O

The	O
unit	O
in	O
the	O
model	O
is	O
the	O
family	O
member	O
.	O

The	O
association	O
between	O
LINE	O
-	O
1	O
and	O
AluYb8	O
repetitive	O
element	O
methylation	O
and	O
aggregate	O
methylation	O
values	O
of	O
the	O
autosomal	O
CpG	O
loci	O
within	O
each	O
of	O
the	O
41	O
bioinformatic	O
classes	O
is	O
depicted	O
inFigure	O
3	O
.	O

Such	O
commonly	O
identified	O
,	O
prenatal	O
risk	O
factors	O
may	O
include	O
advanced	O
-	O
aged	O
parents	O
,	O
a	O
short	O
gestation	O
period	O
,	O
low	O
birth	O
weight	O
,	O
hyperbilirubinemia	O
,	O
and	O
breech	O
presentation	O
[	O
3	O
].	O

Secondary	O
analysis	O
examining	O
baseline	O
data	O
(	O
N	O
=	O
123	O
)	O
from	O
a	O
healthy	O
lifestyle	O
randomized	O
controlled	O
trial	O
conducted	O
in	O
and	O
urban	O
area	O
of	O
the	O
South	O
East	O
.	O

Data	O
are	O
reported	O
as	O
means	O
±	O
SEM	O
;	O
P	O
<	O
0	O
.	O
05	O
,	O
one	O
-	O
way	O
ANOVA	O
and	O
post	O
-	O
hoc	O
of	O
Tukey	O
'	O
s	O
test	O
:	O
†	O
compared	O
to	O
SC	O
counterpart	O
;	O
‡	O
compared	O
to	O
F1	O
generation	O
.	O

First	O
,	O
we	O
know	O
that	O
it	O
would	O
be	O
better	O
to	O
evaluate	O
levels	O
of	O
cord	O
plasma	O
and	O
breast	O
milk	O
concentrations	O
of	O
visfatin	O
and	O
assess	O
their	O
correlation	O
with	O
the	O
children	O
’	O
s	O
anthropometric	O
in	O
order	O
to	O
support	O
our	O
results	O
.	O

The	O
tailing	O
reactions	O
including	O
2	O
µg	O
RNA	O
samples	O
(	O
500	O
ng	O
/	O
µl	O
),	O
4	O
µl	O
of	O
5	O
×	O
Escherichia	O
coli	O
poly	O
(	O
A	O
)	O
polymerase	O
(	O
E	O
-	O
PAP	O
)	O
buffer	O
,	O
2	O
µl	O
of	O
25	O
mM	O
-	O
MgCl2	O
,	O
2	O
µl	O
of	O
10	O
mM	O
-	O
ATP	O
and	O
0	O
.	O
8	O
µl	O
E	O
-	O
PAP	O
(	O
2	O
U	O
/	O
µl	O
)	O
adjusted	O
to	O
20	O
µl	O
with	O
nuclease	O
-	O
free	O
water	O
.	O

When	O
the	O
item	O
was	O
unique	O
in	O
the	O
nutrient	O
profile	O
,	O
it	O
was	O
not	O
combined	O
(	O
e	O
.	O
g	O
.,	O
salt	O
).	O

The	O
adequate	O
intake	O
of	O
vitamin	O
D	O
during	O
pregnancy	O
and	O
lactation	O
is	O
unknown	B
,	O
although	O
it	O
appears	O
to	O
be	O
greater	O
than	O
the	O
current	O
dietary	O
recommendations	O
of	O
400	O
IU	O
/	O
d	O
or	O
10	O
µg	O
/	O
d	O
[	O
58	O
].	O

The	O
effect	O
of	O
each	O
gene	O
is	O
further	O
diluted	O
by	O
variable	O
penetrance	O
[	O
61	O
].	O

Identifying	O
mechanisms	O
of	O
these	O
conditions	O
,	O
and	O
strategies	O
for	O
early	O
detection	O
,	O
prevention	O
,	O
and	O
care	O
,	O
represent	O
an	O
important	O
need	O
for	O
reducing	O
the	O
global	O
burden	O
of	O
preterm	O
birth	O
.	O

Those	O
with	O
serum	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
≥	O
40	O
ng	O
/	O
mL	O
had	O
a	O
62	O
%	O
lower	O
risk	O
of	O
PTB	O
compared	O
to	O
those	O
with	O
concentrations	O
<	O
20	O
ng	O
/	O
mL	O
(	O
OR	O
=	O
0	O
.	O
38	O
,	O
95	O
%	O
CI	O
=	O
0	O
.	O
23	O
–	O
0	O
.	O
63	O
,	O
p	O
<	O
0	O
.	O
0001	O
;	O
AAR	O
=	O
11	O
.	O
3	O
%;	O
NNT	O
=	O
9	O
)	O
(	O
Table	O
2	O
).	O

Women	O
with	O
darker	O
skin	O
Fitzpatrick	O
Class	O
6	O
are	O
more	O
prone	O
to	O
Vitamin	O
D	O
deficiency	O
as	O
they	O
need	O
four	O
to	O
ten	O
times	O
sunlight	O
than	O
Fitzpatrick	O
Class	O
1	O
-	O
4	O
skinned	O
people	O
for	O
adequate	O
Vitamin	O
D	O
synthesis	O
.	O

Dependence	O
of	O
male	O
fertility	O
on	O
VD	O
is	O
depicted	O
inFigure	O
3	O
.	O

Nearly	O
half	O
of	O
the	O
participants	O
(	O
47	O
.	O
8	O
%,	O
451	O
/	O
943	O
)	O
reported	O
having	O
had	O
a	O
prior	O
live	O
birth	O
.	O

In	O
Cameroon	O
,	O
there	O
are	O
few	O
reported	O
studies	O
on	O
the	O
quality	O
of	O
ANC	O
services	O
rendered	O
;	O
meanwhile	O
the	O
study	O
of	O
consumer	O
perceptions	O
in	O
relation	O
to	O
behavioral	O
outcomes	O
has	O
been	O
on	O
the	O
rise	O
in	O
other	O
countries	O
[	O
8	O
].	O

Women	O
who	O
did	O
not	O
conceive	O
while	O
enrolled	O
in	O
PMMST	O
,	O
had	O
received	O
at	O
least	O
one	O
year	O
of	O
MMN	O
supplementation	O
or	O
placebo	O
and	O
were	O
still	O
resident	O
in	O
the	O
selected	O
villages	O
in	O
Kiang	O
West	O
,	O
were	O
eligible	O
for	O
inclusion	O
in	O
the	O
current	O
study	O
.	O

It	O
synchronizes	O
growth	O
and	O
fertility	O
with	O
periods	O
of	O
either	O
adequate	O
or	O
inadequate	O
food	O
availability	O
[	O
45	O
];	O
post	O
-	O
weaning	O
treatment	O
with	O
leptin	O
accelerates	O
puberty	O
in	O
rodents	O
[	O
46	O
],[	O
47	O
],	O
and	O
leptin	O
in	O
the	O
rat	O
neonate	O
affects	O
hypothalamic	O
maturation	O
[	O
48	O
].	O

A	O
growing	O
body	O
of	O
evidence	O
links	O
hypertension	O
,	O
32heart	O
disease	O
,	O
33and	O
autoimmune	O
diseases34to	O
markers	O
of	O
inflammation	O
such	O
as	O
C	O
-	O
reactive	O
protein	O
and	O
assorted	O
chemokines	O
.	O
35Erdei	O
hypothesizes	O
that	O
uranium	O
exposure	O
might	O
contribute	O
to	O
these	O
diseases	O
through	O
effects	O
on	O
inflammation	O
.	O

There	O
is	O
some	O
suggestion	O
that	O
late	O
hypocalcemic	O
tetany	O
is	O
more	O
common	O
in	O
Hispanic	O
infants	O
,	O
although	O
this	O
is	O
not	O
well	O
demonstrated	O
due	O
to	O
the	O
limited	O
published	O
data	O
[	O
14	O
].	O

Volunteering	O
women	O
reporting	O
for	O
ANC	O
planned	O
visits	O
at	O
the	O
study	O
sites	O
were	O
sensitized	O
on	O
the	O
purpose	O
and	O
the	O
procedure	O
of	O
the	O
study	O
.	O

There	O
were	O
significant	O
effect	O
of	O
both	O
diet	O
and	O
time	O
,	O
but	O
no	O
interaction	O
between	O
them	O
on	O
food	O
intake	O
and	O
weight	O
gain	O
,	O
suggesting	O
that	O
vitamin	O
diets	O
strongly	O
alter	O
the	O
phenotype	O
of	O
mature	O
offspring	O
independent	O
of	O
time	O
.	O

Supplementary	O
Material	O
Caption	O
(	O
SUPPLEMENTARY	O
-	O
MATERIAL	O
)	O
Supplementary_Material_CRT_Revisions	O
.	O
docx	O
Caption	O
(	O
MEDIA	O
)	O
Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Multiple	O
regression	O
for	O
mean	O
vitamin	O
D	O
levelVariableUnstandardized	O
regression	O
coefficient	O
(	O
b	O
)±	O
95	O
%	O
confidence	O
intervalP	O
value	O
Intercept71	O
.	O
01	O
//	O
S	O
-	O
ECC	O
(	O
Reference	O
=	O
Yes	O
)	O
5	O
.	O
331	O
.	O
24	O
,	O
9	O
.	O
420	O
.	O
01Regular	O
milk	O
drinker	O
(	O
Reference	O
=	O
Yes	O
)-	O
6	O
.	O
60	O
-	O
13	O
.	O
16	O
,	O
-	O
0	O
.	O
030	O
.	O
05Season	O
(	O
Reference	O
=	O
Winter	O
)	O
5	O
.	O
221	O
.	O
37	O
,	O
9	O
.	O
060	O
.	O
008Vitamin	O
D	O
drop	O
user	O
(	O
Reference	O
=	O
Yes	O
)-	O
2	O
.	O
172	O
.	O
01	O
,	O
-	O
6	O
.	O
130	O
.	O
28Yearly	O
income	O
(	O
Reference	O
=	O
<	O
28	O
k	O
)	O
2	O
.	O
732	O
.	O
06	O
,	O
-	O
1	O
.	O
320	O
.	O
19	O
S	O
-	O
ECC	O
=	O
Severe	O
Early	O
Childhood	O
Caries	O
.	O

Service	O
limitations	O
impaired	O
the	O
delivery	O
of	O
optimal	O
care	O
.	O

Prospective	O
studies	O
are	O
needed	O
to	O
minimize	O
these	O
biases	O
.	O

Plots	O
include	O
only	O
infants	O
delivered	O
vaginally	O
(	O
n	O
=	O
97	O
).	O

In	O
an	O
attempt	O
to	O
assess	O
a	O
stress	O
versus	O
gene	O
interaction	O
,	O
we	O
studied	O
four	O
GR	O
polymorphisms	O
.	O

However	O
,	O
it	O
will	O
be	O
increasingly	O
important	O
to	O
examine	O
,	O
in	O
larger	O
studies	O
,	O
how	O
additional	O
specific	O
exposures	O
,	O
such	O
as	O
lead	O
as	O
has	O
been	O
done	O
by	O
previous	O
researchers	O
(	O
Pilsner	O
et	O
al	O
.	O

Design	O
:	O
Within	O
-	O
randomization	O
group	O
analysis	O
of	O
the	O
Maternal	O
Vitamin	O
D	O
Osteoporosis	O
Study	O
trial	O
of	O
antenatal	O
cholecalciferol	O
supplementation	O
.	O

Chocolate	O
and	O
total	O
caloric	O
intakes	O
relative	O
to	O
body	O
weight	O
(	O
kcal	O
/	O
kg	O
)	O
were	O
calculated	O
for	O
4	O
h	O
.	O
We	O
generated	O
the	O
following	O
eight	O
experimental	O
offspring	O
groups	O
:	O
Vehicle	O
in	O
CC	O
male	O
(	O
n	O
=	O
7	O
);	O
AM251	O
in	O
CC	O
male	O
(	O
n	O
=	O
8	O
);	O
Vehicle	O
in	O
RC	O
male	O
(	O
n	O
=	O
9	O
);	O
AM251	O
in	O
RC	O
male	O
(	O
n	O
=	O
10	O
);	O
Vehicle	O
in	O
CC	O
female	O
(	O
n	O
=	O
6	O
);	O
AM251	O
in	O
CC	O
female	O
(	O
n	O
=	O
7	O
);	O
Vehicle	O
in	O
RC	O
female	O
(	O
n	O
=	O
11	O
);	O
and	O
AM251	O
in	O
RC	O
female	O
(	O
n	O
=	O
11	O
).	O

The	O
recall	O
is	O
done	O
chronologically	O
unless	O
the	O
participant	O
wishes	O
to	O
recall	O
randomly	O
.	O

Bailey	O
et	O
al	O
had	O
discovered	O
that	O
,	O
after	O
transplacental	O
circulation	O
,	O
the	O
concentration	O
of	O
C3	O
-	O
epi	O
-	O
25	O
(	O
OH	O
)	O
D	O
was	O
significant	O
higher	O
in	O
infants	O
than	O
mother	O
[	O
44	O
].	O

Melatonin	O
inhibits	O
the	O
release	O
of	O
insulin	O
from	O
pancreatic	O
beta	O
cells	O
[	O
40	O
,	O
41	O
],	O
although	O
conflicting	O
research	O
exists	O
with	O
the	O
Nurses	O
’	O
Health	O
Study	O
finding	O
low	O
melatonin	O
associated	O
with	O
increased	O
risk	O
of	O
type	O
2	O
diabetes	O
,	O
potentially	O
medicated	O
through	O
increased	O
insulin	O
resistance	O
[	O
42	O
].	O

Farming	O
Farming	O
,	O
by	O
virtue	O
of	O
its	O
seasonal	O
nature	O
,	O
conveys	O
increased	O
risk	O
at	O
certain	O
times	O
of	O
the	O
year	O
of	O
exposure	O
to	O
pesticides	O
and	O
other	O
agricultural	O
chemicals	O
.	O

Of	O
the	O
total	O
ninety	O
-	O
eight	O
patient	O
,,	O
there	O
were	O
twenty	O
patients	O
whose	O
serum	O
levels	O
of	O
total	O
25	O
-	O
OH	O
Vitamin	O
D	O
was	O
lower	O
than	O
50	O
nmol	O
/	O
L	O
which	O
made	O
them	O
meet	O
the	O
criteria	O
for	O
the	O
diagnosis	O
of	O
Vitamin	O
De	O
deficiency	O
,	O
five	O
of	O
them	O
were	O
from	O
control	O
group	O
,	O
and	O
fifteen	O
were	O
from	O
intervention	O
group	O
.	O

Overall	O
,	O
participants	O
included	O
in	O
this	O
analysis	O
tended	O
to	O
be	O
Caucasian	O
,	O
well	O
-	O
educated	O
,	O
and	O
married	O
.	O

Subjects	O
'	O
weight	O
was	O
measured	O
using	O
a	O
balanced	O
digital	O
scale	O
to	O
the	O
nearest	O
100	O
g	O
,	O
in	O
light	O
clothing	O
and	O
barefoot	O
.	O

Finding	O
a	O
molecule	O
with	O
as	O
much	O
efficiency	O
as	O
the	O
β3	O
agonist	O
in	O
rodents	O
,	O
would	O
be	O
of	O
considerable	O
therapeutic	O
relevance	O
for	O
the	O
treatment	O
of	O
obesity	O
,	O
insulin	O
resistance	O
and	O
type	O
2	O
diabetes	O
in	O
humans	O
.	O

In	O
a	O
pooled	O
analysis	O
of	O
data	O
from	O
Canada	O
,	O
UK	O
,	O
Denmark	O
,	O
and	O
Sweden	O
including	O
more	O
than	O
40	O
,	O
000	O
individuals	O
with	O
MS	O
,	O
significantly	O
fewer	O
(	O
8	O
.	O
5	O
%)	O
people	O
with	O
MS	O
were	O
born	O
in	O
November	O
and	O
significantly	O
more	O
(	O
9	O
.	O
1	O
%)	O
were	O
born	O
in	O
May	O
.	O
39This	O
finding	O
suggests	O
that	O
prenatal	O
exposures	O
or	O
exposures	O
in	O
the	O
first	O
months	O
of	O
life	O
could	O
be	O
important	O
in	O
MS	O
etiology	O
,	O
but	O
the	O
link	O
to	O
vitamin	O
D	O
is	O
unclear	B
.	O

The	O
dosage	O
is	O
based	O
on	O
dietary	O
intake	O
recommendations	O
[	O
10	O
,	O
11	O
].	O

Statistical	O
analysis	O
Statistical	O
analysis	O
was	O
performed	O
using	O
SPSS11	O
.	O
5	O
software	O
.	O

While	O
the	O
use	O
of	O
a	O
more	O
sensitive	O
test	O
would	O
provide	O
more	O
detailed	O
and	O
accurate	O
estimates	O
of	O
early	O
neurodevelopmental	O
achievement	O
,	O
the	O
ASQ	O
has	O
been	O
validated	O
against	O
robust	O
assessment	O
tools	O
[	O
32	O
],	O
and	O
in	O
a	O
paediatric	O
population	O
[	O
33	O
].	O

We	O
did	O
not	O
have	O
PTH	O
values	O
on	O
the	O
cord	O
blood	O
but	O
PTH	O
values	O
at	O
three	O
months	O
of	O
age	O
were	O
not	O
correlated	O
significantly	O
with	O
25	O
(	O
OH	O
)	O
D	O
values	O
at	O
birth	O
or	O
three	O
months	O
or	O
with	O
bone	O
mineral	O
outcomes	O
.	O

Maternal	O
consumption	O
of	O
a	O
HF	O
diet	O
both	O
prior	O
to	O
and	O
during	O
pregnancy	O
and	O
lactation	O
,	O
or	O
only	O
during	O
pregnancy	O
and	O
lactation	O
,	O
significantly	O
advanced	O
the	O
age	O
of	O
puberty	O
in	O
female	O
offspring	O
(	O
p	O
<	O
0	O
.	O
001	O
;	O
Figure	O
3A	O
;	O
Table	O
1	O
).	O

Hyperplasia	O
of	O
fat	O
cells	O
mainly	O
occurs	O
from	O
conception	O
until	O
birth	O
,	O
and	O
hypertrophy	O
is	O
a	O
greater	O
contributor	O
to	O
IMF	O
deposition	O
than	O
is	O
hyperplasia	O
from	O
250	O
d	O
of	O
age	O
to	O
slaughter	O
[	O
16	O
,	O
17	O
].	O

Handedness	O
has	O
been	O
shown	O
to	O
follow	O
a	O
gender	O
-	O
invariant	O
seasonal	O
pattern	O
,	O
with	O
more	O
left	O
-	O
handers	O
than	O
right	O
-	O
handers	O
born	O
between	O
March	O
and	O
July	O
[	O
177	O
,	O
178	O
].	O

To	O
confirm	O
the	O
presence	O
of	O
the	O
Bcl	O
I	O
polymorphism	O
,	O
17	O
μ	O
L	O
of	O
the	O
PCR	O
product	O
was	O
digested	O
with	O
2	O
μ	O
L	O
of	O
10x	O
Restriction	O
Endonuclease	O
Buffer	O
and	O
15	O
U	O
of	O
the	O
restriction	O
enzyme	O
Bcl	O
I	O
(	O
New	O
England	O
Biolabs	O
,	O
UK	O
)	O
for	O
1	O
.	O
5	O
hr	O
at	O
50	O
°	O
C	O
.	O

Finally	O
,	O
as	O
a	O
retrospective	O
study	O
,	O
we	O
were	O
limited	O
by	O
available	O
data	O
and	O
the	O
amount	O
of	O
cord	O
blood	O
available	O
for	O
further	O
testing	O
.	O

On	O
the	O
second	O
day	O
,	O
anthropometric	O
measures	O
,	O
blood	O
pressure	O
,	O
and	O
HRV	O
were	O
evaluated	O
.	O

The	O
gene	O
expression	O
of	O
the	O
cannabinoid	O
receptors	O
Cnr1	O
and	O
Cnr2	O
was	O
increased	O
in	O
RC	O
male	O
hypothalamus	O
,	O
but	O
a	O
down	O
-	O
expression	O
of	O
most	O
eCBs	O
-	O
metabolizing	O
enzymes	O
(	O
Faah	O
,	O
Dagl	O
α	O
,	O
Dagl	O
β	O
,	O
Mgll	O
)	O
and	O
several	O
key	O
regulators	O
of	O
fatty	O
-	O
acid	O
β	O
-	O
oxidation	O
(	O
Cpt1b	O
,	O
Acox1	O
),	O
mitochondrial	O
respiration	O
(	O
Cox4i1	O
),	O
and	O
lipid	O
flux	O
(	O
Ppar	O
γ	O
)	O
was	O
found	O
in	O
their	O
PAT	O
.	O

Characteristics	O
of	O
Women	O
Included	O
in	O
the	O
AnalysisCharacteristic	O
Placebo	O
(	O
n	O
=	O
351	O
)	O
Cholecalciferol	O
1000	O
IU	O
/	O
d	O
(	O
n	O
=	O
331	O
)	O
Age	O
(	O
years	O
),	O
mean	O
(	O
SD	O
)	O
30	O
.	O
8	O
(	O
5	O
.	O
4	O
)	O
30	O
.	O
8	O
(	O
5	O
.	O
0	O
)	O
Current	O
smoking	O
,	O
n	O
(%)	O
29	O
(	O
8	O
.	O
3	O
)	O
24	O
(	O
7	O
.	O
3	O
)	O
Educational	O
attainment	O
≥	O
A	O
level	O
(	O
high	O
school	O
),	O
n	O
(%)	O
258	O
(	O
74	O
.	O
4	O
)	O
264	O
(	O
80	O
.	O
0	O
)	O
BMI	O
(	O
kg	O
/	O
m2	O
),	O
median	O
(	O
IQR	O
)	O
25	O
.	O
5	O
(	O
23	O
.	O
0	O
to	O
29	O
.	O
7	O
)	O
24	O
.	O
7	O
(	O
22	O
.	O
3	O
to	O
29	O
.	O
3	O
)	O
Pregnancy	O
weight	O
gain	O
(	O
kg	O
),	O
mean	O
(	O
SD	O
)	O
9	O
.	O
5	O
(	O
3	O
.	O
6	O
)	O
9	O
.	O
5	O
(	O
3	O
.	O
4	O
)	O
Strenuous	O
exercise	O
≥	O
once	O
per	O
week	O
,	O
n	O
(%)	O
45	O
(	O
13	O
.	O
8	O
)	O
50	O
(	O
16	O
.	O
2	O
)	O
25	O
(	O
OH	O
)	O
D	O
at	O
14	O
weeks	O
(	O
nmol	O
/	O
L	O
),	O
mean	O
(	O
SD	O
)	O
45	O
.	O
4	O
(	O
16	O
.	O
5	O
)	O
46	O
.	O
1	O
(	O
17	O
.	O
0	O
)	O
rs12785878	O
(	O
DHCR7	O
),	O
n	O
(%)	O
G	O
:	O
G17	O
(	O
4	O
.	O
8	O
)	O
14	O
(	O
4	O
.	O
3	O
)	O
T	O
:	O
G114	O
(	O
32	O
.	O
5	O
)	O
120	O
(	O
36	O
.	O
6	O
)	O
T	O
:	O
T220	O
(	O
62	O
.	O
7	O
)	O
194	O
(	O
59	O
.	O
1	O
)	O
rs10741657	O
(	O
CYP2R1	O
),	O
n	O
(%)	O
A	O
:	O
A57	O
(	O
16	O
.	O
6	O
)	O
51	O
(	O
15	O
.	O
5	O
)	O
G	O
:	O
A156	O
(	O
45	O
.	O
3	O
)	O
148	O
(	O
45	O
.	O
1	O
)	O
G	O
:	O
G131	O
(	O
38	O
.	O
1	O
)	O
129	O
(	O
39	O
.	O
3	O
)	O
rs6013897	O
(	O
CYP24A1	O
),	O
n	O
(%)	O
A	O
:	O
A10	O
(	O
2	O
.	O
9	O
)	O
15	O
(	O
4	O
.	O
6	O
)	O
T	O
:	O
A126	O
(	O
36	O
.	O
5	O
)	O
102	O
(	O
31	O
.	O
4	O
)	O
T	O
:	O
T209	O
(	O
60	O
.	O
6	O
)	O
208	O
(	O
64	O
.	O
0	O
)	O
rs2282679	O
(	O
GC	O
),	O
n	O
(%)	O
C	O
:	O
C37	O
(	O
10	O
.	O
6	O
)	O
34	O
(	O
10	O
.	O
3	O
)	O
C	O
:	O
A149	O
(	O
42	O
.	O
6	O
)	O
136	O
(	O
41	O
.	O
3	O
)	O
A	O
:	O
A164	O
(	O
46	O
.	O
9	O
)	O
159	O
(	O
48	O
.	O
3	O
)	O
Abbreviation	O
:	O
IQR	O
,	O
interquartile	O
range	O
.	O

Except	O
for	O
a	O
small	O
percentage	O
of	O
cases	O
,	O
the	O
tumors	O
continue	O
to	O
show	O
high	O
morbidity	O
and	O
mortality	O
.	O

Although	O
the	O
primary	O
outcome	O
of	O
birth	O
weight	O
did	O
not	O
significantly	O
differ	O
between	O
the	O
intervention	O
and	O
control	O
group	O
,	O
the	O
secondary	O
outcomes	O
of	O
dietary	O
glycaemic	O
index	O
,	O
gestational	O
weight	O
gain	O
and	O
glucose	O
intolerance	O
were	O
significantly	O
reduced	O
in	O
the	O
intervention	O
arm	O
.	O

The	O
2	O
OPPs	O
,	O
Pb	O
and	O
Hg	O
were	O
included	O
in	O
the	O
model	O
as	O
covariates	O
without	O
hierarchical	O
modeling	O
.	O

Therefore	O
,	O
the	O
observed	O
mRNA	O
expression	O
patterns	O
might	O
contribute	O
to	O
an	O
impaired	O
developmental	O
growth	O
in	O
LP	O
offspring	O
.	O

In	O
the	O
Angus	O
study	O
,	O
early	O
weaning	O
at	O
105	O
d	O
of	O
age	O
and	O
high	O
concentrate	O
feeding	O
for	O
148	O
d	O
followed	O
by	O
grazing	O
and	O
feedlot	O
entry	O
increased	O
both	O
the	O
MS	O
and	O
hot	O
carcass	O
weight	O
(	O
HCW	O
)	O
compared	O
with	O
normal	O
weaning	O
at	O
253	O
d	O
of	O
age	O
(	O
normally	O
weaned	O
calves	O
stayed	O
with	O
their	O
dams	O
to	O
graze	O
on	O
pasture	O
),	O
although	O
feedlot	O
performance	O
remained	O
unchanged	O
[	O
54	O
].	O

Feeding	O
the	O
HV	O
pup	O
diet	O
restored	O
POMC	O
and	O
BDNF	O
expression	O
to	O
control	O
levels	O
in	O
mature	O
offspring	O
.	O

Significantly	O
more	O
women	O
in	O
the	O
exposed	O
group	O
smoked	O
cigarettes	O
during	O
pregnancy	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
failed	O
to	O
use	O
prenatal	O
vitamins	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
compared	O
with	O
controls	O
.	O

The	O
work	O
,	O
which	O
is	O
being	O
overseen	O
by	O
the	O
State	O
Environmental	O
Protection	O
Administration	O
and	O
the	O
Ministry	O
of	O
Agriculture	O
,	O
will	O
also	O
compile	O
information	O
on	O
methods	O
of	O
environmental	O
remediation	O
currently	O
available	O
in	O
the	O
country	O
.	O

Two	O
-	O
thirds	O
of	O
untraced	O
women	O
were	O
nulliparous	O
compared	O
with	O
one	O
third	O
of	O
the	O
traced	O
women	O
,	O
characterising	O
a	O
group	O
of	O
younger	O
,	O
more	O
mobile	O
but	O
less	O
reproductively	O
-	O
active	O
women	O
,	O
akin	O
to	O
that	O
in	O
the	O
Bangladeshi	O
study	O
(	O
Hyder	O
et	O
al	O
2007	O
).	O

studied	O
the	O
association	O
between	O
maternal	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
and	O
antenatal	O
depression	O
.	O

It	O
is	O
important	O
to	O
consider	O
how	O
S	O
-	O
ECC	O
and	O
poor	O
nutritional	O
status	O
are	O
connected	O
.	O

The	O
service	O
launched	O
in	O
February	O
2010	O
and	O
delivers	O
text	O
messages	O
to	O
pregnant	O
women	O
and	O
new	O
mothers	O
.	O

We	O
drew	O
a	O
random	O
sample	O
of	O
all	O
women	O
meeting	O
criteria	O
at	O
the	O
Madigan	O
Obstetrics	O
and	O
Gynecology	O
Clinic	O
between	O
December	O
2011	O
and	O
January	O
2013	O
.	O

Fortunately	O
,	O
we	O
controlled	O
for	O
household	O
income	O
in	O
the	O
regression	O
models	O
.	O

Studies	O
focused	O
on	O
high	O
-	O
risk	O
populations	O
,	O
for	O
example	O
,	O
veiled	O
,	O
dark	O
-	O
skinned	O
or	O
obese	O
women	O
in	O
Australia	O
and	O
New	O
Zealand	O
,	O
report	O
between	O
50	O
and	O
94	O
%	O
of	O
women	O
to	O
be	O
vitamin	O
D	O
deficient	O
[	O
8	O
–	O
10	O
].	O

In	O
third	O
trimester	O
retention	O
of	O
water	O
,	O
constipation	O
is	O
seen	O
&	O
finally	O
preparation	O
of	O
genital	O
tract	O
for	O
delivery	O
is	O
needed	O
.	O

This	O
review	O
will	O
deal	O
only	O
with	O
dietary	O
and	O
environmental	O
control	O
measures	O
(	O
see	O
later	O
)	O
for	O
the	O
prevention	O
(	O
primary	O
and	O
secondary	O
)	O
of	O
atopic	O
diseases	O
.	O

According	O
to	O
the	O
extent	O
of	O
the	O
disease	O
,	O
hemithyroidectomy	O
or	O
radical	O
thyroidectomy	O
is	O
performed	O
.	O

The	O
difference	O
in	O
25	O
(	O
OH	O
)	O
D	O
between	O
GDM	O
and	O
non	O
-	O
GDM	O
mothers	O
was	O
investigated	O
with	O
ANCOVA	O
adjusted	O
for	O
season	O
,	O
maternal	O
age	O
,	O
education	O
and	O
prepregnancy	O
BMI	O
.	O

Food	O
and	O
beverages	O
consumed	O
over	O
three	O
consecutive	O
days	O
were	O
recorded	O
by	O
participants	O
during	O
each	O
trimester	O
using	O
3	O
-	O
day	O
food	O
diaries	O
.	O

<	O
75	O
and	O
<	O
50	O
nmol	O
/	O
L	O
,	O
respectively	O
).	O

It	O
was	O
a	O
review	O
that	O
covered	O
the	O
evidence	O
supporting	O
the	O
idea	O
that	O
prenatal	O
infection	O
on	O
the	O
central	O
nervous	O
system	O
may	O
increase	O
the	O
incidence	O
of	O
autism	O
spectrum	O
disorders	O
[	O
63	O
].	O

For	O
the	O
premature	O
baby	O
care	O
agenda	O
,	O
the	O
greatest	O
emphasis	O
is	O
on	O
development	O
and	O
delivery	O
research	O
,	O
with	O
a	O
shorter	O
timeline	O
to	O
impact	O
at	O
scale	O
.	O

For	O
77	O
.	O
6	O
%	O
of	O
the	O
women	O
their	O
pregnancy	O
was	O
planned	O
(	O
unknown	O
for	O
3	O
.	O
3	O
%	O
of	O
the	O
women	O
).	O

Nutrient	O
density	O
was	O
calculated	O
by	O
dividing	O
the	O
estimated	O
intake	O
of	O
fatty	O
acids	O
,	O
vitamin	O
D	O
and	O
other	O
nutrients	O
by	O
the	O
total	O
energy	O
intake	O
(	O
i	O
.	O
e	O
.,	O
the	O
multivariate	O
nutrient	O
density	O
model	O
)	O
[	O
28	O
].	O

For	O
the	O
QFFQ	O
data	O
,	O
portion	O
sizes	O
are	O
converted	O
to	O
grams	O
per	O
week	O
per	O
food	O
item	O
,	O
by	O
two	O
registered	O
dietitians	O
/	O
nutritionists	O
.	O

Thus	O
,	O
if	O
vitamin	O
D	O
was	O
protective	O
,	O
these	O
cancers	O
would	O
be	O
expected	O
to	O
be	O
rare	O
among	O
individuals	O
with	O
MS	O
.	O

Factors	O
known	O
to	O
influence	O
the	O
development	O
of	O
asthma	O
include	O
race	O
[	O
80	O
,	O
81	O
],	O
low	O
yearly	O
family	O
income	O
[	O
81	O
],	O
less	O
than	O
a	O
high	O
school	O
education	O
[	O
81	O
],	O
residence	O
in	O
high	O
poverty	O
areas	O
[	O
81	O
],	O
exposure	O
to	O
urban	O
air	O
pollution	O
[	O
64	O
]	O
and	O
childhood	O
viral	O
infections	O
[	O
64	O
,	O
82	O
].	O

As	O
the	O
age	O
of	O
the	O
child	O
increased	O
,	O
the	O
concentration	O
of	O
cathelicidin	O
also	O
increased	O
(	O
Fig	O
1	O
).	O

Mean	O
±	O
SD	O
SEI	O
of	O
the	O
Auckland	O
women	O
was	O
also	O
higher	O
compared	O
to	O
that	O
in	O
women	O
recruited	O
in	O
Adelaide	O
(	O
Auckland	O
:	O
48	O
.	O
0	O
±	O
14	O
.	O
8	O
vs	O
.	O
Adelaide	O
:	O
27	O
.	O
7	O
±	O
10	O
.	O
5	O
,	O
P	O
<	O
0	O
.	O
001	O
).	O

The	O
continued	O
transcriptional	O
silencing	O
of	O
such	O
regions	O
is	O
essential	O
for	O
early	O
embryogenesis	O
and	O
genome	O
stability	O
,	O
respectively	O
.	O

However	O
,	O
the	O
situation	O
is	O
often	O
not	O
as	O
straightforward	O
as	O
this	O
.	O

There	O
were	O
no	O
differences	O
in	O
NAL	O
throughout	O
the	O
study	O
.	O

Maternal	O
intake	O
of	O
sugar	O
during	O
pregnancy	O
and	O
childhood	O
respiratory	O
and	O
atopic	O
outcomes	O
Abstract	O
The	O
possible	O
role	O
of	O
maternal	O
consumption	O
of	O
free	O
sugar	O
during	O
pregnancy	O
in	O
the	O
inception	O
of	O
respiratory	O
and	O
atopic	O
diseases	O
has	O
not	B
been	I
studied	I
.	O

Moreover	O
,	O
we	O
observed	O
a	O
sex	O
effect	O
on	O
perirenal	O
,	O
perigonadal	O
and	O
abdominal	O
fat	O
weights	O
,	O
and	O
in	O
the	O
percentage	O
of	O
perigonadal	O
fat	O
relative	O
to	O
body	O
weight	O
.	O

Lewis	O
and	O
colleagues	O
surveyed	O
1	O
,	O
304	O
residents	O
,	O
obtaining	O
basic	O
demographic	O
information	O
,	O
mapping	O
the	O
locations	O
of	O
their	O
homes	O
,	O
and	O
taking	O
samples	O
from	O
the	O
wells	O
where	O
they	O
obtained	O
their	O
drinking	O
water	O
.	O

Results	O
showed	O
that	O
at	O
baseline	O
,	O
in	O
72	O
.	O
8	O
%	O
of	O
the	O
participants	O
,	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
were	O
lower	O
than20	O
ng	O
/	O
mL	O
.	O

Future	O
research	O
should	O
focus	O
on	O
polytherapy	O
in	O
pregnancy	O
in	O
order	O
to	O
define	O
its	O
reproductive	O
safety	O
and	O
to	O
separate	O
the	O
effects	O
of	O
medication	O
exposure	O
,	O
underlying	O
psychopathology	O
and	O
associated	O
comorbidities	O
.	O

Thyroidectomy	O
during	O
pregnancy	O
has	O
not	O
been	O
associated	O
with	O
adverse	O
maternal	O
or	O
neonatal	O
outcomes3536	O
.	O

The	O
mean	O
serum	O
calcifediol	O
concentration	O
was	O
consistently	O
and	O
significantly	O
higher	O
in	O
the	O
vitamin	O
D	O
group	O
than	O
in	O
the	O
placebo	O
group	O
at	O
1	O
week	O
,	O
4	O
weeks	O
,	O
and	O
3	O
months	O
after	O
administration	O
of	O
the	O
first	O
dose	O
of	O
vitamin	O
D	O
during	O
the	O
winter	O
and	O
at	O
2	O
weeks	O
'	O
post	O
administration	O
of	O
dose	O
3	O
(	O
spring	O
;	O
figure	O
3	O
).	O

55	O
obstetric	O
clinics	O
were	O
randomly	O
selected	O
and	O
1311	O
pregnant	O
women	O
participated	O
in	O
the	O
study	O
.	O

Their	O
work	O
turned	O
up	O
mixed	O
results	O
,	O
which	O
are	O
hard	O
to	O
compare	O
due	O
to	O
differences	O
in	O
study	O
design	O
,	O
such	O
as	O
the	O
timing	O
of	O
sample	O
collection	O
.	O

Results	O
The	O
initial	O
search	O
identified	O
279	O
articles	O
after	O
duplicates	O
were	O
removed	O
,	O
eight	O
of	O
which	O
were	O
suitable	O
for	O
inclusion	O
.	O

Multivariable	O
logistic	O
regression	O
analysis	O
of	O
the	O
outcome	O
pregnancy	O
loss	O
was	O
also	O
performed	O
with	O
25OHD	O
at	O
T1	O
(	O
continuous	O
and	O
categorical	O
)	O
as	O
independent	O
variable	O
.	O

(	O
2012	O
)*	O
Jiang	O
et	O
al	O
.	O

Conclusion	O
Children	O
with	O
S	O
-	O
ECC	O
appear	O
to	O
have	O
relatively	O
poor	O
nutritional	O
health	O
compared	O
to	O
caries	O
-	O
free	O
controls	O
,	O
and	O
were	O
significantly	O
more	O
likely	O
to	O
have	O
low	O
vitamin	O
D	O
,	O
calcium	O
,	O
and	O
albumin	O
concentrations	O
and	O
elevated	O
PTH	O
levels	O
.	O

129S1	O
male	O
G0	O
mutagenized	O
mice	O
were	O
crossed	O
to	O
129X1	O
females	O
and	O
the	O
resulting	O
G1	O
males	O
were	O
outcrossed	O
to	O
DBA	O
/	O
2J	O
females	O
to	O
generate	O
G2	O
progeny	O
.	O

Pre	O
-	O
publication	O
history	O
The	O
pre	O
-	O
publication	O
history	O
for	O
this	O
paper	O
can	O
be	O
accessed	O
here	O
:	O
http	O
://	O
www	O
.	O
biomedcentral	O
.	O
com	O
/	O
1471	O
-	O
244X	O
/	O
10	O
/	O
38	O
/	O
prepub	O
Supplementary	O
Material	O
Caption	O
(	O
SUPPLEMENTARY	O
-	O
MATERIAL	O
)	O
Additional	O
file	O
1	O
Appendix	O
1	O
.	O

MS	O
increased	O
with	O
increasing	O
slaughter	O
age	O
from	O
16	O
.	O
2	O
months	O
(	O
485	O
d	O
)	O
to	O
20	O
.	O
3	O
months	O
(	O
610	O
d	O
)	O
in	O
Holstein	O
-	O
Friesian	O
and	O
Norwegian	O
dairy	O
breeds	O
[	O
67	O
].	O

The	O
females	O
with	O
caloric	O
restriction	O
were	O
fed	O
with	O
a	O
daily	O
amount	O
of	O
food	O
corresponding	O
to	O
the	O
80	O
%	O
of	O
the	O
calories	O
that	O
the	O
control	O
rats	O
were	O
fed	O
in	O
the	O
previous	O
day	O
of	O
the	O
experiment	O
,	O
according	O
to	O
the	O
body	O
weight	O
(	O
20	O
%	O
of	O
caloric	O
restriction	O
).	O

Therefore	O
,	O
genetic	O
variations	O
in	O
vitamin	O
-	O
D	O
-	O
related	O
genes	O
might	O
also	O
affect	O
MS	O
risk	O
,	O
either	O
directly	O
or	O
by	O
modifying	O
the	O
effects	O
of	O
vitamin	O
D	O
.	O
40	O
Our	O
implications	O
for	O
future	O
research	O
and	O
MS	O
prevention	O
and	O
according	O
to	O
the	O
basis	O
of	O
the	O
results	O
of	O
the	O
only	O
longitudinal	O
study	O
of	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
and	O
MS	O
onset	O
,	O
18and	O
assum	O
-	O
ing	O
that	O
these	O
results	O
are	O
unbiased	O
and	O
vitamin	O
D	O
is	O
truly	O
protective	O
against	O
MS	O
,	O
over	O
70	O
%	O
of	O
MS	O
cases	O
in	O
the	O
USA	O
and	O
Europe	O
could	O
be	O
prevented	O
by	O
increasing	O
the	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
of	O
adolescents	O
and	O
young	O
adults	O
to	O
above	O
100	O
nmol	O
/	O
L	O
.	O
4142These	O
concentrations	O
are	O
commonly	O
found	O
only	O
in	O
individuals	O
with	O
outdoor	O
lifestyles	O
in	O
sunny	O
regions	O
,	O
but	O
could	O
be	O
reached	O
in	O
most	O
people	O
by	O
taking	O
1000	O
-	O
4000	O
IU	O
colecalciferol	O
daily	O
.	O
8254344Although	O
these	O
doses	O
are	O
largely	O
considered	O
safe	O
and	O
potentially	O
beneficial	O
for	O
other	O
outcomes	O
,	O
819confirmation	O
of	O
safety	O
and	O
efficacy	O
in	O
a	O
large	O
randomized	O
trial	O
is	O
needed	O
before	O
making	O
general	O
recommendations	O
.	O

Interpretations	O
Quarterly	O
bolus	O
doses	O
of	O
oral	O
vitamin	O
D3supplementation	O
to	O
infants	O
are	O
not	O
an	O
effective	O
intervention	O
to	O
reduce	O
the	O
incidence	O
of	O
pneumonia	O
in	O
infants	O
in	O
this	O
setting	O
.	O

PubMed	O
Central	O
:	O

Vitamin	O
D	O
deficiency	O
has	O
been	O
associated	O
with	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
)	O
[	O
6	O
],	O
but	O
the	O
evidence	O
is	O
inconsistent	O
[	O
7	O
,	O
8	O
].	O

There	B
are	I
no	I
studies	O
using	O
glitazones	O
in	O
pregnancy	O
.	O

Moreover	O
,	O
their	O
offspring	O
displayed	O
normoweight	O
at	O
birth	O
and	O
during	O
lactation	O
in	O
a	O
sex	O
and	O
diet	O
-	O
independent	O
manner	O
.	O

We	O
found	O
no	O
significant	O
prenatal	O
predictors	O
of	O
change	O
in	O
WFA	O
z	O
-	O
scores	O
between	O
birth	O
and	O
6	O
months	O
.	O

There	O
are	O
eight	O
data	O
collection	O
time	O
points	O
(	O
here	O
forth	O
referred	O
to	O
as	O
phases	O
).	O

1	O
pregnant	O
woman	O
from	O
2ndtrimester	O
.	O

In	O
hypothyroid	O
or	O
thyroidectomized	O
pregnant	O
women	O
,	O
such	O
physiological	O
changes	O
obviously	O
cannot	O
occur	O
.	O

To	O
more	O
precisely	O
identify	O
which	O
microbial	O
taxa	O
contribute	O
to	O
the	O
observed	O
differences	O
in	O
infant	O
stool	O
microbial	O
community	O
composition	O
by	O
maternal	O
dietary	O
factors	O
,	O
we	O
used	O
a	O
series	O
of	O
linear	O
models	O
to	O
test	O
the	O
relationships	O
between	O
each	O
maternal	O
dietary	O
factor	O
and	O
each	O
OTU	O
.	O

Nevertheless	O
,	O
there	O
was	O
a	O
higher	O
(	O
adequate	O
level	O
)	O
mean	O
serum	O
concentration	O
of	O
calcifediol	O
at	O
the	O
end	O
of	O
first	O
supplementation	O
period	O
in	O
the	O
intervention	O
group	O
compared	O
with	O
the	O
lower	O
(	O
not	O
adequate	O
)	O
mean	O
concentrations	O
in	O
the	O
placebo	O
group	O
(	O
data	O
not	O
shown	O
).	O

The	O
field	O
team	O
consisted	O
of	O
three	O
women	O
and	O
two	O
men	O
trained	O
in	O
anthropology	O
or	O
social	O
sciences	O
,	O
who	O
had	O
experience	O
in	O
collecting	O
qualitative	O
data	O
.	O

Study	O
Protocol	O
Health	O
History	O
Information	O
During	O
the	O
yearly	O
visits	O
,	O
5	O
-	O
mL	O
of	O
whole	O
blood	O
were	O
obtained	O
by	O
venous	O
puncture	O
,	O
and	O
the	O
child	O
’	O
s	O
health	O
status	O
,	O
medication	O
usage	O
,	O
and	O
hospitalization	O
history	O
were	O
assessed	O
by	O
both	O
standardized	O
questionnaires	O
completed	O
by	O
a	O
parent	O
of	O
each	O
child	O
and	O
the	O
child	O
’	O
s	O
medical	O
records	O
.	O

Software	O
.	O
Socio	O
-	O
demographic	O
data	O
was	O
expressed	O
using	O
descriptive	O
statistics	O
and	O
means	O
(±	O
Standard	O
Deviation	O
).	O

Using	O
image	O
analysis	O
with	O
an	O
LC	O
Evolution	O
camera	O
on	O
an	O
Olympus	O
BX51	O
microscope	O
running	O
Image	O
-	O
Pro	O
Plus	O
software	O
version	O
7	O
.	O
01	O
for	O
Windows	O
(	O
Media	O
Cybernetics	O
,	O
Silver	O
Spring	O
,	O
MD	O
,	O
USA	O
),	O
glomerular	O
size	O
(	O
mean	O
diameter	O
)	O
was	O
estimated	O
as	O
described	O
elsewhere	O
using	O
a	O
minimum	O
of	O
100	O
glomeruli	O
per	O
group	O
among	O
those	O
cut	O
equatorially	O
[	O
19	O
].	O

To	O
assess	O
participants	O
'	O
information	O
regarding	O
age	O
and	O
gender	O
,	O
marital	O
status	O
,	O
and	O
educational	O
level	O
,	O
we	O
used	O
a	O
standard	O
self	O
-	O
reported	O
questionnaire	O
.	O

Though	O
consistent	O
with	O
studies	O
of	O
men	O
and	O
non	O
-	O
pregnant	O
women	O
,	O
larger	O
studies	O
that	O
include	O
objective	O
measures	O
of	O
sleep	O
duration	O
,	O
quality	O
and	O
apnea	O
are	O
needed	O
to	O
obtain	O
more	O
precise	O
estimates	O
of	O
observed	O
associations	O
.	O

In	O
addition	O
,	O
more	O
recent	O
studies	O
indicated	O
that	O
,	O
compared	O
to	O
individuals	O
without	O
BAT	O
,	O
the	O
BAT	O
-	O
positive	O
subjects	O
were	O
younger	O
,	O
had	O
lower	O
body	O
mass	O
index	O
,	O
fasting	O
insulin	O
,	O
insulin	O
resistance	O
,	O
but	O
a	O
greater	O
level	O
of	O
high	O
-	O
density	O
lipoprotein	O
cholesterol	O
(	O
Zhang	O
et	O
al	O
.,	O
2013	O
).	O

Our	O
inclusion	O
criteria	O
were	O
infants	O
aged	O
1	O
–	O
11	O
months	O
and	O
living	O
in	O
our	O
study	O
region	O
.	O

Among	O
the	O
140	O
women	O
(	O
13	O
%	O
of	O
cohort	O
)	O
with	O
a	O
prior	O
PTB	O
,	O
29	O
%	O
experienced	O
a	O
recurrent	O
PTB	O
.	O

Inclusion	O
criteria	O
We	O
selected	O
two	O
large	O
public	O
hospitals	O
,	O
Hospital	O
Aleman	O
Nicaragüense	O
and	O
Hospital	O
Bertha	O
Calderon	O
Roque	O
.	O

Possible	O
responses	O
included	O
Yes	O
,	O
Sometimes	O
,	O
or	O
No	O
,	O
with	O
a	O
score	O
in	O
any	O
one	O
domain	O
>	O
2SD	O
below	O
the	O
mean	O
considered	O
indicative	O
of	O
the	O
need	O
for	O
further	O
assessment	O
and	O
when	O
identified	O
,	O
the	O
primary	O
caregiver	O
was	O
advised	O
to	O
seek	O
additional	O
medical	O
advice	O
.	O

Alternately	O
,	O
it	O
might	O
be	O
that	O
immunological	O
effectiveness	O
of	O
supplementation	O
is	O
highly	O
dependent	O
upon	O
other	O
factors	O
as	O
yet	O
unidentified	B
,	O
or	O
other	O
prevalent	O
factors	O
in	O
this	O
high	O
-	O
risk	O
population	O
(	O
for	O
example	O
,	O
other	O
malnutrition	O
factors	O
and	O
that	O
5	O
·	O
5	O
%	O
of	O
the	O
children	O
in	O
our	O
study	O
had	O
a	O
Z	O
score	O
of	O
weight	O
for	O
age	O
below	O
−	O
3	O
).	O

All	O
births	O
were	O
notified	O
either	O
by	O
the	O
respondent	O
/	O
family	O
or	O
upon	O
telephone	O
call	O
by	O
study	O
staff	O
following	O
the	O
estimated	O
date	O
of	O
delivery	O
.	O

Based	O
on	O
the	O
main	O
effects	O
on	O
adiposity	O
,	O
the	O
perirenal	O
fat	O
was	O
considered	O
the	O
most	O
suitable	O
adipose	O
tissue	O
for	O
gene	O
expression	O
analysis	O
.	O

In	O
Models	O
1	O
and	O
4	O
),	O
higher	O
cathelicidin	O
concentrations	O
were	O
significantly	O
associated	O
with	O
male	O
gender	O
(	O
beta	O
=	O
0	O
.	O
318	O
,	O
p	O
=	O
0	O
.	O
047	O
),	O
indicating	O
that	O
after	O
adjusting	O
for	O
the	O
other	O
variables	O
in	O
the	O
model	O
,	O
males	O
’	O
cathelicidin	O
levels	O
were	O
1	O
.	O
4	O
times	O
higher	O
than	O
females	O
’.	O

Syntaxin	O
-	O
binding	O
protein	O
1	O
was	O
also	O
significantly	O
down	O
-	O
regulated	O
in	O
the	O
DVD	O
-	O
deficient	O
rats	O
.	O

The	O
last	O
weakness	O
of	O
this	O
study	O
was	O
that	O
it	O
had	O
the	O
statistical	O
authority	O
to	O
identify	O
differences	O
in	O
depressive	O
symptoms	O
,	O
but	B
not	I
in	O
the	O
diagnoses	O
of	O
major	O
depressive	O
disorder	O
.	O

2shows	O
timing	O
of	O
influenza	O
vaccination	O
(	O
Trivalent	O
inactivated	O
influenza	O
vaccine	O
,	O
southern	O
hemisphere	O
formulation	O
)	O
with	O
respect	O
to	O
influenza	O
circulation	O
in	O
the	O
country	O
;	O
most	O
participants	O
(	O
96	O
%)	O
received	O
influenza	O
vaccination	O
before	O
the	O
peak	O
of	O
influenza	O
circulation	O
in	O
August	O
through	O
November	O
2014	O
.	O

293	O
AR	O
,	O
allergic	O
rhinitis	O
;	O
NP	O
,	O
nasopharyngeal	O
cavity	O
.	O

The	O
researchers	O
believe	O
the	O
antioxidant	O
properties	O
of	O
garlic	O
,	O
along	O
with	O
the	O
chelating	O
efficacy	O
exhibited	O
,	O
led	O
to	O
the	O
success	O
of	O
the	O
treatment	O
.	O

Macronutrient	O
(	O
i	O
.	O
e	O
.,	O
%	O
kcal	O
from	O
sweets	O
,	O
fat	O
,	O
and	O
protein	O
)	O
and	O
specific	O
dietary	O
components	O
(	O
i	O
.	O
e	O
.,	O
fast	O
food	O
or	O
soft	O
drinks	O
)	O
were	O
analyzed	O
in	O
separate	O
models	O
due	O
to	O
their	O
high	O
collinearity	O
.	O

All	O
whole	O
body	O
DEXA	O
scans	O
were	O
done	O
by	O
the	O
same	O
technologist	O
on	O
a	O
Hologic	O
Discovery	O
A	O
densitometer	O
(	O
Bedford	O
,	O
MA	O
,	O
USA	O
).	O

In	O
addition	O
,	O
the	O
type	O
and	O
amounts	O
of	O
fish	O
consumed	O
differed	O
across	O
study	O
locations	O
.	O

It	O
is	O
well	O
known	O
that	O
male	O
heights	O
tend	O
to	O
be	O
greater	O
in	O
reported	O
than	O
measured	O
data	O
.	O
37Our	O
analysis	O
suggests	O
that	O
it	O
is	O
unlikely	O
that	O
correlations	O
were	O
affected	O
by	O
this	O
feature	O
.	O

The	O
best	O
treatment	O
for	O
nearly	O
all	O
identified	O
malignant	O
thyroid	O
neoplasm	O
is	O
surgery	O
.	O

Multiple	O
regression	O
analysis	O
was	O
performed	O
for	O
mean	O
25	O
(	O
OH	O
)	O
D	O
including	O
independent	O
variables	O
significantly	O
associated	O
with	O
vitamin	O
D	O
levels	O
on	O
bivariate	O
analysis	O
or	O
known	O
to	O
influence	O
vitamin	O
D	O
status	O
.	O

We	O
evaluated	O
confounding	O
due	O
to	O
several	O
maternal	O
characteristics	O
.	O

Therefore	O
,	O
at	O
baseline	O
we	O
excluded	O
those	O
mothers	O
with	O
the	O
EPDS	O
scores	O
of	O
>	O
13	O
and	O
they	O
were	O
referred	O
to	O
a	O
psychologist	O
for	O
further	O
evaluation	O
and	O
management	O
.	O

The	O
most	O
common	O
indications	O
for	O
psychotropic	O
medication	O
use	O
were	O
bipolar	O
disorder	O
(	O
36	O
.	O
8	O
%),	O
depression	O
(	O
27	O
.	O
1	O
%),	O
anxiety	O
and	O
depression	O
(	O
9	O
.	O
8	O
%)	O
and	O
sleep	O
disorders	O
(	O
9	O
.	O
8	O
%).	O

Electronic	O
supplementary	O
material	O
The	O
online	O
version	O
of	O
this	O
article	O
(	O
doi	O
:	O
10	O
.	O
1186	O
/	O
s12986	O
-	O
017	O
-	O
0203	O
-	O
5	O
)	O
contains	O
supplementary	O
material	O
,	O
which	O
is	O
available	O
to	O
authorized	O
users	O
.	O

When	O
a	O
woman	O
lactates	O
,	O
she	O
reduces	O
her	O
own	O
body	O
burden	O
of	O
certain	O
chemicals	O
by	O
transferring	O
them	O
to	O
her	O
nursing	O
child	O
via	O
milk	O
.	O

Thus	O
,	O
identifying	O
optimal	O
mHealth	O
dosages	O
could	O
have	O
potential	O
major	O
benefits	O
for	O
future	O
programs	O
in	O
terms	O
of	O
cost	O
effectiveness	O
and	O
outcomes	O
.	O

Herb	O
users	O
were	O
more	O
likely	O
to	O
be	O
high	O
school	O
graduates	O
,	O
identify	O
as	O
black	O
,	O
and	O
have	O
an	O
obstetrical	O
condition	O
.	O

Foods	O
high	O
in	O
N	O
-	O
nitroso	O
compounds	O
have	O
been	O
associated	O
with	O
an	O
increased	O
risk	O
for	O
brain	O
tumors	O
in	O
some	O
studies	O
[	O
162	O
–	O
165	O
].	O

Eligible	O
studies	O
included	O
those	O
of	O
healthy	O
pregnant	O
women	O
who	O
had	O
experienced	O
full	O
term	O
births	O
and	O
those	O
that	O
had	O
measured	O
fish	O
or	O
seafood	O
intake	O
and	O
assessed	O
neurodevelopmental	O
outcomes	O
in	O
offspring	O
.	O

A	O
detailed	O
description	O
of	O
the	O
study	O
methods	O
(	O
14	O
)	O
and	O
primary	O
findings	O
have	O
been	O
published	O
previously	O
(	O
7	O
).	O

Length	O
was	O
similar	O
between	O
Hispanic	O
and	O
Caucasians	O
,	O
50	O
.	O
3	O
±	O
2	O
.	O
1	O
cm	O
versus	O
50	O
.	O
5	O
±	O
2	O
.	O
0	O
cm	O
respectively	O
,	O
p	O
=	O
0	O
.	O
72	O
.	O

In	O
conclusion	O
,	O
common	O
genetic	O
variation	O
is	O
associated	O
with	O
baseline	O
25	O
(	O
OH	O
)	O
D	O
in	O
pregnancy	O
and	O
the	O
response	O
to	O
antenatal	O
supplementation	O
with	O
1000	O
IU	O
/	O
d	O
cholecalciferol	O
,	O
but	O
with	O
differing	O
SNPs	O
appearing	O
to	O
be	O
important	O
before	O
and	O
after	O
supplementation	O
.	O

This	O
association	O
persisted	O
in	O
multivariate	O
analysis	O
adjusting	O
for	O
maternal	O
age	O
,	O
BMI	O
,	O
smoking	O
status	O
,	O
physical	O
activity	O
,	O
educational	O
achievement	O
and	O
season	O
of	O
blood	O
sampling	O
[	O
β	O
=	O
3	O
.	O
1	O
nmol	O
/	O
L	O
per	O
T	O
allele	O
;	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
),	O
1	O
.	O
0	O
to	O
5	O
.	O
2	O
nmol	O
/	O
L	O
;	O
P	O
=	O
0	O
.	O
016	O
].	O

Therefore	O
,	O
the	O
high	O
concentration	O
of	O
C3	O
-	O
epi	O
-	O
25	O
(	O
OH	O
)	O
D	O
in	O
infants	O
may	O
explain	O
that	O
low	O
cord	O
—	O
but	O
not	O
maternal	O
—	O
serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
contribute	O
to	O
poor	O
lung	O
function	O
and	O
increased	O
risk	O
of	O
respiratory	O
infection	O
in	O
this	O
study	O
.	O

In	O
terms	O
of	O
seasonal	O
difference	O
,	O
during	O
autumn	O
,	O
the	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D2	O
level	O
in	O
the	O
group	O
who	O
took	O
Vitamin	O
D	O
supplements	O
was	O
significantly	O
higher	O
than	O
control	O
group	O
(	O
78	O
.	O
59	O
±	O
27	O
.	O
54	O
vs	O
46	O
.	O
18	O
±	O
18	O
.	O
77	O
nmol	O
/	O
L	O
,	O
p	O
=	O
0	O
.	O
045	O
).	O

However	O
,	O
in	O
a	O
recent	O
study	O
,	O
the	O
role	O
of	O
diabetes	O
during	O
gestation	O
on	O
such	O
adverse	O
long	O
-	O
term	O
metabolic	O
consequences	O
has	O
been	O
seriously	O
questioned	O
,	O
as	O
they	O
seem	O
to	O
relate	O
more	O
on	O
known	O
confounders	O
,	O
such	O
as	O
the	O
BMI	O
of	O
either	O
one	O
of	O
the	O
parents	O
(	O
Donovan	O
and	O
Cundy	O
,	O
2014	O
).	O

Interestingly	O
the	O
risk	O
for	O
severe	O
vitamin	O
D	O
deficiency	O
was	O
lower	O
among	O
women	O
who	O
reported	O
alcohol	O
consumption	O
during	O
pregnancy	O
.	O

Therapy	O
with	O
long	O
-	O
acting	O
somatostatin	O
analogues	O
has	O
been	O
tested	O
in	O
metastatic	O
disease	O
,	O
with	O
some	O
positive	O
benefots	O
in	O
most	O
patients	O
.	O

As	O
,	O
in	O
the	O
two	O
subgroups	O
,	O
the	O
depression	O
scores	O
were	O
not	O
significantly	O
lower	O
in	O
vitamin	O
D	O
group	O
compared	O
to	O
control	O
group	O
at	O
38	O
–	O
40	O
weeks	O
.	O

Future	O
studies	O
are	O
warranted	O
for	O
replication	O
and	O
should	O
evaluate	O
if	O
this	O
is	O
a	O
causal	O
relationship	O
.	O

Evidence	O
shows	O
that	O
postnatal	O
depression	O
is	O
an	O
extension	O
of	O
antenatal	O
depression	O
which	O
continues	O
postpartum	O
.	O

The	O
relative	O
quantification	O
method	O
was	O
performed	O
using	O
glyceraldehyde	O
-	O
3	O
-	O
phosphate	O
dehydrogenase	O
(	O
GAPDH	O
;	O
Cat	O
#	O
Rn99999916_s1	O
)	O
as	O
an	O
endogenous	O
control	O
,	O
which	O
was	O
selected	O
based	O
on	O
a	O
preliminary	O
screen	O
for	O
its	O
lowest	O
variation	O
.	O

Conclusions	O
Findings	O
from	O
the	O
current	O
study	O
indicate	O
that	O
excessive	O
GWG	O
and	O
mothers	O
'	O
eating	O
behaviors	O
during	O
pregnancy	O
,	O
especially	O
intake	O
of	O
sweets	O
in	O
overweight	O
/	O
obese	O
mothers	O
,	O
may	O
influence	O
offspring	O
weight	O
status	O
early	O
in	O
infancy	O
.	O

Cord	O
blood	O
25	O
(	O
OH	O
)	O
D	O
levels	O
were	O
analyzed	O
using	O
the	O
LIAISON	O
25	O
OH	O
Vitamin	O
D	O
assay	O
(	O
DiaSorin	O
Inc	O
.,	O
Stillwater	O
,	O
MN	O
,	O
USA	O
).	O

Approximately	O
two	O
to	O
three	O
times	O
as	O
many	O
women	O
in	O
the	O
exposed	O
group	O
suffered	O
from	O
hypertension	O
,	O
gestational	O
diabetes	O
and	O
hypothyroidism	O
.	O

Furthermore	O
,	O
15	O
women	O
(	O
9	O
.	O
8	O
%)	O
had	O
insufficiency	O
(	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
of	O
20	O
–	O
29	O
ng	O
/	O
mL	O
).	O

The	O
researchers	O
found	O
that	O
prematurity	O
,	O
low	O
Apgar	O
scores	O
,	O
growth	O
restriction	O
,	O
or	O
macrosomia	O
,	O
and	O
if	O
the	O
mother	O
was	O
from	O
sub	O
-	O
Saharan	O
Africa	O
or	O
East	O
Asia	O
had	O
a	O
positive	O
correlation	O
with	O
autism	O
spectrum	O
disorders	O
[	O
9	O
].	O

Of	O
course	O
,	O
any	O
strategies	O
to	O
prolong	O
labour	O
,	O
including	O
delaying	O
caesarean	O
birth	O
,	O
must	O
be	O
evaluated	O
against	O
the	O
potential	O
risk	O
of	O
continued	O
exposure	O
of	O
woman	O
and	O
foetus	O
to	O
sub	O
-	O
optimal	O
conditions	O
that	O
may	O
result	O
in	O
harmful	O
effects	O
.	O

Given	O
that	O
this	O
is	O
the	O
first	O
study	O
to	O
be	O
conducted	O
among	O
pregnant	O
women	O
,	O
and	O
that	O
pre	O
-	O
pregnancy	O
BMI	O
may	O
reasonably	O
be	O
considered	O
a	O
confounder	O
or	O
a	O
covariate	O
along	O
the	O
causal	O
pathway	O
between	O
maternal	O
habitual	O
sleep	O
behaviors	O
and	O
GDM	O
,	O
we	O
were	O
careful	O
to	O
assess	O
the	O
potential	O
independent	O
contributions	O
of	O
the	O
sleep	O
variables	O
(	O
from	O
pre	O
-	O
pregnancy	O
BMI	O
).	O

Blood	O
was	O
collected	O
into	O
heparinised	O
Vacutainer	O
tubes	O
and	O
stored	O
on	O
ice	O
until	O
centrifugation	O
and	O
removal	O
of	O
plasma	O
for	O
analysis	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0006744	O
.	O
t002	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Description	O
of	O
early	O
life	O
nutrition	O
and	O
offspring	O
groups	O
.	O
Pre	O
-	O
pregnancyPregnancyLactationOffspring	O
Postnatal	O
DietGroup	O
(	O
sample	O
size	O
)	O
100	O
%	O
Control	O
DietControlCont	O
(	O
18	O
)	O
High	O
FatCont	O
+	O
HF	O
(	O
16	O
)	O
100	O
%	O
Control	O
Diet50	O
%	O
Control	O
Diet100	O
%	O
Control	O
DietControlUNP	O
(	O
14	O
)	O
High	O
FatUNP	O
+	O
HF	O
(	O
14	O
)	O
100	O
%	O
Control	O
Diet50	O
%	O
Control	O
DietControlUNL	O
(	O
12	O
)	O
High	O
FatUNL	O
+	O
HF	O
(	O
12	O
)	O
100	O
%	O
Control	O
Diet50	O
%	O
Control	O
DietControlUNPL	O
(	O
12	O
)	O
High	O
FatUNPL	O
+	O
HF	O
(	O
12	O
)	O
100	O
%	O
Control	O
Diet100	O
%	O
High	O
Fat	O
DietControlPLHF	O
(	O
16	O
)	O
High	O
FatPLHF	O
+	O
HF	O
(	O
16	O
)	O
100	O
%	O
High	O
Fat	O
DietControlMHF	O
(	O
16	O
)	O
High	O
FatMHF	O
+	O
HF	O
(	O
16	O
)	O
Estrous	O
Staging	O
in	O
Adult	O
Offspring	O
In	O
order	O
to	O
assess	O
stage	O
of	O
estrous	O
cycle	O
in	O
adult	O
offspring	O
,	O
vaginal	O
smears	O
were	O
collected	O
at	O
the	O
time	O
of	O
post	O
mortem	O
after	O
pentobarbitone	O
injection	O
prior	O
to	O
decapitation	O
.	O

Miners	O
then	O
transported	O
the	O
ore	O
to	O
a	O
mill	O
,	O
where	O
it	O
was	O
crushed	O
and	O
soaked	O
in	O
sulfuric	O
acid	O
to	O
extract	O
the	O
uranium	O
.	O
20More	O
chemicals	O
were	O
added	O
to	O
precipitate	O
out	O
the	O
uranium	O
,	O
leaving	O
behind	O
a	O
radioactive	O
slurry	O
.	O

However	O
,	O
at	O
adult	O
stage	O
a	O
diet	O
-	O
dependent	O
up	O
-	O
regulation	O
of	O
'	O
mTOR	O
signaling	O
'	O
in	O
LP	O
offspring	O
suggests	O
a	O
transcriptional	O
priority	O
for	O
cellular	O
growth	O
and	O
proliferation	O
.	O

Specifically	O
,	O
recommending	O
vitamin	O
D	O
supplementation	O
for	O
children	O
at	O
risk	O
of	O
dental	O
caries	O
may	O
result	O
in	O
a	O
decrease	O
in	O
the	O
overall	O
prevalence	O
of	O
S	O
-	O
ECC	O
and	O
,	O
ultimately	O
,	O
reduce	O
the	O
burden	O
on	O
pediatric	O
day	O
surgery	O
centres	O
.	O

Authors	O
’	O
contributions	O
All	O
authors	O
listed	O
have	O
contributed	O
sufficiently	O
to	O
the	O
project	O
to	O
be	O
included	O
as	O
authors	O
,	O
and	O
all	O
those	O
who	O
are	O
qualified	O
to	O
be	O
authors	O
are	O
listed	O
in	O
the	O
author	O
byline	O
.	O

Glucocorticoids	O
should	O
be	O
administered	O
early	O
to	O
patients	O
with	O
severe	O
anaphylaxis	O
.	O

Over	O
three	O
-	O
quarters	O
of	O
premature	O
babies	O
who	O
die	O
could	O
be	O
saved	O
if	O
basic	O
care	O
reached	O
them	O
and	O
their	O
mothers	O
.	O

No	O
interaction	O
between	O
diet	O
and	O
sex	O
was	O
detected	O
in	O
hypothalamus	O
,	O
but	O
it	O
was	O
found	O
in	O
the	O
gene	O
expression	O
of	O
Cnr1	O
and	O
Mgll	O
in	O
liver	O
,	O
and	O
Faah	O
,	O
Dagl	O
α	O
,	O
and	O
Dagl	O
β	O
in	O
PAT	O
(	O
TableS2	O
).	O

[	O
22	O
]	O
used	O
developmental	O
testing	O
carried	O
out	O
by	O
the	O
mother	O
and	O
thus	O
results	O
may	O
not	O
be	O
as	O
reliable	O
as	O
those	O
reported	O
by	O
other	O
studies	O
,	O
which	O
used	O
trained	O
professionals	O
.	O

Hypervitaminosis	O
D	O
is	O
thought	O
to	O
be	O
associated	O
with	O
a	O
rare	O
infant	O
disease	O
with	O
supravalvular	O
aortic	O
stenosis	O
,	O
elfin	O
facies	O
and	O
mental	O
retardation	O
.	O

In	O
2010	O
,	O
84	O
women	O
were	O
examined	O
during	O
IVF	O
.	O

The	O
high	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
in	O
Iran	O
was	O
showed	O
in	O
numerous	O
studies	O
.	O

A	O
maternal	O
diet	O
high	O
in	O
fat	O
also	O
causes	O
long	O
-	O
term	O
harm	O
to	O
the	O
offspring	O
.	O

The	O
mechanism	O
of	O
PTH	O
reduction	O
is	O
that	O
an	O
increased	O
serum	O
vitamin	O
D	O
leads	O
to	O
a	O
decrease	O
in	O
PTH	O
gene	O
translation	O
,	O
and	O
thus	O
PTH	O
secretion	O
.	O

There	O
is	O
no	B
universal	O-
standard	I
for	O
which	O
neurodevelopmental	O
tests	O
are	O
most	O
appropriate	O
for	O
use	O
in	O
children	O
of	O
varying	O
ages	O
and	O
at	O
what	O
age	O
meaningful	O
differences	O
in	O
neurocognitive	O
development	O
can	O
be	O
detected	O
[	O
29	O
].	O

Limitations	O
Vitamin	O
D	O
consumption	O
by	O
mothers	O
was	O
merely	O
controlled	O
through	O
reminders	O
during	O
prenatal	O
care	O
visits	O
or	O
over	O
the	O
phone	O
.	O

Introduction	O
The	O
fifth	O
Millennium	O
Development	O
Goal	O
(	O
MDG	O
),	O
“	O
Improvement	O
of	O
Maternal	O
Health	O
”	O
[	O
1	O
]	O
has	O
Antenatal	O
Care	O
(	O
ANC	O
)	O
coverage	O
or	O
attendance	O
as	O
a	O
progress	O
indicator	O
.	O

Wistar	O
rats	O
(	O
age	O
100	O
±	O
5	O
days	O
)	O
were	O
time	O
mated	O
using	O
a	O
rat	O
estrous	O
cycle	O
monitor	O
to	O
assess	O
the	O
stage	O
of	O
estrous	O
before	O
introducing	O
the	O
male	O
.	O

While	O
it	O
has	O
been	O
suggested	O
that	O
body	O
fat	O
and	O
therefore	O
childhood	O
nutrition	O
per	O
se	O
play	O
a	O
direct	O
role	O
in	O
determining	O
the	O
age	O
of	O
pubertal	O
onset	O
[	O
36	O
],[	O
37	O
],	O
the	O
effects	O
of	O
an	O
intrauterine	O
obesogenic	O
environment	O
have	B
not	I
been	I
considered	I
.	O

Prevention	O
strategies	O
for	O
iron	O
deficiency	O
and	O
maternal	O
anaemia	O
include	O
nutritional	O
education	O
,	O
promoting	O
the	O
intake	O
of	O
iron	O
and	O
folic	O
acid	O
supplements	O
,	O
and	O
food	O
fortification	O
[	O
13	O
].	O

Two	O
key	O
global	O
epigenetic	O
re	O
-	O
programing	O
and	O
programing	O
events	O
occur	O
,	O
one	O
after	O
fertilization	O
in	O
the	O
early	O
embryo	O
in	O
all	O
cells	O
,	O
and	O
the	O
second	O
in	O
germ	O
cells	O
only	O
during	O
primordial	O
germ	O
cell	O
(	O
PGC	O
)	O
development	O
(	O
Figure	O
1	O
).	O

Our	O
present	O
findings	O
indicate	O
a	O
reduction	O
in	O
activity	O
of	O
the	O
parasympathetic	O
ANS	O
associated	O
with	O
low	O
birth	O
weight	O
.	O

Of	O
note	O
is	O
that	O
in	O
that	O
study	O
,	O
about	O
10	O
%	O
of	O
infants	O
with	O
these	O
very	O
low	O
25	O
(	O
OH	O
)	O
D	O
levels	O
had	O
evidence	O
of	O
hypocalcemia	O
although	O
none	O
had	O
physical	O
symptoms	O
and	O
it	O
is	O
not	B
clear	I
if	O
there	O
was	O
a	O
true	O
cause	O
and	O
effect	O
in	O
this	O
group	O
.	O

Epidemiological	O
studies	O
have	O
shown	O
that	O
VD	O
deficiency	O
increases	O
not	O
only	O
infertility	O
rate	O
but	O
also	O
the	O
risk	O
of	O
serious	O
pregnancy	O
complications	O
,	O
such	O
as	O
preeclampsia	O
and	O
preterm	O
birth	O
[	O
64	O
].	O

Class	O
9	O
,	O
which	O
was	O
associated	O
with	O
AluYb8	O
methylation	O
extent	O
,	O
contained	O
a	O
high	O
proportion	O
of	O
CpG	O
loci	O
located	O
within	O
CGIs	O
(	O
81	O
%)	O
and	O
whose	O
genes	O
are	O
considered	O
PcG	O
target	O
genes	O
(	O
32	O
%).	O

The	O
authors	O
of	O
the	O
study	O
suggest	O
a	O
direct	O
effect	O
of	O
vitamin	O
D	O
on	O
AMH	O
production	O
,	O
and	O
thus	O
longer	O
maintenance	O
of	O
ovarian	O
reserve	O
in	O
the	O
patients	O
with	O
its	O
higher	O
concentration	O
[	O
46	O
].	O

Methods	O
Study	O
population	O
Women	O
aged	O
30	O
-	O
49	O
years	O
,	O
residing	O
in	O
the	O
Uppsala	O
Health	O
Care	O
Region	O
in	O
Sweden	O
during	O
1991	O
and	O
1992	O
,	O
form	O
the	O
source	O
population	O
for	O
this	O
study	O
.	O

Fine	O
needle	O
aspiration	O
shows	O
a	O
mixture	O
of	O
round	O
,	O
polyhedral	O
and	O
spindle	O
-	O
shaped	O
cells	O
that	O
may	O
seem	O
undifferentiated	O
,	O
and	O
look	O
like	O
a	O
variable	O
amount	O
of	O
extra	O
-	O
cellular	O
amyloid	O
.	O

Of	O
PNV	O
users	O
,	O
477	O
(	O
62	O
.	O
5	O
%)	O
reported	O
use	O
before	O
and	O
after	O
pregnancy	O
diagnosis	O
,	O
238	O
(	O
31	O
.	O
2	O
%)	O
reported	O
use	O
only	O
after	O
pregnancy	O
was	O
diagnosed	O
,	O
and	O
just	O
48	O
(	O
6	O
.	O
3	O
%)	O
of	O
women	O
reported	O
using	O
PNVs	O
prior	O
to	O
pregnancy	O
but	O
discontinuing	O
PNV	O
use	O
after	O
diagnosis	O
of	O
pregnancy	O
.	O

Furthermore	O
,	O
studies	O
have	O
focussed	O
predominantly	O
on	O
measures	O
of	O
adiposity	O
,	O
and	O
have	O
not	O
reported	O
other	O
clinically	O
relevant	O
infant	O
outcomes	O
[	O
18	O
,	O
20	O
],	O
or	O
specifically	O
reported	O
infant	O
outcomes	O
among	O
women	O
who	O
are	O
overweight	O
or	O
obese	O
[	O
19	O
].	O

The	O
participants	O
were	O
in	O
the	O
third	O
trimester	O
of	O
their	O
pregnancy	O
.	O

Epigenetic	O
modifications	O
have	O
been	O
suggested	O
to	O
occur	O
during	O
development	O
(	O
fetal	O
programming	O
),	O
growth	O
,	O
and	O
fat	O
deposition	O
in	O
cattle	O
[	O
13	O
,	O
18	O
,	O
159	O
].	O

PNV	O
use	O
was	O
ascertained	O
by	O
questionnaire	O
that	O
asked	O
women	O
,	O
“	O
Prior	O
to	O
pregnancy	O
,	O
did	O
you	O
take	O
a	O
multivitamin	O
?”	O
and	O
“	O
Since	O
getting	O
pregnant	O
have	O
you	O
taken	O
a	O
multivitamin	O
?”	O
We	O
categorized	O
women	O
as	O
PNV	O
users	O
if	O
they	O
reported	O
any	O
PNV	O
use	O
.	O

Considering	O
that	O
reports	O
that	O
polytherapy	O
do	O
not	O
commonly	O
alter	O
the	O
course	O
and	O
outcome	O
of	O
the	O
baseline	O
disorder	O
,	O
2224indications	O
for	O
polytherapy	O
in	O
pregnant	O
women	O
should	O
be	O
seriously	O
considered	O
and	O
made	O
on	O
an	O
individual	O
basis	O
following	O
a	O
thorough	O
risk	O
/	O
benefit	O
analysis	O
.	O

The	O
data	O
the	O
team	O
amassed	O
over	O
the	O
last	O
13	O
years	O
suggests	O
that	O
health	O
problems	O
from	O
these	O
mines	O
in	O
fact	O
aren	O
’	O
t	O
limited	O
to	O
the	O
miners	O
who	O
worked	O
in	O
them	O
but	O
also	O
extend	O
to	O
those	O
exposed	O
through	O
drinking	O
water	O
or	O
simply	O
living	O
near	O
a	O
mine	O
.	O

“	O
We	O
didn	B
’	I
t	I
know	I
what	O
it	O
is	O
.	O

Birth	O
outcome	O
data	O
were	O
defined	O
and	O
calculated	O
as	O
follows	O
:	O
(	O
1	O
)	O
gestational	O
age	O
at	O
delivery	O
was	O
calculated	O
using	O
LMP	O
,	O
if	O
available	O
,	O
or	O
gestational	O
age	O
at	O
any	O
ultrasound	O
obtained	O
from	O
antenatal	O
medical	O
records	O
(	O
seeSupplementary	O
material	O
A1for	O
gestational	O
age	O
calculation	O
algorithm	O
);	O
(	O
2	O
)	O
small	O
for	O
gestational	O
age	O
(	O
SGA	O
)	O
was	O
calculated	O
from	O
weight	O
and	O
gestational	O
age	O
at	O
delivery	O
according	O
to	O
the	O
International	O
Fetal	O
and	O
Newborn	O
Growth	O
Consortium	O
for	O
the	O
21st	O
Century	O
,	O
or	O
intergrowth	O
-	O
21st	O
standards	O
[	O
36	O
];	O
(	O
3	O
)	O
preterm	O
birth	O
(	O
PTB	O
)	O
was	O
defined	O
as	O
born	O
with	O
<	O
37	O
weeks	O
of	O
gestational	O
age	O
;	O
and	O
(	O
4	O
)	O
low	O
birth	O
weight	O
(	O
LBW	O
)	O
was	O
defined	O
as	O
born	O
weighing	O
<	O
2500	O
g	O
.	O
Statistical	O
analysis	O
We	O
compared	O
all	O
variables	O
by	O
vaccination	O
status	O
using	O
chi	O
-	O
square	O
test	O
to	O
compare	O
differences	O
between	O
vaccinated	O
and	O
unvaccinated	O
women	O
regardless	O
of	O
trimester	O
of	O
receipt	O
of	O
influenza	O
vaccination	O
.	O

Discussion	O
This	O
study	O
demonstrates	O
that	O
the	O
maternal	O
exposure	O
to	O
a	O
moderate	O
(	O
20	O
%)	O
caloric	O
restriction	O
(	O
undernutrition	O
)	O
during	O
preconceptional	O
(	O
2	O
weeks	O
)	O
and	O
gestational	O
(	O
up	O
2	O
days	O
before	O
birth	O
)	O
periods	O
produced	O
long	O
-	O
term	O
effects	O
on	O
body	O
weight	O
,	O
feeding	O
behavior	O
and	O
gene	O
expression	O
of	O
key	O
components	O
of	O
the	O
ECS	O
(	O
receptors	O
and	O
enzymes	O
)	O
in	O
a	O
sex	O
-	O
dependent	O
manner	O
.	O

These	O
metabolites	O
were	O
not	O
,	O
however	O
,	O
included	O
in	O
the	O
regression	O
models	O
as	O
they	O
were	O
strongly	O
correlated	O
with	O
25	O
(	O
OH	O
)	O
D	O
levels	O
.	O

Exclusion	O
criteria	O
were	O
avoiding	O
of	O
follow	O
-	O
up	O
during	O
the	O
study	O
and	O
current	O
-	O
smoker	O
women	O
.	O

GDM	O
was	O
diagnosed	O
in	O
11	O
%	O
of	O
mothers	O
in	O
our	O
cohort	O
.	O

It	O
could	O
be	O
argued	O
that	O
as	O
routine	O
prenatal	O
care	O
in	O
Romania	O
does	O
not	O
usually	O
begin	O
until	O
after	O
the	O
first	O
trimester	O
is	O
almost	O
ended	O
,	O
including	O
advice	O
about	O
folic	O
acid	O
as	O
part	O
of	O
prenatal	O
care	O
is	O
redundant	O
as	O
the	O
neural	O
tube	O
has	O
fully	O
developed	O
within	O
28	O
days	O
of	O
conception	O
[	O
9	O
].	O

Dietary	O
energy	O
and	O
protein	O
levels	O
Studies	O
in	O
pigs	O
indicate	O
that	O
a	O
deficiency	O
of	O
essential	O
amino	O
acids	O
such	O
as	O
lysine	O
increases	O
IMF	O
content	O
[	O
123	O
,	O
124	O
],	O
and	O
it	O
has	O
been	O
suggested	O
that	O
an	O
amino	O
acid	O
imbalance	O
relative	O
to	O
energy	O
levels	O
may	O
increase	O
IMF	O
content	O
in	O
cattle	O
(	O
reviewed	O
in	O
Pethick	O
et	O
al	O
[	O
69	O
]).	O

Vitamin	O
D2	O
was	O
not	O
detected	O
among	O
participants	O
without	O
Vitamin	O
D	O
supplement	O
use	O
in	O
this	O
study	O
.	O

During	O
lactation	O
,	O
all	O
dams	O
were	O
fed	O
the	O
RV	O
diet	O
.	O

The	O
risk	O
was	O
four	O
-	O
fold	O
higher	O
in	O
women	O
with	O
serum	O
25	O
(	O
OH	O
)	O
D	O
levels	O
below	O
37	O
.	O
5	O
nmol	O
/	O
L	O
(	O
15ng	O
/	O
mL	O
)	O
controlling	O
for	O
multiple	O
confounding	O
factors	O
.	O

There	O
are	O
some	O
potentially	O
interesting	O
differences	O
in	O
the	O
impact	O
of	O
DEP	O
and	O
DMP	O
on	O
birth	O
weight	O
when	O
the	O
study	O
sample	O
is	O
stratified	O
by	O
infant	O
sex	O
.	O

The	O
existing	O
literature	O
on	O
pregnancy	O
outcomes	O
following	O
exposure	O
to	O
FGAs	O
has	O
not	O
shown	O
a	O
significantly	O
increased	O
risk	O
for	O
malformations	O
above	O
the	O
baseline	O
incidence	O
.	O

In	O
particular	O
,	O
the	O
degradation	O
of	O
essential	O
,	O
branch	O
-	O
chained	O
amino	O
acids	O
like	O
valine	O
,	O
leucine	O
and	O
isoleucine	O
was	O
found	O
to	O
be	O
regulated	O
,	O
which	O
may	O
illustrate	O
the	O
LP	O
offspring	O
'	O
s	O
efforts	O
to	O
mimic	O
prenatal	O
experiences	O
in	O
terms	O
of	O
dietary	O
supply	O
during	O
postnatal	O
development	O
in	O
the	O
face	O
of	O
richer	O
conditions	O
.	O

Folate	O
Status	O
Both	O
brain	O
(	O
Figure	O
6a	O
)	O
and	O
plasma	O
(	O
Figure	O
6b	O
)	O
folate	O
levels	O
were	O
unaffected	O
by	O
the	O
diets	O
of	O
the	O
dams	O
but	O
were	O
elevated	O
by	O
the	O
high	O
multivitamin	O
or	O
high	O
folate	O
pup	O
diet	O
.	O

Artificial	O
Insemination	O
and	O
Fertility	O
Medications	O
There	O
is	O
an	O
increase	O
in	O
prevalence	O
in	O
the	O
number	O
of	O
women	O
utilizing	O
fertility	O
measures	O
,	O
thus	O
calling	O
for	O
studies	O
to	O
determine	O
the	O
association	O
between	O
assisted	O
reproductive	O
therapy	O
and	O
neurodevelopmental	O
complications	O
,	O
and	O
more	O
specifically	O
autism	O
.	O

Pregnancy	O
itself	O
may	O
also	O
affect	O
the	O
course	O
of	O
asthma	O
and	O
other	O
diseases	O
[	O
10	O
].	O

In	O
the	O
current	O
study	O
the	O
birth	O
weight	O
explained	O
15	O
%	O
of	O
the	O
variance	O
in	O
RMSSD	O
index	O
(	O
R2	O
=	O
0	O
.	O
15	O
)	O
(	O
Table	O
2	O
).	O

Briefly	O
,	O
we	O
conducted	O
a	O
multicentre	O
randomised	O
trial	O
involving	O
women	O
with	O
a	O
singleton	O
pregnancy	O
,	O
between	O
10	O
+	O
0and	O
20	O
+	O
0weeks	O
’	O
gestation	O
,	O
and	O
body	O
mass	O
index	O
≥	O
25	O
.	O
0	O
kg	O
/	O
m2	O
,	O
who	O
were	O
randomised	O
to	O
either	O
an	O
antenatal	O
dietary	O
and	O
lifestyle	O
intervention	O
(	O
Lifestyle	O
Advice	O
Group	O
)	O
or	O
standard	O
antenatal	O
care	O
(	O
Standard	O
Care	O
Group	O
)	O
[	O
22	O
].	O

In	O
this	O
way	O
free	O
sugar	O
intake	O
was	O
estimated	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
5	O
Arachnodactyly	O
and	O
kinked	O
tail	O
in	O
skeletal	O
morphology	O
mutant	O
1	O
(	O
Skm1	O
).	O

The	O
rats	O
were	O
fasted	O
overnight	O
for	O
10	O
h	O
before	O
glucose	O
gavage	O
.	O

The	O
lack	O
of	O
a	O
relation	O
with	O
maternal	O
diabetes	O
would	O
suggest	O
that	O
higher	O
fetal	O
exposure	O
to	O
glucose	O
is	O
unlikely	O
to	O
explain	O
our	O
main	O
findings	O
.	O

Similarly	O
,	O
greater	O
consumption	O
of	O
sweets	O
early	O
in	O
pregnancy	O
was	O
significantly	O
related	O
to	O
higher	O
odds	O
of	O
macrosomia	O
(	O
OR	O
=	O
1	O
.	O
1	O
(	O
1	O
.	O
0	O
,	O
1	O
.	O
2	O
);	O
P	O
=	O
0	O
.	O
004	O
)	O
and	O
WFA	O
>	O
90th	O
percentile	O
at	O
birth	O
(	O
OR	O
=	O
1	O
.	O
2	O
(	O
1	O
.	O
1	O
,	O
1	O
.	O
3	O
);	O
P	O
=	O
0	O
.	O
002	O
).	O

Maternal	O
Disease	O
In	O
addition	O
to	O
environmental	O
factors	O
,	O
infection	O
and	O
disease	O
may	O
play	O
a	O
role	O
in	O
the	O
development	O
of	O
autism	O
.	O

Bonferrroni	O
post	O
-	O
hoc	O
test	O
:*/**/***	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
/	O
0	O
.	O
001	O
vs	O
.	O
CC	O
males	O
;#/##/###	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
/	O
0	O
.	O
001	O
vs	O
.	O
CC	O
females	O
;$	O
P	O
<	O
0	O
.	O
05	O
vs	O
.	O
RC	O
males	O
.	O

Ethics	O
statement	O
The	O
Institutional	O
Review	O
Board	O
at	O
the	O
Nicaraguan	O
Ministry	O
of	O
Health	O
reviewed	O
and	O
approved	O
the	O
protocol	O
.	O

Examinations	O
of	O
infant	O
lung	O
function	O
were	O
successfully	O
performed	O
for	O
71	O
infants	O
at	O
6	O
months	O
of	O
age	O
.	O

There	O
was	O
a	O
significant	O
difference	O
in	O
the	O
frequency	O
of	O
subjects	O
suffering	O
from	O
vitamin	O
deficiency	O
before	O
and	O
after	O
the	O
intervention	O
in	O
the	O
IG	O
,	O
whereas	O
no	O
significant	O
difference	O
was	O
found	O
between	O
these	O
values	O
in	O
the	O
CG	O
.	O

The	O
increase	O
in	O
haemoglobin	O
concentration	O
in	O
the	O
intervention	O
group	O
relative	O
to	O
placebo	O
was	O
more	O
marked	O
in	O
women	O
who	O
were	O
anaemic	O
at	O
the	O
start	O
of	O
the	O
study	O
(	O
Figure	O
2	O
).	O

A	O
breakdown	O
of	O
unit	O
costs	O
is	O
shown	O
inTable	O
2	O
.	O

Although	O
previous	O
small	O
surveys	O
suggest	O
that	O
vitamin	O
D	O
deficiency	O
among	O
pregnant	O
women	O
is	O
common	O
in	O
Europe	O
[	O
29	O
],[	O
30	O
],	O
there	O
are	O
no	O
reliable	O
country	O
-	O
wide	O
estimates	O
of	O
vitamin	O
D	O
status	O
of	O
pregnant	O
women	O
in	O
European	O
countries	O
.	O

Iron	O
deficiency	O
is	O
not	O
only	O
the	O
most	O
prevalent	O
but	O
also	O
the	O
most	O
neglected	O
nutrient	O
deficiency	O
in	O
the	O
world	O
,	O
particularly	O
among	O
pregnant	O
women	O
and	O
children	O
in	O
developing	O
countries	O
[	O
7	O
].	O

Fourth	O
,	O
our	O
study	O
includes	O
both	O
persistent	O
and	O
non	O
-	O
persistent	O
EDCs	O
when	O
examining	O
EDC	O
exposure	O
.	O

The	O
cost	O
per	O
woman	O
treated	O
(	O
defined	O
as	O
consuming	O
at	O
least	O
75	O
%	O
of	O
the	O
recommended	O
intake	O
)	O
was	O
USD0	O
.	O
76	O
per	O
annum	O
.	O

Further	O
adjustment	O
for	O
maternal	O
age	O
,	O
education	O
,	O
smoking	O
status	O
,	O
BMI	O
and	O
race	O
/	O
ethnicity	O
race	O
/	O
ethnicity	O
attenuated	O
these	O
estimates	O
but	O
women	O
reporting	O
no	O
PNV	O
use	O
still	O
had	O
significantly	O
higher	O
odds	O
of	O
25	O
(	O
OH	O
)	O
D	O
levels	O
<	O
50	O
(	O
OR	O
2	O
.	O
1	O
,	O
95	O
%	O
CI	O
1	O
.	O
5	O
,	O
3	O
.	O
0	O
).	O

The	O
seven	O
constituencies	O
,	O
as	O
identified	O
by	O
Every	O
Woman	O
Every	O
Child	O
[	O
7	O
],	O
have	O
four	O
action	O
themes	O
,	O
which	O
link	O
closely	O
to	O
the	O
principles	O
of	O
Act	O
,	O
Monitor	O
and	O
Review	O
recommended	O
by	O
the	O
Commission	O
on	O
Information	O
and	O
Accountability	O
for	O
Women	O
'	O
s	O
and	O
Children	O
'	O
s	O
Health	O
.	O

We	O
will	O
identify	O
any	O
such	O
program	O
by	O
contacting	O
local	O
officials	O
in	O
the	O
sub	O
-	O
districts	O
in	O
the	O
Dhaka	O
Division	O
.	O

Developmental	O
Perspectives	O
on	O
Nutrition	O
and	O
Obesity	O
From	O
Gestation	O
to	O
Adolescence	O
Abstract	O
:	O
KEY	O
-	O
POINTS	O
Obesity	O
results	O
from	O
a	O
complex	O
combination	O
of	O
factors	O
that	O
act	O
at	O
many	O
stages	O
throughout	O
a	O
person	O
'	O
s	O
life	O
.	O

Congenital	O
spine	O
deformities	O
occur	O
with	O
an	O
approximate	O
frequency	O
of	O
0	O
.	O
5	O
–	O
1	O
per	O
1000	O
live	O
births	O
(	O
Sparrow	O
et	O
al	O
.	O

Quartiles	O
,	O
based	O
on	O
the	O
distribution	O
amongst	O
the	O
population	O
of	O
women	O
studied	O
,	O
in	O
the	O
standardised	O
concentrations	O
were	O
then	O
used	O
to	O
create	O
cut	O
-	O
points	O
and	O
designated	O
‘	O
low	O
’	O
(<	O
44	O
nmol	O
/	O
L	O
),	O
‘	O
low	O
-	O
moderate	O
’	O
(	O
44	O
–	O
63	O
nmol	O
/	O
L	O
),	O
‘	O
moderate	O
-	O
high	O
’	O
(	O
63	O
–	O
81	O
nmol	O
/	O
L	O
)	O
and	O
‘	O
high	O
’	O
(>	O
81	O
nmol	O
/	O
L	O
)	O
categories	O
of	O
serum	O
25	O
(	O
OH	O
)	O
D	O
.	O
Generalised	O
linear	O
models	O
(	O
Poisson	O
with	O
log	O
link	O
and	O
robust	O
variance	O
estimates	O
)	O
were	O
used	O
to	O
calculate	O
the	O
risk	O
ratios	O
for	O
pregnancy	O
complications	O
by	O
standardised	O
serum	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
calculated	O
among	O
the	O
women	O
who	O
had	O
an	O
uncomplicated	O
pregnancy	O
.	O

The	O
experiment	O
comprises	O
a	O
valuable	O
model	O
especially	O
for	O
'	O
fetal	O
'	O
programming	O
,	O
because	O
cross	O
-	O
fostering	O
enabled	O
assessment	O
of	O
solely	O
the	O
nutritional	O
effects	O
during	O
gestation	O
.	O

[	O
24	O
]	O
and	O
Hibbeln	O
et	O
al	O
.	O

Program	O
cost	O
data	O
for	O
these	O
latter	O
two	O
interventions	O
are	O
almost	O
non	B
-	I
existent	I
.	O

Note	O
that	O
values	O
in	O
ng	O
/	O
mL	O
can	O
be	O
converted	O
to	O
nmol	O
/	O
L	O
by	O
multiplying	O
by	O
2	O
.	O
5	O
.	O

Additional	O
epigenetic	O
mechanisms	O
are	O
likely	O
to	O
be	O
elucidated	O
as	O
research	O
continues	O
.	O

(	O
DOCX	O
15	O
kb	O
)	O
PubMed	O
Central	O
:	O

At	O
the	O
completion	O
of	O
the	O
amplification	O
protocol	O
,	O
all	O
samples	O
were	O
subjected	O
to	O
melting	O
curve	O
analyses	O
and	O
gel	O
electrophoresis	O
to	O
verify	O
the	O
absence	O
of	O
any	O
non	O
-	O
specific	O
product	O
.	O

Detailed	O
descriptions	O
of	O
the	O
recruitment	O
and	O
data	O
collection	O
have	O
been	O
reported	O
previously	O
[	O
17	O
,	O
18	O
].	O

To	O
complete	O
the	O
network	O
,	O
DNA	O
/	O
RNA	O
binding	O
and	O
modifying	O
proteins	O
can	O
both	O
inhibit	O
or	O
promote	O
gene	O
expression	O
whilst	O
their	O
own	O
expression	O
is	O
under	O
the	O
control	O
of	O
the	O
DNA	O
modifications	O
and	O
ncRNAs	O
they	O
promote	O
and	O
/	O
or	O
interact	O
with	O
.	O

Still	O
,	O
the	O
finding	O
that	O
only	O
39	O
%	O
of	O
households	O
in	O
the	O
intervention	O
were	O
found	O
to	O
have	O
soap	O
and	O
water	O
at	O
a	O
handwashing	O
place	O
at	O
all	O
five	O
of	O
the	O
rapid	O
observations	O
suggests	O
that	O
maintaining	O
handwashing	O
materials	O
at	O
fixed	O
locations	O
at	O
all	O
times	O
was	O
difficult	O
in	O
the	O
newborn	O
period	O
,	O
that	O
such	O
maintenance	O
had	O
not	O
become	O
habitual	O
,	O
or	O
that	O
this	O
approach	O
to	O
handwashing	O
was	O
not	O
acceptable	O
to	O
our	O
study	O
population	O
.	O

Of	O
these	O
,	O
55	O
%	O
had	O
received	O
influenza	O
vaccination	O
in	O
2014	O
.	O

